National;Autonomous Communities and Cities;Cause of death (chapters from the 10th revision of the CIE);Sex;Type of indicator;Total
Total;;All causes;Both sexes;Number of PLYL;2,333,109.00
Total;;All causes;Both sexes;Distribution by chapter of the CIE;100.00
Total;;All causes;Both sexes;Standardised rate of PLYL;51.92
Total;;All causes;Both sexes;Average number of PLYL;14.02
Total;;All causes;Males;Number of PLYL;1,589,919.50
Total;;All causes;Males;Distribution by chapter of the CIE;100.00
Total;;All causes;Males;Standardised rate of PLYL;70.79
Total;;All causes;Males;Average number of PLYL;14.59
Total;;All causes;Females;Number of PLYL;743,189.50
Total;;All causes;Females;Distribution by chapter of the CIE;100.00
Total;;All causes;Females;Standardised rate of PLYL;33.01
Total;;All causes;Females;Average number of PLYL;12.93
Total;;Infectious and parasitic diseases (1);Both sexes;Number of PLYL;67,201.00
Total;;Infectious and parasitic diseases (1);Both sexes;Distribution by chapter of the CIE;2.88
Total;;Infectious and parasitic diseases (1);Both sexes;Standardised rate of PLYL;1.41
Total;;Infectious and parasitic diseases (1);Both sexes;Average number of PLYL;19.64
Total;;Infectious and parasitic diseases (1);Males;Number of PLYL;48,923.00
Total;;Infectious and parasitic diseases (1);Males;Distribution by chapter of the CIE;3.08
Total;;Infectious and parasitic diseases (1);Males;Standardised rate of PLYL;2.03
Total;;Infectious and parasitic diseases (1);Males;Average number of PLYL;21.68
Total;;Infectious and parasitic diseases (1);Females;Number of PLYL;18,278.00
Total;;Infectious and parasitic diseases (1);Females;Distribution by chapter of the CIE;2.46
Total;;Infectious and parasitic diseases (1);Females;Standardised rate of PLYL;0.79
Total;;Infectious and parasitic diseases (1);Females;Average number of PLYL;15.69
Total;;Tumours;Both sexes;Number of PLYL;976,900.50
Total;;Tumours;Both sexes;Distribution by chapter of the CIE;41.87
Total;;Tumours;Both sexes;Standardised rate of PLYL;21.57
Total;;Tumours;Both sexes;Average number of PLYL;14.06
Total;;Tumours;Males;Number of PLYL;613,931.50
Total;;Tumours;Males;Distribution by chapter of the CIE;38.61
Total;;Tumours;Males;Standardised rate of PLYL;27.29
Total;;Tumours;Males;Average number of PLYL;13.56
Total;;Tumours;Females;Number of PLYL;362,969.00
Total;;Tumours;Females;Distribution by chapter of the CIE;48.84
Total;;Tumours;Females;Standardised rate of PLYL;15.84
Total;;Tumours;Females;Average number of PLYL;15.00
Total;;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Number of PLYL;8,490.00
Total;;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Distribution by chapter of the CIE;0.36
Total;;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Standardised rate of PLYL;0.19
Total;;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Average number of PLYL;16.02
Total;;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Number of PLYL;5,244.00
Total;;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Distribution by chapter of the CIE;0.33
Total;;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Standardised rate of PLYL;0.23
Total;;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Average number of PLYL;17.54
Total;;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Number of PLYL;3,246.00
Total;;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Distribution by chapter of the CIE;0.44
Total;;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Standardised rate of PLYL;0.15
Total;;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Average number of PLYL;14.05
Total;;Endocrine, nutritional and metabolic diseases;Both sexes;Number of PLYL;50,893.00
Total;;Endocrine, nutritional and metabolic diseases;Both sexes;Distribution by chapter of the CIE;2.18
Total;;Endocrine, nutritional and metabolic diseases;Both sexes;Standardised rate of PLYL;1.16
Total;;Endocrine, nutritional and metabolic diseases;Both sexes;Average number of PLYL;10.62
Total;;Endocrine, nutritional and metabolic diseases;Males;Number of PLYL;31,026.50
Total;;Endocrine, nutritional and metabolic diseases;Males;Distribution by chapter of the CIE;1.95
Total;;Endocrine, nutritional and metabolic diseases;Males;Standardised rate of PLYL;1.41
Total;;Endocrine, nutritional and metabolic diseases;Males;Average number of PLYL;11.73
Total;;Endocrine, nutritional and metabolic diseases;Females;Number of PLYL;19,866.50
Total;;Endocrine, nutritional and metabolic diseases;Females;Distribution by chapter of the CIE;2.67
Total;;Endocrine, nutritional and metabolic diseases;Females;Standardised rate of PLYL;0.91
Total;;Endocrine, nutritional and metabolic diseases;Females;Average number of PLYL;9.25
Total;;Mental and behavioural disorders;Both sexes;Number of PLYL;21,102.50
Total;;Mental and behavioural disorders;Both sexes;Distribution by chapter of the CIE;0.90
Total;;Mental and behavioural disorders;Both sexes;Standardised rate of PLYL;0.47
Total;;Mental and behavioural disorders;Both sexes;Average number of PLYL;9.05
Total;;Mental and behavioural disorders;Males;Number of PLYL;14,142.50
Total;;Mental and behavioural disorders;Males;Distribution by chapter of the CIE;0.89
Total;;Mental and behavioural disorders;Males;Standardised rate of PLYL;0.62
Total;;Mental and behavioural disorders;Males;Average number of PLYL;10.61
Total;;Mental and behavioural disorders;Females;Number of PLYL;6,960.00
Total;;Mental and behavioural disorders;Females;Distribution by chapter of the CIE;0.94
Total;;Mental and behavioural disorders;Females;Standardised rate of PLYL;0.32
Total;;Mental and behavioural disorders;Females;Average number of PLYL;6.97
Total;;Diseases of the nervous system and the sense organs;Both sexes;Number of PLYL;74,215.50
Total;;Diseases of the nervous system and the sense organs;Both sexes;Distribution by chapter of the CIE;3.18
Total;;Diseases of the nervous system and the sense organs;Both sexes;Standardised rate of PLYL;1.70
Total;;Diseases of the nervous system and the sense organs;Both sexes;Average number of PLYL;11.99
Total;;Diseases of the nervous system and the sense organs;Males;Number of PLYL;43,652.00
Total;;Diseases of the nervous system and the sense organs;Males;Distribution by chapter of the CIE;2.75
Total;;Diseases of the nervous system and the sense organs;Males;Standardised rate of PLYL;2.01
Total;;Diseases of the nervous system and the sense organs;Males;Average number of PLYL;13.39
Total;;Diseases of the nervous system and the sense organs;Females;Number of PLYL;30,563.50
Total;;Diseases of the nervous system and the sense organs;Females;Distribution by chapter of the CIE;4.11
Total;;Diseases of the nervous system and the sense organs;Females;Standardised rate of PLYL;1.40
Total;;Diseases of the nervous system and the sense organs;Females;Average number of PLYL;10.43
Total;;Diseases of the circulatory system;Both sexes;Number of PLYL;436,699.50
Total;;Diseases of the circulatory system;Both sexes;Distribution by chapter of the CIE;18.72
Total;;Diseases of the circulatory system;Both sexes;Standardised rate of PLYL;9.73
Total;;Diseases of the circulatory system;Both sexes;Average number of PLYL;11.12
Total;;Diseases of the circulatory system;Males;Number of PLYL;314,812.00
Total;;Diseases of the circulatory system;Males;Distribution by chapter of the CIE;19.80
Total;;Diseases of the circulatory system;Males;Standardised rate of PLYL;13.93
Total;;Diseases of the circulatory system;Males;Average number of PLYL;12.34
Total;;Diseases of the circulatory system;Females;Number of PLYL;121,887.50
Total;;Diseases of the circulatory system;Females;Distribution by chapter of the CIE;16.40
Total;;Diseases of the circulatory system;Females;Standardised rate of PLYL;5.52
Total;;Diseases of the circulatory system;Females;Average number of PLYL;8.86
Total;;Diseases of the respiratory system;Both sexes;Number of PLYL;123,193.00
Total;;Diseases of the respiratory system;Both sexes;Distribution by chapter of the CIE;5.28
Total;;Diseases of the respiratory system;Both sexes;Standardised rate of PLYL;2.79
Total;;Diseases of the respiratory system;Both sexes;Average number of PLYL;9.99
Total;;Diseases of the respiratory system;Males;Number of PLYL;89,514.00
Total;;Diseases of the respiratory system;Males;Distribution by chapter of the CIE;5.63
Total;;Diseases of the respiratory system;Males;Standardised rate of PLYL;4.05
Total;;Diseases of the respiratory system;Males;Average number of PLYL;9.96
Total;;Diseases of the respiratory system;Females;Number of PLYL;33,679.00
Total;;Diseases of the respiratory system;Females;Distribution by chapter of the CIE;4.53
Total;;Diseases of the respiratory system;Females;Standardised rate of PLYL;1.52
Total;;Diseases of the respiratory system;Females;Average number of PLYL;10.06
Total;;Diseases of the digestive system;Both sexes;Number of PLYL;136,602.50
Total;;Diseases of the digestive system;Both sexes;Distribution by chapter of the CIE;5.85
Total;;Diseases of the digestive system;Both sexes;Standardised rate of PLYL;2.95
Total;;Diseases of the digestive system;Both sexes;Average number of PLYL;14.71
Total;;Diseases of the digestive system;Males;Number of PLYL;100,809.50
Total;;Diseases of the digestive system;Males;Distribution by chapter of the CIE;6.34
Total;;Diseases of the digestive system;Males;Standardised rate of PLYL;4.32
Total;;Diseases of the digestive system;Males;Average number of PLYL;15.83
Total;;Diseases of the digestive system;Females;Number of PLYL;35,793.00
Total;;Diseases of the digestive system;Females;Distribution by chapter of the CIE;4.82
Total;;Diseases of the digestive system;Females;Standardised rate of PLYL;1.58
Total;;Diseases of the digestive system;Females;Average number of PLYL;12.27
Total;;Diseases of the skin and subcutaneous tissue;Both sexes;Number of PLYL;2,454.50
Total;;Diseases of the skin and subcutaneous tissue;Both sexes;Distribution by chapter of the CIE;0.11
Total;;Diseases of the skin and subcutaneous tissue;Both sexes;Standardised rate of PLYL;0.06
Total;;Diseases of the skin and subcutaneous tissue;Both sexes;Average number of PLYL;9.51
Total;;Diseases of the skin and subcutaneous tissue;Males;Number of PLYL;1,262.00
Total;;Diseases of the skin and subcutaneous tissue;Males;Distribution by chapter of the CIE;0.08
Total;;Diseases of the skin and subcutaneous tissue;Males;Standardised rate of PLYL;0.06
Total;;Diseases of the skin and subcutaneous tissue;Males;Average number of PLYL;10.61
Total;;Diseases of the skin and subcutaneous tissue;Females;Number of PLYL;1,192.50
Total;;Diseases of the skin and subcutaneous tissue;Females;Distribution by chapter of the CIE;0.16
Total;;Diseases of the skin and subcutaneous tissue;Females;Standardised rate of PLYL;0.06
Total;;Diseases of the skin and subcutaneous tissue;Females;Average number of PLYL;8.58
Total;;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Number of PLYL;8,809.50
Total;;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Distribution by chapter of the CIE;0.38
Total;;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Standardised rate of PLYL;0.20
Total;;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Average number of PLYL;11.12
Total;;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Number of PLYL;3,674.50
Total;;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Distribution by chapter of the CIE;0.23
Total;;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Standardised rate of PLYL;0.16
Total;;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Average number of PLYL;11.85
Total;;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Number of PLYL;5,135.00
Total;;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Distribution by chapter of the CIE;0.69
Total;;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Standardised rate of PLYL;0.23
Total;;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Average number of PLYL;10.65
Total;;Diseases of the genitourinary system;Both sexes;Number of PLYL;22,458.50
Total;;Diseases of the genitourinary system;Both sexes;Distribution by chapter of the CIE;0.96
Total;;Diseases of the genitourinary system;Both sexes;Standardised rate of PLYL;0.51
Total;;Diseases of the genitourinary system;Both sexes;Average number of PLYL;8.51
Total;;Diseases of the genitourinary system;Males;Number of PLYL;13,676.50
Total;;Diseases of the genitourinary system;Males;Distribution by chapter of the CIE;0.86
Total;;Diseases of the genitourinary system;Males;Standardised rate of PLYL;0.61
Total;;Diseases of the genitourinary system;Males;Average number of PLYL;8.99
Total;;Diseases of the genitourinary system;Females;Number of PLYL;8,782.00
Total;;Diseases of the genitourinary system;Females;Distribution by chapter of the CIE;1.18
Total;;Diseases of the genitourinary system;Females;Standardised rate of PLYL;0.41
Total;;Diseases of the genitourinary system;Females;Average number of PLYL;7.85
Total;;Pregnancy, childbirth and the puerperium;Both sexes;Number of PLYL;980.00
Total;;Pregnancy, childbirth and the puerperium;Both sexes;Distribution by chapter of the CIE;0.04
Total;;Pregnancy, childbirth and the puerperium;Both sexes;Standardised rate of PLYL;0.02
Total;;Pregnancy, childbirth and the puerperium;Both sexes;Average number of PLYL;49.00
Total;;Pregnancy, childbirth and the puerperium;Males;Number of PLYL;..
Total;;Pregnancy, childbirth and the puerperium;Males;Distribution by chapter of the CIE;..
Total;;Pregnancy, childbirth and the puerperium;Males;Standardised rate of PLYL;..
Total;;Pregnancy, childbirth and the puerperium;Males;Average number of PLYL;..
Total;;Pregnancy, childbirth and the puerperium;Females;Number of PLYL;980.00
Total;;Pregnancy, childbirth and the puerperium;Females;Distribution by chapter of the CIE;0.13
Total;;Pregnancy, childbirth and the puerperium;Females;Standardised rate of PLYL;0.05
Total;;Pregnancy, childbirth and the puerperium;Females;Average number of PLYL;49.00
Total;;Affections originated in the perinatal period;Both sexes;Number of PLYL;1,312.00
Total;;Affections originated in the perinatal period;Both sexes;Distribution by chapter of the CIE;0.06
Total;;Affections originated in the perinatal period;Both sexes;Standardised rate of PLYL;0.03
Total;;Affections originated in the perinatal period;Both sexes;Average number of PLYL;54.67
Total;;Affections originated in the perinatal period;Males;Number of PLYL;739.00
Total;;Affections originated in the perinatal period;Males;Distribution by chapter of the CIE;0.05
Total;;Affections originated in the perinatal period;Males;Standardised rate of PLYL;0.04
Total;;Affections originated in the perinatal period;Males;Average number of PLYL;52.79
Total;;Affections originated in the perinatal period;Females;Number of PLYL;573.00
Total;;Affections originated in the perinatal period;Females;Distribution by chapter of the CIE;0.08
Total;;Affections originated in the perinatal period;Females;Standardised rate of PLYL;0.02
Total;;Affections originated in the perinatal period;Females;Average number of PLYL;57.30
Total;;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Number of PLYL;17,951.00
Total;;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Distribution by chapter of the CIE;0.77
Total;;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Standardised rate of PLYL;0.41
Total;;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Average number of PLYL;38.11
Total;;Congenital malformations, deformities and chromosomal abnormalities;Males;Number of PLYL;9,131.50
Total;;Congenital malformations, deformities and chromosomal abnormalities;Males;Distribution by chapter of the CIE;0.57
Total;;Congenital malformations, deformities and chromosomal abnormalities;Males;Standardised rate of PLYL;0.43
Total;;Congenital malformations, deformities and chromosomal abnormalities;Males;Average number of PLYL;38.86
Total;;Congenital malformations, deformities and chromosomal abnormalities;Females;Number of PLYL;8,819.50
Total;;Congenital malformations, deformities and chromosomal abnormalities;Females;Distribution by chapter of the CIE;1.19
Total;;Congenital malformations, deformities and chromosomal abnormalities;Females;Standardised rate of PLYL;0.39
Total;;Congenital malformations, deformities and chromosomal abnormalities;Females;Average number of PLYL;37.37
Total;;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Number of PLYL;102,366.50
Total;;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Distribution by chapter of the CIE;4.39
Total;;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Standardised rate of PLYL;2.24
Total;;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Average number of PLYL;20.98
Total;;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Number of PLYL;76,488.00
Total;;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Distribution by chapter of the CIE;4.81
Total;;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Standardised rate of PLYL;3.35
Total;;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Average number of PLYL;22.22
Total;;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Number of PLYL;25,878.50
Total;;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Distribution by chapter of the CIE;3.48
Total;;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Standardised rate of PLYL;1.13
Total;;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Average number of PLYL;18.01
Total;;External causes of mortality;Both sexes;Number of PLYL;281,479.50
Total;;External causes of mortality;Both sexes;Distribution by chapter of the CIE;12.06
Total;;External causes of mortality;Both sexes;Standardised rate of PLYL;6.47
Total;;External causes of mortality;Both sexes;Average number of PLYL;29.04
Total;;External causes of mortality;Males;Number of PLYL;222,893.00
Total;;External causes of mortality;Males;Distribution by chapter of the CIE;14.02
Total;;External causes of mortality;Males;Standardised rate of PLYL;10.26
Total;;External causes of mortality;Males;Average number of PLYL;30.32
Total;;External causes of mortality;Females;Number of PLYL;58,586.50
Total;;External causes of mortality;Females;Distribution by chapter of the CIE;7.88
Total;;External causes of mortality;Females;Standardised rate of PLYL;2.69
Total;;External causes of mortality;Females;Average number of PLYL;25.04
Total;AndalucÝa;All causes;Both sexes;Number of PLYL;435,781.00
Total;AndalucÝa;All causes;Both sexes;Distribution by chapter of the CIE;100.00
Total;AndalucÝa;All causes;Both sexes;Standardised rate of PLYL;56.82
Total;AndalucÝa;All causes;Both sexes;Average number of PLYL;13.90
Total;AndalucÝa;All causes;Males;Number of PLYL;295,965.50
Total;AndalucÝa;All causes;Males;Distribution by chapter of the CIE;100.00
Total;AndalucÝa;All causes;Males;Standardised rate of PLYL;77.27
Total;AndalucÝa;All causes;Males;Average number of PLYL;14.62
Total;AndalucÝa;All causes;Females;Number of PLYL;139,815.50
Total;AndalucÝa;All causes;Females;Distribution by chapter of the CIE;100.00
Total;AndalucÝa;All causes;Females;Standardised rate of PLYL;36.41
Total;AndalucÝa;All causes;Females;Average number of PLYL;12.57
Total;AndalucÝa;Infectious and parasitic diseases (1);Both sexes;Number of PLYL;13,532.00
Total;AndalucÝa;Infectious and parasitic diseases (1);Both sexes;Distribution by chapter of the CIE;3.11
Total;AndalucÝa;Infectious and parasitic diseases (1);Both sexes;Standardised rate of PLYL;1.61
Total;AndalucÝa;Infectious and parasitic diseases (1);Both sexes;Average number of PLYL;21.83
Total;AndalucÝa;Infectious and parasitic diseases (1);Males;Number of PLYL;9,781.00
Total;AndalucÝa;Infectious and parasitic diseases (1);Males;Distribution by chapter of the CIE;3.30
Total;AndalucÝa;Infectious and parasitic diseases (1);Males;Standardised rate of PLYL;2.29
Total;AndalucÝa;Infectious and parasitic diseases (1);Males;Average number of PLYL;24.03
Total;AndalucÝa;Infectious and parasitic diseases (1);Females;Number of PLYL;3,751.00
Total;AndalucÝa;Infectious and parasitic diseases (1);Females;Distribution by chapter of the CIE;2.68
Total;AndalucÝa;Infectious and parasitic diseases (1);Females;Standardised rate of PLYL;0.93
Total;AndalucÝa;Infectious and parasitic diseases (1);Females;Average number of PLYL;17.61
Total;AndalucÝa;Tumours;Both sexes;Number of PLYL;167,365.50
Total;AndalucÝa;Tumours;Both sexes;Distribution by chapter of the CIE;38.41
Total;AndalucÝa;Tumours;Both sexes;Standardised rate of PLYL;21.94
Total;AndalucÝa;Tumours;Both sexes;Average number of PLYL;14.29
Total;AndalucÝa;Tumours;Males;Number of PLYL;105,191.50
Total;AndalucÝa;Tumours;Males;Distribution by chapter of the CIE;35.54
Total;AndalucÝa;Tumours;Males;Standardised rate of PLYL;27.97
Total;AndalucÝa;Tumours;Males;Average number of PLYL;13.77
Total;AndalucÝa;Tumours;Females;Number of PLYL;62,174.00
Total;AndalucÝa;Tumours;Females;Distribution by chapter of the CIE;44.47
Total;AndalucÝa;Tumours;Females;Standardised rate of PLYL;15.93
Total;AndalucÝa;Tumours;Females;Average number of PLYL;15.26
Total;AndalucÝa;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Number of PLYL;1,189.00
Total;AndalucÝa;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Distribution by chapter of the CIE;0.27
Total;AndalucÝa;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Standardised rate of PLYL;0.16
Total;AndalucÝa;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Average number of PLYL;13.21
Total;AndalucÝa;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Number of PLYL;632.00
Total;AndalucÝa;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Distribution by chapter of the CIE;0.21
Total;AndalucÝa;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Standardised rate of PLYL;0.16
Total;AndalucÝa;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Average number of PLYL;12.90
Total;AndalucÝa;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Number of PLYL;557.00
Total;AndalucÝa;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Distribution by chapter of the CIE;0.40
Total;AndalucÝa;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Standardised rate of PLYL;0.15
Total;AndalucÝa;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Average number of PLYL;13.59
Total;AndalucÝa;Endocrine, nutritional and metabolic diseases;Both sexes;Number of PLYL;10,875.00
Total;AndalucÝa;Endocrine, nutritional and metabolic diseases;Both sexes;Distribution by chapter of the CIE;2.50
Total;AndalucÝa;Endocrine, nutritional and metabolic diseases;Both sexes;Standardised rate of PLYL;1.47
Total;AndalucÝa;Endocrine, nutritional and metabolic diseases;Both sexes;Average number of PLYL;11.29
Total;AndalucÝa;Endocrine, nutritional and metabolic diseases;Males;Number of PLYL;6,306.50
Total;AndalucÝa;Endocrine, nutritional and metabolic diseases;Males;Distribution by chapter of the CIE;2.13
Total;AndalucÝa;Endocrine, nutritional and metabolic diseases;Males;Standardised rate of PLYL;1.71
Total;AndalucÝa;Endocrine, nutritional and metabolic diseases;Males;Average number of PLYL;12.29
Total;AndalucÝa;Endocrine, nutritional and metabolic diseases;Females;Number of PLYL;4,568.50
Total;AndalucÝa;Endocrine, nutritional and metabolic diseases;Females;Distribution by chapter of the CIE;3.27
Total;AndalucÝa;Endocrine, nutritional and metabolic diseases;Females;Standardised rate of PLYL;1.23
Total;AndalucÝa;Endocrine, nutritional and metabolic diseases;Females;Average number of PLYL;10.15
Total;AndalucÝa;Mental and behavioural disorders;Both sexes;Number of PLYL;4,650.00
Total;AndalucÝa;Mental and behavioural disorders;Both sexes;Distribution by chapter of the CIE;1.07
Total;AndalucÝa;Mental and behavioural disorders;Both sexes;Standardised rate of PLYL;0.61
Total;AndalucÝa;Mental and behavioural disorders;Both sexes;Average number of PLYL;10.86
Total;AndalucÝa;Mental and behavioural disorders;Males;Number of PLYL;3,337.50
Total;AndalucÝa;Mental and behavioural disorders;Males;Distribution by chapter of the CIE;1.13
Total;AndalucÝa;Mental and behavioural disorders;Males;Standardised rate of PLYL;0.86
Total;AndalucÝa;Mental and behavioural disorders;Males;Average number of PLYL;13.51
Total;AndalucÝa;Mental and behavioural disorders;Females;Number of PLYL;1,312.50
Total;AndalucÝa;Mental and behavioural disorders;Females;Distribution by chapter of the CIE;0.94
Total;AndalucÝa;Mental and behavioural disorders;Females;Standardised rate of PLYL;0.36
Total;AndalucÝa;Mental and behavioural disorders;Females;Average number of PLYL;7.25
Total;AndalucÝa;Diseases of the nervous system and the sense organs;Both sexes;Number of PLYL;14,992.00
Total;AndalucÝa;Diseases of the nervous system and the sense organs;Both sexes;Distribution by chapter of the CIE;3.44
Total;AndalucÝa;Diseases of the nervous system and the sense organs;Both sexes;Standardised rate of PLYL;2.00
Total;AndalucÝa;Diseases of the nervous system and the sense organs;Both sexes;Average number of PLYL;12.78
Total;AndalucÝa;Diseases of the nervous system and the sense organs;Males;Number of PLYL;9,358.00
Total;AndalucÝa;Diseases of the nervous system and the sense organs;Males;Distribution by chapter of the CIE;3.16
Total;AndalucÝa;Diseases of the nervous system and the sense organs;Males;Standardised rate of PLYL;2.48
Total;AndalucÝa;Diseases of the nervous system and the sense organs;Males;Average number of PLYL;14.55
Total;AndalucÝa;Diseases of the nervous system and the sense organs;Females;Number of PLYL;5,634.00
Total;AndalucÝa;Diseases of the nervous system and the sense organs;Females;Distribution by chapter of the CIE;4.03
Total;AndalucÝa;Diseases of the nervous system and the sense organs;Females;Standardised rate of PLYL;1.52
Total;AndalucÝa;Diseases of the nervous system and the sense organs;Females;Average number of PLYL;10.63
Total;AndalucÝa;Diseases of the circulatory system;Both sexes;Number of PLYL;91,724.00
Total;AndalucÝa;Diseases of the circulatory system;Both sexes;Distribution by chapter of the CIE;21.05
Total;AndalucÝa;Diseases of the circulatory system;Both sexes;Standardised rate of PLYL;12.24
Total;AndalucÝa;Diseases of the circulatory system;Both sexes;Average number of PLYL;10.80
Total;AndalucÝa;Diseases of the circulatory system;Males;Number of PLYL;63,584.50
Total;AndalucÝa;Diseases of the circulatory system;Males;Distribution by chapter of the CIE;21.48
Total;AndalucÝa;Diseases of the circulatory system;Males;Standardised rate of PLYL;16.85
Total;AndalucÝa;Diseases of the circulatory system;Males;Average number of PLYL;12.19
Total;AndalucÝa;Diseases of the circulatory system;Females;Number of PLYL;28,139.50
Total;AndalucÝa;Diseases of the circulatory system;Females;Distribution by chapter of the CIE;20.13
Total;AndalucÝa;Diseases of the circulatory system;Females;Standardised rate of PLYL;7.64
Total;AndalucÝa;Diseases of the circulatory system;Females;Average number of PLYL;8.58
Total;AndalucÝa;Diseases of the respiratory system;Both sexes;Number of PLYL;22,471.00
Total;AndalucÝa;Diseases of the respiratory system;Both sexes;Distribution by chapter of the CIE;5.16
Total;AndalucÝa;Diseases of the respiratory system;Both sexes;Standardised rate of PLYL;3.05
Total;AndalucÝa;Diseases of the respiratory system;Both sexes;Average number of PLYL;9.30
Total;AndalucÝa;Diseases of the respiratory system;Males;Number of PLYL;16,532.50
Total;AndalucÝa;Diseases of the respiratory system;Males;Distribution by chapter of the CIE;5.59
Total;AndalucÝa;Diseases of the respiratory system;Males;Standardised rate of PLYL;4.52
Total;AndalucÝa;Diseases of the respiratory system;Males;Average number of PLYL;9.13
Total;AndalucÝa;Diseases of the respiratory system;Females;Number of PLYL;5,938.50
Total;AndalucÝa;Diseases of the respiratory system;Females;Distribution by chapter of the CIE;4.25
Total;AndalucÝa;Diseases of the respiratory system;Females;Standardised rate of PLYL;1.57
Total;AndalucÝa;Diseases of the respiratory system;Females;Average number of PLYL;9.80
Total;AndalucÝa;Diseases of the digestive system;Both sexes;Number of PLYL;31,569.50
Total;AndalucÝa;Diseases of the digestive system;Both sexes;Distribution by chapter of the CIE;7.24
Total;AndalucÝa;Diseases of the digestive system;Both sexes;Standardised rate of PLYL;4.01
Total;AndalucÝa;Diseases of the digestive system;Both sexes;Average number of PLYL;15.13
Total;AndalucÝa;Diseases of the digestive system;Males;Number of PLYL;23,885.00
Total;AndalucÝa;Diseases of the digestive system;Males;Distribution by chapter of the CIE;8.07
Total;AndalucÝa;Diseases of the digestive system;Males;Standardised rate of PLYL;6.02
Total;AndalucÝa;Diseases of the digestive system;Males;Average number of PLYL;16.56
Total;AndalucÝa;Diseases of the digestive system;Females;Number of PLYL;7,684.50
Total;AndalucÝa;Diseases of the digestive system;Females;Distribution by chapter of the CIE;5.50
Total;AndalucÝa;Diseases of the digestive system;Females;Standardised rate of PLYL;2.01
Total;AndalucÝa;Diseases of the digestive system;Females;Average number of PLYL;11.93
Total;AndalucÝa;Diseases of the skin and subcutaneous tissue;Both sexes;Number of PLYL;570.00
Total;AndalucÝa;Diseases of the skin and subcutaneous tissue;Both sexes;Distribution by chapter of the CIE;0.13
Total;AndalucÝa;Diseases of the skin and subcutaneous tissue;Both sexes;Standardised rate of PLYL;0.08
Total;AndalucÝa;Diseases of the skin and subcutaneous tissue;Both sexes;Average number of PLYL;10.56
Total;AndalucÝa;Diseases of the skin and subcutaneous tissue;Males;Number of PLYL;215.00
Total;AndalucÝa;Diseases of the skin and subcutaneous tissue;Males;Distribution by chapter of the CIE;0.07
Total;AndalucÝa;Diseases of the skin and subcutaneous tissue;Males;Standardised rate of PLYL;0.06
Total;AndalucÝa;Diseases of the skin and subcutaneous tissue;Males;Average number of PLYL;13.44
Total;AndalucÝa;Diseases of the skin and subcutaneous tissue;Females;Number of PLYL;355.00
Total;AndalucÝa;Diseases of the skin and subcutaneous tissue;Females;Distribution by chapter of the CIE;0.25
Total;AndalucÝa;Diseases of the skin and subcutaneous tissue;Females;Standardised rate of PLYL;0.10
Total;AndalucÝa;Diseases of the skin and subcutaneous tissue;Females;Average number of PLYL;9.34
Total;AndalucÝa;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Number of PLYL;1,604.50
Total;AndalucÝa;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Distribution by chapter of the CIE;0.37
Total;AndalucÝa;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Standardised rate of PLYL;0.20
Total;AndalucÝa;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Average number of PLYL;12.34
Total;AndalucÝa;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Number of PLYL;519.50
Total;AndalucÝa;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Distribution by chapter of the CIE;0.18
Total;AndalucÝa;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Standardised rate of PLYL;0.13
Total;AndalucÝa;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Average number of PLYL;12.99
Total;AndalucÝa;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Number of PLYL;1,085.00
Total;AndalucÝa;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Distribution by chapter of the CIE;0.78
Total;AndalucÝa;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Standardised rate of PLYL;0.28
Total;AndalucÝa;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Average number of PLYL;12.06
Total;AndalucÝa;Diseases of the genitourinary system;Both sexes;Number of PLYL;5,110.00
Total;AndalucÝa;Diseases of the genitourinary system;Both sexes;Distribution by chapter of the CIE;1.17
Total;AndalucÝa;Diseases of the genitourinary system;Both sexes;Standardised rate of PLYL;0.70
Total;AndalucÝa;Diseases of the genitourinary system;Both sexes;Average number of PLYL;8.43
Total;AndalucÝa;Diseases of the genitourinary system;Males;Number of PLYL;3,127.50
Total;AndalucÝa;Diseases of the genitourinary system;Males;Distribution by chapter of the CIE;1.06
Total;AndalucÝa;Diseases of the genitourinary system;Males;Standardised rate of PLYL;0.84
Total;AndalucÝa;Diseases of the genitourinary system;Males;Average number of PLYL;9.12
Total;AndalucÝa;Diseases of the genitourinary system;Females;Number of PLYL;1,982.50
Total;AndalucÝa;Diseases of the genitourinary system;Females;Distribution by chapter of the CIE;1.42
Total;AndalucÝa;Diseases of the genitourinary system;Females;Standardised rate of PLYL;0.55
Total;AndalucÝa;Diseases of the genitourinary system;Females;Average number of PLYL;7.54
Total;AndalucÝa;Pregnancy, childbirth and the puerperium;Both sexes;Number of PLYL;220.00
Total;AndalucÝa;Pregnancy, childbirth and the puerperium;Both sexes;Distribution by chapter of the CIE;0.05
Total;AndalucÝa;Pregnancy, childbirth and the puerperium;Both sexes;Standardised rate of PLYL;0.03
Total;AndalucÝa;Pregnancy, childbirth and the puerperium;Both sexes;Average number of PLYL;55.00
Total;AndalucÝa;Pregnancy, childbirth and the puerperium;Males;Number of PLYL;..
Total;AndalucÝa;Pregnancy, childbirth and the puerperium;Males;Distribution by chapter of the CIE;..
Total;AndalucÝa;Pregnancy, childbirth and the puerperium;Males;Standardised rate of PLYL;..
Total;AndalucÝa;Pregnancy, childbirth and the puerperium;Males;Average number of PLYL;..
Total;AndalucÝa;Pregnancy, childbirth and the puerperium;Females;Number of PLYL;220.00
Total;AndalucÝa;Pregnancy, childbirth and the puerperium;Females;Distribution by chapter of the CIE;0.16
Total;AndalucÝa;Pregnancy, childbirth and the puerperium;Females;Standardised rate of PLYL;0.06
Total;AndalucÝa;Pregnancy, childbirth and the puerperium;Females;Average number of PLYL;55.00
Total;AndalucÝa;Affections originated in the perinatal period;Both sexes;Number of PLYL;581.00
Total;AndalucÝa;Affections originated in the perinatal period;Both sexes;Distribution by chapter of the CIE;0.13
Total;AndalucÝa;Affections originated in the perinatal period;Both sexes;Standardised rate of PLYL;0.06
Total;AndalucÝa;Affections originated in the perinatal period;Both sexes;Average number of PLYL;52.82
Total;AndalucÝa;Affections originated in the perinatal period;Males;Number of PLYL;265.00
Total;AndalucÝa;Affections originated in the perinatal period;Males;Distribution by chapter of the CIE;0.09
Total;AndalucÝa;Affections originated in the perinatal period;Males;Standardised rate of PLYL;0.06
Total;AndalucÝa;Affections originated in the perinatal period;Males;Average number of PLYL;44.17
Total;AndalucÝa;Affections originated in the perinatal period;Females;Number of PLYL;316.00
Total;AndalucÝa;Affections originated in the perinatal period;Females;Distribution by chapter of the CIE;0.23
Total;AndalucÝa;Affections originated in the perinatal period;Females;Standardised rate of PLYL;0.07
Total;AndalucÝa;Affections originated in the perinatal period;Females;Average number of PLYL;63.20
Total;AndalucÝa;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Number of PLYL;5,026.00
Total;AndalucÝa;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Distribution by chapter of the CIE;1.15
Total;AndalucÝa;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Standardised rate of PLYL;0.61
Total;AndalucÝa;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Average number of PLYL;47.42
Total;AndalucÝa;Congenital malformations, deformities and chromosomal abnormalities;Males;Number of PLYL;2,466.50
Total;AndalucÝa;Congenital malformations, deformities and chromosomal abnormalities;Males;Distribution by chapter of the CIE;0.83
Total;AndalucÝa;Congenital malformations, deformities and chromosomal abnormalities;Males;Standardised rate of PLYL;0.61
Total;AndalucÝa;Congenital malformations, deformities and chromosomal abnormalities;Males;Average number of PLYL;47.43
Total;AndalucÝa;Congenital malformations, deformities and chromosomal abnormalities;Females;Number of PLYL;2,559.50
Total;AndalucÝa;Congenital malformations, deformities and chromosomal abnormalities;Females;Distribution by chapter of the CIE;1.83
Total;AndalucÝa;Congenital malformations, deformities and chromosomal abnormalities;Females;Standardised rate of PLYL;0.60
Total;AndalucÝa;Congenital malformations, deformities and chromosomal abnormalities;Females;Average number of PLYL;47.40
Total;AndalucÝa;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Number of PLYL;10,016.00
Total;AndalucÝa;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Distribution by chapter of the CIE;2.30
Total;AndalucÝa;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Standardised rate of PLYL;1.26
Total;AndalucÝa;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Average number of PLYL;16.03
Total;AndalucÝa;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Number of PLYL;7,674.00
Total;AndalucÝa;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Distribution by chapter of the CIE;2.59
Total;AndalucÝa;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Standardised rate of PLYL;1.92
Total;AndalucÝa;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Average number of PLYL;18.45
Total;AndalucÝa;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Number of PLYL;2,342.00
Total;AndalucÝa;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Distribution by chapter of the CIE;1.68
Total;AndalucÝa;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Standardised rate of PLYL;0.61
Total;AndalucÝa;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Average number of PLYL;11.21
Total;AndalucÝa;External causes of mortality;Both sexes;Number of PLYL;54,285.50
Total;AndalucÝa;External causes of mortality;Both sexes;Distribution by chapter of the CIE;12.46
Total;AndalucÝa;External causes of mortality;Both sexes;Standardised rate of PLYL;6.81
Total;AndalucÝa;External causes of mortality;Both sexes;Average number of PLYL;29.42
Total;AndalucÝa;External causes of mortality;Males;Number of PLYL;43,089.50
Total;AndalucÝa;External causes of mortality;Males;Distribution by chapter of the CIE;14.56
Total;AndalucÝa;External causes of mortality;Males;Standardised rate of PLYL;10.80
Total;AndalucÝa;External causes of mortality;Males;Average number of PLYL;30.76
Total;AndalucÝa;External causes of mortality;Females;Number of PLYL;11,196.00
Total;AndalucÝa;External causes of mortality;Females;Distribution by chapter of the CIE;8.01
Total;AndalucÝa;External causes of mortality;Females;Standardised rate of PLYL;2.81
Total;AndalucÝa;External causes of mortality;Females;Average number of PLYL;25.22
Total;Arag¾n;All causes;Both sexes;Number of PLYL;68,074.50
Total;Arag¾n;All causes;Both sexes;Distribution by chapter of the CIE;100.00
Total;Arag¾n;All causes;Both sexes;Standardised rate of PLYL;51.62
Total;Arag¾n;All causes;Both sexes;Average number of PLYL;13.49
Total;Arag¾n;All causes;Males;Number of PLYL;45,995.00
Total;Arag¾n;All causes;Males;Distribution by chapter of the CIE;100.00
Total;Arag¾n;All causes;Males;Standardised rate of PLYL;68.37
Total;Arag¾n;All causes;Males;Average number of PLYL;13.94
Total;Arag¾n;All causes;Females;Number of PLYL;22,079.50
Total;Arag¾n;All causes;Females;Distribution by chapter of the CIE;100.00
Total;Arag¾n;All causes;Females;Standardised rate of PLYL;34.15
Total;Arag¾n;All causes;Females;Average number of PLYL;12.65
Total;Arag¾n;Infectious and parasitic diseases (1);Both sexes;Number of PLYL;1,655.00
Total;Arag¾n;Infectious and parasitic diseases (1);Both sexes;Distribution by chapter of the CIE;2.43
Total;Arag¾n;Infectious and parasitic diseases (1);Both sexes;Standardised rate of PLYL;1.22
Total;Arag¾n;Infectious and parasitic diseases (1);Both sexes;Average number of PLYL;17.24
Total;Arag¾n;Infectious and parasitic diseases (1);Males;Number of PLYL;1,110.00
Total;Arag¾n;Infectious and parasitic diseases (1);Males;Distribution by chapter of the CIE;2.41
Total;Arag¾n;Infectious and parasitic diseases (1);Males;Standardised rate of PLYL;1.62
Total;Arag¾n;Infectious and parasitic diseases (1);Males;Average number of PLYL;17.90
Total;Arag¾n;Infectious and parasitic diseases (1);Females;Number of PLYL;545.00
Total;Arag¾n;Infectious and parasitic diseases (1);Females;Distribution by chapter of the CIE;2.47
Total;Arag¾n;Infectious and parasitic diseases (1);Females;Standardised rate of PLYL;0.80
Total;Arag¾n;Infectious and parasitic diseases (1);Females;Average number of PLYL;16.03
Total;Arag¾n;Tumours;Both sexes;Number of PLYL;30,283.50
Total;Arag¾n;Tumours;Both sexes;Distribution by chapter of the CIE;44.49
Total;Arag¾n;Tumours;Both sexes;Standardised rate of PLYL;22.52
Total;Arag¾n;Tumours;Both sexes;Average number of PLYL;13.64
Total;Arag¾n;Tumours;Males;Number of PLYL;19,197.00
Total;Arag¾n;Tumours;Males;Distribution by chapter of the CIE;41.74
Total;Arag¾n;Tumours;Males;Standardised rate of PLYL;28.02
Total;Arag¾n;Tumours;Males;Average number of PLYL;13.12
Total;Arag¾n;Tumours;Females;Number of PLYL;11,086.50
Total;Arag¾n;Tumours;Females;Distribution by chapter of the CIE;50.21
Total;Arag¾n;Tumours;Females;Standardised rate of PLYL;16.78
Total;Arag¾n;Tumours;Females;Average number of PLYL;14.65
Total;Arag¾n;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Number of PLYL;319.50
Total;Arag¾n;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Distribution by chapter of the CIE;0.47
Total;Arag¾n;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Standardised rate of PLYL;0.24
Total;Arag¾n;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Average number of PLYL;17.75
Total;Arag¾n;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Number of PLYL;167.50
Total;Arag¾n;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Distribution by chapter of the CIE;0.36
Total;Arag¾n;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Standardised rate of PLYL;0.25
Total;Arag¾n;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Average number of PLYL;18.61
Total;Arag¾n;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Number of PLYL;152.00
Total;Arag¾n;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Distribution by chapter of the CIE;0.69
Total;Arag¾n;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Standardised rate of PLYL;0.22
Total;Arag¾n;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Average number of PLYL;16.89
Total;Arag¾n;Endocrine, nutritional and metabolic diseases;Both sexes;Number of PLYL;1,340.00
Total;Arag¾n;Endocrine, nutritional and metabolic diseases;Both sexes;Distribution by chapter of the CIE;1.97
Total;Arag¾n;Endocrine, nutritional and metabolic diseases;Both sexes;Standardised rate of PLYL;1.07
Total;Arag¾n;Endocrine, nutritional and metabolic diseases;Both sexes;Average number of PLYL;9.71
Total;Arag¾n;Endocrine, nutritional and metabolic diseases;Males;Number of PLYL;880.00
Total;Arag¾n;Endocrine, nutritional and metabolic diseases;Males;Distribution by chapter of the CIE;1.91
Total;Arag¾n;Endocrine, nutritional and metabolic diseases;Males;Standardised rate of PLYL;1.42
Total;Arag¾n;Endocrine, nutritional and metabolic diseases;Males;Average number of PLYL;12.57
Total;Arag¾n;Endocrine, nutritional and metabolic diseases;Females;Number of PLYL;460.00
Total;Arag¾n;Endocrine, nutritional and metabolic diseases;Females;Distribution by chapter of the CIE;2.08
Total;Arag¾n;Endocrine, nutritional and metabolic diseases;Females;Standardised rate of PLYL;0.70
Total;Arag¾n;Endocrine, nutritional and metabolic diseases;Females;Average number of PLYL;6.76
Total;Arag¾n;Mental and behavioural disorders;Both sexes;Number of PLYL;625.00
Total;Arag¾n;Mental and behavioural disorders;Both sexes;Distribution by chapter of the CIE;0.92
Total;Arag¾n;Mental and behavioural disorders;Both sexes;Standardised rate of PLYL;0.46
Total;Arag¾n;Mental and behavioural disorders;Both sexes;Average number of PLYL;8.22
Total;Arag¾n;Mental and behavioural disorders;Males;Number of PLYL;472.50
Total;Arag¾n;Mental and behavioural disorders;Males;Distribution by chapter of the CIE;1.03
Total;Arag¾n;Mental and behavioural disorders;Males;Standardised rate of PLYL;0.68
Total;Arag¾n;Mental and behavioural disorders;Males;Average number of PLYL;8.92
Total;Arag¾n;Mental and behavioural disorders;Females;Number of PLYL;152.50
Total;Arag¾n;Mental and behavioural disorders;Females;Distribution by chapter of the CIE;0.69
Total;Arag¾n;Mental and behavioural disorders;Females;Standardised rate of PLYL;0.23
Total;Arag¾n;Mental and behavioural disorders;Females;Average number of PLYL;6.63
Total;Arag¾n;Diseases of the nervous system and the sense organs;Both sexes;Number of PLYL;2,172.50
Total;Arag¾n;Diseases of the nervous system and the sense organs;Both sexes;Distribution by chapter of the CIE;3.19
Total;Arag¾n;Diseases of the nervous system and the sense organs;Both sexes;Standardised rate of PLYL;1.75
Total;Arag¾n;Diseases of the nervous system and the sense organs;Both sexes;Average number of PLYL;11.37
Total;Arag¾n;Diseases of the nervous system and the sense organs;Males;Number of PLYL;1,315.00
Total;Arag¾n;Diseases of the nervous system and the sense organs;Males;Distribution by chapter of the CIE;2.86
Total;Arag¾n;Diseases of the nervous system and the sense organs;Males;Standardised rate of PLYL;2.08
Total;Arag¾n;Diseases of the nervous system and the sense organs;Males;Average number of PLYL;12.89
Total;Arag¾n;Diseases of the nervous system and the sense organs;Females;Number of PLYL;857.50
Total;Arag¾n;Diseases of the nervous system and the sense organs;Females;Distribution by chapter of the CIE;3.88
Total;Arag¾n;Diseases of the nervous system and the sense organs;Females;Standardised rate of PLYL;1.40
Total;Arag¾n;Diseases of the nervous system and the sense organs;Females;Average number of PLYL;9.63
Total;Arag¾n;Diseases of the circulatory system;Both sexes;Number of PLYL;13,256.00
Total;Arag¾n;Diseases of the circulatory system;Both sexes;Distribution by chapter of the CIE;19.47
Total;Arag¾n;Diseases of the circulatory system;Both sexes;Standardised rate of PLYL;9.79
Total;Arag¾n;Diseases of the circulatory system;Both sexes;Average number of PLYL;11.38
Total;Arag¾n;Diseases of the circulatory system;Males;Number of PLYL;9,727.00
Total;Arag¾n;Diseases of the circulatory system;Males;Distribution by chapter of the CIE;21.15
Total;Arag¾n;Diseases of the circulatory system;Males;Standardised rate of PLYL;14.03
Total;Arag¾n;Diseases of the circulatory system;Males;Average number of PLYL;12.52
Total;Arag¾n;Diseases of the circulatory system;Females;Number of PLYL;3,529.00
Total;Arag¾n;Diseases of the circulatory system;Females;Distribution by chapter of the CIE;15.98
Total;Arag¾n;Diseases of the circulatory system;Females;Standardised rate of PLYL;5.35
Total;Arag¾n;Diseases of the circulatory system;Females;Average number of PLYL;9.10
Total;Arag¾n;Diseases of the respiratory system;Both sexes;Number of PLYL;3,232.50
Total;Arag¾n;Diseases of the respiratory system;Both sexes;Distribution by chapter of the CIE;4.75
Total;Arag¾n;Diseases of the respiratory system;Both sexes;Standardised rate of PLYL;2.38
Total;Arag¾n;Diseases of the respiratory system;Both sexes;Average number of PLYL;9.37
Total;Arag¾n;Diseases of the respiratory system;Males;Number of PLYL;2,247.50
Total;Arag¾n;Diseases of the respiratory system;Males;Distribution by chapter of the CIE;4.89
Total;Arag¾n;Diseases of the respiratory system;Males;Standardised rate of PLYL;3.23
Total;Arag¾n;Diseases of the respiratory system;Males;Average number of PLYL;9.56
Total;Arag¾n;Diseases of the respiratory system;Females;Number of PLYL;985.00
Total;Arag¾n;Diseases of the respiratory system;Females;Distribution by chapter of the CIE;4.46
Total;Arag¾n;Diseases of the respiratory system;Females;Standardised rate of PLYL;1.50
Total;Arag¾n;Diseases of the respiratory system;Females;Average number of PLYL;8.95
Total;Arag¾n;Diseases of the digestive system;Both sexes;Number of PLYL;3,290.00
Total;Arag¾n;Diseases of the digestive system;Both sexes;Distribution by chapter of the CIE;4.83
Total;Arag¾n;Diseases of the digestive system;Both sexes;Standardised rate of PLYL;2.41
Total;Arag¾n;Diseases of the digestive system;Both sexes;Average number of PLYL;12.37
Total;Arag¾n;Diseases of the digestive system;Males;Number of PLYL;2,405.00
Total;Arag¾n;Diseases of the digestive system;Males;Distribution by chapter of the CIE;5.23
Total;Arag¾n;Diseases of the digestive system;Males;Standardised rate of PLYL;3.44
Total;Arag¾n;Diseases of the digestive system;Males;Average number of PLYL;13.98
Total;Arag¾n;Diseases of the digestive system;Females;Number of PLYL;885.00
Total;Arag¾n;Diseases of the digestive system;Females;Distribution by chapter of the CIE;4.01
Total;Arag¾n;Diseases of the digestive system;Females;Standardised rate of PLYL;1.35
Total;Arag¾n;Diseases of the digestive system;Females;Average number of PLYL;9.41
Total;Arag¾n;Diseases of the skin and subcutaneous tissue;Both sexes;Number of PLYL;7.50
Total;Arag¾n;Diseases of the skin and subcutaneous tissue;Both sexes;Distribution by chapter of the CIE;0.01
Total;Arag¾n;Diseases of the skin and subcutaneous tissue;Both sexes;Standardised rate of PLYL;0.00
Total;Arag¾n;Diseases of the skin and subcutaneous tissue;Both sexes;Average number of PLYL;2.50
Total;Arag¾n;Diseases of the skin and subcutaneous tissue;Males;Number of PLYL;5.00
Total;Arag¾n;Diseases of the skin and subcutaneous tissue;Males;Distribution by chapter of the CIE;0.01
Total;Arag¾n;Diseases of the skin and subcutaneous tissue;Males;Standardised rate of PLYL;0.01
Total;Arag¾n;Diseases of the skin and subcutaneous tissue;Males;Average number of PLYL;2.50
Total;Arag¾n;Diseases of the skin and subcutaneous tissue;Females;Number of PLYL;2.50
Total;Arag¾n;Diseases of the skin and subcutaneous tissue;Females;Distribution by chapter of the CIE;0.01
Total;Arag¾n;Diseases of the skin and subcutaneous tissue;Females;Standardised rate of PLYL;0.00
Total;Arag¾n;Diseases of the skin and subcutaneous tissue;Females;Average number of PLYL;2.50
Total;Arag¾n;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Number of PLYL;377.50
Total;Arag¾n;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Distribution by chapter of the CIE;0.55
Total;Arag¾n;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Standardised rate of PLYL;0.27
Total;Arag¾n;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Average number of PLYL;10.79
Total;Arag¾n;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Number of PLYL;240.00
Total;Arag¾n;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Distribution by chapter of the CIE;0.52
Total;Arag¾n;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Standardised rate of PLYL;0.33
Total;Arag¾n;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Average number of PLYL;12.00
Total;Arag¾n;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Number of PLYL;137.50
Total;Arag¾n;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Distribution by chapter of the CIE;0.62
Total;Arag¾n;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Standardised rate of PLYL;0.20
Total;Arag¾n;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Average number of PLYL;9.17
Total;Arag¾n;Diseases of the genitourinary system;Both sexes;Number of PLYL;607.00
Total;Arag¾n;Diseases of the genitourinary system;Both sexes;Distribution by chapter of the CIE;0.89
Total;Arag¾n;Diseases of the genitourinary system;Both sexes;Standardised rate of PLYL;0.45
Total;Arag¾n;Diseases of the genitourinary system;Both sexes;Average number of PLYL;6.82
Total;Arag¾n;Diseases of the genitourinary system;Males;Number of PLYL;262.50
Total;Arag¾n;Diseases of the genitourinary system;Males;Distribution by chapter of the CIE;0.57
Total;Arag¾n;Diseases of the genitourinary system;Males;Standardised rate of PLYL;0.37
Total;Arag¾n;Diseases of the genitourinary system;Males;Average number of PLYL;6.10
Total;Arag¾n;Diseases of the genitourinary system;Females;Number of PLYL;344.50
Total;Arag¾n;Diseases of the genitourinary system;Females;Distribution by chapter of the CIE;1.56
Total;Arag¾n;Diseases of the genitourinary system;Females;Standardised rate of PLYL;0.53
Total;Arag¾n;Diseases of the genitourinary system;Females;Average number of PLYL;7.49
Total;Arag¾n;Pregnancy, childbirth and the puerperium;Both sexes;Number of PLYL;..
Total;Arag¾n;Pregnancy, childbirth and the puerperium;Both sexes;Distribution by chapter of the CIE;..
Total;Arag¾n;Pregnancy, childbirth and the puerperium;Both sexes;Standardised rate of PLYL;..
Total;Arag¾n;Pregnancy, childbirth and the puerperium;Both sexes;Average number of PLYL;..
Total;Arag¾n;Pregnancy, childbirth and the puerperium;Males;Number of PLYL;..
Total;Arag¾n;Pregnancy, childbirth and the puerperium;Males;Distribution by chapter of the CIE;..
Total;Arag¾n;Pregnancy, childbirth and the puerperium;Males;Standardised rate of PLYL;..
Total;Arag¾n;Pregnancy, childbirth and the puerperium;Males;Average number of PLYL;..
Total;Arag¾n;Pregnancy, childbirth and the puerperium;Females;Number of PLYL;..
Total;Arag¾n;Pregnancy, childbirth and the puerperium;Females;Distribution by chapter of the CIE;..
Total;Arag¾n;Pregnancy, childbirth and the puerperium;Females;Standardised rate of PLYL;..
Total;Arag¾n;Pregnancy, childbirth and the puerperium;Females;Average number of PLYL;..
Total;Arag¾n;Affections originated in the perinatal period;Both sexes;Number of PLYL;..
Total;Arag¾n;Affections originated in the perinatal period;Both sexes;Distribution by chapter of the CIE;..
Total;Arag¾n;Affections originated in the perinatal period;Both sexes;Standardised rate of PLYL;..
Total;Arag¾n;Affections originated in the perinatal period;Both sexes;Average number of PLYL;..
Total;Arag¾n;Affections originated in the perinatal period;Males;Number of PLYL;..
Total;Arag¾n;Affections originated in the perinatal period;Males;Distribution by chapter of the CIE;..
Total;Arag¾n;Affections originated in the perinatal period;Males;Standardised rate of PLYL;..
Total;Arag¾n;Affections originated in the perinatal period;Males;Average number of PLYL;..
Total;Arag¾n;Affections originated in the perinatal period;Females;Number of PLYL;..
Total;Arag¾n;Affections originated in the perinatal period;Females;Distribution by chapter of the CIE;..
Total;Arag¾n;Affections originated in the perinatal period;Females;Standardised rate of PLYL;..
Total;Arag¾n;Affections originated in the perinatal period;Females;Average number of PLYL;..
Total;Arag¾n;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Number of PLYL;559.00
Total;Arag¾n;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Distribution by chapter of the CIE;0.82
Total;Arag¾n;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Standardised rate of PLYL;0.48
Total;Arag¾n;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Average number of PLYL;27.95
Total;Arag¾n;Congenital malformations, deformities and chromosomal abnormalities;Males;Number of PLYL;289.50
Total;Arag¾n;Congenital malformations, deformities and chromosomal abnormalities;Males;Distribution by chapter of the CIE;0.63
Total;Arag¾n;Congenital malformations, deformities and chromosomal abnormalities;Males;Standardised rate of PLYL;0.48
Total;Arag¾n;Congenital malformations, deformities and chromosomal abnormalities;Males;Average number of PLYL;28.95
Total;Arag¾n;Congenital malformations, deformities and chromosomal abnormalities;Females;Number of PLYL;269.50
Total;Arag¾n;Congenital malformations, deformities and chromosomal abnormalities;Females;Distribution by chapter of the CIE;1.22
Total;Arag¾n;Congenital malformations, deformities and chromosomal abnormalities;Females;Standardised rate of PLYL;0.48
Total;Arag¾n;Congenital malformations, deformities and chromosomal abnormalities;Females;Average number of PLYL;26.95
Total;Arag¾n;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Number of PLYL;2,062.00
Total;Arag¾n;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Distribution by chapter of the CIE;3.03
Total;Arag¾n;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Standardised rate of PLYL;1.52
Total;Arag¾n;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Average number of PLYL;19.64
Total;Arag¾n;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Number of PLYL;1,627.50
Total;Arag¾n;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Distribution by chapter of the CIE;3.54
Total;Arag¾n;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Standardised rate of PLYL;2.31
Total;Arag¾n;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Average number of PLYL;20.60
Total;Arag¾n;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Number of PLYL;434.50
Total;Arag¾n;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Distribution by chapter of the CIE;1.97
Total;Arag¾n;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Standardised rate of PLYL;0.68
Total;Arag¾n;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Average number of PLYL;16.71
Total;Arag¾n;External causes of mortality;Both sexes;Number of PLYL;8,287.50
Total;Arag¾n;External causes of mortality;Both sexes;Distribution by chapter of the CIE;12.17
Total;Arag¾n;External causes of mortality;Both sexes;Standardised rate of PLYL;7.06
Total;Arag¾n;External causes of mortality;Both sexes;Average number of PLYL;29.81
Total;Arag¾n;External causes of mortality;Males;Number of PLYL;6,049.00
Total;Arag¾n;External causes of mortality;Males;Distribution by chapter of the CIE;13.15
Total;Arag¾n;External causes of mortality;Males;Standardised rate of PLYL;10.09
Total;Arag¾n;External causes of mortality;Males;Average number of PLYL;29.95
Total;Arag¾n;External causes of mortality;Females;Number of PLYL;2,238.50
Total;Arag¾n;External causes of mortality;Females;Distribution by chapter of the CIE;10.14
Total;Arag¾n;External causes of mortality;Females;Standardised rate of PLYL;3.92
Total;Arag¾n;External causes of mortality;Females;Average number of PLYL;29.45
Total;Asturias, Principado de;All causes;Both sexes;Number of PLYL;69,093.00
Total;Asturias, Principado de;All causes;Both sexes;Distribution by chapter of the CIE;100.00
Total;Asturias, Principado de;All causes;Both sexes;Standardised rate of PLYL;60.11
Total;Asturias, Principado de;All causes;Both sexes;Average number of PLYL;13.54
Total;Asturias, Principado de;All causes;Males;Number of PLYL;48,192.00
Total;Asturias, Principado de;All causes;Males;Distribution by chapter of the CIE;100.00
Total;Asturias, Principado de;All causes;Males;Standardised rate of PLYL;85.46
Total;Asturias, Principado de;All causes;Males;Average number of PLYL;14.19
Total;Asturias, Principado de;All causes;Females;Number of PLYL;20,901.00
Total;Asturias, Principado de;All causes;Females;Distribution by chapter of the CIE;100.00
Total;Asturias, Principado de;All causes;Females;Standardised rate of PLYL;35.66
Total;Asturias, Principado de;All causes;Females;Average number of PLYL;12.23
Total;Asturias, Principado de;Infectious and parasitic diseases (1);Both sexes;Number of PLYL;1,535.00
Total;Asturias, Principado de;Infectious and parasitic diseases (1);Both sexes;Distribution by chapter of the CIE;2.22
Total;Asturias, Principado de;Infectious and parasitic diseases (1);Both sexes;Standardised rate of PLYL;1.36
Total;Asturias, Principado de;Infectious and parasitic diseases (1);Both sexes;Average number of PLYL;18.27
Total;Asturias, Principado de;Infectious and parasitic diseases (1);Males;Number of PLYL;1,065.00
Total;Asturias, Principado de;Infectious and parasitic diseases (1);Males;Distribution by chapter of the CIE;2.21
Total;Asturias, Principado de;Infectious and parasitic diseases (1);Males;Standardised rate of PLYL;1.86
Total;Asturias, Principado de;Infectious and parasitic diseases (1);Males;Average number of PLYL;19.02
Total;Asturias, Principado de;Infectious and parasitic diseases (1);Females;Number of PLYL;470.00
Total;Asturias, Principado de;Infectious and parasitic diseases (1);Females;Distribution by chapter of the CIE;2.25
Total;Asturias, Principado de;Infectious and parasitic diseases (1);Females;Standardised rate of PLYL;0.88
Total;Asturias, Principado de;Infectious and parasitic diseases (1);Females;Average number of PLYL;16.79
Total;Asturias, Principado de;Tumours;Both sexes;Number of PLYL;30,957.50
Total;Asturias, Principado de;Tumours;Both sexes;Distribution by chapter of the CIE;44.81
Total;Asturias, Principado de;Tumours;Both sexes;Standardised rate of PLYL;25.82
Total;Asturias, Principado de;Tumours;Both sexes;Average number of PLYL;13.77
Total;Asturias, Principado de;Tumours;Males;Number of PLYL;20,727.50
Total;Asturias, Principado de;Tumours;Males;Distribution by chapter of the CIE;43.01
Total;Asturias, Principado de;Tumours;Males;Standardised rate of PLYL;35.04
Total;Asturias, Principado de;Tumours;Males;Average number of PLYL;13.61
Total;Asturias, Principado de;Tumours;Females;Number of PLYL;10,230.00
Total;Asturias, Principado de;Tumours;Females;Distribution by chapter of the CIE;48.95
Total;Asturias, Principado de;Tumours;Females;Standardised rate of PLYL;16.96
Total;Asturias, Principado de;Tumours;Females;Average number of PLYL;14.09
Total;Asturias, Principado de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Number of PLYL;175.00
Total;Asturias, Principado de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Distribution by chapter of the CIE;0.25
Total;Asturias, Principado de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Standardised rate of PLYL;0.19
Total;Asturias, Principado de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Average number of PLYL;9.72
Total;Asturias, Principado de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Number of PLYL;70.00
Total;Asturias, Principado de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Distribution by chapter of the CIE;0.15
Total;Asturias, Principado de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Standardised rate of PLYL;0.10
Total;Asturias, Principado de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Average number of PLYL;5.83
Total;Asturias, Principado de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Number of PLYL;105.00
Total;Asturias, Principado de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Distribution by chapter of the CIE;0.50
Total;Asturias, Principado de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Standardised rate of PLYL;0.28
Total;Asturias, Principado de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Average number of PLYL;17.50
Total;Asturias, Principado de;Endocrine, nutritional and metabolic diseases;Both sexes;Number of PLYL;1,487.50
Total;Asturias, Principado de;Endocrine, nutritional and metabolic diseases;Both sexes;Distribution by chapter of the CIE;2.15
Total;Asturias, Principado de;Endocrine, nutritional and metabolic diseases;Both sexes;Standardised rate of PLYL;1.29
Total;Asturias, Principado de;Endocrine, nutritional and metabolic diseases;Both sexes;Average number of PLYL;11.53
Total;Asturias, Principado de;Endocrine, nutritional and metabolic diseases;Males;Number of PLYL;962.50
Total;Asturias, Principado de;Endocrine, nutritional and metabolic diseases;Males;Distribution by chapter of the CIE;2.00
Total;Asturias, Principado de;Endocrine, nutritional and metabolic diseases;Males;Standardised rate of PLYL;1.69
Total;Asturias, Principado de;Endocrine, nutritional and metabolic diseases;Males;Average number of PLYL;13.56
Total;Asturias, Principado de;Endocrine, nutritional and metabolic diseases;Females;Number of PLYL;525.00
Total;Asturias, Principado de;Endocrine, nutritional and metabolic diseases;Females;Distribution by chapter of the CIE;2.51
Total;Asturias, Principado de;Endocrine, nutritional and metabolic diseases;Females;Standardised rate of PLYL;0.91
Total;Asturias, Principado de;Endocrine, nutritional and metabolic diseases;Females;Average number of PLYL;9.05
Total;Asturias, Principado de;Mental and behavioural disorders;Both sexes;Number of PLYL;887.50
Total;Asturias, Principado de;Mental and behavioural disorders;Both sexes;Distribution by chapter of the CIE;1.28
Total;Asturias, Principado de;Mental and behavioural disorders;Both sexes;Standardised rate of PLYL;0.74
Total;Asturias, Principado de;Mental and behavioural disorders;Both sexes;Average number of PLYL;8.14
Total;Asturias, Principado de;Mental and behavioural disorders;Males;Number of PLYL;555.00
Total;Asturias, Principado de;Mental and behavioural disorders;Males;Distribution by chapter of the CIE;1.15
Total;Asturias, Principado de;Mental and behavioural disorders;Males;Standardised rate of PLYL;0.91
Total;Asturias, Principado de;Mental and behavioural disorders;Males;Average number of PLYL;8.95
Total;Asturias, Principado de;Mental and behavioural disorders;Females;Number of PLYL;332.50
Total;Asturias, Principado de;Mental and behavioural disorders;Females;Distribution by chapter of the CIE;1.59
Total;Asturias, Principado de;Mental and behavioural disorders;Females;Standardised rate of PLYL;0.58
Total;Asturias, Principado de;Mental and behavioural disorders;Females;Average number of PLYL;7.07
Total;Asturias, Principado de;Diseases of the nervous system and the sense organs;Both sexes;Number of PLYL;1,545.00
Total;Asturias, Principado de;Diseases of the nervous system and the sense organs;Both sexes;Distribution by chapter of the CIE;2.24
Total;Asturias, Principado de;Diseases of the nervous system and the sense organs;Both sexes;Standardised rate of PLYL;1.35
Total;Asturias, Principado de;Diseases of the nervous system and the sense organs;Both sexes;Average number of PLYL;9.66
Total;Asturias, Principado de;Diseases of the nervous system and the sense organs;Males;Number of PLYL;680.00
Total;Asturias, Principado de;Diseases of the nervous system and the sense organs;Males;Distribution by chapter of the CIE;1.41
Total;Asturias, Principado de;Diseases of the nervous system and the sense organs;Males;Standardised rate of PLYL;1.12
Total;Asturias, Principado de;Diseases of the nervous system and the sense organs;Males;Average number of PLYL;9.71
Total;Asturias, Principado de;Diseases of the nervous system and the sense organs;Females;Number of PLYL;865.00
Total;Asturias, Principado de;Diseases of the nervous system and the sense organs;Females;Distribution by chapter of the CIE;4.14
Total;Asturias, Principado de;Diseases of the nervous system and the sense organs;Females;Standardised rate of PLYL;1.58
Total;Asturias, Principado de;Diseases of the nervous system and the sense organs;Females;Average number of PLYL;9.61
Total;Asturias, Principado de;Diseases of the circulatory system;Both sexes;Number of PLYL;14,392.50
Total;Asturias, Principado de;Diseases of the circulatory system;Both sexes;Distribution by chapter of the CIE;20.83
Total;Asturias, Principado de;Diseases of the circulatory system;Both sexes;Standardised rate of PLYL;12.19
Total;Asturias, Principado de;Diseases of the circulatory system;Both sexes;Average number of PLYL;11.27
Total;Asturias, Principado de;Diseases of the circulatory system;Males;Number of PLYL;10,090.00
Total;Asturias, Principado de;Diseases of the circulatory system;Males;Distribution by chapter of the CIE;20.94
Total;Asturias, Principado de;Diseases of the circulatory system;Males;Standardised rate of PLYL;17.49
Total;Asturias, Principado de;Diseases of the circulatory system;Males;Average number of PLYL;12.49
Total;Asturias, Principado de;Diseases of the circulatory system;Females;Number of PLYL;4,302.50
Total;Asturias, Principado de;Diseases of the circulatory system;Females;Distribution by chapter of the CIE;20.59
Total;Asturias, Principado de;Diseases of the circulatory system;Females;Standardised rate of PLYL;7.09
Total;Asturias, Principado de;Diseases of the circulatory system;Females;Average number of PLYL;9.17
Total;Asturias, Principado de;Diseases of the respiratory system;Both sexes;Number of PLYL;3,030.00
Total;Asturias, Principado de;Diseases of the respiratory system;Both sexes;Distribution by chapter of the CIE;4.39
Total;Asturias, Principado de;Diseases of the respiratory system;Both sexes;Standardised rate of PLYL;2.55
Total;Asturias, Principado de;Diseases of the respiratory system;Both sexes;Average number of PLYL;9.07
Total;Asturias, Principado de;Diseases of the respiratory system;Males;Number of PLYL;2,345.00
Total;Asturias, Principado de;Diseases of the respiratory system;Males;Distribution by chapter of the CIE;4.87
Total;Asturias, Principado de;Diseases of the respiratory system;Males;Standardised rate of PLYL;3.99
Total;Asturias, Principado de;Diseases of the respiratory system;Males;Average number of PLYL;8.95
Total;Asturias, Principado de;Diseases of the respiratory system;Females;Number of PLYL;685.00
Total;Asturias, Principado de;Diseases of the respiratory system;Females;Distribution by chapter of the CIE;3.28
Total;Asturias, Principado de;Diseases of the respiratory system;Females;Standardised rate of PLYL;1.17
Total;Asturias, Principado de;Diseases of the respiratory system;Females;Average number of PLYL;9.51
Total;Asturias, Principado de;Diseases of the digestive system;Both sexes;Number of PLYL;4,372.50
Total;Asturias, Principado de;Diseases of the digestive system;Both sexes;Distribution by chapter of the CIE;6.33
Total;Asturias, Principado de;Diseases of the digestive system;Both sexes;Standardised rate of PLYL;3.71
Total;Asturias, Principado de;Diseases of the digestive system;Both sexes;Average number of PLYL;15.03
Total;Asturias, Principado de;Diseases of the digestive system;Males;Number of PLYL;3,417.50
Total;Asturias, Principado de;Diseases of the digestive system;Males;Distribution by chapter of the CIE;7.09
Total;Asturias, Principado de;Diseases of the digestive system;Males;Standardised rate of PLYL;5.88
Total;Asturias, Principado de;Diseases of the digestive system;Males;Average number of PLYL;16.51
Total;Asturias, Principado de;Diseases of the digestive system;Females;Number of PLYL;955.00
Total;Asturias, Principado de;Diseases of the digestive system;Females;Distribution by chapter of the CIE;4.57
Total;Asturias, Principado de;Diseases of the digestive system;Females;Standardised rate of PLYL;1.64
Total;Asturias, Principado de;Diseases of the digestive system;Females;Average number of PLYL;11.37
Total;Asturias, Principado de;Diseases of the skin and subcutaneous tissue;Both sexes;Number of PLYL;37.50
Total;Asturias, Principado de;Diseases of the skin and subcutaneous tissue;Both sexes;Distribution by chapter of the CIE;0.05
Total;Asturias, Principado de;Diseases of the skin and subcutaneous tissue;Both sexes;Standardised rate of PLYL;0.03
Total;Asturias, Principado de;Diseases of the skin and subcutaneous tissue;Both sexes;Average number of PLYL;4.17
Total;Asturias, Principado de;Diseases of the skin and subcutaneous tissue;Males;Number of PLYL;25.00
Total;Asturias, Principado de;Diseases of the skin and subcutaneous tissue;Males;Distribution by chapter of the CIE;0.05
Total;Asturias, Principado de;Diseases of the skin and subcutaneous tissue;Males;Standardised rate of PLYL;0.04
Total;Asturias, Principado de;Diseases of the skin and subcutaneous tissue;Males;Average number of PLYL;4.17
Total;Asturias, Principado de;Diseases of the skin and subcutaneous tissue;Females;Number of PLYL;12.50
Total;Asturias, Principado de;Diseases of the skin and subcutaneous tissue;Females;Distribution by chapter of the CIE;0.06
Total;Asturias, Principado de;Diseases of the skin and subcutaneous tissue;Females;Standardised rate of PLYL;0.02
Total;Asturias, Principado de;Diseases of the skin and subcutaneous tissue;Females;Average number of PLYL;4.17
Total;Asturias, Principado de;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Number of PLYL;147.50
Total;Asturias, Principado de;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Distribution by chapter of the CIE;0.21
Total;Asturias, Principado de;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Standardised rate of PLYL;0.12
Total;Asturias, Principado de;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Average number of PLYL;6.41
Total;Asturias, Principado de;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Number of PLYL;32.50
Total;Asturias, Principado de;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Distribution by chapter of the CIE;0.07
Total;Asturias, Principado de;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Standardised rate of PLYL;0.05
Total;Asturias, Principado de;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Average number of PLYL;3.61
Total;Asturias, Principado de;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Number of PLYL;115.00
Total;Asturias, Principado de;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Distribution by chapter of the CIE;0.55
Total;Asturias, Principado de;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Standardised rate of PLYL;0.18
Total;Asturias, Principado de;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Average number of PLYL;8.21
Total;Asturias, Principado de;Diseases of the genitourinary system;Both sexes;Number of PLYL;490.00
Total;Asturias, Principado de;Diseases of the genitourinary system;Both sexes;Distribution by chapter of the CIE;0.71
Total;Asturias, Principado de;Diseases of the genitourinary system;Both sexes;Standardised rate of PLYL;0.44
Total;Asturias, Principado de;Diseases of the genitourinary system;Both sexes;Average number of PLYL;8.75
Total;Asturias, Principado de;Diseases of the genitourinary system;Males;Number of PLYL;417.50
Total;Asturias, Principado de;Diseases of the genitourinary system;Males;Distribution by chapter of the CIE;0.87
Total;Asturias, Principado de;Diseases of the genitourinary system;Males;Standardised rate of PLYL;0.77
Total;Asturias, Principado de;Diseases of the genitourinary system;Males;Average number of PLYL;10.18
Total;Asturias, Principado de;Diseases of the genitourinary system;Females;Number of PLYL;72.50
Total;Asturias, Principado de;Diseases of the genitourinary system;Females;Distribution by chapter of the CIE;0.35
Total;Asturias, Principado de;Diseases of the genitourinary system;Females;Standardised rate of PLYL;0.12
Total;Asturias, Principado de;Diseases of the genitourinary system;Females;Average number of PLYL;4.83
Total;Asturias, Principado de;Pregnancy, childbirth and the puerperium;Both sexes;Number of PLYL;..
Total;Asturias, Principado de;Pregnancy, childbirth and the puerperium;Both sexes;Distribution by chapter of the CIE;..
Total;Asturias, Principado de;Pregnancy, childbirth and the puerperium;Both sexes;Standardised rate of PLYL;..
Total;Asturias, Principado de;Pregnancy, childbirth and the puerperium;Both sexes;Average number of PLYL;..
Total;Asturias, Principado de;Pregnancy, childbirth and the puerperium;Males;Number of PLYL;..
Total;Asturias, Principado de;Pregnancy, childbirth and the puerperium;Males;Distribution by chapter of the CIE;..
Total;Asturias, Principado de;Pregnancy, childbirth and the puerperium;Males;Standardised rate of PLYL;..
Total;Asturias, Principado de;Pregnancy, childbirth and the puerperium;Males;Average number of PLYL;..
Total;Asturias, Principado de;Pregnancy, childbirth and the puerperium;Females;Number of PLYL;..
Total;Asturias, Principado de;Pregnancy, childbirth and the puerperium;Females;Distribution by chapter of the CIE;..
Total;Asturias, Principado de;Pregnancy, childbirth and the puerperium;Females;Standardised rate of PLYL;..
Total;Asturias, Principado de;Pregnancy, childbirth and the puerperium;Females;Average number of PLYL;..
Total;Asturias, Principado de;Affections originated in the perinatal period;Both sexes;Number of PLYL;..
Total;Asturias, Principado de;Affections originated in the perinatal period;Both sexes;Distribution by chapter of the CIE;..
Total;Asturias, Principado de;Affections originated in the perinatal period;Both sexes;Standardised rate of PLYL;..
Total;Asturias, Principado de;Affections originated in the perinatal period;Both sexes;Average number of PLYL;..
Total;Asturias, Principado de;Affections originated in the perinatal period;Males;Number of PLYL;..
Total;Asturias, Principado de;Affections originated in the perinatal period;Males;Distribution by chapter of the CIE;..
Total;Asturias, Principado de;Affections originated in the perinatal period;Males;Standardised rate of PLYL;..
Total;Asturias, Principado de;Affections originated in the perinatal period;Males;Average number of PLYL;..
Total;Asturias, Principado de;Affections originated in the perinatal period;Females;Number of PLYL;..
Total;Asturias, Principado de;Affections originated in the perinatal period;Females;Distribution by chapter of the CIE;..
Total;Asturias, Principado de;Affections originated in the perinatal period;Females;Standardised rate of PLYL;..
Total;Asturias, Principado de;Affections originated in the perinatal period;Females;Average number of PLYL;..
Total;Asturias, Principado de;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Number of PLYL;564.00
Total;Asturias, Principado de;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Distribution by chapter of the CIE;0.82
Total;Asturias, Principado de;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Standardised rate of PLYL;0.63
Total;Asturias, Principado de;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Average number of PLYL;40.29
Total;Asturias, Principado de;Congenital malformations, deformities and chromosomal abnormalities;Males;Number of PLYL;332.00
Total;Asturias, Principado de;Congenital malformations, deformities and chromosomal abnormalities;Males;Distribution by chapter of the CIE;0.69
Total;Asturias, Principado de;Congenital malformations, deformities and chromosomal abnormalities;Males;Standardised rate of PLYL;0.81
Total;Asturias, Principado de;Congenital malformations, deformities and chromosomal abnormalities;Males;Average number of PLYL;47.43
Total;Asturias, Principado de;Congenital malformations, deformities and chromosomal abnormalities;Females;Number of PLYL;232.00
Total;Asturias, Principado de;Congenital malformations, deformities and chromosomal abnormalities;Females;Distribution by chapter of the CIE;1.11
Total;Asturias, Principado de;Congenital malformations, deformities and chromosomal abnormalities;Females;Standardised rate of PLYL;0.45
Total;Asturias, Principado de;Congenital malformations, deformities and chromosomal abnormalities;Females;Average number of PLYL;33.14
Total;Asturias, Principado de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Number of PLYL;352.50
Total;Asturias, Principado de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Distribution by chapter of the CIE;0.51
Total;Asturias, Principado de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Standardised rate of PLYL;0.29
Total;Asturias, Principado de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Average number of PLYL;18.55
Total;Asturias, Principado de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Number of PLYL;255.00
Total;Asturias, Principado de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Distribution by chapter of the CIE;0.53
Total;Asturias, Principado de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Standardised rate of PLYL;0.44
Total;Asturias, Principado de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Average number of PLYL;21.25
Total;Asturias, Principado de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Number of PLYL;97.50
Total;Asturias, Principado de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Distribution by chapter of the CIE;0.47
Total;Asturias, Principado de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Standardised rate of PLYL;0.15
Total;Asturias, Principado de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Average number of PLYL;13.93
Total;Asturias, Principado de;External causes of mortality;Both sexes;Number of PLYL;9,119.00
Total;Asturias, Principado de;External causes of mortality;Both sexes;Distribution by chapter of the CIE;13.20
Total;Asturias, Principado de;External causes of mortality;Both sexes;Standardised rate of PLYL;9.38
Total;Asturias, Principado de;External causes of mortality;Both sexes;Average number of PLYL;27.47
Total;Asturias, Principado de;External causes of mortality;Males;Number of PLYL;7,217.50
Total;Asturias, Principado de;External causes of mortality;Males;Distribution by chapter of the CIE;14.98
Total;Asturias, Principado de;External causes of mortality;Males;Standardised rate of PLYL;15.26
Total;Asturias, Principado de;External causes of mortality;Males;Average number of PLYL;28.99
Total;Asturias, Principado de;External causes of mortality;Females;Number of PLYL;1,901.50
Total;Asturias, Principado de;External causes of mortality;Females;Distribution by chapter of the CIE;9.10
Total;Asturias, Principado de;External causes of mortality;Females;Standardised rate of PLYL;3.66
Total;Asturias, Principado de;External causes of mortality;Females;Average number of PLYL;22.91
Total;Balears, Illes;All causes;Both sexes;Number of PLYL;53,320.00
Total;Balears, Illes;All causes;Both sexes;Distribution by chapter of the CIE;100.00
Total;Balears, Illes;All causes;Both sexes;Standardised rate of PLYL;52.72
Total;Balears, Illes;All causes;Both sexes;Average number of PLYL;15.26
Total;Balears, Illes;All causes;Males;Number of PLYL;36,907.00
Total;Balears, Illes;All causes;Males;Distribution by chapter of the CIE;100.00
Total;Balears, Illes;All causes;Males;Standardised rate of PLYL;71.49
Total;Balears, Illes;All causes;Males;Average number of PLYL;16.03
Total;Balears, Illes;All causes;Females;Number of PLYL;16,413.00
Total;Balears, Illes;All causes;Females;Distribution by chapter of the CIE;100.00
Total;Balears, Illes;All causes;Females;Standardised rate of PLYL;33.18
Total;Balears, Illes;All causes;Females;Average number of PLYL;13.77
Total;Balears, Illes;Infectious and parasitic diseases (1);Both sexes;Number of PLYL;1,255.00
Total;Balears, Illes;Infectious and parasitic diseases (1);Both sexes;Distribution by chapter of the CIE;2.35
Total;Balears, Illes;Infectious and parasitic diseases (1);Both sexes;Standardised rate of PLYL;1.15
Total;Balears, Illes;Infectious and parasitic diseases (1);Both sexes;Average number of PLYL;17.93
Total;Balears, Illes;Infectious and parasitic diseases (1);Males;Number of PLYL;977.50
Total;Balears, Illes;Infectious and parasitic diseases (1);Males;Distribution by chapter of the CIE;2.65
Total;Balears, Illes;Infectious and parasitic diseases (1);Males;Standardised rate of PLYL;1.71
Total;Balears, Illes;Infectious and parasitic diseases (1);Males;Average number of PLYL;21.72
Total;Balears, Illes;Infectious and parasitic diseases (1);Females;Number of PLYL;277.50
Total;Balears, Illes;Infectious and parasitic diseases (1);Females;Distribution by chapter of the CIE;1.69
Total;Balears, Illes;Infectious and parasitic diseases (1);Females;Standardised rate of PLYL;0.56
Total;Balears, Illes;Infectious and parasitic diseases (1);Females;Average number of PLYL;11.10
Total;Balears, Illes;Tumours;Both sexes;Number of PLYL;22,287.00
Total;Balears, Illes;Tumours;Both sexes;Distribution by chapter of the CIE;41.80
Total;Balears, Illes;Tumours;Both sexes;Standardised rate of PLYL;22.17
Total;Balears, Illes;Tumours;Both sexes;Average number of PLYL;15.23
Total;Balears, Illes;Tumours;Males;Number of PLYL;14,047.00
Total;Balears, Illes;Tumours;Males;Distribution by chapter of the CIE;38.06
Total;Balears, Illes;Tumours;Males;Standardised rate of PLYL;27.69
Total;Balears, Illes;Tumours;Males;Average number of PLYL;14.83
Total;Balears, Illes;Tumours;Females;Number of PLYL;8,240.00
Total;Balears, Illes;Tumours;Females;Distribution by chapter of the CIE;50.20
Total;Balears, Illes;Tumours;Females;Standardised rate of PLYL;16.35
Total;Balears, Illes;Tumours;Females;Average number of PLYL;15.97
Total;Balears, Illes;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Number of PLYL;180.00
Total;Balears, Illes;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Distribution by chapter of the CIE;0.34
Total;Balears, Illes;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Standardised rate of PLYL;0.17
Total;Balears, Illes;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Average number of PLYL;15.00
Total;Balears, Illes;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Number of PLYL;130.00
Total;Balears, Illes;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Distribution by chapter of the CIE;0.35
Total;Balears, Illes;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Standardised rate of PLYL;0.24
Total;Balears, Illes;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Average number of PLYL;16.25
Total;Balears, Illes;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Number of PLYL;50.00
Total;Balears, Illes;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Distribution by chapter of the CIE;0.30
Total;Balears, Illes;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Standardised rate of PLYL;0.09
Total;Balears, Illes;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Average number of PLYL;12.50
Total;Balears, Illes;Endocrine, nutritional and metabolic diseases;Both sexes;Number of PLYL;1,012.00
Total;Balears, Illes;Endocrine, nutritional and metabolic diseases;Both sexes;Distribution by chapter of the CIE;1.90
Total;Balears, Illes;Endocrine, nutritional and metabolic diseases;Both sexes;Standardised rate of PLYL;1.06
Total;Balears, Illes;Endocrine, nutritional and metabolic diseases;Both sexes;Average number of PLYL;10.65
Total;Balears, Illes;Endocrine, nutritional and metabolic diseases;Males;Number of PLYL;619.50
Total;Balears, Illes;Endocrine, nutritional and metabolic diseases;Males;Distribution by chapter of the CIE;1.68
Total;Balears, Illes;Endocrine, nutritional and metabolic diseases;Males;Standardised rate of PLYL;1.24
Total;Balears, Illes;Endocrine, nutritional and metabolic diseases;Males;Average number of PLYL;11.06
Total;Balears, Illes;Endocrine, nutritional and metabolic diseases;Females;Number of PLYL;392.50
Total;Balears, Illes;Endocrine, nutritional and metabolic diseases;Females;Distribution by chapter of the CIE;2.39
Total;Balears, Illes;Endocrine, nutritional and metabolic diseases;Females;Standardised rate of PLYL;0.88
Total;Balears, Illes;Endocrine, nutritional and metabolic diseases;Females;Average number of PLYL;10.06
Total;Balears, Illes;Mental and behavioural disorders;Both sexes;Number of PLYL;622.50
Total;Balears, Illes;Mental and behavioural disorders;Both sexes;Distribution by chapter of the CIE;1.17
Total;Balears, Illes;Mental and behavioural disorders;Both sexes;Standardised rate of PLYL;0.64
Total;Balears, Illes;Mental and behavioural disorders;Both sexes;Average number of PLYL;10.20
Total;Balears, Illes;Mental and behavioural disorders;Males;Number of PLYL;407.50
Total;Balears, Illes;Mental and behavioural disorders;Males;Distribution by chapter of the CIE;1.10
Total;Balears, Illes;Mental and behavioural disorders;Males;Standardised rate of PLYL;0.79
Total;Balears, Illes;Mental and behavioural disorders;Males;Average number of PLYL;11.64
Total;Balears, Illes;Mental and behavioural disorders;Females;Number of PLYL;215.00
Total;Balears, Illes;Mental and behavioural disorders;Females;Distribution by chapter of the CIE;1.31
Total;Balears, Illes;Mental and behavioural disorders;Females;Standardised rate of PLYL;0.49
Total;Balears, Illes;Mental and behavioural disorders;Females;Average number of PLYL;8.27
Total;Balears, Illes;Diseases of the nervous system and the sense organs;Both sexes;Number of PLYL;1,969.50
Total;Balears, Illes;Diseases of the nervous system and the sense organs;Both sexes;Distribution by chapter of the CIE;3.69
Total;Balears, Illes;Diseases of the nervous system and the sense organs;Both sexes;Standardised rate of PLYL;1.92
Total;Balears, Illes;Diseases of the nervous system and the sense organs;Both sexes;Average number of PLYL;12.96
Total;Balears, Illes;Diseases of the nervous system and the sense organs;Males;Number of PLYL;1,132.00
Total;Balears, Illes;Diseases of the nervous system and the sense organs;Males;Distribution by chapter of the CIE;3.07
Total;Balears, Illes;Diseases of the nervous system and the sense organs;Males;Standardised rate of PLYL;2.18
Total;Balears, Illes;Diseases of the nervous system and the sense organs;Males;Average number of PLYL;13.98
Total;Balears, Illes;Diseases of the nervous system and the sense organs;Females;Number of PLYL;837.50
Total;Balears, Illes;Diseases of the nervous system and the sense organs;Females;Distribution by chapter of the CIE;5.10
Total;Balears, Illes;Diseases of the nervous system and the sense organs;Females;Standardised rate of PLYL;1.65
Total;Balears, Illes;Diseases of the nervous system and the sense organs;Females;Average number of PLYL;11.80
Total;Balears, Illes;Diseases of the circulatory system;Both sexes;Number of PLYL;9,622.50
Total;Balears, Illes;Diseases of the circulatory system;Both sexes;Distribution by chapter of the CIE;18.05
Total;Balears, Illes;Diseases of the circulatory system;Both sexes;Standardised rate of PLYL;9.77
Total;Balears, Illes;Diseases of the circulatory system;Both sexes;Average number of PLYL;12.20
Total;Balears, Illes;Diseases of the circulatory system;Males;Number of PLYL;7,060.00
Total;Balears, Illes;Diseases of the circulatory system;Males;Distribution by chapter of the CIE;19.13
Total;Balears, Illes;Diseases of the circulatory system;Males;Standardised rate of PLYL;13.77
Total;Balears, Illes;Diseases of the circulatory system;Males;Average number of PLYL;13.63
Total;Balears, Illes;Diseases of the circulatory system;Females;Number of PLYL;2,562.50
Total;Balears, Illes;Diseases of the circulatory system;Females;Distribution by chapter of the CIE;15.61
Total;Balears, Illes;Diseases of the circulatory system;Females;Standardised rate of PLYL;5.60
Total;Balears, Illes;Diseases of the circulatory system;Females;Average number of PLYL;9.46
Total;Balears, Illes;Diseases of the respiratory system;Both sexes;Number of PLYL;3,022.50
Total;Balears, Illes;Diseases of the respiratory system;Both sexes;Distribution by chapter of the CIE;5.67
Total;Balears, Illes;Diseases of the respiratory system;Both sexes;Standardised rate of PLYL;3.05
Total;Balears, Illes;Diseases of the respiratory system;Both sexes;Average number of PLYL;12.34
Total;Balears, Illes;Diseases of the respiratory system;Males;Number of PLYL;2,250.00
Total;Balears, Illes;Diseases of the respiratory system;Males;Distribution by chapter of the CIE;6.10
Total;Balears, Illes;Diseases of the respiratory system;Males;Standardised rate of PLYL;4.41
Total;Balears, Illes;Diseases of the respiratory system;Males;Average number of PLYL;12.93
Total;Balears, Illes;Diseases of the respiratory system;Females;Number of PLYL;772.50
Total;Balears, Illes;Diseases of the respiratory system;Females;Distribution by chapter of the CIE;4.71
Total;Balears, Illes;Diseases of the respiratory system;Females;Standardised rate of PLYL;1.61
Total;Balears, Illes;Diseases of the respiratory system;Females;Average number of PLYL;10.88
Total;Balears, Illes;Diseases of the digestive system;Both sexes;Number of PLYL;2,805.00
Total;Balears, Illes;Diseases of the digestive system;Both sexes;Distribution by chapter of the CIE;5.26
Total;Balears, Illes;Diseases of the digestive system;Both sexes;Standardised rate of PLYL;2.73
Total;Balears, Illes;Diseases of the digestive system;Both sexes;Average number of PLYL;14.61
Total;Balears, Illes;Diseases of the digestive system;Males;Number of PLYL;2,187.50
Total;Balears, Illes;Diseases of the digestive system;Males;Distribution by chapter of the CIE;5.93
Total;Balears, Illes;Diseases of the digestive system;Males;Standardised rate of PLYL;4.15
Total;Balears, Illes;Diseases of the digestive system;Males;Average number of PLYL;16.20
Total;Balears, Illes;Diseases of the digestive system;Females;Number of PLYL;617.50
Total;Balears, Illes;Diseases of the digestive system;Females;Distribution by chapter of the CIE;3.76
Total;Balears, Illes;Diseases of the digestive system;Females;Standardised rate of PLYL;1.25
Total;Balears, Illes;Diseases of the digestive system;Females;Average number of PLYL;10.83
Total;Balears, Illes;Diseases of the skin and subcutaneous tissue;Both sexes;Number of PLYL;90.00
Total;Balears, Illes;Diseases of the skin and subcutaneous tissue;Both sexes;Distribution by chapter of the CIE;0.17
Total;Balears, Illes;Diseases of the skin and subcutaneous tissue;Both sexes;Standardised rate of PLYL;0.08
Total;Balears, Illes;Diseases of the skin and subcutaneous tissue;Both sexes;Average number of PLYL;11.25
Total;Balears, Illes;Diseases of the skin and subcutaneous tissue;Males;Number of PLYL;52.50
Total;Balears, Illes;Diseases of the skin and subcutaneous tissue;Males;Distribution by chapter of the CIE;0.14
Total;Balears, Illes;Diseases of the skin and subcutaneous tissue;Males;Standardised rate of PLYL;0.09
Total;Balears, Illes;Diseases of the skin and subcutaneous tissue;Males;Average number of PLYL;17.50
Total;Balears, Illes;Diseases of the skin and subcutaneous tissue;Females;Number of PLYL;37.50
Total;Balears, Illes;Diseases of the skin and subcutaneous tissue;Females;Distribution by chapter of the CIE;0.23
Total;Balears, Illes;Diseases of the skin and subcutaneous tissue;Females;Standardised rate of PLYL;0.08
Total;Balears, Illes;Diseases of the skin and subcutaneous tissue;Females;Average number of PLYL;7.50
Total;Balears, Illes;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Number of PLYL;145.00
Total;Balears, Illes;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Distribution by chapter of the CIE;0.27
Total;Balears, Illes;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Standardised rate of PLYL;0.15
Total;Balears, Illes;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Average number of PLYL;8.06
Total;Balears, Illes;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Number of PLYL;67.50
Total;Balears, Illes;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Distribution by chapter of the CIE;0.18
Total;Balears, Illes;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Standardised rate of PLYL;0.15
Total;Balears, Illes;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Average number of PLYL;7.50
Total;Balears, Illes;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Number of PLYL;77.50
Total;Balears, Illes;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Distribution by chapter of the CIE;0.47
Total;Balears, Illes;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Standardised rate of PLYL;0.14
Total;Balears, Illes;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Average number of PLYL;8.61
Total;Balears, Illes;Diseases of the genitourinary system;Both sexes;Number of PLYL;500.00
Total;Balears, Illes;Diseases of the genitourinary system;Both sexes;Distribution by chapter of the CIE;0.94
Total;Balears, Illes;Diseases of the genitourinary system;Both sexes;Standardised rate of PLYL;0.52
Total;Balears, Illes;Diseases of the genitourinary system;Both sexes;Average number of PLYL;8.33
Total;Balears, Illes;Diseases of the genitourinary system;Males;Number of PLYL;265.00
Total;Balears, Illes;Diseases of the genitourinary system;Males;Distribution by chapter of the CIE;0.72
Total;Balears, Illes;Diseases of the genitourinary system;Males;Standardised rate of PLYL;0.53
Total;Balears, Illes;Diseases of the genitourinary system;Males;Average number of PLYL;7.79
Total;Balears, Illes;Diseases of the genitourinary system;Females;Number of PLYL;235.00
Total;Balears, Illes;Diseases of the genitourinary system;Females;Distribution by chapter of the CIE;1.43
Total;Balears, Illes;Diseases of the genitourinary system;Females;Standardised rate of PLYL;0.51
Total;Balears, Illes;Diseases of the genitourinary system;Females;Average number of PLYL;9.04
Total;Balears, Illes;Pregnancy, childbirth and the puerperium;Both sexes;Number of PLYL;..
Total;Balears, Illes;Pregnancy, childbirth and the puerperium;Both sexes;Distribution by chapter of the CIE;..
Total;Balears, Illes;Pregnancy, childbirth and the puerperium;Both sexes;Standardised rate of PLYL;..
Total;Balears, Illes;Pregnancy, childbirth and the puerperium;Both sexes;Average number of PLYL;..
Total;Balears, Illes;Pregnancy, childbirth and the puerperium;Males;Number of PLYL;..
Total;Balears, Illes;Pregnancy, childbirth and the puerperium;Males;Distribution by chapter of the CIE;..
Total;Balears, Illes;Pregnancy, childbirth and the puerperium;Males;Standardised rate of PLYL;..
Total;Balears, Illes;Pregnancy, childbirth and the puerperium;Males;Average number of PLYL;..
Total;Balears, Illes;Pregnancy, childbirth and the puerperium;Females;Number of PLYL;..
Total;Balears, Illes;Pregnancy, childbirth and the puerperium;Females;Distribution by chapter of the CIE;..
Total;Balears, Illes;Pregnancy, childbirth and the puerperium;Females;Standardised rate of PLYL;..
Total;Balears, Illes;Pregnancy, childbirth and the puerperium;Females;Average number of PLYL;..
Total;Balears, Illes;Affections originated in the perinatal period;Both sexes;Number of PLYL;77.00
Total;Balears, Illes;Affections originated in the perinatal period;Both sexes;Distribution by chapter of the CIE;0.14
Total;Balears, Illes;Affections originated in the perinatal period;Both sexes;Standardised rate of PLYL;0.06
Total;Balears, Illes;Affections originated in the perinatal period;Both sexes;Average number of PLYL;77.00
Total;Balears, Illes;Affections originated in the perinatal period;Males;Number of PLYL;..
Total;Balears, Illes;Affections originated in the perinatal period;Males;Distribution by chapter of the CIE;..
Total;Balears, Illes;Affections originated in the perinatal period;Males;Standardised rate of PLYL;..
Total;Balears, Illes;Affections originated in the perinatal period;Males;Average number of PLYL;..
Total;Balears, Illes;Affections originated in the perinatal period;Females;Number of PLYL;77.00
Total;Balears, Illes;Affections originated in the perinatal period;Females;Distribution by chapter of the CIE;0.47
Total;Balears, Illes;Affections originated in the perinatal period;Females;Standardised rate of PLYL;0.12
Total;Balears, Illes;Affections originated in the perinatal period;Females;Average number of PLYL;77.00
Total;Balears, Illes;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Number of PLYL;142.50
Total;Balears, Illes;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Distribution by chapter of the CIE;0.27
Total;Balears, Illes;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Standardised rate of PLYL;0.13
Total;Balears, Illes;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Average number of PLYL;20.36
Total;Balears, Illes;Congenital malformations, deformities and chromosomal abnormalities;Males;Number of PLYL;112.50
Total;Balears, Illes;Congenital malformations, deformities and chromosomal abnormalities;Males;Distribution by chapter of the CIE;0.30
Total;Balears, Illes;Congenital malformations, deformities and chromosomal abnormalities;Males;Standardised rate of PLYL;0.20
Total;Balears, Illes;Congenital malformations, deformities and chromosomal abnormalities;Males;Average number of PLYL;22.50
Total;Balears, Illes;Congenital malformations, deformities and chromosomal abnormalities;Females;Number of PLYL;30.00
Total;Balears, Illes;Congenital malformations, deformities and chromosomal abnormalities;Females;Distribution by chapter of the CIE;0.18
Total;Balears, Illes;Congenital malformations, deformities and chromosomal abnormalities;Females;Standardised rate of PLYL;0.06
Total;Balears, Illes;Congenital malformations, deformities and chromosomal abnormalities;Females;Average number of PLYL;15.00
Total;Balears, Illes;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Number of PLYL;1,426.50
Total;Balears, Illes;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Distribution by chapter of the CIE;2.68
Total;Balears, Illes;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Standardised rate of PLYL;1.33
Total;Balears, Illes;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Average number of PLYL;23.39
Total;Balears, Illes;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Number of PLYL;1,221.50
Total;Balears, Illes;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Distribution by chapter of the CIE;3.31
Total;Balears, Illes;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Standardised rate of PLYL;2.26
Total;Balears, Illes;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Average number of PLYL;24.93
Total;Balears, Illes;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Number of PLYL;205.00
Total;Balears, Illes;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Distribution by chapter of the CIE;1.25
Total;Balears, Illes;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Standardised rate of PLYL;0.39
Total;Balears, Illes;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Average number of PLYL;17.08
Total;Balears, Illes;External causes of mortality;Both sexes;Number of PLYL;8,163.00
Total;Balears, Illes;External causes of mortality;Both sexes;Distribution by chapter of the CIE;15.31
Total;Balears, Illes;External causes of mortality;Both sexes;Standardised rate of PLYL;7.78
Total;Balears, Illes;External causes of mortality;Both sexes;Average number of PLYL;31.40
Total;Balears, Illes;External causes of mortality;Males;Number of PLYL;6,377.00
Total;Balears, Illes;External causes of mortality;Males;Distribution by chapter of the CIE;17.28
Total;Balears, Illes;External causes of mortality;Males;Standardised rate of PLYL;12.07
Total;Balears, Illes;External causes of mortality;Males;Average number of PLYL;31.41
Total;Balears, Illes;External causes of mortality;Females;Number of PLYL;1,786.00
Total;Balears, Illes;External causes of mortality;Females;Distribution by chapter of the CIE;10.88
Total;Balears, Illes;External causes of mortality;Females;Standardised rate of PLYL;3.40
Total;Balears, Illes;External causes of mortality;Females;Average number of PLYL;31.33
Total;Canarias;All causes;Both sexes;Number of PLYL;110,175.00
Total;Canarias;All causes;Both sexes;Distribution by chapter of the CIE;100.00
Total;Canarias;All causes;Both sexes;Standardised rate of PLYL;55.86
Total;Canarias;All causes;Both sexes;Average number of PLYL;15.15
Total;Canarias;All causes;Males;Number of PLYL;75,257.00
Total;Canarias;All causes;Males;Distribution by chapter of the CIE;100.00
Total;Canarias;All causes;Males;Standardised rate of PLYL;75.22
Total;Canarias;All causes;Males;Average number of PLYL;15.90
Total;Canarias;All causes;Females;Number of PLYL;34,918.00
Total;Canarias;All causes;Females;Distribution by chapter of the CIE;100.00
Total;Canarias;All causes;Females;Standardised rate of PLYL;36.01
Total;Canarias;All causes;Females;Average number of PLYL;13.76
Total;Canarias;Infectious and parasitic diseases (1);Both sexes;Number of PLYL;2,764.50
Total;Canarias;Infectious and parasitic diseases (1);Both sexes;Distribution by chapter of the CIE;2.51
Total;Canarias;Infectious and parasitic diseases (1);Both sexes;Standardised rate of PLYL;1.29
Total;Canarias;Infectious and parasitic diseases (1);Both sexes;Average number of PLYL;20.94
Total;Canarias;Infectious and parasitic diseases (1);Males;Number of PLYL;2,172.00
Total;Canarias;Infectious and parasitic diseases (1);Males;Distribution by chapter of the CIE;2.89
Total;Canarias;Infectious and parasitic diseases (1);Males;Standardised rate of PLYL;1.95
Total;Canarias;Infectious and parasitic diseases (1);Males;Average number of PLYL;24.97
Total;Canarias;Infectious and parasitic diseases (1);Females;Number of PLYL;592.50
Total;Canarias;Infectious and parasitic diseases (1);Females;Distribution by chapter of the CIE;1.70
Total;Canarias;Infectious and parasitic diseases (1);Females;Standardised rate of PLYL;0.62
Total;Canarias;Infectious and parasitic diseases (1);Females;Average number of PLYL;13.17
Total;Canarias;Tumours;Both sexes;Number of PLYL;43,438.50
Total;Canarias;Tumours;Both sexes;Distribution by chapter of the CIE;39.43
Total;Canarias;Tumours;Both sexes;Standardised rate of PLYL;22.19
Total;Canarias;Tumours;Both sexes;Average number of PLYL;14.73
Total;Canarias;Tumours;Males;Number of PLYL;27,276.50
Total;Canarias;Tumours;Males;Distribution by chapter of the CIE;36.24
Total;Canarias;Tumours;Males;Standardised rate of PLYL;27.82
Total;Canarias;Tumours;Males;Average number of PLYL;14.23
Total;Canarias;Tumours;Females;Number of PLYL;16,162.00
Total;Canarias;Tumours;Females;Distribution by chapter of the CIE;46.29
Total;Canarias;Tumours;Females;Standardised rate of PLYL;16.35
Total;Canarias;Tumours;Females;Average number of PLYL;15.68
Total;Canarias;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Number of PLYL;642.50
Total;Canarias;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Distribution by chapter of the CIE;0.58
Total;Canarias;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Standardised rate of PLYL;0.32
Total;Canarias;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Average number of PLYL;20.73
Total;Canarias;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Number of PLYL;410.00
Total;Canarias;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Distribution by chapter of the CIE;0.54
Total;Canarias;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Standardised rate of PLYL;0.41
Total;Canarias;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Average number of PLYL;25.63
Total;Canarias;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Number of PLYL;232.50
Total;Canarias;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Distribution by chapter of the CIE;0.67
Total;Canarias;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Standardised rate of PLYL;0.23
Total;Canarias;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Average number of PLYL;15.50
Total;Canarias;Endocrine, nutritional and metabolic diseases;Both sexes;Number of PLYL;5,127.50
Total;Canarias;Endocrine, nutritional and metabolic diseases;Both sexes;Distribution by chapter of the CIE;4.65
Total;Canarias;Endocrine, nutritional and metabolic diseases;Both sexes;Standardised rate of PLYL;2.86
Total;Canarias;Endocrine, nutritional and metabolic diseases;Both sexes;Average number of PLYL;9.73
Total;Canarias;Endocrine, nutritional and metabolic diseases;Males;Number of PLYL;3,092.50
Total;Canarias;Endocrine, nutritional and metabolic diseases;Males;Distribution by chapter of the CIE;4.11
Total;Canarias;Endocrine, nutritional and metabolic diseases;Males;Standardised rate of PLYL;3.30
Total;Canarias;Endocrine, nutritional and metabolic diseases;Males;Average number of PLYL;10.85
Total;Canarias;Endocrine, nutritional and metabolic diseases;Females;Number of PLYL;2,035.00
Total;Canarias;Endocrine, nutritional and metabolic diseases;Females;Distribution by chapter of the CIE;5.83
Total;Canarias;Endocrine, nutritional and metabolic diseases;Females;Standardised rate of PLYL;2.39
Total;Canarias;Endocrine, nutritional and metabolic diseases;Females;Average number of PLYL;8.41
Total;Canarias;Mental and behavioural disorders;Both sexes;Number of PLYL;1,652.50
Total;Canarias;Mental and behavioural disorders;Both sexes;Distribution by chapter of the CIE;1.50
Total;Canarias;Mental and behavioural disorders;Both sexes;Standardised rate of PLYL;0.84
Total;Canarias;Mental and behavioural disorders;Both sexes;Average number of PLYL;12.24
Total;Canarias;Mental and behavioural disorders;Males;Number of PLYL;1,157.50
Total;Canarias;Mental and behavioural disorders;Males;Distribution by chapter of the CIE;1.54
Total;Canarias;Mental and behavioural disorders;Males;Standardised rate of PLYL;1.11
Total;Canarias;Mental and behavioural disorders;Males;Average number of PLYL;15.03
Total;Canarias;Mental and behavioural disorders;Females;Number of PLYL;495.00
Total;Canarias;Mental and behavioural disorders;Females;Distribution by chapter of the CIE;1.42
Total;Canarias;Mental and behavioural disorders;Females;Standardised rate of PLYL;0.55
Total;Canarias;Mental and behavioural disorders;Females;Average number of PLYL;8.53
Total;Canarias;Diseases of the nervous system and the sense organs;Both sexes;Number of PLYL;3,332.50
Total;Canarias;Diseases of the nervous system and the sense organs;Both sexes;Distribution by chapter of the CIE;3.02
Total;Canarias;Diseases of the nervous system and the sense organs;Both sexes;Standardised rate of PLYL;1.75
Total;Canarias;Diseases of the nervous system and the sense organs;Both sexes;Average number of PLYL;12.67
Total;Canarias;Diseases of the nervous system and the sense organs;Males;Number of PLYL;1,912.50
Total;Canarias;Diseases of the nervous system and the sense organs;Males;Distribution by chapter of the CIE;2.54
Total;Canarias;Diseases of the nervous system and the sense organs;Males;Standardised rate of PLYL;1.99
Total;Canarias;Diseases of the nervous system and the sense organs;Males;Average number of PLYL;12.50
Total;Canarias;Diseases of the nervous system and the sense organs;Females;Number of PLYL;1,420.00
Total;Canarias;Diseases of the nervous system and the sense organs;Females;Distribution by chapter of the CIE;4.07
Total;Canarias;Diseases of the nervous system and the sense organs;Females;Standardised rate of PLYL;1.50
Total;Canarias;Diseases of the nervous system and the sense organs;Females;Average number of PLYL;12.91
Total;Canarias;Diseases of the circulatory system;Both sexes;Number of PLYL;21,169.50
Total;Canarias;Diseases of the circulatory system;Both sexes;Distribution by chapter of the CIE;19.21
Total;Canarias;Diseases of the circulatory system;Both sexes;Standardised rate of PLYL;10.78
Total;Canarias;Diseases of the circulatory system;Both sexes;Average number of PLYL;13.42
Total;Canarias;Diseases of the circulatory system;Males;Number of PLYL;15,335.00
Total;Canarias;Diseases of the circulatory system;Males;Distribution by chapter of the CIE;20.38
Total;Canarias;Diseases of the circulatory system;Males;Standardised rate of PLYL;15.26
Total;Canarias;Diseases of the circulatory system;Males;Average number of PLYL;14.89
Total;Canarias;Diseases of the circulatory system;Females;Number of PLYL;5,834.50
Total;Canarias;Diseases of the circulatory system;Females;Distribution by chapter of the CIE;16.71
Total;Canarias;Diseases of the circulatory system;Females;Standardised rate of PLYL;6.19
Total;Canarias;Diseases of the circulatory system;Females;Average number of PLYL;10.65
Total;Canarias;Diseases of the respiratory system;Both sexes;Number of PLYL;7,107.50
Total;Canarias;Diseases of the respiratory system;Both sexes;Distribution by chapter of the CIE;6.45
Total;Canarias;Diseases of the respiratory system;Both sexes;Standardised rate of PLYL;3.67
Total;Canarias;Diseases of the respiratory system;Both sexes;Average number of PLYL;13.85
Total;Canarias;Diseases of the respiratory system;Males;Number of PLYL;5,220.00
Total;Canarias;Diseases of the respiratory system;Males;Distribution by chapter of the CIE;6.94
Total;Canarias;Diseases of the respiratory system;Males;Standardised rate of PLYL;5.43
Total;Canarias;Diseases of the respiratory system;Males;Average number of PLYL;13.81
Total;Canarias;Diseases of the respiratory system;Females;Number of PLYL;1,887.50
Total;Canarias;Diseases of the respiratory system;Females;Distribution by chapter of the CIE;5.41
Total;Canarias;Diseases of the respiratory system;Females;Standardised rate of PLYL;1.87
Total;Canarias;Diseases of the respiratory system;Females;Average number of PLYL;13.98
Total;Canarias;Diseases of the digestive system;Both sexes;Number of PLYL;6,190.00
Total;Canarias;Diseases of the digestive system;Both sexes;Distribution by chapter of the CIE;5.62
Total;Canarias;Diseases of the digestive system;Both sexes;Standardised rate of PLYL;3.00
Total;Canarias;Diseases of the digestive system;Both sexes;Average number of PLYL;17.01
Total;Canarias;Diseases of the digestive system;Males;Number of PLYL;4,792.50
Total;Canarias;Diseases of the digestive system;Males;Distribution by chapter of the CIE;6.37
Total;Canarias;Diseases of the digestive system;Males;Standardised rate of PLYL;4.53
Total;Canarias;Diseases of the digestive system;Males;Average number of PLYL;18.08
Total;Canarias;Diseases of the digestive system;Females;Number of PLYL;1,397.50
Total;Canarias;Diseases of the digestive system;Females;Distribution by chapter of the CIE;4.00
Total;Canarias;Diseases of the digestive system;Females;Standardised rate of PLYL;1.43
Total;Canarias;Diseases of the digestive system;Females;Average number of PLYL;14.12
Total;Canarias;Diseases of the skin and subcutaneous tissue;Both sexes;Number of PLYL;40.00
Total;Canarias;Diseases of the skin and subcutaneous tissue;Both sexes;Distribution by chapter of the CIE;0.04
Total;Canarias;Diseases of the skin and subcutaneous tissue;Both sexes;Standardised rate of PLYL;0.02
Total;Canarias;Diseases of the skin and subcutaneous tissue;Both sexes;Average number of PLYL;10.00
Total;Canarias;Diseases of the skin and subcutaneous tissue;Males;Number of PLYL;40.00
Total;Canarias;Diseases of the skin and subcutaneous tissue;Males;Distribution by chapter of the CIE;0.05
Total;Canarias;Diseases of the skin and subcutaneous tissue;Males;Standardised rate of PLYL;0.04
Total;Canarias;Diseases of the skin and subcutaneous tissue;Males;Average number of PLYL;10.00
Total;Canarias;Diseases of the skin and subcutaneous tissue;Females;Number of PLYL;..
Total;Canarias;Diseases of the skin and subcutaneous tissue;Females;Distribution by chapter of the CIE;..
Total;Canarias;Diseases of the skin and subcutaneous tissue;Females;Standardised rate of PLYL;..
Total;Canarias;Diseases of the skin and subcutaneous tissue;Females;Average number of PLYL;..
Total;Canarias;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Number of PLYL;665.00
Total;Canarias;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Distribution by chapter of the CIE;0.60
Total;Canarias;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Standardised rate of PLYL;0.34
Total;Canarias;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Average number of PLYL;13.85
Total;Canarias;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Number of PLYL;397.50
Total;Canarias;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Distribution by chapter of the CIE;0.53
Total;Canarias;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Standardised rate of PLYL;0.40
Total;Canarias;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Average number of PLYL;18.93
Total;Canarias;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Number of PLYL;267.50
Total;Canarias;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Distribution by chapter of the CIE;0.77
Total;Canarias;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Standardised rate of PLYL;0.29
Total;Canarias;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Average number of PLYL;9.91
Total;Canarias;Diseases of the genitourinary system;Both sexes;Number of PLYL;1,120.00
Total;Canarias;Diseases of the genitourinary system;Both sexes;Distribution by chapter of the CIE;1.02
Total;Canarias;Diseases of the genitourinary system;Both sexes;Standardised rate of PLYL;0.63
Total;Canarias;Diseases of the genitourinary system;Both sexes;Average number of PLYL;9.18
Total;Canarias;Diseases of the genitourinary system;Males;Number of PLYL;687.50
Total;Canarias;Diseases of the genitourinary system;Males;Distribution by chapter of the CIE;0.91
Total;Canarias;Diseases of the genitourinary system;Males;Standardised rate of PLYL;0.74
Total;Canarias;Diseases of the genitourinary system;Males;Average number of PLYL;9.96
Total;Canarias;Diseases of the genitourinary system;Females;Number of PLYL;432.50
Total;Canarias;Diseases of the genitourinary system;Females;Distribution by chapter of the CIE;1.24
Total;Canarias;Diseases of the genitourinary system;Females;Standardised rate of PLYL;0.51
Total;Canarias;Diseases of the genitourinary system;Females;Average number of PLYL;8.16
Total;Canarias;Pregnancy, childbirth and the puerperium;Both sexes;Number of PLYL;42.50
Total;Canarias;Pregnancy, childbirth and the puerperium;Both sexes;Distribution by chapter of the CIE;0.04
Total;Canarias;Pregnancy, childbirth and the puerperium;Both sexes;Standardised rate of PLYL;0.02
Total;Canarias;Pregnancy, childbirth and the puerperium;Both sexes;Average number of PLYL;42.50
Total;Canarias;Pregnancy, childbirth and the puerperium;Males;Number of PLYL;..
Total;Canarias;Pregnancy, childbirth and the puerperium;Males;Distribution by chapter of the CIE;..
Total;Canarias;Pregnancy, childbirth and the puerperium;Males;Standardised rate of PLYL;..
Total;Canarias;Pregnancy, childbirth and the puerperium;Males;Average number of PLYL;..
Total;Canarias;Pregnancy, childbirth and the puerperium;Females;Number of PLYL;42.50
Total;Canarias;Pregnancy, childbirth and the puerperium;Females;Distribution by chapter of the CIE;0.12
Total;Canarias;Pregnancy, childbirth and the puerperium;Females;Standardised rate of PLYL;0.04
Total;Canarias;Pregnancy, childbirth and the puerperium;Females;Average number of PLYL;42.50
Total;Canarias;Affections originated in the perinatal period;Both sexes;Number of PLYL;57.50
Total;Canarias;Affections originated in the perinatal period;Both sexes;Distribution by chapter of the CIE;0.05
Total;Canarias;Affections originated in the perinatal period;Both sexes;Standardised rate of PLYL;0.04
Total;Canarias;Affections originated in the perinatal period;Both sexes;Average number of PLYL;57.50
Total;Canarias;Affections originated in the perinatal period;Males;Number of PLYL;57.50
Total;Canarias;Affections originated in the perinatal period;Males;Distribution by chapter of the CIE;0.08
Total;Canarias;Affections originated in the perinatal period;Males;Standardised rate of PLYL;0.08
Total;Canarias;Affections originated in the perinatal period;Males;Average number of PLYL;57.50
Total;Canarias;Affections originated in the perinatal period;Females;Number of PLYL;..
Total;Canarias;Affections originated in the perinatal period;Females;Distribution by chapter of the CIE;..
Total;Canarias;Affections originated in the perinatal period;Females;Standardised rate of PLYL;..
Total;Canarias;Affections originated in the perinatal period;Females;Average number of PLYL;..
Total;Canarias;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Number of PLYL;722.00
Total;Canarias;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Distribution by chapter of the CIE;0.66
Total;Canarias;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Standardised rate of PLYL;0.37
Total;Canarias;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Average number of PLYL;31.39
Total;Canarias;Congenital malformations, deformities and chromosomal abnormalities;Males;Number of PLYL;310.00
Total;Canarias;Congenital malformations, deformities and chromosomal abnormalities;Males;Distribution by chapter of the CIE;0.41
Total;Canarias;Congenital malformations, deformities and chromosomal abnormalities;Males;Standardised rate of PLYL;0.36
Total;Canarias;Congenital malformations, deformities and chromosomal abnormalities;Males;Average number of PLYL;31.00
Total;Canarias;Congenital malformations, deformities and chromosomal abnormalities;Females;Number of PLYL;412.00
Total;Canarias;Congenital malformations, deformities and chromosomal abnormalities;Females;Distribution by chapter of the CIE;1.18
Total;Canarias;Congenital malformations, deformities and chromosomal abnormalities;Females;Standardised rate of PLYL;0.39
Total;Canarias;Congenital malformations, deformities and chromosomal abnormalities;Females;Average number of PLYL;31.69
Total;Canarias;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Number of PLYL;2,737.50
Total;Canarias;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Distribution by chapter of the CIE;2.48
Total;Canarias;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Standardised rate of PLYL;1.30
Total;Canarias;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Average number of PLYL;20.90
Total;Canarias;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Number of PLYL;1,892.50
Total;Canarias;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Distribution by chapter of the CIE;2.51
Total;Canarias;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Standardised rate of PLYL;1.76
Total;Canarias;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Average number of PLYL;22.26
Total;Canarias;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Number of PLYL;845.00
Total;Canarias;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Distribution by chapter of the CIE;2.42
Total;Canarias;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Standardised rate of PLYL;0.83
Total;Canarias;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Average number of PLYL;18.37
Total;Canarias;External causes of mortality;Both sexes;Number of PLYL;13,365.50
Total;Canarias;External causes of mortality;Both sexes;Distribution by chapter of the CIE;12.13
Total;Canarias;External causes of mortality;Both sexes;Standardised rate of PLYL;6.45
Total;Canarias;External causes of mortality;Both sexes;Average number of PLYL;29.64
Total;Canarias;External causes of mortality;Males;Number of PLYL;10,503.50
Total;Canarias;External causes of mortality;Males;Distribution by chapter of the CIE;13.96
Total;Canarias;External causes of mortality;Males;Standardised rate of PLYL;10.05
Total;Canarias;External causes of mortality;Males;Average number of PLYL;31.26
Total;Canarias;External causes of mortality;Females;Number of PLYL;2,862.00
Total;Canarias;External causes of mortality;Females;Distribution by chapter of the CIE;8.20
Total;Canarias;External causes of mortality;Females;Standardised rate of PLYL;2.83
Total;Canarias;External causes of mortality;Females;Average number of PLYL;24.89
Total;Cantabria;All causes;Both sexes;Number of PLYL;31,712.50
Total;Cantabria;All causes;Both sexes;Distribution by chapter of the CIE;100.00
Total;Cantabria;All causes;Both sexes;Standardised rate of PLYL;53.59
Total;Cantabria;All causes;Both sexes;Average number of PLYL;13.86
Total;Cantabria;All causes;Males;Number of PLYL;22,273.50
Total;Cantabria;All causes;Males;Distribution by chapter of the CIE;100.00
Total;Cantabria;All causes;Males;Standardised rate of PLYL;75.79
Total;Cantabria;All causes;Males;Average number of PLYL;14.35
Total;Cantabria;All causes;Females;Number of PLYL;9,439.00
Total;Cantabria;All causes;Females;Distribution by chapter of the CIE;100.00
Total;Cantabria;All causes;Females;Standardised rate of PLYL;31.42
Total;Cantabria;All causes;Females;Average number of PLYL;12.82
Total;Cantabria;Infectious and parasitic diseases (1);Both sexes;Number of PLYL;867.00
Total;Cantabria;Infectious and parasitic diseases (1);Both sexes;Distribution by chapter of the CIE;2.73
Total;Cantabria;Infectious and parasitic diseases (1);Both sexes;Standardised rate of PLYL;1.35
Total;Cantabria;Infectious and parasitic diseases (1);Both sexes;Average number of PLYL;19.27
Total;Cantabria;Infectious and parasitic diseases (1);Males;Number of PLYL;630.00
Total;Cantabria;Infectious and parasitic diseases (1);Males;Distribution by chapter of the CIE;2.83
Total;Cantabria;Infectious and parasitic diseases (1);Males;Standardised rate of PLYL;1.93
Total;Cantabria;Infectious and parasitic diseases (1);Males;Average number of PLYL;19.69
Total;Cantabria;Infectious and parasitic diseases (1);Females;Number of PLYL;237.00
Total;Cantabria;Infectious and parasitic diseases (1);Females;Distribution by chapter of the CIE;2.51
Total;Cantabria;Infectious and parasitic diseases (1);Females;Standardised rate of PLYL;0.77
Total;Cantabria;Infectious and parasitic diseases (1);Females;Average number of PLYL;18.23
Total;Cantabria;Tumours;Both sexes;Number of PLYL;14,614.50
Total;Cantabria;Tumours;Both sexes;Distribution by chapter of the CIE;46.08
Total;Cantabria;Tumours;Both sexes;Standardised rate of PLYL;23.91
Total;Cantabria;Tumours;Both sexes;Average number of PLYL;13.87
Total;Cantabria;Tumours;Males;Number of PLYL;9,619.50
Total;Cantabria;Tumours;Males;Distribution by chapter of the CIE;43.19
Total;Cantabria;Tumours;Males;Standardised rate of PLYL;31.81
Total;Cantabria;Tumours;Males;Average number of PLYL;13.55
Total;Cantabria;Tumours;Females;Number of PLYL;4,995.00
Total;Cantabria;Tumours;Females;Distribution by chapter of the CIE;52.92
Total;Cantabria;Tumours;Females;Standardised rate of PLYL;16.00
Total;Cantabria;Tumours;Females;Average number of PLYL;14.52
Total;Cantabria;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Number of PLYL;72.50
Total;Cantabria;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Distribution by chapter of the CIE;0.23
Total;Cantabria;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Standardised rate of PLYL;0.20
Total;Cantabria;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Average number of PLYL;24.17
Total;Cantabria;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Number of PLYL;57.50
Total;Cantabria;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Distribution by chapter of the CIE;0.26
Total;Cantabria;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Standardised rate of PLYL;0.34
Total;Cantabria;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Average number of PLYL;57.50
Total;Cantabria;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Number of PLYL;15.00
Total;Cantabria;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Distribution by chapter of the CIE;0.16
Total;Cantabria;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Standardised rate of PLYL;0.06
Total;Cantabria;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Average number of PLYL;7.50
Total;Cantabria;Endocrine, nutritional and metabolic diseases;Both sexes;Number of PLYL;245.00
Total;Cantabria;Endocrine, nutritional and metabolic diseases;Both sexes;Distribution by chapter of the CIE;0.77
Total;Cantabria;Endocrine, nutritional and metabolic diseases;Both sexes;Standardised rate of PLYL;0.41
Total;Cantabria;Endocrine, nutritional and metabolic diseases;Both sexes;Average number of PLYL;9.42
Total;Cantabria;Endocrine, nutritional and metabolic diseases;Males;Number of PLYL;182.50
Total;Cantabria;Endocrine, nutritional and metabolic diseases;Males;Distribution by chapter of the CIE;0.82
Total;Cantabria;Endocrine, nutritional and metabolic diseases;Males;Standardised rate of PLYL;0.59
Total;Cantabria;Endocrine, nutritional and metabolic diseases;Males;Average number of PLYL;12.17
Total;Cantabria;Endocrine, nutritional and metabolic diseases;Females;Number of PLYL;62.50
Total;Cantabria;Endocrine, nutritional and metabolic diseases;Females;Distribution by chapter of the CIE;0.66
Total;Cantabria;Endocrine, nutritional and metabolic diseases;Females;Standardised rate of PLYL;0.22
Total;Cantabria;Endocrine, nutritional and metabolic diseases;Females;Average number of PLYL;5.68
Total;Cantabria;Mental and behavioural disorders;Both sexes;Number of PLYL;127.50
Total;Cantabria;Mental and behavioural disorders;Both sexes;Distribution by chapter of the CIE;0.40
Total;Cantabria;Mental and behavioural disorders;Both sexes;Standardised rate of PLYL;0.21
Total;Cantabria;Mental and behavioural disorders;Both sexes;Average number of PLYL;6.07
Total;Cantabria;Mental and behavioural disorders;Males;Number of PLYL;52.50
Total;Cantabria;Mental and behavioural disorders;Males;Distribution by chapter of the CIE;0.24
Total;Cantabria;Mental and behavioural disorders;Males;Standardised rate of PLYL;0.17
Total;Cantabria;Mental and behavioural disorders;Males;Average number of PLYL;4.77
Total;Cantabria;Mental and behavioural disorders;Females;Number of PLYL;75.00
Total;Cantabria;Mental and behavioural disorders;Females;Distribution by chapter of the CIE;0.79
Total;Cantabria;Mental and behavioural disorders;Females;Standardised rate of PLYL;0.24
Total;Cantabria;Mental and behavioural disorders;Females;Average number of PLYL;7.50
Total;Cantabria;Diseases of the nervous system and the sense organs;Both sexes;Number of PLYL;885.00
Total;Cantabria;Diseases of the nervous system and the sense organs;Both sexes;Distribution by chapter of the CIE;2.79
Total;Cantabria;Diseases of the nervous system and the sense organs;Both sexes;Standardised rate of PLYL;1.66
Total;Cantabria;Diseases of the nervous system and the sense organs;Both sexes;Average number of PLYL;9.41
Total;Cantabria;Diseases of the nervous system and the sense organs;Males;Number of PLYL;652.50
Total;Cantabria;Diseases of the nervous system and the sense organs;Males;Distribution by chapter of the CIE;2.93
Total;Cantabria;Diseases of the nervous system and the sense organs;Males;Standardised rate of PLYL;2.35
Total;Cantabria;Diseases of the nervous system and the sense organs;Males;Average number of PLYL;10.36
Total;Cantabria;Diseases of the nervous system and the sense organs;Females;Number of PLYL;232.50
Total;Cantabria;Diseases of the nervous system and the sense organs;Females;Distribution by chapter of the CIE;2.46
Total;Cantabria;Diseases of the nervous system and the sense organs;Females;Standardised rate of PLYL;0.96
Total;Cantabria;Diseases of the nervous system and the sense organs;Females;Average number of PLYL;7.50
Total;Cantabria;Diseases of the circulatory system;Both sexes;Number of PLYL;5,227.00
Total;Cantabria;Diseases of the circulatory system;Both sexes;Distribution by chapter of the CIE;16.48
Total;Cantabria;Diseases of the circulatory system;Both sexes;Standardised rate of PLYL;8.81
Total;Cantabria;Diseases of the circulatory system;Both sexes;Average number of PLYL;10.27
Total;Cantabria;Diseases of the circulatory system;Males;Number of PLYL;3,912.00
Total;Cantabria;Diseases of the circulatory system;Males;Distribution by chapter of the CIE;17.56
Total;Cantabria;Diseases of the circulatory system;Males;Standardised rate of PLYL;13.12
Total;Cantabria;Diseases of the circulatory system;Males;Average number of PLYL;11.61
Total;Cantabria;Diseases of the circulatory system;Females;Number of PLYL;1,315.00
Total;Cantabria;Diseases of the circulatory system;Females;Distribution by chapter of the CIE;13.93
Total;Cantabria;Diseases of the circulatory system;Females;Standardised rate of PLYL;4.50
Total;Cantabria;Diseases of the circulatory system;Females;Average number of PLYL;7.65
Total;Cantabria;Diseases of the respiratory system;Both sexes;Number of PLYL;1,170.00
Total;Cantabria;Diseases of the respiratory system;Both sexes;Distribution by chapter of the CIE;3.69
Total;Cantabria;Diseases of the respiratory system;Both sexes;Standardised rate of PLYL;1.97
Total;Cantabria;Diseases of the respiratory system;Both sexes;Average number of PLYL;8.36
Total;Cantabria;Diseases of the respiratory system;Males;Number of PLYL;827.50
Total;Cantabria;Diseases of the respiratory system;Males;Distribution by chapter of the CIE;3.72
Total;Cantabria;Diseases of the respiratory system;Males;Standardised rate of PLYL;2.76
Total;Cantabria;Diseases of the respiratory system;Males;Average number of PLYL;8.03
Total;Cantabria;Diseases of the respiratory system;Females;Number of PLYL;342.50
Total;Cantabria;Diseases of the respiratory system;Females;Distribution by chapter of the CIE;3.63
Total;Cantabria;Diseases of the respiratory system;Females;Standardised rate of PLYL;1.18
Total;Cantabria;Diseases of the respiratory system;Females;Average number of PLYL;9.26
Total;Cantabria;Diseases of the digestive system;Both sexes;Number of PLYL;1,625.00
Total;Cantabria;Diseases of the digestive system;Both sexes;Distribution by chapter of the CIE;5.12
Total;Cantabria;Diseases of the digestive system;Both sexes;Standardised rate of PLYL;2.63
Total;Cantabria;Diseases of the digestive system;Both sexes;Average number of PLYL;15.05
Total;Cantabria;Diseases of the digestive system;Males;Number of PLYL;1,360.00
Total;Cantabria;Diseases of the digestive system;Males;Distribution by chapter of the CIE;6.11
Total;Cantabria;Diseases of the digestive system;Males;Standardised rate of PLYL;4.32
Total;Cantabria;Diseases of the digestive system;Males;Average number of PLYL;16.59
Total;Cantabria;Diseases of the digestive system;Females;Number of PLYL;265.00
Total;Cantabria;Diseases of the digestive system;Females;Distribution by chapter of the CIE;2.81
Total;Cantabria;Diseases of the digestive system;Females;Standardised rate of PLYL;0.93
Total;Cantabria;Diseases of the digestive system;Females;Average number of PLYL;10.19
Total;Cantabria;Diseases of the skin and subcutaneous tissue;Both sexes;Number of PLYL;32.50
Total;Cantabria;Diseases of the skin and subcutaneous tissue;Both sexes;Distribution by chapter of the CIE;0.10
Total;Cantabria;Diseases of the skin and subcutaneous tissue;Both sexes;Standardised rate of PLYL;0.05
Total;Cantabria;Diseases of the skin and subcutaneous tissue;Both sexes;Average number of PLYL;10.83
Total;Cantabria;Diseases of the skin and subcutaneous tissue;Males;Number of PLYL;32.50
Total;Cantabria;Diseases of the skin and subcutaneous tissue;Males;Distribution by chapter of the CIE;0.15
Total;Cantabria;Diseases of the skin and subcutaneous tissue;Males;Standardised rate of PLYL;0.10
Total;Cantabria;Diseases of the skin and subcutaneous tissue;Males;Average number of PLYL;10.83
Total;Cantabria;Diseases of the skin and subcutaneous tissue;Females;Number of PLYL;..
Total;Cantabria;Diseases of the skin and subcutaneous tissue;Females;Distribution by chapter of the CIE;..
Total;Cantabria;Diseases of the skin and subcutaneous tissue;Females;Standardised rate of PLYL;..
Total;Cantabria;Diseases of the skin and subcutaneous tissue;Females;Average number of PLYL;..
Total;Cantabria;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Number of PLYL;110.00
Total;Cantabria;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Distribution by chapter of the CIE;0.35
Total;Cantabria;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Standardised rate of PLYL;0.17
Total;Cantabria;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Average number of PLYL;11.00
Total;Cantabria;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Number of PLYL;42.50
Total;Cantabria;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Distribution by chapter of the CIE;0.19
Total;Cantabria;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Standardised rate of PLYL;0.13
Total;Cantabria;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Average number of PLYL;14.17
Total;Cantabria;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Number of PLYL;67.50
Total;Cantabria;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Distribution by chapter of the CIE;0.72
Total;Cantabria;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Standardised rate of PLYL;0.21
Total;Cantabria;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Average number of PLYL;9.64
Total;Cantabria;Diseases of the genitourinary system;Both sexes;Number of PLYL;297.50
Total;Cantabria;Diseases of the genitourinary system;Both sexes;Distribution by chapter of the CIE;0.94
Total;Cantabria;Diseases of the genitourinary system;Both sexes;Standardised rate of PLYL;0.49
Total;Cantabria;Diseases of the genitourinary system;Both sexes;Average number of PLYL;8.04
Total;Cantabria;Diseases of the genitourinary system;Males;Number of PLYL;165.00
Total;Cantabria;Diseases of the genitourinary system;Males;Distribution by chapter of the CIE;0.74
Total;Cantabria;Diseases of the genitourinary system;Males;Standardised rate of PLYL;0.55
Total;Cantabria;Diseases of the genitourinary system;Males;Average number of PLYL;7.50
Total;Cantabria;Diseases of the genitourinary system;Females;Number of PLYL;132.50
Total;Cantabria;Diseases of the genitourinary system;Females;Distribution by chapter of the CIE;1.40
Total;Cantabria;Diseases of the genitourinary system;Females;Standardised rate of PLYL;0.42
Total;Cantabria;Diseases of the genitourinary system;Females;Average number of PLYL;8.83
Total;Cantabria;Pregnancy, childbirth and the puerperium;Both sexes;Number of PLYL;42.50
Total;Cantabria;Pregnancy, childbirth and the puerperium;Both sexes;Distribution by chapter of the CIE;0.13
Total;Cantabria;Pregnancy, childbirth and the puerperium;Both sexes;Standardised rate of PLYL;0.07
Total;Cantabria;Pregnancy, childbirth and the puerperium;Both sexes;Average number of PLYL;42.50
Total;Cantabria;Pregnancy, childbirth and the puerperium;Males;Number of PLYL;..
Total;Cantabria;Pregnancy, childbirth and the puerperium;Males;Distribution by chapter of the CIE;..
Total;Cantabria;Pregnancy, childbirth and the puerperium;Males;Standardised rate of PLYL;..
Total;Cantabria;Pregnancy, childbirth and the puerperium;Males;Average number of PLYL;..
Total;Cantabria;Pregnancy, childbirth and the puerperium;Females;Number of PLYL;42.50
Total;Cantabria;Pregnancy, childbirth and the puerperium;Females;Distribution by chapter of the CIE;0.45
Total;Cantabria;Pregnancy, childbirth and the puerperium;Females;Standardised rate of PLYL;0.14
Total;Cantabria;Pregnancy, childbirth and the puerperium;Females;Average number of PLYL;42.50
Total;Cantabria;Affections originated in the perinatal period;Both sexes;Number of PLYL;..
Total;Cantabria;Affections originated in the perinatal period;Both sexes;Distribution by chapter of the CIE;..
Total;Cantabria;Affections originated in the perinatal period;Both sexes;Standardised rate of PLYL;..
Total;Cantabria;Affections originated in the perinatal period;Both sexes;Average number of PLYL;..
Total;Cantabria;Affections originated in the perinatal period;Males;Number of PLYL;..
Total;Cantabria;Affections originated in the perinatal period;Males;Distribution by chapter of the CIE;..
Total;Cantabria;Affections originated in the perinatal period;Males;Standardised rate of PLYL;..
Total;Cantabria;Affections originated in the perinatal period;Males;Average number of PLYL;..
Total;Cantabria;Affections originated in the perinatal period;Females;Number of PLYL;..
Total;Cantabria;Affections originated in the perinatal period;Females;Distribution by chapter of the CIE;..
Total;Cantabria;Affections originated in the perinatal period;Females;Standardised rate of PLYL;..
Total;Cantabria;Affections originated in the perinatal period;Females;Average number of PLYL;..
Total;Cantabria;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Number of PLYL;77.50
Total;Cantabria;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Distribution by chapter of the CIE;0.24
Total;Cantabria;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Standardised rate of PLYL;0.12
Total;Cantabria;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Average number of PLYL;25.83
Total;Cantabria;Congenital malformations, deformities and chromosomal abnormalities;Males;Number of PLYL;..
Total;Cantabria;Congenital malformations, deformities and chromosomal abnormalities;Males;Distribution by chapter of the CIE;..
Total;Cantabria;Congenital malformations, deformities and chromosomal abnormalities;Males;Standardised rate of PLYL;..
Total;Cantabria;Congenital malformations, deformities and chromosomal abnormalities;Males;Average number of PLYL;..
Total;Cantabria;Congenital malformations, deformities and chromosomal abnormalities;Females;Number of PLYL;77.50
Total;Cantabria;Congenital malformations, deformities and chromosomal abnormalities;Females;Distribution by chapter of the CIE;0.82
Total;Cantabria;Congenital malformations, deformities and chromosomal abnormalities;Females;Standardised rate of PLYL;0.23
Total;Cantabria;Congenital malformations, deformities and chromosomal abnormalities;Females;Average number of PLYL;25.83
Total;Cantabria;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Number of PLYL;2,525.00
Total;Cantabria;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Distribution by chapter of the CIE;7.96
Total;Cantabria;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Standardised rate of PLYL;4.31
Total;Cantabria;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Average number of PLYL;23.82
Total;Cantabria;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Number of PLYL;1,780.00
Total;Cantabria;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Distribution by chapter of the CIE;7.99
Total;Cantabria;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Standardised rate of PLYL;6.05
Total;Cantabria;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Average number of PLYL;24.05
Total;Cantabria;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Number of PLYL;745.00
Total;Cantabria;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Distribution by chapter of the CIE;7.89
Total;Cantabria;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Standardised rate of PLYL;2.57
Total;Cantabria;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Average number of PLYL;23.28
Total;Cantabria;External causes of mortality;Both sexes;Number of PLYL;3,794.00
Total;Cantabria;External causes of mortality;Both sexes;Distribution by chapter of the CIE;11.96
Total;Cantabria;External causes of mortality;Both sexes;Standardised rate of PLYL;7.26
Total;Cantabria;External causes of mortality;Both sexes;Average number of PLYL;29.64
Total;Cantabria;External causes of mortality;Males;Number of PLYL;2,959.50
Total;Cantabria;External causes of mortality;Males;Distribution by chapter of the CIE;13.29
Total;Cantabria;External causes of mortality;Males;Standardised rate of PLYL;11.56
Total;Cantabria;External causes of mortality;Males;Average number of PLYL;30.83
Total;Cantabria;External causes of mortality;Females;Number of PLYL;834.50
Total;Cantabria;External causes of mortality;Females;Distribution by chapter of the CIE;8.84
Total;Cantabria;External causes of mortality;Females;Standardised rate of PLYL;2.99
Total;Cantabria;External causes of mortality;Females;Average number of PLYL;26.08
Total;Castilla y Le¾n;All causes;Both sexes;Number of PLYL;127,261.00
Total;Castilla y Le¾n;All causes;Both sexes;Distribution by chapter of the CIE;100.00
Total;Castilla y Le¾n;All causes;Both sexes;Standardised rate of PLYL;49.43
Total;Castilla y Le¾n;All causes;Both sexes;Average number of PLYL;12.98
Total;Castilla y Le¾n;All causes;Males;Number of PLYL;89,001.50
Total;Castilla y Le¾n;All causes;Males;Distribution by chapter of the CIE;100.00
Total;Castilla y Le¾n;All causes;Males;Standardised rate of PLYL;67.92
Total;Castilla y Le¾n;All causes;Males;Average number of PLYL;13.45
Total;Castilla y Le¾n;All causes;Females;Number of PLYL;38,259.50
Total;Castilla y Le¾n;All causes;Females;Distribution by chapter of the CIE;100.00
Total;Castilla y Le¾n;All causes;Females;Standardised rate of PLYL;30.00
Total;Castilla y Le¾n;All causes;Females;Average number of PLYL;12.01
Total;Castilla y Le¾n;Infectious and parasitic diseases (1);Both sexes;Number of PLYL;3,517.50
Total;Castilla y Le¾n;Infectious and parasitic diseases (1);Both sexes;Distribution by chapter of the CIE;2.76
Total;Castilla y Le¾n;Infectious and parasitic diseases (1);Both sexes;Standardised rate of PLYL;1.34
Total;Castilla y Le¾n;Infectious and parasitic diseases (1);Both sexes;Average number of PLYL;16.99
Total;Castilla y Le¾n;Infectious and parasitic diseases (1);Males;Number of PLYL;2,620.00
Total;Castilla y Le¾n;Infectious and parasitic diseases (1);Males;Distribution by chapter of the CIE;2.94
Total;Castilla y Le¾n;Infectious and parasitic diseases (1);Males;Standardised rate of PLYL;1.97
Total;Castilla y Le¾n;Infectious and parasitic diseases (1);Males;Average number of PLYL;18.45
Total;Castilla y Le¾n;Infectious and parasitic diseases (1);Females;Number of PLYL;897.50
Total;Castilla y Le¾n;Infectious and parasitic diseases (1);Females;Distribution by chapter of the CIE;2.35
Total;Castilla y Le¾n;Infectious and parasitic diseases (1);Females;Standardised rate of PLYL;0.68
Total;Castilla y Le¾n;Infectious and parasitic diseases (1);Females;Average number of PLYL;13.81
Total;Castilla y Le¾n;Tumours;Both sexes;Number of PLYL;56,311.00
Total;Castilla y Le¾n;Tumours;Both sexes;Distribution by chapter of the CIE;44.25
Total;Castilla y Le¾n;Tumours;Both sexes;Standardised rate of PLYL;21.23
Total;Castilla y Le¾n;Tumours;Both sexes;Average number of PLYL;12.69
Total;Castilla y Le¾n;Tumours;Males;Number of PLYL;36,352.00
Total;Castilla y Le¾n;Tumours;Males;Distribution by chapter of the CIE;40.84
Total;Castilla y Le¾n;Tumours;Males;Standardised rate of PLYL;26.61
Total;Castilla y Le¾n;Tumours;Males;Average number of PLYL;12.19
Total;Castilla y Le¾n;Tumours;Females;Number of PLYL;19,959.00
Total;Castilla y Le¾n;Tumours;Females;Distribution by chapter of the CIE;52.17
Total;Castilla y Le¾n;Tumours;Females;Standardised rate of PLYL;15.45
Total;Castilla y Le¾n;Tumours;Females;Average number of PLYL;13.69
Total;Castilla y Le¾n;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Number of PLYL;399.50
Total;Castilla y Le¾n;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Distribution by chapter of the CIE;0.31
Total;Castilla y Le¾n;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Standardised rate of PLYL;0.15
Total;Castilla y Le¾n;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Average number of PLYL;11.75
Total;Castilla y Le¾n;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Number of PLYL;317.00
Total;Castilla y Le¾n;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Distribution by chapter of the CIE;0.36
Total;Castilla y Le¾n;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Standardised rate of PLYL;0.24
Total;Castilla y Le¾n;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Average number of PLYL;12.68
Total;Castilla y Le¾n;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Number of PLYL;82.50
Total;Castilla y Le¾n;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Distribution by chapter of the CIE;0.22
Total;Castilla y Le¾n;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Standardised rate of PLYL;0.06
Total;Castilla y Le¾n;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Average number of PLYL;9.17
Total;Castilla y Le¾n;Endocrine, nutritional and metabolic diseases;Both sexes;Number of PLYL;2,839.50
Total;Castilla y Le¾n;Endocrine, nutritional and metabolic diseases;Both sexes;Distribution by chapter of the CIE;2.23
Total;Castilla y Le¾n;Endocrine, nutritional and metabolic diseases;Both sexes;Standardised rate of PLYL;1.11
Total;Castilla y Le¾n;Endocrine, nutritional and metabolic diseases;Both sexes;Average number of PLYL;9.72
Total;Castilla y Le¾n;Endocrine, nutritional and metabolic diseases;Males;Number of PLYL;1,827.50
Total;Castilla y Le¾n;Endocrine, nutritional and metabolic diseases;Males;Distribution by chapter of the CIE;2.05
Total;Castilla y Le¾n;Endocrine, nutritional and metabolic diseases;Males;Standardised rate of PLYL;1.44
Total;Castilla y Le¾n;Endocrine, nutritional and metabolic diseases;Males;Average number of PLYL;11.35
Total;Castilla y Le¾n;Endocrine, nutritional and metabolic diseases;Females;Number of PLYL;1,012.00
Total;Castilla y Le¾n;Endocrine, nutritional and metabolic diseases;Females;Distribution by chapter of the CIE;2.65
Total;Castilla y Le¾n;Endocrine, nutritional and metabolic diseases;Females;Standardised rate of PLYL;0.78
Total;Castilla y Le¾n;Endocrine, nutritional and metabolic diseases;Females;Average number of PLYL;7.73
Total;Castilla y Le¾n;Mental and behavioural disorders;Both sexes;Number of PLYL;845.00
Total;Castilla y Le¾n;Mental and behavioural disorders;Both sexes;Distribution by chapter of the CIE;0.66
Total;Castilla y Le¾n;Mental and behavioural disorders;Both sexes;Standardised rate of PLYL;0.31
Total;Castilla y Le¾n;Mental and behavioural disorders;Both sexes;Average number of PLYL;8.62
Total;Castilla y Le¾n;Mental and behavioural disorders;Males;Number of PLYL;565.00
Total;Castilla y Le¾n;Mental and behavioural disorders;Males;Distribution by chapter of the CIE;0.63
Total;Castilla y Le¾n;Mental and behavioural disorders;Males;Standardised rate of PLYL;0.40
Total;Castilla y Le¾n;Mental and behavioural disorders;Males;Average number of PLYL;9.74
Total;Castilla y Le¾n;Mental and behavioural disorders;Females;Number of PLYL;280.00
Total;Castilla y Le¾n;Mental and behavioural disorders;Females;Distribution by chapter of the CIE;0.73
Total;Castilla y Le¾n;Mental and behavioural disorders;Females;Standardised rate of PLYL;0.22
Total;Castilla y Le¾n;Mental and behavioural disorders;Females;Average number of PLYL;7.00
Total;Castilla y Le¾n;Diseases of the nervous system and the sense organs;Both sexes;Number of PLYL;3,845.00
Total;Castilla y Le¾n;Diseases of the nervous system and the sense organs;Both sexes;Distribution by chapter of the CIE;3.02
Total;Castilla y Le¾n;Diseases of the nervous system and the sense organs;Both sexes;Standardised rate of PLYL;1.55
Total;Castilla y Le¾n;Diseases of the nervous system and the sense organs;Both sexes;Average number of PLYL;11.31
Total;Castilla y Le¾n;Diseases of the nervous system and the sense organs;Males;Number of PLYL;2,237.50
Total;Castilla y Le¾n;Diseases of the nervous system and the sense organs;Males;Distribution by chapter of the CIE;2.51
Total;Castilla y Le¾n;Diseases of the nervous system and the sense organs;Males;Standardised rate of PLYL;1.82
Total;Castilla y Le¾n;Diseases of the nervous system and the sense organs;Males;Average number of PLYL;12.79
Total;Castilla y Le¾n;Diseases of the nervous system and the sense organs;Females;Number of PLYL;1,607.50
Total;Castilla y Le¾n;Diseases of the nervous system and the sense organs;Females;Distribution by chapter of the CIE;4.20
Total;Castilla y Le¾n;Diseases of the nervous system and the sense organs;Females;Standardised rate of PLYL;1.26
Total;Castilla y Le¾n;Diseases of the nervous system and the sense organs;Females;Average number of PLYL;9.74
Total;Castilla y Le¾n;Diseases of the circulatory system;Both sexes;Number of PLYL;23,201.50
Total;Castilla y Le¾n;Diseases of the circulatory system;Both sexes;Distribution by chapter of the CIE;18.23
Total;Castilla y Le¾n;Diseases of the circulatory system;Both sexes;Standardised rate of PLYL;8.71
Total;Castilla y Le¾n;Diseases of the circulatory system;Both sexes;Average number of PLYL;10.69
Total;Castilla y Le¾n;Diseases of the circulatory system;Males;Number of PLYL;17,104.50
Total;Castilla y Le¾n;Diseases of the circulatory system;Males;Distribution by chapter of the CIE;19.22
Total;Castilla y Le¾n;Diseases of the circulatory system;Males;Standardised rate of PLYL;12.47
Total;Castilla y Le¾n;Diseases of the circulatory system;Males;Average number of PLYL;11.73
Total;Castilla y Le¾n;Diseases of the circulatory system;Females;Number of PLYL;6,097.00
Total;Castilla y Le¾n;Diseases of the circulatory system;Females;Distribution by chapter of the CIE;15.94
Total;Castilla y Le¾n;Diseases of the circulatory system;Females;Standardised rate of PLYL;4.73
Total;Castilla y Le¾n;Diseases of the circulatory system;Females;Average number of PLYL;8.55
Total;Castilla y Le¾n;Diseases of the respiratory system;Both sexes;Number of PLYL;5,651.50
Total;Castilla y Le¾n;Diseases of the respiratory system;Both sexes;Distribution by chapter of the CIE;4.44
Total;Castilla y Le¾n;Diseases of the respiratory system;Both sexes;Standardised rate of PLYL;2.20
Total;Castilla y Le¾n;Diseases of the respiratory system;Both sexes;Average number of PLYL;8.63
Total;Castilla y Le¾n;Diseases of the respiratory system;Males;Number of PLYL;4,451.50
Total;Castilla y Le¾n;Diseases of the respiratory system;Males;Distribution by chapter of the CIE;5.00
Total;Castilla y Le¾n;Diseases of the respiratory system;Males;Standardised rate of PLYL;3.36
Total;Castilla y Le¾n;Diseases of the respiratory system;Males;Average number of PLYL;8.85
Total;Castilla y Le¾n;Diseases of the respiratory system;Females;Number of PLYL;1,200.00
Total;Castilla y Le¾n;Diseases of the respiratory system;Females;Distribution by chapter of the CIE;3.14
Total;Castilla y Le¾n;Diseases of the respiratory system;Females;Standardised rate of PLYL;0.97
Total;Castilla y Le¾n;Diseases of the respiratory system;Females;Average number of PLYL;7.89
Total;Castilla y Le¾n;Diseases of the digestive system;Both sexes;Number of PLYL;7,272.50
Total;Castilla y Le¾n;Diseases of the digestive system;Both sexes;Distribution by chapter of the CIE;5.71
Total;Castilla y Le¾n;Diseases of the digestive system;Both sexes;Standardised rate of PLYL;2.70
Total;Castilla y Le¾n;Diseases of the digestive system;Both sexes;Average number of PLYL;14.01
Total;Castilla y Le¾n;Diseases of the digestive system;Males;Number of PLYL;5,680.00
Total;Castilla y Le¾n;Diseases of the digestive system;Males;Distribution by chapter of the CIE;6.38
Total;Castilla y Le¾n;Diseases of the digestive system;Males;Standardised rate of PLYL;4.14
Total;Castilla y Le¾n;Diseases of the digestive system;Males;Average number of PLYL;15.03
Total;Castilla y Le¾n;Diseases of the digestive system;Females;Number of PLYL;1,592.50
Total;Castilla y Le¾n;Diseases of the digestive system;Females;Distribution by chapter of the CIE;4.16
Total;Castilla y Le¾n;Diseases of the digestive system;Females;Standardised rate of PLYL;1.19
Total;Castilla y Le¾n;Diseases of the digestive system;Females;Average number of PLYL;11.29
Total;Castilla y Le¾n;Diseases of the skin and subcutaneous tissue;Both sexes;Number of PLYL;182.50
Total;Castilla y Le¾n;Diseases of the skin and subcutaneous tissue;Both sexes;Distribution by chapter of the CIE;0.14
Total;Castilla y Le¾n;Diseases of the skin and subcutaneous tissue;Both sexes;Standardised rate of PLYL;0.07
Total;Castilla y Le¾n;Diseases of the skin and subcutaneous tissue;Both sexes;Average number of PLYL;7.93
Total;Castilla y Le¾n;Diseases of the skin and subcutaneous tissue;Males;Number of PLYL;120.00
Total;Castilla y Le¾n;Diseases of the skin and subcutaneous tissue;Males;Distribution by chapter of the CIE;0.13
Total;Castilla y Le¾n;Diseases of the skin and subcutaneous tissue;Males;Standardised rate of PLYL;0.08
Total;Castilla y Le¾n;Diseases of the skin and subcutaneous tissue;Males;Average number of PLYL;10.00
Total;Castilla y Le¾n;Diseases of the skin and subcutaneous tissue;Females;Number of PLYL;62.50
Total;Castilla y Le¾n;Diseases of the skin and subcutaneous tissue;Females;Distribution by chapter of the CIE;0.16
Total;Castilla y Le¾n;Diseases of the skin and subcutaneous tissue;Females;Standardised rate of PLYL;0.05
Total;Castilla y Le¾n;Diseases of the skin and subcutaneous tissue;Females;Average number of PLYL;5.68
Total;Castilla y Le¾n;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Number of PLYL;522.50
Total;Castilla y Le¾n;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Distribution by chapter of the CIE;0.41
Total;Castilla y Le¾n;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Standardised rate of PLYL;0.20
Total;Castilla y Le¾n;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Average number of PLYL;8.86
Total;Castilla y Le¾n;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Number of PLYL;267.50
Total;Castilla y Le¾n;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Distribution by chapter of the CIE;0.30
Total;Castilla y Le¾n;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Standardised rate of PLYL;0.19
Total;Castilla y Le¾n;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Average number of PLYL;9.91
Total;Castilla y Le¾n;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Number of PLYL;255.00
Total;Castilla y Le¾n;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Distribution by chapter of the CIE;0.67
Total;Castilla y Le¾n;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Standardised rate of PLYL;0.20
Total;Castilla y Le¾n;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Average number of PLYL;7.97
Total;Castilla y Le¾n;Diseases of the genitourinary system;Both sexes;Number of PLYL;1,322.50
Total;Castilla y Le¾n;Diseases of the genitourinary system;Both sexes;Distribution by chapter of the CIE;1.04
Total;Castilla y Le¾n;Diseases of the genitourinary system;Both sexes;Standardised rate of PLYL;0.50
Total;Castilla y Le¾n;Diseases of the genitourinary system;Both sexes;Average number of PLYL;8.76
Total;Castilla y Le¾n;Diseases of the genitourinary system;Males;Number of PLYL;885.00
Total;Castilla y Le¾n;Diseases of the genitourinary system;Males;Distribution by chapter of the CIE;0.99
Total;Castilla y Le¾n;Diseases of the genitourinary system;Males;Standardised rate of PLYL;0.65
Total;Castilla y Le¾n;Diseases of the genitourinary system;Males;Average number of PLYL;9.62
Total;Castilla y Le¾n;Diseases of the genitourinary system;Females;Number of PLYL;437.50
Total;Castilla y Le¾n;Diseases of the genitourinary system;Females;Distribution by chapter of the CIE;1.14
Total;Castilla y Le¾n;Diseases of the genitourinary system;Females;Standardised rate of PLYL;0.33
Total;Castilla y Le¾n;Diseases of the genitourinary system;Females;Average number of PLYL;7.42
Total;Castilla y Le¾n;Pregnancy, childbirth and the puerperium;Both sexes;Number of PLYL;42.50
Total;Castilla y Le¾n;Pregnancy, childbirth and the puerperium;Both sexes;Distribution by chapter of the CIE;0.03
Total;Castilla y Le¾n;Pregnancy, childbirth and the puerperium;Both sexes;Standardised rate of PLYL;0.02
Total;Castilla y Le¾n;Pregnancy, childbirth and the puerperium;Both sexes;Average number of PLYL;42.50
Total;Castilla y Le¾n;Pregnancy, childbirth and the puerperium;Males;Number of PLYL;..
Total;Castilla y Le¾n;Pregnancy, childbirth and the puerperium;Males;Distribution by chapter of the CIE;..
Total;Castilla y Le¾n;Pregnancy, childbirth and the puerperium;Males;Standardised rate of PLYL;..
Total;Castilla y Le¾n;Pregnancy, childbirth and the puerperium;Males;Average number of PLYL;..
Total;Castilla y Le¾n;Pregnancy, childbirth and the puerperium;Females;Number of PLYL;42.50
Total;Castilla y Le¾n;Pregnancy, childbirth and the puerperium;Females;Distribution by chapter of the CIE;0.11
Total;Castilla y Le¾n;Pregnancy, childbirth and the puerperium;Females;Standardised rate of PLYL;0.04
Total;Castilla y Le¾n;Pregnancy, childbirth and the puerperium;Females;Average number of PLYL;42.50
Total;Castilla y Le¾n;Affections originated in the perinatal period;Both sexes;Number of PLYL;62.50
Total;Castilla y Le¾n;Affections originated in the perinatal period;Both sexes;Distribution by chapter of the CIE;0.05
Total;Castilla y Le¾n;Affections originated in the perinatal period;Both sexes;Standardised rate of PLYL;0.04
Total;Castilla y Le¾n;Affections originated in the perinatal period;Both sexes;Average number of PLYL;62.50
Total;Castilla y Le¾n;Affections originated in the perinatal period;Males;Number of PLYL;62.50
Total;Castilla y Le¾n;Affections originated in the perinatal period;Males;Distribution by chapter of the CIE;0.07
Total;Castilla y Le¾n;Affections originated in the perinatal period;Males;Standardised rate of PLYL;0.08
Total;Castilla y Le¾n;Affections originated in the perinatal period;Males;Average number of PLYL;62.50
Total;Castilla y Le¾n;Affections originated in the perinatal period;Females;Number of PLYL;..
Total;Castilla y Le¾n;Affections originated in the perinatal period;Females;Distribution by chapter of the CIE;..
Total;Castilla y Le¾n;Affections originated in the perinatal period;Females;Standardised rate of PLYL;..
Total;Castilla y Le¾n;Affections originated in the perinatal period;Females;Average number of PLYL;..
Total;Castilla y Le¾n;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Number of PLYL;799.50
Total;Castilla y Le¾n;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Distribution by chapter of the CIE;0.63
Total;Castilla y Le¾n;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Standardised rate of PLYL;0.36
Total;Castilla y Le¾n;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Average number of PLYL;30.75
Total;Castilla y Le¾n;Congenital malformations, deformities and chromosomal abnormalities;Males;Number of PLYL;282.50
Total;Castilla y Le¾n;Congenital malformations, deformities and chromosomal abnormalities;Males;Distribution by chapter of the CIE;0.32
Total;Castilla y Le¾n;Congenital malformations, deformities and chromosomal abnormalities;Males;Standardised rate of PLYL;0.25
Total;Castilla y Le¾n;Congenital malformations, deformities and chromosomal abnormalities;Males;Average number of PLYL;25.68
Total;Castilla y Le¾n;Congenital malformations, deformities and chromosomal abnormalities;Females;Number of PLYL;517.00
Total;Castilla y Le¾n;Congenital malformations, deformities and chromosomal abnormalities;Females;Distribution by chapter of the CIE;1.35
Total;Castilla y Le¾n;Congenital malformations, deformities and chromosomal abnormalities;Females;Standardised rate of PLYL;0.47
Total;Castilla y Le¾n;Congenital malformations, deformities and chromosomal abnormalities;Females;Average number of PLYL;34.47
Total;Castilla y Le¾n;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Number of PLYL;4,922.00
Total;Castilla y Le¾n;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Distribution by chapter of the CIE;3.87
Total;Castilla y Le¾n;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Standardised rate of PLYL;2.04
Total;Castilla y Le¾n;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Average number of PLYL;23.78
Total;Castilla y Le¾n;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Number of PLYL;3,764.50
Total;Castilla y Le¾n;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Distribution by chapter of the CIE;4.23
Total;Castilla y Le¾n;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Standardised rate of PLYL;3.11
Total;Castilla y Le¾n;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Average number of PLYL;24.44
Total;Castilla y Le¾n;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Number of PLYL;1,157.50
Total;Castilla y Le¾n;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Distribution by chapter of the CIE;3.03
Total;Castilla y Le¾n;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Standardised rate of PLYL;0.94
Total;Castilla y Le¾n;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Average number of PLYL;21.84
Total;Castilla y Le¾n;External causes of mortality;Both sexes;Number of PLYL;15,524.00
Total;Castilla y Le¾n;External causes of mortality;Both sexes;Distribution by chapter of the CIE;12.20
Total;Castilla y Le¾n;External causes of mortality;Both sexes;Standardised rate of PLYL;6.91
Total;Castilla y Le¾n;External causes of mortality;Both sexes;Average number of PLYL;26.77
Total;Castilla y Le¾n;External causes of mortality;Males;Number of PLYL;12,464.50
Total;Castilla y Le¾n;External causes of mortality;Males;Distribution by chapter of the CIE;14.00
Total;Castilla y Le¾n;External causes of mortality;Males;Standardised rate of PLYL;11.11
Total;Castilla y Le¾n;External causes of mortality;Males;Average number of PLYL;28.33
Total;Castilla y Le¾n;External causes of mortality;Females;Number of PLYL;3,059.50
Total;Castilla y Le¾n;External causes of mortality;Females;Distribution by chapter of the CIE;8.00
Total;Castilla y Le¾n;External causes of mortality;Females;Standardised rate of PLYL;2.63
Total;Castilla y Le¾n;External causes of mortality;Females;Average number of PLYL;21.85
Total;Castilla-La Mancha;All causes;Both sexes;Number of PLYL;88,865.00
Total;Castilla-La Mancha;All causes;Both sexes;Distribution by chapter of the CIE;100.00
Total;Castilla-La Mancha;All causes;Both sexes;Standardised rate of PLYL;46.75
Total;Castilla-La Mancha;All causes;Both sexes;Average number of PLYL;13.36
Total;Castilla-La Mancha;All causes;Males;Number of PLYL;61,387.00
Total;Castilla-La Mancha;All causes;Males;Distribution by chapter of the CIE;100.00
Total;Castilla-La Mancha;All causes;Males;Standardised rate of PLYL;62.95
Total;Castilla-La Mancha;All causes;Males;Average number of PLYL;14.25
Total;Castilla-La Mancha;All causes;Females;Number of PLYL;27,478.00
Total;Castilla-La Mancha;All causes;Females;Distribution by chapter of the CIE;100.00
Total;Castilla-La Mancha;All causes;Females;Standardised rate of PLYL;29.61
Total;Castilla-La Mancha;All causes;Females;Average number of PLYL;11.73
Total;Castilla-La Mancha;Infectious and parasitic diseases (1);Both sexes;Number of PLYL;1,872.00
Total;Castilla-La Mancha;Infectious and parasitic diseases (1);Both sexes;Distribution by chapter of the CIE;2.11
Total;Castilla-La Mancha;Infectious and parasitic diseases (1);Both sexes;Standardised rate of PLYL;0.96
Total;Castilla-La Mancha;Infectious and parasitic diseases (1);Both sexes;Average number of PLYL;16.57
Total;Castilla-La Mancha;Infectious and parasitic diseases (1);Males;Number of PLYL;1,394.50
Total;Castilla-La Mancha;Infectious and parasitic diseases (1);Males;Distribution by chapter of the CIE;2.27
Total;Castilla-La Mancha;Infectious and parasitic diseases (1);Males;Standardised rate of PLYL;1.36
Total;Castilla-La Mancha;Infectious and parasitic diseases (1);Males;Average number of PLYL;19.37
Total;Castilla-La Mancha;Infectious and parasitic diseases (1);Females;Number of PLYL;477.50
Total;Castilla-La Mancha;Infectious and parasitic diseases (1);Females;Distribution by chapter of the CIE;1.74
Total;Castilla-La Mancha;Infectious and parasitic diseases (1);Females;Standardised rate of PLYL;0.54
Total;Castilla-La Mancha;Infectious and parasitic diseases (1);Females;Average number of PLYL;11.65
Total;Castilla-La Mancha;Tumours;Both sexes;Number of PLYL;35,950.50
Total;Castilla-La Mancha;Tumours;Both sexes;Distribution by chapter of the CIE;40.46
Total;Castilla-La Mancha;Tumours;Both sexes;Standardised rate of PLYL;18.98
Total;Castilla-La Mancha;Tumours;Both sexes;Average number of PLYL;13.44
Total;Castilla-La Mancha;Tumours;Males;Number of PLYL;23,841.50
Total;Castilla-La Mancha;Tumours;Males;Distribution by chapter of the CIE;38.84
Total;Castilla-La Mancha;Tumours;Males;Standardised rate of PLYL;24.70
Total;Castilla-La Mancha;Tumours;Males;Average number of PLYL;13.34
Total;Castilla-La Mancha;Tumours;Females;Number of PLYL;12,109.00
Total;Castilla-La Mancha;Tumours;Females;Distribution by chapter of the CIE;44.07
Total;Castilla-La Mancha;Tumours;Females;Standardised rate of PLYL;12.93
Total;Castilla-La Mancha;Tumours;Females;Average number of PLYL;13.64
Total;Castilla-La Mancha;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Number of PLYL;252.50
Total;Castilla-La Mancha;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Distribution by chapter of the CIE;0.28
Total;Castilla-La Mancha;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Standardised rate of PLYL;0.13
Total;Castilla-La Mancha;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Average number of PLYL;13.29
Total;Castilla-La Mancha;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Number of PLYL;80.00
Total;Castilla-La Mancha;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Distribution by chapter of the CIE;0.13
Total;Castilla-La Mancha;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Standardised rate of PLYL;0.09
Total;Castilla-La Mancha;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Average number of PLYL;10.00
Total;Castilla-La Mancha;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Number of PLYL;172.50
Total;Castilla-La Mancha;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Distribution by chapter of the CIE;0.63
Total;Castilla-La Mancha;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Standardised rate of PLYL;0.18
Total;Castilla-La Mancha;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Average number of PLYL;15.68
Total;Castilla-La Mancha;Endocrine, nutritional and metabolic diseases;Both sexes;Number of PLYL;2,510.00
Total;Castilla-La Mancha;Endocrine, nutritional and metabolic diseases;Both sexes;Distribution by chapter of the CIE;2.82
Total;Castilla-La Mancha;Endocrine, nutritional and metabolic diseases;Both sexes;Standardised rate of PLYL;1.34
Total;Castilla-La Mancha;Endocrine, nutritional and metabolic diseases;Both sexes;Average number of PLYL;11.31
Total;Castilla-La Mancha;Endocrine, nutritional and metabolic diseases;Males;Number of PLYL;1,632.50
Total;Castilla-La Mancha;Endocrine, nutritional and metabolic diseases;Males;Distribution by chapter of the CIE;2.66
Total;Castilla-La Mancha;Endocrine, nutritional and metabolic diseases;Males;Standardised rate of PLYL;1.69
Total;Castilla-La Mancha;Endocrine, nutritional and metabolic diseases;Males;Average number of PLYL;13.49
Total;Castilla-La Mancha;Endocrine, nutritional and metabolic diseases;Females;Number of PLYL;877.50
Total;Castilla-La Mancha;Endocrine, nutritional and metabolic diseases;Females;Distribution by chapter of the CIE;3.19
Total;Castilla-La Mancha;Endocrine, nutritional and metabolic diseases;Females;Standardised rate of PLYL;0.96
Total;Castilla-La Mancha;Endocrine, nutritional and metabolic diseases;Females;Average number of PLYL;8.69
Total;Castilla-La Mancha;Mental and behavioural disorders;Both sexes;Number of PLYL;547.50
Total;Castilla-La Mancha;Mental and behavioural disorders;Both sexes;Distribution by chapter of the CIE;0.62
Total;Castilla-La Mancha;Mental and behavioural disorders;Both sexes;Standardised rate of PLYL;0.28
Total;Castilla-La Mancha;Mental and behavioural disorders;Both sexes;Average number of PLYL;6.60
Total;Castilla-La Mancha;Mental and behavioural disorders;Males;Number of PLYL;367.50
Total;Castilla-La Mancha;Mental and behavioural disorders;Males;Distribution by chapter of the CIE;0.60
Total;Castilla-La Mancha;Mental and behavioural disorders;Males;Standardised rate of PLYL;0.36
Total;Castilla-La Mancha;Mental and behavioural disorders;Males;Average number of PLYL;7.82
Total;Castilla-La Mancha;Mental and behavioural disorders;Females;Number of PLYL;180.00
Total;Castilla-La Mancha;Mental and behavioural disorders;Females;Distribution by chapter of the CIE;0.66
Total;Castilla-La Mancha;Mental and behavioural disorders;Females;Standardised rate of PLYL;0.20
Total;Castilla-La Mancha;Mental and behavioural disorders;Females;Average number of PLYL;5.00
Total;Castilla-La Mancha;Diseases of the nervous system and the sense organs;Both sexes;Number of PLYL;3,615.50
Total;Castilla-La Mancha;Diseases of the nervous system and the sense organs;Both sexes;Distribution by chapter of the CIE;4.07
Total;Castilla-La Mancha;Diseases of the nervous system and the sense organs;Both sexes;Standardised rate of PLYL;1.91
Total;Castilla-La Mancha;Diseases of the nervous system and the sense organs;Both sexes;Average number of PLYL;13.34
Total;Castilla-La Mancha;Diseases of the nervous system and the sense organs;Males;Number of PLYL;2,246.50
Total;Castilla-La Mancha;Diseases of the nervous system and the sense organs;Males;Distribution by chapter of the CIE;3.66
Total;Castilla-La Mancha;Diseases of the nervous system and the sense organs;Males;Standardised rate of PLYL;2.34
Total;Castilla-La Mancha;Diseases of the nervous system and the sense organs;Males;Average number of PLYL;15.93
Total;Castilla-La Mancha;Diseases of the nervous system and the sense organs;Females;Number of PLYL;1,369.00
Total;Castilla-La Mancha;Diseases of the nervous system and the sense organs;Females;Distribution by chapter of the CIE;4.98
Total;Castilla-La Mancha;Diseases of the nervous system and the sense organs;Females;Standardised rate of PLYL;1.46
Total;Castilla-La Mancha;Diseases of the nervous system and the sense organs;Females;Average number of PLYL;10.53
Total;Castilla-La Mancha;Diseases of the circulatory system;Both sexes;Number of PLYL;16,632.00
Total;Castilla-La Mancha;Diseases of the circulatory system;Both sexes;Distribution by chapter of the CIE;18.72
Total;Castilla-La Mancha;Diseases of the circulatory system;Both sexes;Standardised rate of PLYL;8.71
Total;Castilla-La Mancha;Diseases of the circulatory system;Both sexes;Average number of PLYL;10.29
Total;Castilla-La Mancha;Diseases of the circulatory system;Males;Number of PLYL;11,932.00
Total;Castilla-La Mancha;Diseases of the circulatory system;Males;Distribution by chapter of the CIE;19.44
Total;Castilla-La Mancha;Diseases of the circulatory system;Males;Standardised rate of PLYL;12.09
Total;Castilla-La Mancha;Diseases of the circulatory system;Males;Average number of PLYL;11.80
Total;Castilla-La Mancha;Diseases of the circulatory system;Females;Number of PLYL;4,700.00
Total;Castilla-La Mancha;Diseases of the circulatory system;Females;Distribution by chapter of the CIE;17.10
Total;Castilla-La Mancha;Diseases of the circulatory system;Females;Standardised rate of PLYL;5.13
Total;Castilla-La Mancha;Diseases of the circulatory system;Females;Average number of PLYL;7.76
Total;Castilla-La Mancha;Diseases of the respiratory system;Both sexes;Number of PLYL;4,652.00
Total;Castilla-La Mancha;Diseases of the respiratory system;Both sexes;Distribution by chapter of the CIE;5.23
Total;Castilla-La Mancha;Diseases of the respiratory system;Both sexes;Standardised rate of PLYL;2.51
Total;Castilla-La Mancha;Diseases of the respiratory system;Both sexes;Average number of PLYL;9.03
Total;Castilla-La Mancha;Diseases of the respiratory system;Males;Number of PLYL;3,170.00
Total;Castilla-La Mancha;Diseases of the respiratory system;Males;Distribution by chapter of the CIE;5.16
Total;Castilla-La Mancha;Diseases of the respiratory system;Males;Standardised rate of PLYL;3.33
Total;Castilla-La Mancha;Diseases of the respiratory system;Males;Average number of PLYL;8.66
Total;Castilla-La Mancha;Diseases of the respiratory system;Females;Number of PLYL;1,482.00
Total;Castilla-La Mancha;Diseases of the respiratory system;Females;Distribution by chapter of the CIE;5.39
Total;Castilla-La Mancha;Diseases of the respiratory system;Females;Standardised rate of PLYL;1.63
Total;Castilla-La Mancha;Diseases of the respiratory system;Females;Average number of PLYL;9.95
Total;Castilla-La Mancha;Diseases of the digestive system;Both sexes;Number of PLYL;4,960.00
Total;Castilla-La Mancha;Diseases of the digestive system;Both sexes;Distribution by chapter of the CIE;5.58
Total;Castilla-La Mancha;Diseases of the digestive system;Both sexes;Standardised rate of PLYL;2.53
Total;Castilla-La Mancha;Diseases of the digestive system;Both sexes;Average number of PLYL;13.48
Total;Castilla-La Mancha;Diseases of the digestive system;Males;Number of PLYL;3,597.50
Total;Castilla-La Mancha;Diseases of the digestive system;Males;Distribution by chapter of the CIE;5.86
Total;Castilla-La Mancha;Diseases of the digestive system;Males;Standardised rate of PLYL;3.50
Total;Castilla-La Mancha;Diseases of the digestive system;Males;Average number of PLYL;15.44
Total;Castilla-La Mancha;Diseases of the digestive system;Females;Number of PLYL;1,362.50
Total;Castilla-La Mancha;Diseases of the digestive system;Females;Distribution by chapter of the CIE;4.96
Total;Castilla-La Mancha;Diseases of the digestive system;Females;Standardised rate of PLYL;1.48
Total;Castilla-La Mancha;Diseases of the digestive system;Females;Average number of PLYL;10.09
Total;Castilla-La Mancha;Diseases of the skin and subcutaneous tissue;Both sexes;Number of PLYL;132.50
Total;Castilla-La Mancha;Diseases of the skin and subcutaneous tissue;Both sexes;Distribution by chapter of the CIE;0.15
Total;Castilla-La Mancha;Diseases of the skin and subcutaneous tissue;Both sexes;Standardised rate of PLYL;0.07
Total;Castilla-La Mancha;Diseases of the skin and subcutaneous tissue;Both sexes;Average number of PLYL;6.97
Total;Castilla-La Mancha;Diseases of the skin and subcutaneous tissue;Males;Number of PLYL;32.50
Total;Castilla-La Mancha;Diseases of the skin and subcutaneous tissue;Males;Distribution by chapter of the CIE;0.05
Total;Castilla-La Mancha;Diseases of the skin and subcutaneous tissue;Males;Standardised rate of PLYL;0.03
Total;Castilla-La Mancha;Diseases of the skin and subcutaneous tissue;Males;Average number of PLYL;10.83
Total;Castilla-La Mancha;Diseases of the skin and subcutaneous tissue;Females;Number of PLYL;100.00
Total;Castilla-La Mancha;Diseases of the skin and subcutaneous tissue;Females;Distribution by chapter of the CIE;0.36
Total;Castilla-La Mancha;Diseases of the skin and subcutaneous tissue;Females;Standardised rate of PLYL;0.11
Total;Castilla-La Mancha;Diseases of the skin and subcutaneous tissue;Females;Average number of PLYL;6.25
Total;Castilla-La Mancha;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Number of PLYL;300.00
Total;Castilla-La Mancha;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Distribution by chapter of the CIE;0.34
Total;Castilla-La Mancha;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Standardised rate of PLYL;0.16
Total;Castilla-La Mancha;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Average number of PLYL;9.38
Total;Castilla-La Mancha;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Number of PLYL;112.50
Total;Castilla-La Mancha;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Distribution by chapter of the CIE;0.18
Total;Castilla-La Mancha;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Standardised rate of PLYL;0.11
Total;Castilla-La Mancha;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Average number of PLYL;8.65
Total;Castilla-La Mancha;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Number of PLYL;187.50
Total;Castilla-La Mancha;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Distribution by chapter of the CIE;0.68
Total;Castilla-La Mancha;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Standardised rate of PLYL;0.20
Total;Castilla-La Mancha;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Average number of PLYL;9.87
Total;Castilla-La Mancha;Diseases of the genitourinary system;Both sexes;Number of PLYL;772.50
Total;Castilla-La Mancha;Diseases of the genitourinary system;Both sexes;Distribution by chapter of the CIE;0.87
Total;Castilla-La Mancha;Diseases of the genitourinary system;Both sexes;Standardised rate of PLYL;0.40
Total;Castilla-La Mancha;Diseases of the genitourinary system;Both sexes;Average number of PLYL;8.31
Total;Castilla-La Mancha;Diseases of the genitourinary system;Males;Number of PLYL;480.00
Total;Castilla-La Mancha;Diseases of the genitourinary system;Males;Distribution by chapter of the CIE;0.78
Total;Castilla-La Mancha;Diseases of the genitourinary system;Males;Standardised rate of PLYL;0.50
Total;Castilla-La Mancha;Diseases of the genitourinary system;Males;Average number of PLYL;10.43
Total;Castilla-La Mancha;Diseases of the genitourinary system;Females;Number of PLYL;292.50
Total;Castilla-La Mancha;Diseases of the genitourinary system;Females;Distribution by chapter of the CIE;1.06
Total;Castilla-La Mancha;Diseases of the genitourinary system;Females;Standardised rate of PLYL;0.30
Total;Castilla-La Mancha;Diseases of the genitourinary system;Females;Average number of PLYL;6.22
Total;Castilla-La Mancha;Pregnancy, childbirth and the puerperium;Both sexes;Number of PLYL;..
Total;Castilla-La Mancha;Pregnancy, childbirth and the puerperium;Both sexes;Distribution by chapter of the CIE;..
Total;Castilla-La Mancha;Pregnancy, childbirth and the puerperium;Both sexes;Standardised rate of PLYL;..
Total;Castilla-La Mancha;Pregnancy, childbirth and the puerperium;Both sexes;Average number of PLYL;..
Total;Castilla-La Mancha;Pregnancy, childbirth and the puerperium;Males;Number of PLYL;..
Total;Castilla-La Mancha;Pregnancy, childbirth and the puerperium;Males;Distribution by chapter of the CIE;..
Total;Castilla-La Mancha;Pregnancy, childbirth and the puerperium;Males;Standardised rate of PLYL;..
Total;Castilla-La Mancha;Pregnancy, childbirth and the puerperium;Males;Average number of PLYL;..
Total;Castilla-La Mancha;Pregnancy, childbirth and the puerperium;Females;Number of PLYL;..
Total;Castilla-La Mancha;Pregnancy, childbirth and the puerperium;Females;Distribution by chapter of the CIE;..
Total;Castilla-La Mancha;Pregnancy, childbirth and the puerperium;Females;Standardised rate of PLYL;..
Total;Castilla-La Mancha;Pregnancy, childbirth and the puerperium;Females;Average number of PLYL;..
Total;Castilla-La Mancha;Affections originated in the perinatal period;Both sexes;Number of PLYL;..
Total;Castilla-La Mancha;Affections originated in the perinatal period;Both sexes;Distribution by chapter of the CIE;..
Total;Castilla-La Mancha;Affections originated in the perinatal period;Both sexes;Standardised rate of PLYL;..
Total;Castilla-La Mancha;Affections originated in the perinatal period;Both sexes;Average number of PLYL;..
Total;Castilla-La Mancha;Affections originated in the perinatal period;Males;Number of PLYL;..
Total;Castilla-La Mancha;Affections originated in the perinatal period;Males;Distribution by chapter of the CIE;..
Total;Castilla-La Mancha;Affections originated in the perinatal period;Males;Standardised rate of PLYL;..
Total;Castilla-La Mancha;Affections originated in the perinatal period;Males;Average number of PLYL;..
Total;Castilla-La Mancha;Affections originated in the perinatal period;Females;Number of PLYL;..
Total;Castilla-La Mancha;Affections originated in the perinatal period;Females;Distribution by chapter of the CIE;..
Total;Castilla-La Mancha;Affections originated in the perinatal period;Females;Standardised rate of PLYL;..
Total;Castilla-La Mancha;Affections originated in the perinatal period;Females;Average number of PLYL;..
Total;Castilla-La Mancha;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Number of PLYL;732.00
Total;Castilla-La Mancha;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Distribution by chapter of the CIE;0.82
Total;Castilla-La Mancha;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Standardised rate of PLYL;0.40
Total;Castilla-La Mancha;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Average number of PLYL;31.83
Total;Castilla-La Mancha;Congenital malformations, deformities and chromosomal abnormalities;Males;Number of PLYL;200.00
Total;Castilla-La Mancha;Congenital malformations, deformities and chromosomal abnormalities;Males;Distribution by chapter of the CIE;0.33
Total;Castilla-La Mancha;Congenital malformations, deformities and chromosomal abnormalities;Males;Standardised rate of PLYL;0.24
Total;Castilla-La Mancha;Congenital malformations, deformities and chromosomal abnormalities;Males;Average number of PLYL;33.33
Total;Castilla-La Mancha;Congenital malformations, deformities and chromosomal abnormalities;Females;Number of PLYL;532.00
Total;Castilla-La Mancha;Congenital malformations, deformities and chromosomal abnormalities;Females;Distribution by chapter of the CIE;1.94
Total;Castilla-La Mancha;Congenital malformations, deformities and chromosomal abnormalities;Females;Standardised rate of PLYL;0.58
Total;Castilla-La Mancha;Congenital malformations, deformities and chromosomal abnormalities;Females;Average number of PLYL;31.29
Total;Castilla-La Mancha;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Number of PLYL;4,290.50
Total;Castilla-La Mancha;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Distribution by chapter of the CIE;4.83
Total;Castilla-La Mancha;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Standardised rate of PLYL;2.20
Total;Castilla-La Mancha;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Average number of PLYL;25.09
Total;Castilla-La Mancha;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Number of PLYL;3,343.50
Total;Castilla-La Mancha;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Distribution by chapter of the CIE;5.45
Total;Castilla-La Mancha;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Standardised rate of PLYL;3.38
Total;Castilla-La Mancha;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Average number of PLYL;26.12
Total;Castilla-La Mancha;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Number of PLYL;947.00
Total;Castilla-La Mancha;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Distribution by chapter of the CIE;3.45
Total;Castilla-La Mancha;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Standardised rate of PLYL;0.97
Total;Castilla-La Mancha;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Average number of PLYL;22.02
Total;Castilla-La Mancha;External causes of mortality;Both sexes;Number of PLYL;11,645.50
Total;Castilla-La Mancha;External causes of mortality;Both sexes;Distribution by chapter of the CIE;13.10
Total;Castilla-La Mancha;External causes of mortality;Both sexes;Standardised rate of PLYL;6.17
Total;Castilla-La Mancha;External causes of mortality;Both sexes;Average number of PLYL;27.15
Total;Castilla-La Mancha;External causes of mortality;Males;Number of PLYL;8,956.50
Total;Castilla-La Mancha;External causes of mortality;Males;Distribution by chapter of the CIE;14.59
Total;Castilla-La Mancha;External causes of mortality;Males;Standardised rate of PLYL;9.23
Total;Castilla-La Mancha;External causes of mortality;Males;Average number of PLYL;27.56
Total;Castilla-La Mancha;External causes of mortality;Females;Number of PLYL;2,689.00
Total;Castilla-La Mancha;External causes of mortality;Females;Distribution by chapter of the CIE;9.79
Total;Castilla-La Mancha;External causes of mortality;Females;Standardised rate of PLYL;2.95
Total;Castilla-La Mancha;External causes of mortality;Females;Average number of PLYL;25.86
Total;Catalu±a;All causes;Both sexes;Number of PLYL;358,032.50
Total;Catalu±a;All causes;Both sexes;Distribution by chapter of the CIE;100.00
Total;Catalu±a;All causes;Both sexes;Standardised rate of PLYL;49.95
Total;Catalu±a;All causes;Both sexes;Average number of PLYL;14.22
Total;Catalu±a;All causes;Males;Number of PLYL;242,925.50
Total;Catalu±a;All causes;Males;Distribution by chapter of the CIE;100.00
Total;Catalu±a;All causes;Males;Standardised rate of PLYL;67.98
Total;Catalu±a;All causes;Males;Average number of PLYL;14.73
Total;Catalu±a;All causes;Females;Number of PLYL;115,107.00
Total;Catalu±a;All causes;Females;Distribution by chapter of the CIE;100.00
Total;Catalu±a;All causes;Females;Standardised rate of PLYL;31.92
Total;Catalu±a;All causes;Females;Average number of PLYL;13.25
Total;Catalu±a;Infectious and parasitic diseases (1);Both sexes;Number of PLYL;10,276.00
Total;Catalu±a;Infectious and parasitic diseases (1);Both sexes;Distribution by chapter of the CIE;2.87
Total;Catalu±a;Infectious and parasitic diseases (1);Both sexes;Standardised rate of PLYL;1.37
Total;Catalu±a;Infectious and parasitic diseases (1);Both sexes;Average number of PLYL;18.32
Total;Catalu±a;Infectious and parasitic diseases (1);Males;Number of PLYL;7,430.00
Total;Catalu±a;Infectious and parasitic diseases (1);Males;Distribution by chapter of the CIE;3.06
Total;Catalu±a;Infectious and parasitic diseases (1);Males;Standardised rate of PLYL;1.95
Total;Catalu±a;Infectious and parasitic diseases (1);Males;Average number of PLYL;19.97
Total;Catalu±a;Infectious and parasitic diseases (1);Females;Number of PLYL;2,846.00
Total;Catalu±a;Infectious and parasitic diseases (1);Females;Distribution by chapter of the CIE;2.47
Total;Catalu±a;Infectious and parasitic diseases (1);Females;Standardised rate of PLYL;0.79
Total;Catalu±a;Infectious and parasitic diseases (1);Females;Average number of PLYL;15.06
Total;Catalu±a;Tumours;Both sexes;Number of PLYL;158,246.50
Total;Catalu±a;Tumours;Both sexes;Distribution by chapter of the CIE;44.20
Total;Catalu±a;Tumours;Both sexes;Standardised rate of PLYL;21.79
Total;Catalu±a;Tumours;Both sexes;Average number of PLYL;14.42
Total;Catalu±a;Tumours;Males;Number of PLYL;98,467.00
Total;Catalu±a;Tumours;Males;Distribution by chapter of the CIE;40.53
Total;Catalu±a;Tumours;Males;Standardised rate of PLYL;27.32
Total;Catalu±a;Tumours;Males;Average number of PLYL;13.79
Total;Catalu±a;Tumours;Females;Number of PLYL;59,779.50
Total;Catalu±a;Tumours;Females;Distribution by chapter of the CIE;51.93
Total;Catalu±a;Tumours;Females;Standardised rate of PLYL;16.27
Total;Catalu±a;Tumours;Females;Average number of PLYL;15.58
Total;Catalu±a;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Number of PLYL;2,141.00
Total;Catalu±a;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Distribution by chapter of the CIE;0.60
Total;Catalu±a;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Standardised rate of PLYL;0.31
Total;Catalu±a;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Average number of PLYL;18.30
Total;Catalu±a;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Number of PLYL;1,606.00
Total;Catalu±a;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Distribution by chapter of the CIE;0.66
Total;Catalu±a;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Standardised rate of PLYL;0.46
Total;Catalu±a;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Average number of PLYL;21.41
Total;Catalu±a;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Number of PLYL;535.00
Total;Catalu±a;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Distribution by chapter of the CIE;0.46
Total;Catalu±a;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Standardised rate of PLYL;0.16
Total;Catalu±a;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Average number of PLYL;12.74
Total;Catalu±a;Endocrine, nutritional and metabolic diseases;Both sexes;Number of PLYL;8,304.50
Total;Catalu±a;Endocrine, nutritional and metabolic diseases;Both sexes;Distribution by chapter of the CIE;2.32
Total;Catalu±a;Endocrine, nutritional and metabolic diseases;Both sexes;Standardised rate of PLYL;1.18
Total;Catalu±a;Endocrine, nutritional and metabolic diseases;Both sexes;Average number of PLYL;10.47
Total;Catalu±a;Endocrine, nutritional and metabolic diseases;Males;Number of PLYL;5,410.50
Total;Catalu±a;Endocrine, nutritional and metabolic diseases;Males;Distribution by chapter of the CIE;2.23
Total;Catalu±a;Endocrine, nutritional and metabolic diseases;Males;Standardised rate of PLYL;1.53
Total;Catalu±a;Endocrine, nutritional and metabolic diseases;Males;Average number of PLYL;11.44
Total;Catalu±a;Endocrine, nutritional and metabolic diseases;Females;Number of PLYL;2,894.00
Total;Catalu±a;Endocrine, nutritional and metabolic diseases;Females;Distribution by chapter of the CIE;2.51
Total;Catalu±a;Endocrine, nutritional and metabolic diseases;Females;Standardised rate of PLYL;0.83
Total;Catalu±a;Endocrine, nutritional and metabolic diseases;Females;Average number of PLYL;9.04
Total;Catalu±a;Mental and behavioural disorders;Both sexes;Number of PLYL;3,337.50
Total;Catalu±a;Mental and behavioural disorders;Both sexes;Distribution by chapter of the CIE;0.93
Total;Catalu±a;Mental and behavioural disorders;Both sexes;Standardised rate of PLYL;0.47
Total;Catalu±a;Mental and behavioural disorders;Both sexes;Average number of PLYL;7.60
Total;Catalu±a;Mental and behavioural disorders;Males;Number of PLYL;2,030.00
Total;Catalu±a;Mental and behavioural disorders;Males;Distribution by chapter of the CIE;0.84
Total;Catalu±a;Mental and behavioural disorders;Males;Standardised rate of PLYL;0.57
Total;Catalu±a;Mental and behavioural disorders;Males;Average number of PLYL;8.90
Total;Catalu±a;Mental and behavioural disorders;Females;Number of PLYL;1,307.50
Total;Catalu±a;Mental and behavioural disorders;Females;Distribution by chapter of the CIE;1.14
Total;Catalu±a;Mental and behavioural disorders;Females;Standardised rate of PLYL;0.36
Total;Catalu±a;Mental and behavioural disorders;Females;Average number of PLYL;6.20
Total;Catalu±a;Diseases of the nervous system and the sense organs;Both sexes;Number of PLYL;12,467.00
Total;Catalu±a;Diseases of the nervous system and the sense organs;Both sexes;Distribution by chapter of the CIE;3.48
Total;Catalu±a;Diseases of the nervous system and the sense organs;Both sexes;Standardised rate of PLYL;1.79
Total;Catalu±a;Diseases of the nervous system and the sense organs;Both sexes;Average number of PLYL;11.83
Total;Catalu±a;Diseases of the nervous system and the sense organs;Males;Number of PLYL;7,233.00
Total;Catalu±a;Diseases of the nervous system and the sense organs;Males;Distribution by chapter of the CIE;2.98
Total;Catalu±a;Diseases of the nervous system and the sense organs;Males;Standardised rate of PLYL;2.10
Total;Catalu±a;Diseases of the nervous system and the sense organs;Males;Average number of PLYL;13.44
Total;Catalu±a;Diseases of the nervous system and the sense organs;Females;Number of PLYL;5,234.00
Total;Catalu±a;Diseases of the nervous system and the sense organs;Females;Distribution by chapter of the CIE;4.55
Total;Catalu±a;Diseases of the nervous system and the sense organs;Females;Standardised rate of PLYL;1.48
Total;Catalu±a;Diseases of the nervous system and the sense organs;Females;Average number of PLYL;10.14
Total;Catalu±a;Diseases of the circulatory system;Both sexes;Number of PLYL;59,919.00
Total;Catalu±a;Diseases of the circulatory system;Both sexes;Distribution by chapter of the CIE;16.74
Total;Catalu±a;Diseases of the circulatory system;Both sexes;Standardised rate of PLYL;8.38
Total;Catalu±a;Diseases of the circulatory system;Both sexes;Average number of PLYL;11.21
Total;Catalu±a;Diseases of the circulatory system;Males;Number of PLYL;43,784.50
Total;Catalu±a;Diseases of the circulatory system;Males;Distribution by chapter of the CIE;18.02
Total;Catalu±a;Diseases of the circulatory system;Males;Standardised rate of PLYL;12.17
Total;Catalu±a;Diseases of the circulatory system;Males;Average number of PLYL;12.35
Total;Catalu±a;Diseases of the circulatory system;Females;Number of PLYL;16,134.50
Total;Catalu±a;Diseases of the circulatory system;Females;Distribution by chapter of the CIE;14.02
Total;Catalu±a;Diseases of the circulatory system;Females;Standardised rate of PLYL;4.57
Total;Catalu±a;Diseases of the circulatory system;Females;Average number of PLYL;8.96
Total;Catalu±a;Diseases of the respiratory system;Both sexes;Number of PLYL;20,641.50
Total;Catalu±a;Diseases of the respiratory system;Both sexes;Distribution by chapter of the CIE;5.77
Total;Catalu±a;Diseases of the respiratory system;Both sexes;Standardised rate of PLYL;2.93
Total;Catalu±a;Diseases of the respiratory system;Both sexes;Average number of PLYL;10.95
Total;Catalu±a;Diseases of the respiratory system;Males;Number of PLYL;15,422.00
Total;Catalu±a;Diseases of the respiratory system;Males;Distribution by chapter of the CIE;6.35
Total;Catalu±a;Diseases of the respiratory system;Males;Standardised rate of PLYL;4.37
Total;Catalu±a;Diseases of the respiratory system;Males;Average number of PLYL;11.18
Total;Catalu±a;Diseases of the respiratory system;Females;Number of PLYL;5,219.50
Total;Catalu±a;Diseases of the respiratory system;Females;Distribution by chapter of the CIE;4.53
Total;Catalu±a;Diseases of the respiratory system;Females;Standardised rate of PLYL;1.46
Total;Catalu±a;Diseases of the respiratory system;Females;Average number of PLYL;10.32
Total;Catalu±a;Diseases of the digestive system;Both sexes;Number of PLYL;19,259.50
Total;Catalu±a;Diseases of the digestive system;Both sexes;Distribution by chapter of the CIE;5.38
Total;Catalu±a;Diseases of the digestive system;Both sexes;Standardised rate of PLYL;2.60
Total;Catalu±a;Diseases of the digestive system;Both sexes;Average number of PLYL;14.18
Total;Catalu±a;Diseases of the digestive system;Males;Number of PLYL;13,434.50
Total;Catalu±a;Diseases of the digestive system;Males;Distribution by chapter of the CIE;5.53
Total;Catalu±a;Diseases of the digestive system;Males;Standardised rate of PLYL;3.62
Total;Catalu±a;Diseases of the digestive system;Males;Average number of PLYL;15.20
Total;Catalu±a;Diseases of the digestive system;Females;Number of PLYL;5,825.00
Total;Catalu±a;Diseases of the digestive system;Females;Distribution by chapter of the CIE;5.06
Total;Catalu±a;Diseases of the digestive system;Females;Standardised rate of PLYL;1.59
Total;Catalu±a;Diseases of the digestive system;Females;Average number of PLYL;12.29
Total;Catalu±a;Diseases of the skin and subcutaneous tissue;Both sexes;Number of PLYL;342.00
Total;Catalu±a;Diseases of the skin and subcutaneous tissue;Both sexes;Distribution by chapter of the CIE;0.10
Total;Catalu±a;Diseases of the skin and subcutaneous tissue;Both sexes;Standardised rate of PLYL;0.05
Total;Catalu±a;Diseases of the skin and subcutaneous tissue;Both sexes;Average number of PLYL;20.12
Total;Catalu±a;Diseases of the skin and subcutaneous tissue;Males;Number of PLYL;247.00
Total;Catalu±a;Diseases of the skin and subcutaneous tissue;Males;Distribution by chapter of the CIE;0.10
Total;Catalu±a;Diseases of the skin and subcutaneous tissue;Males;Standardised rate of PLYL;0.08
Total;Catalu±a;Diseases of the skin and subcutaneous tissue;Males;Average number of PLYL;27.44
Total;Catalu±a;Diseases of the skin and subcutaneous tissue;Females;Number of PLYL;95.00
Total;Catalu±a;Diseases of the skin and subcutaneous tissue;Females;Distribution by chapter of the CIE;0.08
Total;Catalu±a;Diseases of the skin and subcutaneous tissue;Females;Standardised rate of PLYL;0.03
Total;Catalu±a;Diseases of the skin and subcutaneous tissue;Females;Average number of PLYL;11.88
Total;Catalu±a;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Number of PLYL;1,262.50
Total;Catalu±a;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Distribution by chapter of the CIE;0.35
Total;Catalu±a;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Standardised rate of PLYL;0.18
Total;Catalu±a;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Average number of PLYL;10.61
Total;Catalu±a;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Number of PLYL;522.50
Total;Catalu±a;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Distribution by chapter of the CIE;0.22
Total;Catalu±a;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Standardised rate of PLYL;0.15
Total;Catalu±a;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Average number of PLYL;12.15
Total;Catalu±a;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Number of PLYL;740.00
Total;Catalu±a;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Distribution by chapter of the CIE;0.64
Total;Catalu±a;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Standardised rate of PLYL;0.20
Total;Catalu±a;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Average number of PLYL;9.74
Total;Catalu±a;Diseases of the genitourinary system;Both sexes;Number of PLYL;2,787.50
Total;Catalu±a;Diseases of the genitourinary system;Both sexes;Distribution by chapter of the CIE;0.78
Total;Catalu±a;Diseases of the genitourinary system;Both sexes;Standardised rate of PLYL;0.39
Total;Catalu±a;Diseases of the genitourinary system;Both sexes;Average number of PLYL;9.58
Total;Catalu±a;Diseases of the genitourinary system;Males;Number of PLYL;1,572.50
Total;Catalu±a;Diseases of the genitourinary system;Males;Distribution by chapter of the CIE;0.65
Total;Catalu±a;Diseases of the genitourinary system;Males;Standardised rate of PLYL;0.43
Total;Catalu±a;Diseases of the genitourinary system;Males;Average number of PLYL;9.20
Total;Catalu±a;Diseases of the genitourinary system;Females;Number of PLYL;1,215.00
Total;Catalu±a;Diseases of the genitourinary system;Females;Distribution by chapter of the CIE;1.06
Total;Catalu±a;Diseases of the genitourinary system;Females;Standardised rate of PLYL;0.35
Total;Catalu±a;Diseases of the genitourinary system;Females;Average number of PLYL;10.13
Total;Catalu±a;Pregnancy, childbirth and the puerperium;Both sexes;Number of PLYL;200.00
Total;Catalu±a;Pregnancy, childbirth and the puerperium;Both sexes;Distribution by chapter of the CIE;0.06
Total;Catalu±a;Pregnancy, childbirth and the puerperium;Both sexes;Standardised rate of PLYL;0.03
Total;Catalu±a;Pregnancy, childbirth and the puerperium;Both sexes;Average number of PLYL;50.00
Total;Catalu±a;Pregnancy, childbirth and the puerperium;Males;Number of PLYL;..
Total;Catalu±a;Pregnancy, childbirth and the puerperium;Males;Distribution by chapter of the CIE;..
Total;Catalu±a;Pregnancy, childbirth and the puerperium;Males;Standardised rate of PLYL;..
Total;Catalu±a;Pregnancy, childbirth and the puerperium;Males;Average number of PLYL;..
Total;Catalu±a;Pregnancy, childbirth and the puerperium;Females;Number of PLYL;200.00
Total;Catalu±a;Pregnancy, childbirth and the puerperium;Females;Distribution by chapter of the CIE;0.17
Total;Catalu±a;Pregnancy, childbirth and the puerperium;Females;Standardised rate of PLYL;0.07
Total;Catalu±a;Pregnancy, childbirth and the puerperium;Females;Average number of PLYL;50.00
Total;Catalu±a;Affections originated in the perinatal period;Both sexes;Number of PLYL;67.50
Total;Catalu±a;Affections originated in the perinatal period;Both sexes;Distribution by chapter of the CIE;0.02
Total;Catalu±a;Affections originated in the perinatal period;Both sexes;Standardised rate of PLYL;0.01
Total;Catalu±a;Affections originated in the perinatal period;Both sexes;Average number of PLYL;67.50
Total;Catalu±a;Affections originated in the perinatal period;Males;Number of PLYL;67.50
Total;Catalu±a;Affections originated in the perinatal period;Males;Distribution by chapter of the CIE;0.03
Total;Catalu±a;Affections originated in the perinatal period;Males;Standardised rate of PLYL;0.02
Total;Catalu±a;Affections originated in the perinatal period;Males;Average number of PLYL;67.50
Total;Catalu±a;Affections originated in the perinatal period;Females;Number of PLYL;..
Total;Catalu±a;Affections originated in the perinatal period;Females;Distribution by chapter of the CIE;..
Total;Catalu±a;Affections originated in the perinatal period;Females;Standardised rate of PLYL;..
Total;Catalu±a;Affections originated in the perinatal period;Females;Average number of PLYL;..
Total;Catalu±a;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Number of PLYL;2,178.00
Total;Catalu±a;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Distribution by chapter of the CIE;0.61
Total;Catalu±a;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Standardised rate of PLYL;0.31
Total;Catalu±a;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Average number of PLYL;34.03
Total;Catalu±a;Congenital malformations, deformities and chromosomal abnormalities;Males;Number of PLYL;1,054.50
Total;Catalu±a;Congenital malformations, deformities and chromosomal abnormalities;Males;Distribution by chapter of the CIE;0.43
Total;Catalu±a;Congenital malformations, deformities and chromosomal abnormalities;Males;Standardised rate of PLYL;0.30
Total;Catalu±a;Congenital malformations, deformities and chromosomal abnormalities;Males;Average number of PLYL;32.95
Total;Catalu±a;Congenital malformations, deformities and chromosomal abnormalities;Females;Number of PLYL;1,123.50
Total;Catalu±a;Congenital malformations, deformities and chromosomal abnormalities;Females;Distribution by chapter of the CIE;0.98
Total;Catalu±a;Congenital malformations, deformities and chromosomal abnormalities;Females;Standardised rate of PLYL;0.31
Total;Catalu±a;Congenital malformations, deformities and chromosomal abnormalities;Females;Average number of PLYL;35.11
Total;Catalu±a;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Number of PLYL;13,340.00
Total;Catalu±a;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Distribution by chapter of the CIE;3.73
Total;Catalu±a;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Standardised rate of PLYL;1.86
Total;Catalu±a;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Average number of PLYL;21.66
Total;Catalu±a;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Number of PLYL;10,275.00
Total;Catalu±a;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Distribution by chapter of the CIE;4.23
Total;Catalu±a;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Standardised rate of PLYL;2.85
Total;Catalu±a;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Average number of PLYL;22.94
Total;Catalu±a;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Number of PLYL;3,065.00
Total;Catalu±a;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Distribution by chapter of the CIE;2.66
Total;Catalu±a;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Standardised rate of PLYL;0.88
Total;Catalu±a;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Average number of PLYL;18.24
Total;Catalu±a;External causes of mortality;Both sexes;Number of PLYL;43,262.50
Total;Catalu±a;External causes of mortality;Both sexes;Distribution by chapter of the CIE;12.08
Total;Catalu±a;External causes of mortality;Both sexes;Standardised rate of PLYL;6.31
Total;Catalu±a;External causes of mortality;Both sexes;Average number of PLYL;28.26
Total;Catalu±a;External causes of mortality;Males;Number of PLYL;34,369.00
Total;Catalu±a;External causes of mortality;Males;Distribution by chapter of the CIE;14.15
Total;Catalu±a;External causes of mortality;Males;Standardised rate of PLYL;10.05
Total;Catalu±a;External causes of mortality;Males;Average number of PLYL;29.91
Total;Catalu±a;External causes of mortality;Females;Number of PLYL;8,893.50
Total;Catalu±a;External causes of mortality;Females;Distribution by chapter of the CIE;7.73
Total;Catalu±a;External causes of mortality;Females;Standardised rate of PLYL;2.57
Total;Catalu±a;External causes of mortality;Females;Average number of PLYL;23.28
Total;Comunitat Valenciana;All causes;Both sexes;Number of PLYL;255,507.50
Total;Comunitat Valenciana;All causes;Both sexes;Distribution by chapter of the CIE;100.00
Total;Comunitat Valenciana;All causes;Both sexes;Standardised rate of PLYL;52.36
Total;Comunitat Valenciana;All causes;Both sexes;Average number of PLYL;14.03
Total;Comunitat Valenciana;All causes;Males;Number of PLYL;173,828.50
Total;Comunitat Valenciana;All causes;Males;Distribution by chapter of the CIE;100.00
Total;Comunitat Valenciana;All causes;Males;Standardised rate of PLYL;70.76
Total;Comunitat Valenciana;All causes;Males;Average number of PLYL;14.66
Total;Comunitat Valenciana;All causes;Females;Number of PLYL;81,679.00
Total;Comunitat Valenciana;All causes;Females;Distribution by chapter of the CIE;100.00
Total;Comunitat Valenciana;All causes;Females;Standardised rate of PLYL;33.73
Total;Comunitat Valenciana;All causes;Females;Average number of PLYL;12.86
Total;Comunitat Valenciana;Infectious and parasitic diseases (1);Both sexes;Number of PLYL;7,894.00
Total;Comunitat Valenciana;Infectious and parasitic diseases (1);Both sexes;Distribution by chapter of the CIE;3.09
Total;Comunitat Valenciana;Infectious and parasitic diseases (1);Both sexes;Standardised rate of PLYL;1.51
Total;Comunitat Valenciana;Infectious and parasitic diseases (1);Both sexes;Average number of PLYL;20.77
Total;Comunitat Valenciana;Infectious and parasitic diseases (1);Males;Number of PLYL;5,754.00
Total;Comunitat Valenciana;Infectious and parasitic diseases (1);Males;Distribution by chapter of the CIE;3.31
Total;Comunitat Valenciana;Infectious and parasitic diseases (1);Males;Standardised rate of PLYL;2.16
Total;Comunitat Valenciana;Infectious and parasitic diseases (1);Males;Average number of PLYL;22.65
Total;Comunitat Valenciana;Infectious and parasitic diseases (1);Females;Number of PLYL;2,140.00
Total;Comunitat Valenciana;Infectious and parasitic diseases (1);Females;Distribution by chapter of the CIE;2.62
Total;Comunitat Valenciana;Infectious and parasitic diseases (1);Females;Standardised rate of PLYL;0.85
Total;Comunitat Valenciana;Infectious and parasitic diseases (1);Females;Average number of PLYL;16.98
Total;Comunitat Valenciana;Tumours;Both sexes;Number of PLYL;106,766.00
Total;Comunitat Valenciana;Tumours;Both sexes;Distribution by chapter of the CIE;41.79
Total;Comunitat Valenciana;Tumours;Both sexes;Standardised rate of PLYL;21.72
Total;Comunitat Valenciana;Tumours;Both sexes;Average number of PLYL;14.28
Total;Comunitat Valenciana;Tumours;Males;Number of PLYL;67,142.50
Total;Comunitat Valenciana;Tumours;Males;Distribution by chapter of the CIE;38.63
Total;Comunitat Valenciana;Tumours;Males;Standardised rate of PLYL;27.30
Total;Comunitat Valenciana;Tumours;Males;Average number of PLYL;13.92
Total;Comunitat Valenciana;Tumours;Females;Number of PLYL;39,623.50
Total;Comunitat Valenciana;Tumours;Females;Distribution by chapter of the CIE;48.51
Total;Comunitat Valenciana;Tumours;Females;Standardised rate of PLYL;16.09
Total;Comunitat Valenciana;Tumours;Females;Average number of PLYL;14.95
Total;Comunitat Valenciana;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Number of PLYL;709.50
Total;Comunitat Valenciana;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Distribution by chapter of the CIE;0.28
Total;Comunitat Valenciana;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Standardised rate of PLYL;0.14
Total;Comunitat Valenciana;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Average number of PLYL;13.14
Total;Comunitat Valenciana;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Number of PLYL;572.00
Total;Comunitat Valenciana;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Distribution by chapter of the CIE;0.33
Total;Comunitat Valenciana;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Standardised rate of PLYL;0.22
Total;Comunitat Valenciana;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Average number of PLYL;15.46
Total;Comunitat Valenciana;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Number of PLYL;137.50
Total;Comunitat Valenciana;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Distribution by chapter of the CIE;0.17
Total;Comunitat Valenciana;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Standardised rate of PLYL;0.06
Total;Comunitat Valenciana;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Average number of PLYL;8.09
Total;Comunitat Valenciana;Endocrine, nutritional and metabolic diseases;Both sexes;Number of PLYL;5,360.00
Total;Comunitat Valenciana;Endocrine, nutritional and metabolic diseases;Both sexes;Distribution by chapter of the CIE;2.10
Total;Comunitat Valenciana;Endocrine, nutritional and metabolic diseases;Both sexes;Standardised rate of PLYL;1.12
Total;Comunitat Valenciana;Endocrine, nutritional and metabolic diseases;Both sexes;Average number of PLYL;10.63
Total;Comunitat Valenciana;Endocrine, nutritional and metabolic diseases;Males;Number of PLYL;3,125.00
Total;Comunitat Valenciana;Endocrine, nutritional and metabolic diseases;Males;Distribution by chapter of the CIE;1.80
Total;Comunitat Valenciana;Endocrine, nutritional and metabolic diseases;Males;Standardised rate of PLYL;1.30
Total;Comunitat Valenciana;Endocrine, nutritional and metabolic diseases;Males;Average number of PLYL;11.84
Total;Comunitat Valenciana;Endocrine, nutritional and metabolic diseases;Females;Number of PLYL;2,235.00
Total;Comunitat Valenciana;Endocrine, nutritional and metabolic diseases;Females;Distribution by chapter of the CIE;2.74
Total;Comunitat Valenciana;Endocrine, nutritional and metabolic diseases;Females;Standardised rate of PLYL;0.94
Total;Comunitat Valenciana;Endocrine, nutritional and metabolic diseases;Females;Average number of PLYL;9.31
Total;Comunitat Valenciana;Mental and behavioural disorders;Both sexes;Number of PLYL;2,960.00
Total;Comunitat Valenciana;Mental and behavioural disorders;Both sexes;Distribution by chapter of the CIE;1.16
Total;Comunitat Valenciana;Mental and behavioural disorders;Both sexes;Standardised rate of PLYL;0.60
Total;Comunitat Valenciana;Mental and behavioural disorders;Both sexes;Average number of PLYL;9.61
Total;Comunitat Valenciana;Mental and behavioural disorders;Males;Number of PLYL;1,962.50
Total;Comunitat Valenciana;Mental and behavioural disorders;Males;Distribution by chapter of the CIE;1.13
Total;Comunitat Valenciana;Mental and behavioural disorders;Males;Standardised rate of PLYL;0.77
Total;Comunitat Valenciana;Mental and behavioural disorders;Males;Average number of PLYL;11.21
Total;Comunitat Valenciana;Mental and behavioural disorders;Females;Number of PLYL;997.50
Total;Comunitat Valenciana;Mental and behavioural disorders;Females;Distribution by chapter of the CIE;1.22
Total;Comunitat Valenciana;Mental and behavioural disorders;Females;Standardised rate of PLYL;0.42
Total;Comunitat Valenciana;Mental and behavioural disorders;Females;Average number of PLYL;7.50
Total;Comunitat Valenciana;Diseases of the nervous system and the sense organs;Both sexes;Number of PLYL;7,054.00
Total;Comunitat Valenciana;Diseases of the nervous system and the sense organs;Both sexes;Distribution by chapter of the CIE;2.76
Total;Comunitat Valenciana;Diseases of the nervous system and the sense organs;Both sexes;Standardised rate of PLYL;1.52
Total;Comunitat Valenciana;Diseases of the nervous system and the sense organs;Both sexes;Average number of PLYL;10.40
Total;Comunitat Valenciana;Diseases of the nervous system and the sense organs;Males;Number of PLYL;3,614.00
Total;Comunitat Valenciana;Diseases of the nervous system and the sense organs;Males;Distribution by chapter of the CIE;2.08
Total;Comunitat Valenciana;Diseases of the nervous system and the sense organs;Males;Standardised rate of PLYL;1.52
Total;Comunitat Valenciana;Diseases of the nervous system and the sense organs;Males;Average number of PLYL;10.57
Total;Comunitat Valenciana;Diseases of the nervous system and the sense organs;Females;Number of PLYL;3,440.00
Total;Comunitat Valenciana;Diseases of the nervous system and the sense organs;Females;Distribution by chapter of the CIE;4.21
Total;Comunitat Valenciana;Diseases of the nervous system and the sense organs;Females;Standardised rate of PLYL;1.52
Total;Comunitat Valenciana;Diseases of the nervous system and the sense organs;Females;Average number of PLYL;10.24
Total;Comunitat Valenciana;Diseases of the circulatory system;Both sexes;Number of PLYL;53,494.50
Total;Comunitat Valenciana;Diseases of the circulatory system;Both sexes;Distribution by chapter of the CIE;20.94
Total;Comunitat Valenciana;Diseases of the circulatory system;Both sexes;Standardised rate of PLYL;11.03
Total;Comunitat Valenciana;Diseases of the circulatory system;Both sexes;Average number of PLYL;11.25
Total;Comunitat Valenciana;Diseases of the circulatory system;Males;Number of PLYL;38,661.00
Total;Comunitat Valenciana;Diseases of the circulatory system;Males;Distribution by chapter of the CIE;22.24
Total;Comunitat Valenciana;Diseases of the circulatory system;Males;Standardised rate of PLYL;15.76
Total;Comunitat Valenciana;Diseases of the circulatory system;Males;Average number of PLYL;12.39
Total;Comunitat Valenciana;Diseases of the circulatory system;Females;Number of PLYL;14,833.50
Total;Comunitat Valenciana;Diseases of the circulatory system;Females;Distribution by chapter of the CIE;18.16
Total;Comunitat Valenciana;Diseases of the circulatory system;Females;Standardised rate of PLYL;6.23
Total;Comunitat Valenciana;Diseases of the circulatory system;Females;Average number of PLYL;9.09
Total;Comunitat Valenciana;Diseases of the respiratory system;Both sexes;Number of PLYL;13,074.50
Total;Comunitat Valenciana;Diseases of the respiratory system;Both sexes;Distribution by chapter of the CIE;5.12
Total;Comunitat Valenciana;Diseases of the respiratory system;Both sexes;Standardised rate of PLYL;2.76
Total;Comunitat Valenciana;Diseases of the respiratory system;Both sexes;Average number of PLYL;10.34
Total;Comunitat Valenciana;Diseases of the respiratory system;Males;Number of PLYL;9,272.50
Total;Comunitat Valenciana;Diseases of the respiratory system;Males;Distribution by chapter of the CIE;5.33
Total;Comunitat Valenciana;Diseases of the respiratory system;Males;Standardised rate of PLYL;3.86
Total;Comunitat Valenciana;Diseases of the respiratory system;Males;Average number of PLYL;10.20
Total;Comunitat Valenciana;Diseases of the respiratory system;Females;Number of PLYL;3,802.00
Total;Comunitat Valenciana;Diseases of the respiratory system;Females;Distribution by chapter of the CIE;4.65
Total;Comunitat Valenciana;Diseases of the respiratory system;Females;Standardised rate of PLYL;1.63
Total;Comunitat Valenciana;Diseases of the respiratory system;Females;Average number of PLYL;10.71
Total;Comunitat Valenciana;Diseases of the digestive system;Both sexes;Number of PLYL;15,582.00
Total;Comunitat Valenciana;Diseases of the digestive system;Both sexes;Distribution by chapter of the CIE;6.10
Total;Comunitat Valenciana;Diseases of the digestive system;Both sexes;Standardised rate of PLYL;3.11
Total;Comunitat Valenciana;Diseases of the digestive system;Both sexes;Average number of PLYL;15.44
Total;Comunitat Valenciana;Diseases of the digestive system;Males;Number of PLYL;11,592.50
Total;Comunitat Valenciana;Diseases of the digestive system;Males;Distribution by chapter of the CIE;6.67
Total;Comunitat Valenciana;Diseases of the digestive system;Males;Standardised rate of PLYL;4.55
Total;Comunitat Valenciana;Diseases of the digestive system;Males;Average number of PLYL;16.58
Total;Comunitat Valenciana;Diseases of the digestive system;Females;Number of PLYL;3,989.50
Total;Comunitat Valenciana;Diseases of the digestive system;Females;Distribution by chapter of the CIE;4.88
Total;Comunitat Valenciana;Diseases of the digestive system;Females;Standardised rate of PLYL;1.65
Total;Comunitat Valenciana;Diseases of the digestive system;Females;Average number of PLYL;12.87
Total;Comunitat Valenciana;Diseases of the skin and subcutaneous tissue;Both sexes;Number of PLYL;360.00
Total;Comunitat Valenciana;Diseases of the skin and subcutaneous tissue;Both sexes;Distribution by chapter of the CIE;0.14
Total;Comunitat Valenciana;Diseases of the skin and subcutaneous tissue;Both sexes;Standardised rate of PLYL;0.08
Total;Comunitat Valenciana;Diseases of the skin and subcutaneous tissue;Both sexes;Average number of PLYL;10.00
Total;Comunitat Valenciana;Diseases of the skin and subcutaneous tissue;Males;Number of PLYL;130.00
Total;Comunitat Valenciana;Diseases of the skin and subcutaneous tissue;Males;Distribution by chapter of the CIE;0.07
Total;Comunitat Valenciana;Diseases of the skin and subcutaneous tissue;Males;Standardised rate of PLYL;0.06
Total;Comunitat Valenciana;Diseases of the skin and subcutaneous tissue;Males;Average number of PLYL;6.50
Total;Comunitat Valenciana;Diseases of the skin and subcutaneous tissue;Females;Number of PLYL;230.00
Total;Comunitat Valenciana;Diseases of the skin and subcutaneous tissue;Females;Distribution by chapter of the CIE;0.28
Total;Comunitat Valenciana;Diseases of the skin and subcutaneous tissue;Females;Standardised rate of PLYL;0.10
Total;Comunitat Valenciana;Diseases of the skin and subcutaneous tissue;Females;Average number of PLYL;14.38
Total;Comunitat Valenciana;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Number of PLYL;1,052.50
Total;Comunitat Valenciana;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Distribution by chapter of the CIE;0.41
Total;Comunitat Valenciana;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Standardised rate of PLYL;0.22
Total;Comunitat Valenciana;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Average number of PLYL;11.08
Total;Comunitat Valenciana;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Number of PLYL;355.00
Total;Comunitat Valenciana;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Distribution by chapter of the CIE;0.20
Total;Comunitat Valenciana;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Standardised rate of PLYL;0.14
Total;Comunitat Valenciana;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Average number of PLYL;9.86
Total;Comunitat Valenciana;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Number of PLYL;697.50
Total;Comunitat Valenciana;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Distribution by chapter of the CIE;0.85
Total;Comunitat Valenciana;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Standardised rate of PLYL;0.29
Total;Comunitat Valenciana;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Average number of PLYL;11.82
Total;Comunitat Valenciana;Diseases of the genitourinary system;Both sexes;Number of PLYL;2,775.00
Total;Comunitat Valenciana;Diseases of the genitourinary system;Both sexes;Distribution by chapter of the CIE;1.09
Total;Comunitat Valenciana;Diseases of the genitourinary system;Both sexes;Standardised rate of PLYL;0.59
Total;Comunitat Valenciana;Diseases of the genitourinary system;Both sexes;Average number of PLYL;8.21
Total;Comunitat Valenciana;Diseases of the genitourinary system;Males;Number of PLYL;1,570.00
Total;Comunitat Valenciana;Diseases of the genitourinary system;Males;Distribution by chapter of the CIE;0.90
Total;Comunitat Valenciana;Diseases of the genitourinary system;Males;Standardised rate of PLYL;0.66
Total;Comunitat Valenciana;Diseases of the genitourinary system;Males;Average number of PLYL;8.01
Total;Comunitat Valenciana;Diseases of the genitourinary system;Females;Number of PLYL;1,205.00
Total;Comunitat Valenciana;Diseases of the genitourinary system;Females;Distribution by chapter of the CIE;1.48
Total;Comunitat Valenciana;Diseases of the genitourinary system;Females;Standardised rate of PLYL;0.51
Total;Comunitat Valenciana;Diseases of the genitourinary system;Females;Average number of PLYL;8.49
Total;Comunitat Valenciana;Pregnancy, childbirth and the puerperium;Both sexes;Number of PLYL;95.00
Total;Comunitat Valenciana;Pregnancy, childbirth and the puerperium;Both sexes;Distribution by chapter of the CIE;0.04
Total;Comunitat Valenciana;Pregnancy, childbirth and the puerperium;Both sexes;Standardised rate of PLYL;0.02
Total;Comunitat Valenciana;Pregnancy, childbirth and the puerperium;Both sexes;Average number of PLYL;47.50
Total;Comunitat Valenciana;Pregnancy, childbirth and the puerperium;Males;Number of PLYL;..
Total;Comunitat Valenciana;Pregnancy, childbirth and the puerperium;Males;Distribution by chapter of the CIE;..
Total;Comunitat Valenciana;Pregnancy, childbirth and the puerperium;Males;Standardised rate of PLYL;..
Total;Comunitat Valenciana;Pregnancy, childbirth and the puerperium;Males;Average number of PLYL;..
Total;Comunitat Valenciana;Pregnancy, childbirth and the puerperium;Females;Number of PLYL;95.00
Total;Comunitat Valenciana;Pregnancy, childbirth and the puerperium;Females;Distribution by chapter of the CIE;0.12
Total;Comunitat Valenciana;Pregnancy, childbirth and the puerperium;Females;Standardised rate of PLYL;0.04
Total;Comunitat Valenciana;Pregnancy, childbirth and the puerperium;Females;Average number of PLYL;47.50
Total;Comunitat Valenciana;Affections originated in the perinatal period;Both sexes;Number of PLYL;52.50
Total;Comunitat Valenciana;Affections originated in the perinatal period;Both sexes;Distribution by chapter of the CIE;0.02
Total;Comunitat Valenciana;Affections originated in the perinatal period;Both sexes;Standardised rate of PLYL;0.01
Total;Comunitat Valenciana;Affections originated in the perinatal period;Both sexes;Average number of PLYL;52.50
Total;Comunitat Valenciana;Affections originated in the perinatal period;Males;Number of PLYL;..
Total;Comunitat Valenciana;Affections originated in the perinatal period;Males;Distribution by chapter of the CIE;..
Total;Comunitat Valenciana;Affections originated in the perinatal period;Males;Standardised rate of PLYL;..
Total;Comunitat Valenciana;Affections originated in the perinatal period;Males;Average number of PLYL;..
Total;Comunitat Valenciana;Affections originated in the perinatal period;Females;Number of PLYL;52.50
Total;Comunitat Valenciana;Affections originated in the perinatal period;Females;Distribution by chapter of the CIE;0.06
Total;Comunitat Valenciana;Affections originated in the perinatal period;Females;Standardised rate of PLYL;0.03
Total;Comunitat Valenciana;Affections originated in the perinatal period;Females;Average number of PLYL;52.50
Total;Comunitat Valenciana;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Number of PLYL;1,992.50
Total;Comunitat Valenciana;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Distribution by chapter of the CIE;0.78
Total;Comunitat Valenciana;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Standardised rate of PLYL;0.43
Total;Comunitat Valenciana;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Average number of PLYL;41.51
Total;Comunitat Valenciana;Congenital malformations, deformities and chromosomal abnormalities;Males;Number of PLYL;1,081.00
Total;Comunitat Valenciana;Congenital malformations, deformities and chromosomal abnormalities;Males;Distribution by chapter of the CIE;0.62
Total;Comunitat Valenciana;Congenital malformations, deformities and chromosomal abnormalities;Males;Standardised rate of PLYL;0.46
Total;Comunitat Valenciana;Congenital malformations, deformities and chromosomal abnormalities;Males;Average number of PLYL;40.04
Total;Comunitat Valenciana;Congenital malformations, deformities and chromosomal abnormalities;Females;Number of PLYL;911.50
Total;Comunitat Valenciana;Congenital malformations, deformities and chromosomal abnormalities;Females;Distribution by chapter of the CIE;1.12
Total;Comunitat Valenciana;Congenital malformations, deformities and chromosomal abnormalities;Females;Standardised rate of PLYL;0.39
Total;Comunitat Valenciana;Congenital malformations, deformities and chromosomal abnormalities;Females;Average number of PLYL;43.40
Total;Comunitat Valenciana;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Number of PLYL;4,461.50
Total;Comunitat Valenciana;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Distribution by chapter of the CIE;1.75
Total;Comunitat Valenciana;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Standardised rate of PLYL;0.90
Total;Comunitat Valenciana;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Average number of PLYL;22.20
Total;Comunitat Valenciana;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Number of PLYL;3,487.00
Total;Comunitat Valenciana;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Distribution by chapter of the CIE;2.01
Total;Comunitat Valenciana;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Standardised rate of PLYL;1.41
Total;Comunitat Valenciana;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Average number of PLYL;24.05
Total;Comunitat Valenciana;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Number of PLYL;974.50
Total;Comunitat Valenciana;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Distribution by chapter of the CIE;1.19
Total;Comunitat Valenciana;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Standardised rate of PLYL;0.39
Total;Comunitat Valenciana;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Average number of PLYL;17.40
Total;Comunitat Valenciana;External causes of mortality;Both sexes;Number of PLYL;31,824.00
Total;Comunitat Valenciana;External causes of mortality;Both sexes;Distribution by chapter of the CIE;12.46
Total;Comunitat Valenciana;External causes of mortality;Both sexes;Standardised rate of PLYL;6.61
Total;Comunitat Valenciana;External causes of mortality;Both sexes;Average number of PLYL;29.99
Total;Comunitat Valenciana;External causes of mortality;Males;Number of PLYL;25,509.50
Total;Comunitat Valenciana;External causes of mortality;Males;Distribution by chapter of the CIE;14.68
Total;Comunitat Valenciana;External causes of mortality;Males;Standardised rate of PLYL;10.60
Total;Comunitat Valenciana;External causes of mortality;Males;Average number of PLYL;31.65
Total;Comunitat Valenciana;External causes of mortality;Females;Number of PLYL;6,314.50
Total;Comunitat Valenciana;External causes of mortality;Females;Distribution by chapter of the CIE;7.73
Total;Comunitat Valenciana;External causes of mortality;Females;Standardised rate of PLYL;2.58
Total;Comunitat Valenciana;External causes of mortality;Females;Average number of PLYL;24.76
Total;Extremadura;All causes;Both sexes;Number of PLYL;59,153.50
Total;Extremadura;All causes;Both sexes;Distribution by chapter of the CIE;100.00
Total;Extremadura;All causes;Both sexes;Standardised rate of PLYL;56.71
Total;Extremadura;All causes;Both sexes;Average number of PLYL;12.92
Total;Extremadura;All causes;Males;Number of PLYL;41,215.00
Total;Extremadura;All causes;Males;Distribution by chapter of the CIE;100.00
Total;Extremadura;All causes;Males;Standardised rate of PLYL;77.82
Total;Extremadura;All causes;Males;Average number of PLYL;13.72
Total;Extremadura;All causes;Females;Number of PLYL;17,938.50
Total;Extremadura;All causes;Females;Distribution by chapter of the CIE;100.00
Total;Extremadura;All causes;Females;Standardised rate of PLYL;34.74
Total;Extremadura;All causes;Females;Average number of PLYL;11.40
Total;Extremadura;Infectious and parasitic diseases (1);Both sexes;Number of PLYL;1,315.00
Total;Extremadura;Infectious and parasitic diseases (1);Both sexes;Distribution by chapter of the CIE;2.22
Total;Extremadura;Infectious and parasitic diseases (1);Both sexes;Standardised rate of PLYL;1.24
Total;Extremadura;Infectious and parasitic diseases (1);Both sexes;Average number of PLYL;13.99
Total;Extremadura;Infectious and parasitic diseases (1);Males;Number of PLYL;950.00
Total;Extremadura;Infectious and parasitic diseases (1);Males;Distribution by chapter of the CIE;2.30
Total;Extremadura;Infectious and parasitic diseases (1);Males;Standardised rate of PLYL;1.75
Total;Extremadura;Infectious and parasitic diseases (1);Males;Average number of PLYL;18.27
Total;Extremadura;Infectious and parasitic diseases (1);Females;Number of PLYL;365.00
Total;Extremadura;Infectious and parasitic diseases (1);Females;Distribution by chapter of the CIE;2.03
Total;Extremadura;Infectious and parasitic diseases (1);Females;Standardised rate of PLYL;0.71
Total;Extremadura;Infectious and parasitic diseases (1);Females;Average number of PLYL;8.69
Total;Extremadura;Tumours;Both sexes;Number of PLYL;24,380.00
Total;Extremadura;Tumours;Both sexes;Distribution by chapter of the CIE;41.21
Total;Extremadura;Tumours;Both sexes;Standardised rate of PLYL;23.19
Total;Extremadura;Tumours;Both sexes;Average number of PLYL;13.04
Total;Extremadura;Tumours;Males;Number of PLYL;15,837.50
Total;Extremadura;Tumours;Males;Distribution by chapter of the CIE;38.43
Total;Extremadura;Tumours;Males;Standardised rate of PLYL;29.70
Total;Extremadura;Tumours;Males;Average number of PLYL;12.64
Total;Extremadura;Tumours;Females;Number of PLYL;8,542.50
Total;Extremadura;Tumours;Females;Distribution by chapter of the CIE;47.62
Total;Extremadura;Tumours;Females;Standardised rate of PLYL;16.35
Total;Extremadura;Tumours;Females;Average number of PLYL;13.85
Total;Extremadura;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Number of PLYL;220.00
Total;Extremadura;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Distribution by chapter of the CIE;0.37
Total;Extremadura;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Standardised rate of PLYL;0.21
Total;Extremadura;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Average number of PLYL;12.22
Total;Extremadura;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Number of PLYL;70.00
Total;Extremadura;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Distribution by chapter of the CIE;0.17
Total;Extremadura;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Standardised rate of PLYL;0.12
Total;Extremadura;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Average number of PLYL;17.50
Total;Extremadura;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Number of PLYL;150.00
Total;Extremadura;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Distribution by chapter of the CIE;0.84
Total;Extremadura;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Standardised rate of PLYL;0.30
Total;Extremadura;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Average number of PLYL;10.71
Total;Extremadura;Endocrine, nutritional and metabolic diseases;Both sexes;Number of PLYL;1,155.00
Total;Extremadura;Endocrine, nutritional and metabolic diseases;Both sexes;Distribution by chapter of the CIE;1.95
Total;Extremadura;Endocrine, nutritional and metabolic diseases;Both sexes;Standardised rate of PLYL;1.11
Total;Extremadura;Endocrine, nutritional and metabolic diseases;Both sexes;Average number of PLYL;9.96
Total;Extremadura;Endocrine, nutritional and metabolic diseases;Males;Number of PLYL;715.00
Total;Extremadura;Endocrine, nutritional and metabolic diseases;Males;Distribution by chapter of the CIE;1.73
Total;Extremadura;Endocrine, nutritional and metabolic diseases;Males;Standardised rate of PLYL;1.34
Total;Extremadura;Endocrine, nutritional and metabolic diseases;Males;Average number of PLYL;11.53
Total;Extremadura;Endocrine, nutritional and metabolic diseases;Females;Number of PLYL;440.00
Total;Extremadura;Endocrine, nutritional and metabolic diseases;Females;Distribution by chapter of the CIE;2.45
Total;Extremadura;Endocrine, nutritional and metabolic diseases;Females;Standardised rate of PLYL;0.87
Total;Extremadura;Endocrine, nutritional and metabolic diseases;Females;Average number of PLYL;8.15
Total;Extremadura;Mental and behavioural disorders;Both sexes;Number of PLYL;425.00
Total;Extremadura;Mental and behavioural disorders;Both sexes;Distribution by chapter of the CIE;0.72
Total;Extremadura;Mental and behavioural disorders;Both sexes;Standardised rate of PLYL;0.38
Total;Extremadura;Mental and behavioural disorders;Both sexes;Average number of PLYL;10.63
Total;Extremadura;Mental and behavioural disorders;Males;Number of PLYL;287.50
Total;Extremadura;Mental and behavioural disorders;Males;Distribution by chapter of the CIE;0.70
Total;Extremadura;Mental and behavioural disorders;Males;Standardised rate of PLYL;0.50
Total;Extremadura;Mental and behavioural disorders;Males;Average number of PLYL;13.69
Total;Extremadura;Mental and behavioural disorders;Females;Number of PLYL;137.50
Total;Extremadura;Mental and behavioural disorders;Females;Distribution by chapter of the CIE;0.77
Total;Extremadura;Mental and behavioural disorders;Females;Standardised rate of PLYL;0.26
Total;Extremadura;Mental and behavioural disorders;Females;Average number of PLYL;7.24
Total;Extremadura;Diseases of the nervous system and the sense organs;Both sexes;Number of PLYL;1,999.50
Total;Extremadura;Diseases of the nervous system and the sense organs;Both sexes;Distribution by chapter of the CIE;3.38
Total;Extremadura;Diseases of the nervous system and the sense organs;Both sexes;Standardised rate of PLYL;1.97
Total;Extremadura;Diseases of the nervous system and the sense organs;Both sexes;Average number of PLYL;13.33
Total;Extremadura;Diseases of the nervous system and the sense organs;Males;Number of PLYL;1,062.50
Total;Extremadura;Diseases of the nervous system and the sense organs;Males;Distribution by chapter of the CIE;2.58
Total;Extremadura;Diseases of the nervous system and the sense organs;Males;Standardised rate of PLYL;2.11
Total;Extremadura;Diseases of the nervous system and the sense organs;Males;Average number of PLYL;14.17
Total;Extremadura;Diseases of the nervous system and the sense organs;Females;Number of PLYL;937.00
Total;Extremadura;Diseases of the nervous system and the sense organs;Females;Distribution by chapter of the CIE;5.22
Total;Extremadura;Diseases of the nervous system and the sense organs;Females;Standardised rate of PLYL;1.82
Total;Extremadura;Diseases of the nervous system and the sense organs;Females;Average number of PLYL;12.49
Total;Extremadura;Diseases of the circulatory system;Both sexes;Number of PLYL;11,590.00
Total;Extremadura;Diseases of the circulatory system;Both sexes;Distribution by chapter of the CIE;19.59
Total;Extremadura;Diseases of the circulatory system;Both sexes;Standardised rate of PLYL;11.09
Total;Extremadura;Diseases of the circulatory system;Both sexes;Average number of PLYL;10.20
Total;Extremadura;Diseases of the circulatory system;Males;Number of PLYL;8,625.00
Total;Extremadura;Diseases of the circulatory system;Males;Distribution by chapter of the CIE;20.93
Total;Extremadura;Diseases of the circulatory system;Males;Standardised rate of PLYL;16.17
Total;Extremadura;Diseases of the circulatory system;Males;Average number of PLYL;11.72
Total;Extremadura;Diseases of the circulatory system;Females;Number of PLYL;2,965.00
Total;Extremadura;Diseases of the circulatory system;Females;Distribution by chapter of the CIE;16.53
Total;Extremadura;Diseases of the circulatory system;Females;Standardised rate of PLYL;5.77
Total;Extremadura;Diseases of the circulatory system;Females;Average number of PLYL;7.41
Total;Extremadura;Diseases of the respiratory system;Both sexes;Number of PLYL;3,797.00
Total;Extremadura;Diseases of the respiratory system;Both sexes;Distribution by chapter of the CIE;6.42
Total;Extremadura;Diseases of the respiratory system;Both sexes;Standardised rate of PLYL;3.66
Total;Extremadura;Diseases of the respiratory system;Both sexes;Average number of PLYL;9.66
Total;Extremadura;Diseases of the respiratory system;Males;Number of PLYL;2,722.50
Total;Extremadura;Diseases of the respiratory system;Males;Distribution by chapter of the CIE;6.61
Total;Extremadura;Diseases of the respiratory system;Males;Standardised rate of PLYL;5.17
Total;Extremadura;Diseases of the respiratory system;Males;Average number of PLYL;9.76
Total;Extremadura;Diseases of the respiratory system;Females;Number of PLYL;1,074.50
Total;Extremadura;Diseases of the respiratory system;Females;Distribution by chapter of the CIE;5.99
Total;Extremadura;Diseases of the respiratory system;Females;Standardised rate of PLYL;2.07
Total;Extremadura;Diseases of the respiratory system;Females;Average number of PLYL;9.43
Total;Extremadura;Diseases of the digestive system;Both sexes;Number of PLYL;3,087.50
Total;Extremadura;Diseases of the digestive system;Both sexes;Distribution by chapter of the CIE;5.22
Total;Extremadura;Diseases of the digestive system;Both sexes;Standardised rate of PLYL;2.92
Total;Extremadura;Diseases of the digestive system;Both sexes;Average number of PLYL;12.92
Total;Extremadura;Diseases of the digestive system;Males;Number of PLYL;2,192.50
Total;Extremadura;Diseases of the digestive system;Males;Distribution by chapter of the CIE;5.32
Total;Extremadura;Diseases of the digestive system;Males;Standardised rate of PLYL;4.04
Total;Extremadura;Diseases of the digestive system;Males;Average number of PLYL;13.96
Total;Extremadura;Diseases of the digestive system;Females;Number of PLYL;895.00
Total;Extremadura;Diseases of the digestive system;Females;Distribution by chapter of the CIE;4.99
Total;Extremadura;Diseases of the digestive system;Females;Standardised rate of PLYL;1.75
Total;Extremadura;Diseases of the digestive system;Females;Average number of PLYL;10.91
Total;Extremadura;Diseases of the skin and subcutaneous tissue;Both sexes;Number of PLYL;130.00
Total;Extremadura;Diseases of the skin and subcutaneous tissue;Both sexes;Distribution by chapter of the CIE;0.22
Total;Extremadura;Diseases of the skin and subcutaneous tissue;Both sexes;Standardised rate of PLYL;0.11
Total;Extremadura;Diseases of the skin and subcutaneous tissue;Both sexes;Average number of PLYL;8.13
Total;Extremadura;Diseases of the skin and subcutaneous tissue;Males;Number of PLYL;95.00
Total;Extremadura;Diseases of the skin and subcutaneous tissue;Males;Distribution by chapter of the CIE;0.23
Total;Extremadura;Diseases of the skin and subcutaneous tissue;Males;Standardised rate of PLYL;0.16
Total;Extremadura;Diseases of the skin and subcutaneous tissue;Males;Average number of PLYL;15.83
Total;Extremadura;Diseases of the skin and subcutaneous tissue;Females;Number of PLYL;35.00
Total;Extremadura;Diseases of the skin and subcutaneous tissue;Females;Distribution by chapter of the CIE;0.20
Total;Extremadura;Diseases of the skin and subcutaneous tissue;Females;Standardised rate of PLYL;0.06
Total;Extremadura;Diseases of the skin and subcutaneous tissue;Females;Average number of PLYL;3.50
Total;Extremadura;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Number of PLYL;347.50
Total;Extremadura;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Distribution by chapter of the CIE;0.59
Total;Extremadura;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Standardised rate of PLYL;0.34
Total;Extremadura;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Average number of PLYL;11.98
Total;Extremadura;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Number of PLYL;75.00
Total;Extremadura;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Distribution by chapter of the CIE;0.18
Total;Extremadura;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Standardised rate of PLYL;0.14
Total;Extremadura;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Average number of PLYL;6.25
Total;Extremadura;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Number of PLYL;272.50
Total;Extremadura;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Distribution by chapter of the CIE;1.52
Total;Extremadura;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Standardised rate of PLYL;0.53
Total;Extremadura;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Average number of PLYL;16.03
Total;Extremadura;Diseases of the genitourinary system;Both sexes;Number of PLYL;805.00
Total;Extremadura;Diseases of the genitourinary system;Both sexes;Distribution by chapter of the CIE;1.36
Total;Extremadura;Diseases of the genitourinary system;Both sexes;Standardised rate of PLYL;0.78
Total;Extremadura;Diseases of the genitourinary system;Both sexes;Average number of PLYL;8.94
Total;Extremadura;Diseases of the genitourinary system;Males;Number of PLYL;412.50
Total;Extremadura;Diseases of the genitourinary system;Males;Distribution by chapter of the CIE;1.00
Total;Extremadura;Diseases of the genitourinary system;Males;Standardised rate of PLYL;0.78
Total;Extremadura;Diseases of the genitourinary system;Males;Average number of PLYL;9.59
Total;Extremadura;Diseases of the genitourinary system;Females;Number of PLYL;392.50
Total;Extremadura;Diseases of the genitourinary system;Females;Distribution by chapter of the CIE;2.19
Total;Extremadura;Diseases of the genitourinary system;Females;Standardised rate of PLYL;0.78
Total;Extremadura;Diseases of the genitourinary system;Females;Average number of PLYL;8.35
Total;Extremadura;Pregnancy, childbirth and the puerperium;Both sexes;Number of PLYL;..
Total;Extremadura;Pregnancy, childbirth and the puerperium;Both sexes;Distribution by chapter of the CIE;..
Total;Extremadura;Pregnancy, childbirth and the puerperium;Both sexes;Standardised rate of PLYL;..
Total;Extremadura;Pregnancy, childbirth and the puerperium;Both sexes;Average number of PLYL;..
Total;Extremadura;Pregnancy, childbirth and the puerperium;Males;Number of PLYL;..
Total;Extremadura;Pregnancy, childbirth and the puerperium;Males;Distribution by chapter of the CIE;..
Total;Extremadura;Pregnancy, childbirth and the puerperium;Males;Standardised rate of PLYL;..
Total;Extremadura;Pregnancy, childbirth and the puerperium;Males;Average number of PLYL;..
Total;Extremadura;Pregnancy, childbirth and the puerperium;Females;Number of PLYL;..
Total;Extremadura;Pregnancy, childbirth and the puerperium;Females;Distribution by chapter of the CIE;..
Total;Extremadura;Pregnancy, childbirth and the puerperium;Females;Standardised rate of PLYL;..
Total;Extremadura;Pregnancy, childbirth and the puerperium;Females;Average number of PLYL;..
Total;Extremadura;Affections originated in the perinatal period;Both sexes;Number of PLYL;191.50
Total;Extremadura;Affections originated in the perinatal period;Both sexes;Distribution by chapter of the CIE;0.32
Total;Extremadura;Affections originated in the perinatal period;Both sexes;Standardised rate of PLYL;0.17
Total;Extremadura;Affections originated in the perinatal period;Both sexes;Average number of PLYL;63.83
Total;Extremadura;Affections originated in the perinatal period;Males;Number of PLYL;154.00
Total;Extremadura;Affections originated in the perinatal period;Males;Distribution by chapter of the CIE;0.37
Total;Extremadura;Affections originated in the perinatal period;Males;Standardised rate of PLYL;0.28
Total;Extremadura;Affections originated in the perinatal period;Males;Average number of PLYL;77.00
Total;Extremadura;Affections originated in the perinatal period;Females;Number of PLYL;37.50
Total;Extremadura;Affections originated in the perinatal period;Females;Distribution by chapter of the CIE;0.21
Total;Extremadura;Affections originated in the perinatal period;Females;Standardised rate of PLYL;0.07
Total;Extremadura;Affections originated in the perinatal period;Females;Average number of PLYL;37.50
Total;Extremadura;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Number of PLYL;325.00
Total;Extremadura;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Distribution by chapter of the CIE;0.55
Total;Extremadura;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Standardised rate of PLYL;0.33
Total;Extremadura;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Average number of PLYL;32.50
Total;Extremadura;Congenital malformations, deformities and chromosomal abnormalities;Males;Number of PLYL;192.50
Total;Extremadura;Congenital malformations, deformities and chromosomal abnormalities;Males;Distribution by chapter of the CIE;0.47
Total;Extremadura;Congenital malformations, deformities and chromosomal abnormalities;Males;Standardised rate of PLYL;0.41
Total;Extremadura;Congenital malformations, deformities and chromosomal abnormalities;Males;Average number of PLYL;38.50
Total;Extremadura;Congenital malformations, deformities and chromosomal abnormalities;Females;Number of PLYL;132.50
Total;Extremadura;Congenital malformations, deformities and chromosomal abnormalities;Females;Distribution by chapter of the CIE;0.74
Total;Extremadura;Congenital malformations, deformities and chromosomal abnormalities;Females;Standardised rate of PLYL;0.26
Total;Extremadura;Congenital malformations, deformities and chromosomal abnormalities;Females;Average number of PLYL;26.50
Total;Extremadura;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Number of PLYL;2,492.50
Total;Extremadura;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Distribution by chapter of the CIE;4.21
Total;Extremadura;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Standardised rate of PLYL;2.33
Total;Extremadura;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Average number of PLYL;16.51
Total;Extremadura;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Number of PLYL;2,060.00
Total;Extremadura;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Distribution by chapter of the CIE;5.00
Total;Extremadura;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Standardised rate of PLYL;3.84
Total;Extremadura;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Average number of PLYL;18.39
Total;Extremadura;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Number of PLYL;432.50
Total;Extremadura;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Distribution by chapter of the CIE;2.41
Total;Extremadura;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Standardised rate of PLYL;0.78
Total;Extremadura;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Average number of PLYL;11.09
Total;Extremadura;External causes of mortality;Both sexes;Number of PLYL;6,893.00
Total;Extremadura;External causes of mortality;Both sexes;Distribution by chapter of the CIE;11.65
Total;Extremadura;External causes of mortality;Both sexes;Standardised rate of PLYL;6.87
Total;Extremadura;External causes of mortality;Both sexes;Average number of PLYL;31.05
Total;Extremadura;External causes of mortality;Males;Number of PLYL;5,763.50
Total;Extremadura;External causes of mortality;Males;Distribution by chapter of the CIE;13.98
Total;Extremadura;External causes of mortality;Males;Standardised rate of PLYL;11.29
Total;Extremadura;External causes of mortality;Males;Average number of PLYL;31.32
Total;Extremadura;External causes of mortality;Females;Number of PLYL;1,129.50
Total;Extremadura;External causes of mortality;Females;Distribution by chapter of the CIE;6.30
Total;Extremadura;External causes of mortality;Females;Standardised rate of PLYL;2.35
Total;Extremadura;External causes of mortality;Females;Average number of PLYL;29.72
Total;Galicia;All causes;Both sexes;Number of PLYL;162,966.00
Total;Galicia;All causes;Both sexes;Distribution by chapter of the CIE;100.00
Total;Galicia;All causes;Both sexes;Standardised rate of PLYL;57.19
Total;Galicia;All causes;Both sexes;Average number of PLYL;13.53
Total;Galicia;All causes;Males;Number of PLYL;113,039.50
Total;Galicia;All causes;Males;Distribution by chapter of the CIE;100.00
Total;Galicia;All causes;Males;Standardised rate of PLYL;80.59
Total;Galicia;All causes;Males;Average number of PLYL;14.12
Total;Galicia;All causes;Females;Number of PLYL;49,926.50
Total;Galicia;All causes;Females;Distribution by chapter of the CIE;100.00
Total;Galicia;All causes;Females;Standardised rate of PLYL;34.29
Total;Galicia;All causes;Females;Average number of PLYL;12.37
Total;Galicia;Infectious and parasitic diseases (1);Both sexes;Number of PLYL;4,530.00
Total;Galicia;Infectious and parasitic diseases (1);Both sexes;Distribution by chapter of the CIE;2.78
Total;Galicia;Infectious and parasitic diseases (1);Both sexes;Standardised rate of PLYL;1.65
Total;Galicia;Infectious and parasitic diseases (1);Both sexes;Average number of PLYL;19.70
Total;Galicia;Infectious and parasitic diseases (1);Males;Number of PLYL;3,177.50
Total;Galicia;Infectious and parasitic diseases (1);Males;Distribution by chapter of the CIE;2.81
Total;Galicia;Infectious and parasitic diseases (1);Males;Standardised rate of PLYL;2.33
Total;Galicia;Infectious and parasitic diseases (1);Males;Average number of PLYL;21.62
Total;Galicia;Infectious and parasitic diseases (1);Females;Number of PLYL;1,352.50
Total;Galicia;Infectious and parasitic diseases (1);Females;Distribution by chapter of the CIE;2.71
Total;Galicia;Infectious and parasitic diseases (1);Females;Standardised rate of PLYL;1.00
Total;Galicia;Infectious and parasitic diseases (1);Females;Average number of PLYL;16.30
Total;Galicia;Tumours;Both sexes;Number of PLYL;67,971.00
Total;Galicia;Tumours;Both sexes;Distribution by chapter of the CIE;41.71
Total;Galicia;Tumours;Both sexes;Standardised rate of PLYL;23.00
Total;Galicia;Tumours;Both sexes;Average number of PLYL;13.34
Total;Galicia;Tumours;Males;Number of PLYL;43,553.50
Total;Galicia;Tumours;Males;Distribution by chapter of the CIE;38.53
Total;Galicia;Tumours;Males;Standardised rate of PLYL;29.68
Total;Galicia;Tumours;Males;Average number of PLYL;13.15
Total;Galicia;Tumours;Females;Number of PLYL;24,417.50
Total;Galicia;Tumours;Females;Distribution by chapter of the CIE;48.91
Total;Galicia;Tumours;Females;Standardised rate of PLYL;16.44
Total;Galicia;Tumours;Females;Average number of PLYL;13.69
Total;Galicia;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Number of PLYL;305.00
Total;Galicia;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Distribution by chapter of the CIE;0.19
Total;Galicia;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Standardised rate of PLYL;0.13
Total;Galicia;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Average number of PLYL;13.86
Total;Galicia;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Number of PLYL;110.00
Total;Galicia;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Distribution by chapter of the CIE;0.10
Total;Galicia;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Standardised rate of PLYL;0.07
Total;Galicia;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Average number of PLYL;11.00
Total;Galicia;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Number of PLYL;195.00
Total;Galicia;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Distribution by chapter of the CIE;0.39
Total;Galicia;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Standardised rate of PLYL;0.19
Total;Galicia;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Average number of PLYL;16.25
Total;Galicia;Endocrine, nutritional and metabolic diseases;Both sexes;Number of PLYL;2,450.00
Total;Galicia;Endocrine, nutritional and metabolic diseases;Both sexes;Distribution by chapter of the CIE;1.50
Total;Galicia;Endocrine, nutritional and metabolic diseases;Both sexes;Standardised rate of PLYL;0.84
Total;Galicia;Endocrine, nutritional and metabolic diseases;Both sexes;Average number of PLYL;11.14
Total;Galicia;Endocrine, nutritional and metabolic diseases;Males;Number of PLYL;1,655.00
Total;Galicia;Endocrine, nutritional and metabolic diseases;Males;Distribution by chapter of the CIE;1.46
Total;Galicia;Endocrine, nutritional and metabolic diseases;Males;Standardised rate of PLYL;1.16
Total;Galicia;Endocrine, nutritional and metabolic diseases;Males;Average number of PLYL;12.35
Total;Galicia;Endocrine, nutritional and metabolic diseases;Females;Number of PLYL;795.00
Total;Galicia;Endocrine, nutritional and metabolic diseases;Females;Distribution by chapter of the CIE;1.59
Total;Galicia;Endocrine, nutritional and metabolic diseases;Females;Standardised rate of PLYL;0.53
Total;Galicia;Endocrine, nutritional and metabolic diseases;Females;Average number of PLYL;9.24
Total;Galicia;Mental and behavioural disorders;Both sexes;Number of PLYL;1,575.00
Total;Galicia;Mental and behavioural disorders;Both sexes;Distribution by chapter of the CIE;0.97
Total;Galicia;Mental and behavioural disorders;Both sexes;Standardised rate of PLYL;0.53
Total;Galicia;Mental and behavioural disorders;Both sexes;Average number of PLYL;8.47
Total;Galicia;Mental and behavioural disorders;Males;Number of PLYL;1,092.50
Total;Galicia;Mental and behavioural disorders;Males;Distribution by chapter of the CIE;0.97
Total;Galicia;Mental and behavioural disorders;Males;Standardised rate of PLYL;0.74
Total;Galicia;Mental and behavioural disorders;Males;Average number of PLYL;9.67
Total;Galicia;Mental and behavioural disorders;Females;Number of PLYL;482.50
Total;Galicia;Mental and behavioural disorders;Females;Distribution by chapter of the CIE;0.97
Total;Galicia;Mental and behavioural disorders;Females;Standardised rate of PLYL;0.32
Total;Galicia;Mental and behavioural disorders;Females;Average number of PLYL;6.61
Total;Galicia;Diseases of the nervous system and the sense organs;Both sexes;Number of PLYL;4,661.50
Total;Galicia;Diseases of the nervous system and the sense organs;Both sexes;Distribution by chapter of the CIE;2.86
Total;Galicia;Diseases of the nervous system and the sense organs;Both sexes;Standardised rate of PLYL;1.68
Total;Galicia;Diseases of the nervous system and the sense organs;Both sexes;Average number of PLYL;11.02
Total;Galicia;Diseases of the nervous system and the sense organs;Males;Number of PLYL;2,522.50
Total;Galicia;Diseases of the nervous system and the sense organs;Males;Distribution by chapter of the CIE;2.23
Total;Galicia;Diseases of the nervous system and the sense organs;Males;Standardised rate of PLYL;1.86
Total;Galicia;Diseases of the nervous system and the sense organs;Males;Average number of PLYL;11.31
Total;Galicia;Diseases of the nervous system and the sense organs;Females;Number of PLYL;2,139.00
Total;Galicia;Diseases of the nervous system and the sense organs;Females;Distribution by chapter of the CIE;4.28
Total;Galicia;Diseases of the nervous system and the sense organs;Females;Standardised rate of PLYL;1.49
Total;Galicia;Diseases of the nervous system and the sense organs;Females;Average number of PLYL;10.70
Total;Galicia;Diseases of the circulatory system;Both sexes;Number of PLYL;27,080.00
Total;Galicia;Diseases of the circulatory system;Both sexes;Distribution by chapter of the CIE;16.62
Total;Galicia;Diseases of the circulatory system;Both sexes;Standardised rate of PLYL;9.07
Total;Galicia;Diseases of the circulatory system;Both sexes;Average number of PLYL;9.99
Total;Galicia;Diseases of the circulatory system;Males;Number of PLYL;19,675.00
Total;Galicia;Diseases of the circulatory system;Males;Distribution by chapter of the CIE;17.41
Total;Galicia;Diseases of the circulatory system;Males;Standardised rate of PLYL;13.33
Total;Galicia;Diseases of the circulatory system;Males;Average number of PLYL;10.87
Total;Galicia;Diseases of the circulatory system;Females;Number of PLYL;7,405.00
Total;Galicia;Diseases of the circulatory system;Females;Distribution by chapter of the CIE;14.83
Total;Galicia;Diseases of the circulatory system;Females;Standardised rate of PLYL;4.90
Total;Galicia;Diseases of the circulatory system;Females;Average number of PLYL;8.21
Total;Galicia;Diseases of the respiratory system;Both sexes;Number of PLYL;8,310.50
Total;Galicia;Diseases of the respiratory system;Both sexes;Distribution by chapter of the CIE;5.10
Total;Galicia;Diseases of the respiratory system;Both sexes;Standardised rate of PLYL;2.83
Total;Galicia;Diseases of the respiratory system;Both sexes;Average number of PLYL;9.22
Total;Galicia;Diseases of the respiratory system;Males;Number of PLYL;6,330.50
Total;Galicia;Diseases of the respiratory system;Males;Distribution by chapter of the CIE;5.60
Total;Galicia;Diseases of the respiratory system;Males;Standardised rate of PLYL;4.38
Total;Galicia;Diseases of the respiratory system;Males;Average number of PLYL;9.35
Total;Galicia;Diseases of the respiratory system;Females;Number of PLYL;1,980.00
Total;Galicia;Diseases of the respiratory system;Females;Distribution by chapter of the CIE;3.97
Total;Galicia;Diseases of the respiratory system;Females;Standardised rate of PLYL;1.31
Total;Galicia;Diseases of the respiratory system;Females;Average number of PLYL;8.84
Total;Galicia;Diseases of the digestive system;Both sexes;Number of PLYL;9,557.50
Total;Galicia;Diseases of the digestive system;Both sexes;Distribution by chapter of the CIE;5.86
Total;Galicia;Diseases of the digestive system;Both sexes;Standardised rate of PLYL;3.22
Total;Galicia;Diseases of the digestive system;Both sexes;Average number of PLYL;14.42
Total;Galicia;Diseases of the digestive system;Males;Number of PLYL;6,660.00
Total;Galicia;Diseases of the digestive system;Males;Distribution by chapter of the CIE;5.89
Total;Galicia;Diseases of the digestive system;Males;Standardised rate of PLYL;4.51
Total;Galicia;Diseases of the digestive system;Males;Average number of PLYL;15.00
Total;Galicia;Diseases of the digestive system;Females;Number of PLYL;2,897.50
Total;Galicia;Diseases of the digestive system;Females;Distribution by chapter of the CIE;5.80
Total;Galicia;Diseases of the digestive system;Females;Standardised rate of PLYL;1.96
Total;Galicia;Diseases of the digestive system;Females;Average number of PLYL;13.23
Total;Galicia;Diseases of the skin and subcutaneous tissue;Both sexes;Number of PLYL;155.00
Total;Galicia;Diseases of the skin and subcutaneous tissue;Both sexes;Distribution by chapter of the CIE;0.10
Total;Galicia;Diseases of the skin and subcutaneous tissue;Both sexes;Standardised rate of PLYL;0.05
Total;Galicia;Diseases of the skin and subcutaneous tissue;Both sexes;Average number of PLYL;6.46
Total;Galicia;Diseases of the skin and subcutaneous tissue;Males;Number of PLYL;130.00
Total;Galicia;Diseases of the skin and subcutaneous tissue;Males;Distribution by chapter of the CIE;0.12
Total;Galicia;Diseases of the skin and subcutaneous tissue;Males;Standardised rate of PLYL;0.09
Total;Galicia;Diseases of the skin and subcutaneous tissue;Males;Average number of PLYL;7.22
Total;Galicia;Diseases of the skin and subcutaneous tissue;Females;Number of PLYL;25.00
Total;Galicia;Diseases of the skin and subcutaneous tissue;Females;Distribution by chapter of the CIE;0.05
Total;Galicia;Diseases of the skin and subcutaneous tissue;Females;Standardised rate of PLYL;0.02
Total;Galicia;Diseases of the skin and subcutaneous tissue;Females;Average number of PLYL;4.17
Total;Galicia;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Number of PLYL;522.50
Total;Galicia;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Distribution by chapter of the CIE;0.32
Total;Galicia;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Standardised rate of PLYL;0.18
Total;Galicia;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Average number of PLYL;13.40
Total;Galicia;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Number of PLYL;275.00
Total;Galicia;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Distribution by chapter of the CIE;0.24
Total;Galicia;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Standardised rate of PLYL;0.20
Total;Galicia;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Average number of PLYL;15.28
Total;Galicia;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Number of PLYL;247.50
Total;Galicia;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Distribution by chapter of the CIE;0.50
Total;Galicia;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Standardised rate of PLYL;0.16
Total;Galicia;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Average number of PLYL;11.79
Total;Galicia;Diseases of the genitourinary system;Both sexes;Number of PLYL;1,367.50
Total;Galicia;Diseases of the genitourinary system;Both sexes;Distribution by chapter of the CIE;0.84
Total;Galicia;Diseases of the genitourinary system;Both sexes;Standardised rate of PLYL;0.45
Total;Galicia;Diseases of the genitourinary system;Both sexes;Average number of PLYL;7.64
Total;Galicia;Diseases of the genitourinary system;Males;Number of PLYL;825.00
Total;Galicia;Diseases of the genitourinary system;Males;Distribution by chapter of the CIE;0.73
Total;Galicia;Diseases of the genitourinary system;Males;Standardised rate of PLYL;0.55
Total;Galicia;Diseases of the genitourinary system;Males;Average number of PLYL;8.09
Total;Galicia;Diseases of the genitourinary system;Females;Number of PLYL;542.50
Total;Galicia;Diseases of the genitourinary system;Females;Distribution by chapter of the CIE;1.09
Total;Galicia;Diseases of the genitourinary system;Females;Standardised rate of PLYL;0.36
Total;Galicia;Diseases of the genitourinary system;Females;Average number of PLYL;7.05
Total;Galicia;Pregnancy, childbirth and the puerperium;Both sexes;Number of PLYL;52.50
Total;Galicia;Pregnancy, childbirth and the puerperium;Both sexes;Distribution by chapter of the CIE;0.03
Total;Galicia;Pregnancy, childbirth and the puerperium;Both sexes;Standardised rate of PLYL;0.02
Total;Galicia;Pregnancy, childbirth and the puerperium;Both sexes;Average number of PLYL;52.50
Total;Galicia;Pregnancy, childbirth and the puerperium;Males;Number of PLYL;..
Total;Galicia;Pregnancy, childbirth and the puerperium;Males;Distribution by chapter of the CIE;..
Total;Galicia;Pregnancy, childbirth and the puerperium;Males;Standardised rate of PLYL;..
Total;Galicia;Pregnancy, childbirth and the puerperium;Males;Average number of PLYL;..
Total;Galicia;Pregnancy, childbirth and the puerperium;Females;Number of PLYL;52.50
Total;Galicia;Pregnancy, childbirth and the puerperium;Females;Distribution by chapter of the CIE;0.11
Total;Galicia;Pregnancy, childbirth and the puerperium;Females;Standardised rate of PLYL;0.05
Total;Galicia;Pregnancy, childbirth and the puerperium;Females;Average number of PLYL;52.50
Total;Galicia;Affections originated in the perinatal period;Both sexes;Number of PLYL;47.50
Total;Galicia;Affections originated in the perinatal period;Both sexes;Distribution by chapter of the CIE;0.03
Total;Galicia;Affections originated in the perinatal period;Both sexes;Standardised rate of PLYL;0.02
Total;Galicia;Affections originated in the perinatal period;Both sexes;Average number of PLYL;47.50
Total;Galicia;Affections originated in the perinatal period;Males;Number of PLYL;47.50
Total;Galicia;Affections originated in the perinatal period;Males;Distribution by chapter of the CIE;0.04
Total;Galicia;Affections originated in the perinatal period;Males;Standardised rate of PLYL;0.04
Total;Galicia;Affections originated in the perinatal period;Males;Average number of PLYL;47.50
Total;Galicia;Affections originated in the perinatal period;Females;Number of PLYL;..
Total;Galicia;Affections originated in the perinatal period;Females;Distribution by chapter of the CIE;..
Total;Galicia;Affections originated in the perinatal period;Females;Standardised rate of PLYL;..
Total;Galicia;Affections originated in the perinatal period;Females;Average number of PLYL;..
Total;Galicia;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Number of PLYL;1,109.50
Total;Galicia;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Distribution by chapter of the CIE;0.68
Total;Galicia;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Standardised rate of PLYL;0.53
Total;Galicia;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Average number of PLYL;36.98
Total;Galicia;Congenital malformations, deformities and chromosomal abnormalities;Males;Number of PLYL;842.00
Total;Galicia;Congenital malformations, deformities and chromosomal abnormalities;Males;Distribution by chapter of the CIE;0.74
Total;Galicia;Congenital malformations, deformities and chromosomal abnormalities;Males;Standardised rate of PLYL;0.81
Total;Galicia;Congenital malformations, deformities and chromosomal abnormalities;Males;Average number of PLYL;40.10
Total;Galicia;Congenital malformations, deformities and chromosomal abnormalities;Females;Number of PLYL;267.50
Total;Galicia;Congenital malformations, deformities and chromosomal abnormalities;Females;Distribution by chapter of the CIE;0.54
Total;Galicia;Congenital malformations, deformities and chromosomal abnormalities;Females;Standardised rate of PLYL;0.25
Total;Galicia;Congenital malformations, deformities and chromosomal abnormalities;Females;Average number of PLYL;29.72
Total;Galicia;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Number of PLYL;12,429.50
Total;Galicia;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Distribution by chapter of the CIE;7.63
Total;Galicia;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Standardised rate of PLYL;4.52
Total;Galicia;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Average number of PLYL;22.60
Total;Galicia;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Number of PLYL;9,417.00
Total;Galicia;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Distribution by chapter of the CIE;8.33
Total;Galicia;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Standardised rate of PLYL;7.01
Total;Galicia;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Average number of PLYL;23.60
Total;Galicia;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Number of PLYL;3,012.50
Total;Galicia;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Distribution by chapter of the CIE;6.03
Total;Galicia;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Standardised rate of PLYL;2.10
Total;Galicia;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Average number of PLYL;19.95
Total;Galicia;External causes of mortality;Both sexes;Number of PLYL;20,841.50
Total;Galicia;External causes of mortality;Both sexes;Distribution by chapter of the CIE;12.79
Total;Galicia;External causes of mortality;Both sexes;Standardised rate of PLYL;8.46
Total;Galicia;External causes of mortality;Both sexes;Average number of PLYL;27.24
Total;Galicia;External causes of mortality;Males;Number of PLYL;16,726.50
Total;Galicia;External causes of mortality;Males;Distribution by chapter of the CIE;14.80
Total;Galicia;External causes of mortality;Males;Standardised rate of PLYL;13.83
Total;Galicia;External causes of mortality;Males;Average number of PLYL;29.09
Total;Galicia;External causes of mortality;Females;Number of PLYL;4,115.00
Total;Galicia;External causes of mortality;Females;Distribution by chapter of the CIE;8.24
Total;Galicia;External causes of mortality;Females;Standardised rate of PLYL;3.22
Total;Galicia;External causes of mortality;Females;Average number of PLYL;21.66
Total;Madrid, Comunidad de;All causes;Both sexes;Number of PLYL;255,935.50
Total;Madrid, Comunidad de;All causes;Both sexes;Distribution by chapter of the CIE;100.00
Total;Madrid, Comunidad de;All causes;Both sexes;Standardised rate of PLYL;41.78
Total;Madrid, Comunidad de;All causes;Both sexes;Average number of PLYL;14.49
Total;Madrid, Comunidad de;All causes;Males;Number of PLYL;166,480.00
Total;Madrid, Comunidad de;All causes;Males;Distribution by chapter of the CIE;100.00
Total;Madrid, Comunidad de;All causes;Males;Standardised rate of PLYL;56.02
Total;Madrid, Comunidad de;All causes;Males;Average number of PLYL;14.74
Total;Madrid, Comunidad de;All causes;Females;Number of PLYL;89,455.50
Total;Madrid, Comunidad de;All causes;Females;Distribution by chapter of the CIE;100.00
Total;Madrid, Comunidad de;All causes;Females;Standardised rate of PLYL;28.37
Total;Madrid, Comunidad de;All causes;Females;Average number of PLYL;14.03
Total;Madrid, Comunidad de;Infectious and parasitic diseases (1);Both sexes;Number of PLYL;9,315.00
Total;Madrid, Comunidad de;Infectious and parasitic diseases (1);Both sexes;Distribution by chapter of the CIE;3.64
Total;Madrid, Comunidad de;Infectious and parasitic diseases (1);Both sexes;Standardised rate of PLYL;1.39
Total;Madrid, Comunidad de;Infectious and parasitic diseases (1);Both sexes;Average number of PLYL;20.98
Total;Madrid, Comunidad de;Infectious and parasitic diseases (1);Males;Number of PLYL;6,792.50
Total;Madrid, Comunidad de;Infectious and parasitic diseases (1);Males;Distribution by chapter of the CIE;4.08
Total;Madrid, Comunidad de;Infectious and parasitic diseases (1);Males;Standardised rate of PLYL;2.06
Total;Madrid, Comunidad de;Infectious and parasitic diseases (1);Males;Average number of PLYL;22.87
Total;Madrid, Comunidad de;Infectious and parasitic diseases (1);Females;Number of PLYL;2,522.50
Total;Madrid, Comunidad de;Infectious and parasitic diseases (1);Females;Distribution by chapter of the CIE;2.82
Total;Madrid, Comunidad de;Infectious and parasitic diseases (1);Females;Standardised rate of PLYL;0.75
Total;Madrid, Comunidad de;Infectious and parasitic diseases (1);Females;Average number of PLYL;17.16
Total;Madrid, Comunidad de;Tumours;Both sexes;Number of PLYL;113,211.00
Total;Madrid, Comunidad de;Tumours;Both sexes;Distribution by chapter of the CIE;44.23
Total;Madrid, Comunidad de;Tumours;Both sexes;Standardised rate of PLYL;18.48
Total;Madrid, Comunidad de;Tumours;Both sexes;Average number of PLYL;14.30
Total;Madrid, Comunidad de;Tumours;Males;Number of PLYL;66,940.50
Total;Madrid, Comunidad de;Tumours;Males;Distribution by chapter of the CIE;40.21
Total;Madrid, Comunidad de;Tumours;Males;Standardised rate of PLYL;22.85
Total;Madrid, Comunidad de;Tumours;Males;Average number of PLYL;13.58
Total;Madrid, Comunidad de;Tumours;Females;Number of PLYL;46,270.50
Total;Madrid, Comunidad de;Tumours;Females;Distribution by chapter of the CIE;51.72
Total;Madrid, Comunidad de;Tumours;Females;Standardised rate of PLYL;14.40
Total;Madrid, Comunidad de;Tumours;Females;Average number of PLYL;15.48
Total;Madrid, Comunidad de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Number of PLYL;959.50
Total;Madrid, Comunidad de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Distribution by chapter of the CIE;0.37
Total;Madrid, Comunidad de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Standardised rate of PLYL;0.16
Total;Madrid, Comunidad de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Average number of PLYL;21.81
Total;Madrid, Comunidad de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Number of PLYL;592.00
Total;Madrid, Comunidad de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Distribution by chapter of the CIE;0.36
Total;Madrid, Comunidad de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Standardised rate of PLYL;0.19
Total;Madrid, Comunidad de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Average number of PLYL;28.19
Total;Madrid, Comunidad de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Number of PLYL;367.50
Total;Madrid, Comunidad de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Distribution by chapter of the CIE;0.41
Total;Madrid, Comunidad de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Standardised rate of PLYL;0.14
Total;Madrid, Comunidad de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Average number of PLYL;15.98
Total;Madrid, Comunidad de;Endocrine, nutritional and metabolic diseases;Both sexes;Number of PLYL;2,827.50
Total;Madrid, Comunidad de;Endocrine, nutritional and metabolic diseases;Both sexes;Distribution by chapter of the CIE;1.10
Total;Madrid, Comunidad de;Endocrine, nutritional and metabolic diseases;Both sexes;Standardised rate of PLYL;0.48
Total;Madrid, Comunidad de;Endocrine, nutritional and metabolic diseases;Both sexes;Average number of PLYL;10.43
Total;Madrid, Comunidad de;Endocrine, nutritional and metabolic diseases;Males;Number of PLYL;1,602.50
Total;Madrid, Comunidad de;Endocrine, nutritional and metabolic diseases;Males;Distribution by chapter of the CIE;0.96
Total;Madrid, Comunidad de;Endocrine, nutritional and metabolic diseases;Males;Standardised rate of PLYL;0.55
Total;Madrid, Comunidad de;Endocrine, nutritional and metabolic diseases;Males;Average number of PLYL;10.61
Total;Madrid, Comunidad de;Endocrine, nutritional and metabolic diseases;Females;Number of PLYL;1,225.00
Total;Madrid, Comunidad de;Endocrine, nutritional and metabolic diseases;Females;Distribution by chapter of the CIE;1.37
Total;Madrid, Comunidad de;Endocrine, nutritional and metabolic diseases;Females;Standardised rate of PLYL;0.41
Total;Madrid, Comunidad de;Endocrine, nutritional and metabolic diseases;Females;Average number of PLYL;10.21
Total;Madrid, Comunidad de;Mental and behavioural disorders;Both sexes;Number of PLYL;970.00
Total;Madrid, Comunidad de;Mental and behavioural disorders;Both sexes;Distribution by chapter of the CIE;0.38
Total;Madrid, Comunidad de;Mental and behavioural disorders;Both sexes;Standardised rate of PLYL;0.17
Total;Madrid, Comunidad de;Mental and behavioural disorders;Both sexes;Average number of PLYL;8.66
Total;Madrid, Comunidad de;Mental and behavioural disorders;Males;Number of PLYL;725.00
Total;Madrid, Comunidad de;Mental and behavioural disorders;Males;Distribution by chapter of the CIE;0.44
Total;Madrid, Comunidad de;Mental and behavioural disorders;Males;Standardised rate of PLYL;0.24
Total;Madrid, Comunidad de;Mental and behavioural disorders;Males;Average number of PLYL;9.80
Total;Madrid, Comunidad de;Mental and behavioural disorders;Females;Number of PLYL;245.00
Total;Madrid, Comunidad de;Mental and behavioural disorders;Females;Distribution by chapter of the CIE;0.27
Total;Madrid, Comunidad de;Mental and behavioural disorders;Females;Standardised rate of PLYL;0.09
Total;Madrid, Comunidad de;Mental and behavioural disorders;Females;Average number of PLYL;6.45
Total;Madrid, Comunidad de;Diseases of the nervous system and the sense organs;Both sexes;Number of PLYL;7,268.50
Total;Madrid, Comunidad de;Diseases of the nervous system and the sense organs;Both sexes;Distribution by chapter of the CIE;2.84
Total;Madrid, Comunidad de;Diseases of the nervous system and the sense organs;Both sexes;Standardised rate of PLYL;1.21
Total;Madrid, Comunidad de;Diseases of the nervous system and the sense organs;Both sexes;Average number of PLYL;13.77
Total;Madrid, Comunidad de;Diseases of the nervous system and the sense organs;Males;Number of PLYL;4,504.50
Total;Madrid, Comunidad de;Diseases of the nervous system and the sense organs;Males;Distribution by chapter of the CIE;2.71
Total;Madrid, Comunidad de;Diseases of the nervous system and the sense organs;Males;Standardised rate of PLYL;1.54
Total;Madrid, Comunidad de;Diseases of the nervous system and the sense organs;Males;Average number of PLYL;15.97
Total;Madrid, Comunidad de;Diseases of the nervous system and the sense organs;Females;Number of PLYL;2,764.00
Total;Madrid, Comunidad de;Diseases of the nervous system and the sense organs;Females;Distribution by chapter of the CIE;3.09
Total;Madrid, Comunidad de;Diseases of the nervous system and the sense organs;Females;Standardised rate of PLYL;0.89
Total;Madrid, Comunidad de;Diseases of the nervous system and the sense organs;Females;Average number of PLYL;11.24
Total;Madrid, Comunidad de;Diseases of the circulatory system;Both sexes;Number of PLYL;37,697.50
Total;Madrid, Comunidad de;Diseases of the circulatory system;Both sexes;Distribution by chapter of the CIE;14.73
Total;Madrid, Comunidad de;Diseases of the circulatory system;Both sexes;Standardised rate of PLYL;6.30
Total;Madrid, Comunidad de;Diseases of the circulatory system;Both sexes;Average number of PLYL;11.12
Total;Madrid, Comunidad de;Diseases of the circulatory system;Males;Number of PLYL;26,820.00
Total;Madrid, Comunidad de;Diseases of the circulatory system;Males;Distribution by chapter of the CIE;16.11
Total;Madrid, Comunidad de;Diseases of the circulatory system;Males;Standardised rate of PLYL;9.13
Total;Madrid, Comunidad de;Diseases of the circulatory system;Males;Average number of PLYL;12.28
Total;Madrid, Comunidad de;Diseases of the circulatory system;Females;Number of PLYL;10,877.50
Total;Madrid, Comunidad de;Diseases of the circulatory system;Females;Distribution by chapter of the CIE;12.16
Total;Madrid, Comunidad de;Diseases of the circulatory system;Females;Standardised rate of PLYL;3.65
Total;Madrid, Comunidad de;Diseases of the circulatory system;Females;Average number of PLYL;9.01
Total;Madrid, Comunidad de;Diseases of the respiratory system;Both sexes;Number of PLYL;14,300.00
Total;Madrid, Comunidad de;Diseases of the respiratory system;Both sexes;Distribution by chapter of the CIE;5.59
Total;Madrid, Comunidad de;Diseases of the respiratory system;Both sexes;Standardised rate of PLYL;2.47
Total;Madrid, Comunidad de;Diseases of the respiratory system;Both sexes;Average number of PLYL;9.53
Total;Madrid, Comunidad de;Diseases of the respiratory system;Males;Number of PLYL;9,577.50
Total;Madrid, Comunidad de;Diseases of the respiratory system;Males;Distribution by chapter of the CIE;5.75
Total;Madrid, Comunidad de;Diseases of the respiratory system;Males;Standardised rate of PLYL;3.40
Total;Madrid, Comunidad de;Diseases of the respiratory system;Males;Average number of PLYL;9.44
Total;Madrid, Comunidad de;Diseases of the respiratory system;Females;Number of PLYL;4,722.50
Total;Madrid, Comunidad de;Diseases of the respiratory system;Females;Distribution by chapter of the CIE;5.28
Total;Madrid, Comunidad de;Diseases of the respiratory system;Females;Standardised rate of PLYL;1.58
Total;Madrid, Comunidad de;Diseases of the respiratory system;Females;Average number of PLYL;9.74
Total;Madrid, Comunidad de;Diseases of the digestive system;Both sexes;Number of PLYL;12,932.00
Total;Madrid, Comunidad de;Diseases of the digestive system;Both sexes;Distribution by chapter of the CIE;5.05
Total;Madrid, Comunidad de;Diseases of the digestive system;Both sexes;Standardised rate of PLYL;2.06
Total;Madrid, Comunidad de;Diseases of the digestive system;Both sexes;Average number of PLYL;14.88
Total;Madrid, Comunidad de;Diseases of the digestive system;Males;Number of PLYL;9,245.00
Total;Madrid, Comunidad de;Diseases of the digestive system;Males;Distribution by chapter of the CIE;5.55
Total;Madrid, Comunidad de;Diseases of the digestive system;Males;Standardised rate of PLYL;3.02
Total;Madrid, Comunidad de;Diseases of the digestive system;Males;Average number of PLYL;15.41
Total;Madrid, Comunidad de;Diseases of the digestive system;Females;Number of PLYL;3,687.00
Total;Madrid, Comunidad de;Diseases of the digestive system;Females;Distribution by chapter of the CIE;4.12
Total;Madrid, Comunidad de;Diseases of the digestive system;Females;Standardised rate of PLYL;1.17
Total;Madrid, Comunidad de;Diseases of the digestive system;Females;Average number of PLYL;13.71
Total;Madrid, Comunidad de;Diseases of the skin and subcutaneous tissue;Both sexes;Number of PLYL;155.00
Total;Madrid, Comunidad de;Diseases of the skin and subcutaneous tissue;Both sexes;Distribution by chapter of the CIE;0.06
Total;Madrid, Comunidad de;Diseases of the skin and subcutaneous tissue;Both sexes;Standardised rate of PLYL;0.03
Total;Madrid, Comunidad de;Diseases of the skin and subcutaneous tissue;Both sexes;Average number of PLYL;7.05
Total;Madrid, Comunidad de;Diseases of the skin and subcutaneous tissue;Males;Number of PLYL;37.50
Total;Madrid, Comunidad de;Diseases of the skin and subcutaneous tissue;Males;Distribution by chapter of the CIE;0.02
Total;Madrid, Comunidad de;Diseases of the skin and subcutaneous tissue;Males;Standardised rate of PLYL;0.01
Total;Madrid, Comunidad de;Diseases of the skin and subcutaneous tissue;Males;Average number of PLYL;5.36
Total;Madrid, Comunidad de;Diseases of the skin and subcutaneous tissue;Females;Number of PLYL;117.50
Total;Madrid, Comunidad de;Diseases of the skin and subcutaneous tissue;Females;Distribution by chapter of the CIE;0.13
Total;Madrid, Comunidad de;Diseases of the skin and subcutaneous tissue;Females;Standardised rate of PLYL;0.04
Total;Madrid, Comunidad de;Diseases of the skin and subcutaneous tissue;Females;Average number of PLYL;7.83
Total;Madrid, Comunidad de;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Number of PLYL;600.00
Total;Madrid, Comunidad de;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Distribution by chapter of the CIE;0.23
Total;Madrid, Comunidad de;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Standardised rate of PLYL;0.10
Total;Madrid, Comunidad de;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Average number of PLYL;9.68
Total;Madrid, Comunidad de;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Number of PLYL;210.00
Total;Madrid, Comunidad de;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Distribution by chapter of the CIE;0.13
Total;Madrid, Comunidad de;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Standardised rate of PLYL;0.07
Total;Madrid, Comunidad de;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Average number of PLYL;10.50
Total;Madrid, Comunidad de;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Number of PLYL;390.00
Total;Madrid, Comunidad de;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Distribution by chapter of the CIE;0.44
Total;Madrid, Comunidad de;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Standardised rate of PLYL;0.13
Total;Madrid, Comunidad de;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Average number of PLYL;9.29
Total;Madrid, Comunidad de;Diseases of the genitourinary system;Both sexes;Number of PLYL;2,367.50
Total;Madrid, Comunidad de;Diseases of the genitourinary system;Both sexes;Distribution by chapter of the CIE;0.93
Total;Madrid, Comunidad de;Diseases of the genitourinary system;Both sexes;Standardised rate of PLYL;0.41
Total;Madrid, Comunidad de;Diseases of the genitourinary system;Both sexes;Average number of PLYL;8.55
Total;Madrid, Comunidad de;Diseases of the genitourinary system;Males;Number of PLYL;1,552.50
Total;Madrid, Comunidad de;Diseases of the genitourinary system;Males;Distribution by chapter of the CIE;0.93
Total;Madrid, Comunidad de;Diseases of the genitourinary system;Males;Standardised rate of PLYL;0.54
Total;Madrid, Comunidad de;Diseases of the genitourinary system;Males;Average number of PLYL;8.97
Total;Madrid, Comunidad de;Diseases of the genitourinary system;Females;Number of PLYL;815.00
Total;Madrid, Comunidad de;Diseases of the genitourinary system;Females;Distribution by chapter of the CIE;0.91
Total;Madrid, Comunidad de;Diseases of the genitourinary system;Females;Standardised rate of PLYL;0.28
Total;Madrid, Comunidad de;Diseases of the genitourinary system;Females;Average number of PLYL;7.84
Total;Madrid, Comunidad de;Pregnancy, childbirth and the puerperium;Both sexes;Number of PLYL;147.50
Total;Madrid, Comunidad de;Pregnancy, childbirth and the puerperium;Both sexes;Distribution by chapter of the CIE;0.06
Total;Madrid, Comunidad de;Pregnancy, childbirth and the puerperium;Both sexes;Standardised rate of PLYL;0.02
Total;Madrid, Comunidad de;Pregnancy, childbirth and the puerperium;Both sexes;Average number of PLYL;49.17
Total;Madrid, Comunidad de;Pregnancy, childbirth and the puerperium;Males;Number of PLYL;..
Total;Madrid, Comunidad de;Pregnancy, childbirth and the puerperium;Males;Distribution by chapter of the CIE;..
Total;Madrid, Comunidad de;Pregnancy, childbirth and the puerperium;Males;Standardised rate of PLYL;..
Total;Madrid, Comunidad de;Pregnancy, childbirth and the puerperium;Males;Average number of PLYL;..
Total;Madrid, Comunidad de;Pregnancy, childbirth and the puerperium;Females;Number of PLYL;147.50
Total;Madrid, Comunidad de;Pregnancy, childbirth and the puerperium;Females;Distribution by chapter of the CIE;0.16
Total;Madrid, Comunidad de;Pregnancy, childbirth and the puerperium;Females;Standardised rate of PLYL;0.05
Total;Madrid, Comunidad de;Pregnancy, childbirth and the puerperium;Females;Average number of PLYL;49.17
Total;Madrid, Comunidad de;Affections originated in the perinatal period;Both sexes;Number of PLYL;..
Total;Madrid, Comunidad de;Affections originated in the perinatal period;Both sexes;Distribution by chapter of the CIE;..
Total;Madrid, Comunidad de;Affections originated in the perinatal period;Both sexes;Standardised rate of PLYL;..
Total;Madrid, Comunidad de;Affections originated in the perinatal period;Both sexes;Average number of PLYL;..
Total;Madrid, Comunidad de;Affections originated in the perinatal period;Males;Number of PLYL;..
Total;Madrid, Comunidad de;Affections originated in the perinatal period;Males;Distribution by chapter of the CIE;..
Total;Madrid, Comunidad de;Affections originated in the perinatal period;Males;Standardised rate of PLYL;..
Total;Madrid, Comunidad de;Affections originated in the perinatal period;Males;Average number of PLYL;..
Total;Madrid, Comunidad de;Affections originated in the perinatal period;Females;Number of PLYL;..
Total;Madrid, Comunidad de;Affections originated in the perinatal period;Females;Distribution by chapter of the CIE;..
Total;Madrid, Comunidad de;Affections originated in the perinatal period;Females;Standardised rate of PLYL;..
Total;Madrid, Comunidad de;Affections originated in the perinatal period;Females;Average number of PLYL;..
Total;Madrid, Comunidad de;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Number of PLYL;1,805.50
Total;Madrid, Comunidad de;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Distribution by chapter of the CIE;0.71
Total;Madrid, Comunidad de;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Standardised rate of PLYL;0.28
Total;Madrid, Comunidad de;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Average number of PLYL;39.25
Total;Madrid, Comunidad de;Congenital malformations, deformities and chromosomal abnormalities;Males;Number of PLYL;948.50
Total;Madrid, Comunidad de;Congenital malformations, deformities and chromosomal abnormalities;Males;Distribution by chapter of the CIE;0.57
Total;Madrid, Comunidad de;Congenital malformations, deformities and chromosomal abnormalities;Males;Standardised rate of PLYL;0.31
Total;Madrid, Comunidad de;Congenital malformations, deformities and chromosomal abnormalities;Males;Average number of PLYL;39.52
Total;Madrid, Comunidad de;Congenital malformations, deformities and chromosomal abnormalities;Females;Number of PLYL;857.00
Total;Madrid, Comunidad de;Congenital malformations, deformities and chromosomal abnormalities;Females;Distribution by chapter of the CIE;0.96
Total;Madrid, Comunidad de;Congenital malformations, deformities and chromosomal abnormalities;Females;Standardised rate of PLYL;0.25
Total;Madrid, Comunidad de;Congenital malformations, deformities and chromosomal abnormalities;Females;Average number of PLYL;38.95
Total;Madrid, Comunidad de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Number of PLYL;35,191.50
Total;Madrid, Comunidad de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Distribution by chapter of the CIE;13.75
Total;Madrid, Comunidad de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Standardised rate of PLYL;5.54
Total;Madrid, Comunidad de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Average number of PLYL;21.80
Total;Madrid, Comunidad de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Number of PLYL;24,753.50
Total;Madrid, Comunidad de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Distribution by chapter of the CIE;14.87
Total;Madrid, Comunidad de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Standardised rate of PLYL;7.97
Total;Madrid, Comunidad de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Average number of PLYL;22.42
Total;Madrid, Comunidad de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Number of PLYL;10,438.00
Total;Madrid, Comunidad de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Distribution by chapter of the CIE;11.67
Total;Madrid, Comunidad de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Standardised rate of PLYL;3.23
Total;Madrid, Comunidad de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Average number of PLYL;20.47
Total;Madrid, Comunidad de;External causes of mortality;Both sexes;Number of PLYL;16,187.50
Total;Madrid, Comunidad de;External causes of mortality;Both sexes;Distribution by chapter of the CIE;6.32
Total;Madrid, Comunidad de;External causes of mortality;Both sexes;Standardised rate of PLYL;2.69
Total;Madrid, Comunidad de;External causes of mortality;Both sexes;Average number of PLYL;28.70
Total;Madrid, Comunidad de;External causes of mortality;Males;Number of PLYL;12,178.50
Total;Madrid, Comunidad de;External causes of mortality;Males;Distribution by chapter of the CIE;7.32
Total;Madrid, Comunidad de;External causes of mortality;Males;Standardised rate of PLYL;4.13
Total;Madrid, Comunidad de;External causes of mortality;Males;Average number of PLYL;29.70
Total;Madrid, Comunidad de;External causes of mortality;Females;Number of PLYL;4,009.00
Total;Madrid, Comunidad de;External causes of mortality;Females;Distribution by chapter of the CIE;4.48
Total;Madrid, Comunidad de;External causes of mortality;Females;Standardised rate of PLYL;1.32
Total;Madrid, Comunidad de;External causes of mortality;Females;Average number of PLYL;26.03
Total;Murcia, Regi¾n de;All causes;Both sexes;Number of PLYL;64,225.00
Total;Murcia, Regi¾n de;All causes;Both sexes;Distribution by chapter of the CIE;100.00
Total;Murcia, Regi¾n de;All causes;Both sexes;Standardised rate of PLYL;49.81
Total;Murcia, Regi¾n de;All causes;Both sexes;Average number of PLYL;13.96
Total;Murcia, Regi¾n de;All causes;Males;Number of PLYL;43,961.00
Total;Murcia, Regi¾n de;All causes;Males;Distribution by chapter of the CIE;100.00
Total;Murcia, Regi¾n de;All causes;Males;Standardised rate of PLYL;67.19
Total;Murcia, Regi¾n de;All causes;Males;Average number of PLYL;14.78
Total;Murcia, Regi¾n de;All causes;Females;Number of PLYL;20,264.00
Total;Murcia, Regi¾n de;All causes;Females;Distribution by chapter of the CIE;100.00
Total;Murcia, Regi¾n de;All causes;Females;Standardised rate of PLYL;31.94
Total;Murcia, Regi¾n de;All causes;Females;Average number of PLYL;12.46
Total;Murcia, Regi¾n de;Infectious and parasitic diseases (1);Both sexes;Number of PLYL;1,650.00
Total;Murcia, Regi¾n de;Infectious and parasitic diseases (1);Both sexes;Distribution by chapter of the CIE;2.57
Total;Murcia, Regi¾n de;Infectious and parasitic diseases (1);Both sexes;Standardised rate of PLYL;1.16
Total;Murcia, Regi¾n de;Infectious and parasitic diseases (1);Both sexes;Average number of PLYL;19.19
Total;Murcia, Regi¾n de;Infectious and parasitic diseases (1);Males;Number of PLYL;1,257.50
Total;Murcia, Regi¾n de;Infectious and parasitic diseases (1);Males;Distribution by chapter of the CIE;2.86
Total;Murcia, Regi¾n de;Infectious and parasitic diseases (1);Males;Standardised rate of PLYL;1.71
Total;Murcia, Regi¾n de;Infectious and parasitic diseases (1);Males;Average number of PLYL;22.06
Total;Murcia, Regi¾n de;Infectious and parasitic diseases (1);Females;Number of PLYL;392.50
Total;Murcia, Regi¾n de;Infectious and parasitic diseases (1);Females;Distribution by chapter of the CIE;1.94
Total;Murcia, Regi¾n de;Infectious and parasitic diseases (1);Females;Standardised rate of PLYL;0.59
Total;Murcia, Regi¾n de;Infectious and parasitic diseases (1);Females;Average number of PLYL;13.53
Total;Murcia, Regi¾n de;Tumours;Both sexes;Number of PLYL;27,136.50
Total;Murcia, Regi¾n de;Tumours;Both sexes;Distribution by chapter of the CIE;42.25
Total;Murcia, Regi¾n de;Tumours;Both sexes;Standardised rate of PLYL;21.39
Total;Murcia, Regi¾n de;Tumours;Both sexes;Average number of PLYL;14.50
Total;Murcia, Regi¾n de;Tumours;Males;Number of PLYL;16,859.50
Total;Murcia, Regi¾n de;Tumours;Males;Distribution by chapter of the CIE;38.35
Total;Murcia, Regi¾n de;Tumours;Males;Standardised rate of PLYL;26.92
Total;Murcia, Regi¾n de;Tumours;Males;Average number of PLYL;13.77
Total;Murcia, Regi¾n de;Tumours;Females;Number of PLYL;10,277.00
Total;Murcia, Regi¾n de;Tumours;Females;Distribution by chapter of the CIE;50.72
Total;Murcia, Regi¾n de;Tumours;Females;Standardised rate of PLYL;15.82
Total;Murcia, Regi¾n de;Tumours;Females;Average number of PLYL;15.88
Total;Murcia, Regi¾n de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Number of PLYL;282.50
Total;Murcia, Regi¾n de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Distribution by chapter of the CIE;0.44
Total;Murcia, Regi¾n de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Standardised rate of PLYL;0.22
Total;Murcia, Regi¾n de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Average number of PLYL;16.62
Total;Murcia, Regi¾n de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Number of PLYL;85.00
Total;Murcia, Regi¾n de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Distribution by chapter of the CIE;0.19
Total;Murcia, Regi¾n de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Standardised rate of PLYL;0.12
Total;Murcia, Regi¾n de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Average number of PLYL;14.17
Total;Murcia, Regi¾n de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Number of PLYL;197.50
Total;Murcia, Regi¾n de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Distribution by chapter of the CIE;0.97
Total;Murcia, Regi¾n de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Standardised rate of PLYL;0.32
Total;Murcia, Regi¾n de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Average number of PLYL;17.95
Total;Murcia, Regi¾n de;Endocrine, nutritional and metabolic diseases;Both sexes;Number of PLYL;1,320.00
Total;Murcia, Regi¾n de;Endocrine, nutritional and metabolic diseases;Both sexes;Distribution by chapter of the CIE;2.06
Total;Murcia, Regi¾n de;Endocrine, nutritional and metabolic diseases;Both sexes;Standardised rate of PLYL;1.08
Total;Murcia, Regi¾n de;Endocrine, nutritional and metabolic diseases;Both sexes;Average number of PLYL;10.00
Total;Murcia, Regi¾n de;Endocrine, nutritional and metabolic diseases;Males;Number of PLYL;697.50
Total;Murcia, Regi¾n de;Endocrine, nutritional and metabolic diseases;Males;Distribution by chapter of the CIE;1.59
Total;Murcia, Regi¾n de;Endocrine, nutritional and metabolic diseases;Males;Standardised rate of PLYL;1.09
Total;Murcia, Regi¾n de;Endocrine, nutritional and metabolic diseases;Males;Average number of PLYL;11.43
Total;Murcia, Regi¾n de;Endocrine, nutritional and metabolic diseases;Females;Number of PLYL;622.50
Total;Murcia, Regi¾n de;Endocrine, nutritional and metabolic diseases;Females;Distribution by chapter of the CIE;3.07
Total;Murcia, Regi¾n de;Endocrine, nutritional and metabolic diseases;Females;Standardised rate of PLYL;1.06
Total;Murcia, Regi¾n de;Endocrine, nutritional and metabolic diseases;Females;Average number of PLYL;8.77
Total;Murcia, Regi¾n de;Mental and behavioural disorders;Both sexes;Number of PLYL;507.50
Total;Murcia, Regi¾n de;Mental and behavioural disorders;Both sexes;Distribution by chapter of the CIE;0.79
Total;Murcia, Regi¾n de;Mental and behavioural disorders;Both sexes;Standardised rate of PLYL;0.41
Total;Murcia, Regi¾n de;Mental and behavioural disorders;Both sexes;Average number of PLYL;9.58
Total;Murcia, Regi¾n de;Mental and behavioural disorders;Males;Number of PLYL;320.00
Total;Murcia, Regi¾n de;Mental and behavioural disorders;Males;Distribution by chapter of the CIE;0.73
Total;Murcia, Regi¾n de;Mental and behavioural disorders;Males;Standardised rate of PLYL;0.51
Total;Murcia, Regi¾n de;Mental and behavioural disorders;Males;Average number of PLYL;9.41
Total;Murcia, Regi¾n de;Mental and behavioural disorders;Females;Number of PLYL;187.50
Total;Murcia, Regi¾n de;Mental and behavioural disorders;Females;Distribution by chapter of the CIE;0.93
Total;Murcia, Regi¾n de;Mental and behavioural disorders;Females;Standardised rate of PLYL;0.30
Total;Murcia, Regi¾n de;Mental and behavioural disorders;Females;Average number of PLYL;9.87
Total;Murcia, Regi¾n de;Diseases of the nervous system and the sense organs;Both sexes;Number of PLYL;1,999.50
Total;Murcia, Regi¾n de;Diseases of the nervous system and the sense organs;Both sexes;Distribution by chapter of the CIE;3.11
Total;Murcia, Regi¾n de;Diseases of the nervous system and the sense organs;Both sexes;Standardised rate of PLYL;1.57
Total;Murcia, Regi¾n de;Diseases of the nervous system and the sense organs;Both sexes;Average number of PLYL;11.23
Total;Murcia, Regi¾n de;Diseases of the nervous system and the sense organs;Males;Number of PLYL;1,254.50
Total;Murcia, Regi¾n de;Diseases of the nervous system and the sense organs;Males;Distribution by chapter of the CIE;2.85
Total;Murcia, Regi¾n de;Diseases of the nervous system and the sense organs;Males;Standardised rate of PLYL;1.83
Total;Murcia, Regi¾n de;Diseases of the nervous system and the sense organs;Males;Average number of PLYL;14.93
Total;Murcia, Regi¾n de;Diseases of the nervous system and the sense organs;Females;Number of PLYL;745.00
Total;Murcia, Regi¾n de;Diseases of the nervous system and the sense organs;Females;Distribution by chapter of the CIE;3.68
Total;Murcia, Regi¾n de;Diseases of the nervous system and the sense organs;Females;Standardised rate of PLYL;1.29
Total;Murcia, Regi¾n de;Diseases of the nervous system and the sense organs;Females;Average number of PLYL;7.93
Total;Murcia, Regi¾n de;Diseases of the circulatory system;Both sexes;Number of PLYL;12,127.50
Total;Murcia, Regi¾n de;Diseases of the circulatory system;Both sexes;Distribution by chapter of the CIE;18.88
Total;Murcia, Regi¾n de;Diseases of the circulatory system;Both sexes;Standardised rate of PLYL;9.70
Total;Murcia, Regi¾n de;Diseases of the circulatory system;Both sexes;Average number of PLYL;10.74
Total;Murcia, Regi¾n de;Diseases of the circulatory system;Males;Number of PLYL;8,762.50
Total;Murcia, Regi¾n de;Diseases of the circulatory system;Males;Distribution by chapter of the CIE;19.93
Total;Murcia, Regi¾n de;Diseases of the circulatory system;Males;Standardised rate of PLYL;13.63
Total;Murcia, Regi¾n de;Diseases of the circulatory system;Males;Average number of PLYL;12.29
Total;Murcia, Regi¾n de;Diseases of the circulatory system;Females;Number of PLYL;3,365.00
Total;Murcia, Regi¾n de;Diseases of the circulatory system;Females;Distribution by chapter of the CIE;16.61
Total;Murcia, Regi¾n de;Diseases of the circulatory system;Females;Standardised rate of PLYL;5.66
Total;Murcia, Regi¾n de;Diseases of the circulatory system;Females;Average number of PLYL;8.09
Total;Murcia, Regi¾n de;Diseases of the respiratory system;Both sexes;Number of PLYL;3,755.00
Total;Murcia, Regi¾n de;Diseases of the respiratory system;Both sexes;Distribution by chapter of the CIE;5.85
Total;Murcia, Regi¾n de;Diseases of the respiratory system;Both sexes;Standardised rate of PLYL;2.99
Total;Murcia, Regi¾n de;Diseases of the respiratory system;Both sexes;Average number of PLYL;9.68
Total;Murcia, Regi¾n de;Diseases of the respiratory system;Males;Number of PLYL;2,872.50
Total;Murcia, Regi¾n de;Diseases of the respiratory system;Males;Distribution by chapter of the CIE;6.53
Total;Murcia, Regi¾n de;Diseases of the respiratory system;Males;Standardised rate of PLYL;4.47
Total;Murcia, Regi¾n de;Diseases of the respiratory system;Males;Average number of PLYL;10.37
Total;Murcia, Regi¾n de;Diseases of the respiratory system;Females;Number of PLYL;882.50
Total;Murcia, Regi¾n de;Diseases of the respiratory system;Females;Distribution by chapter of the CIE;4.36
Total;Murcia, Regi¾n de;Diseases of the respiratory system;Females;Standardised rate of PLYL;1.46
Total;Murcia, Regi¾n de;Diseases of the respiratory system;Females;Average number of PLYL;7.95
Total;Murcia, Regi¾n de;Diseases of the digestive system;Both sexes;Number of PLYL;4,005.00
Total;Murcia, Regi¾n de;Diseases of the digestive system;Both sexes;Distribution by chapter of the CIE;6.24
Total;Murcia, Regi¾n de;Diseases of the digestive system;Both sexes;Standardised rate of PLYL;3.07
Total;Murcia, Regi¾n de;Diseases of the digestive system;Both sexes;Average number of PLYL;14.41
Total;Murcia, Regi¾n de;Diseases of the digestive system;Males;Number of PLYL;2,882.50
Total;Murcia, Regi¾n de;Diseases of the digestive system;Males;Distribution by chapter of the CIE;6.56
Total;Murcia, Regi¾n de;Diseases of the digestive system;Males;Standardised rate of PLYL;4.37
Total;Murcia, Regi¾n de;Diseases of the digestive system;Males;Average number of PLYL;15.25
Total;Murcia, Regi¾n de;Diseases of the digestive system;Females;Number of PLYL;1,122.50
Total;Murcia, Regi¾n de;Diseases of the digestive system;Females;Distribution by chapter of the CIE;5.54
Total;Murcia, Regi¾n de;Diseases of the digestive system;Females;Standardised rate of PLYL;1.74
Total;Murcia, Regi¾n de;Diseases of the digestive system;Females;Average number of PLYL;12.61
Total;Murcia, Regi¾n de;Diseases of the skin and subcutaneous tissue;Both sexes;Number of PLYL;62.50
Total;Murcia, Regi¾n de;Diseases of the skin and subcutaneous tissue;Both sexes;Distribution by chapter of the CIE;0.10
Total;Murcia, Regi¾n de;Diseases of the skin and subcutaneous tissue;Both sexes;Standardised rate of PLYL;0.05
Total;Murcia, Regi¾n de;Diseases of the skin and subcutaneous tissue;Both sexes;Average number of PLYL;12.50
Total;Murcia, Regi¾n de;Diseases of the skin and subcutaneous tissue;Males;Number of PLYL;37.50
Total;Murcia, Regi¾n de;Diseases of the skin and subcutaneous tissue;Males;Distribution by chapter of the CIE;0.09
Total;Murcia, Regi¾n de;Diseases of the skin and subcutaneous tissue;Males;Standardised rate of PLYL;0.06
Total;Murcia, Regi¾n de;Diseases of the skin and subcutaneous tissue;Males;Average number of PLYL;12.50
Total;Murcia, Regi¾n de;Diseases of the skin and subcutaneous tissue;Females;Number of PLYL;25.00
Total;Murcia, Regi¾n de;Diseases of the skin and subcutaneous tissue;Females;Distribution by chapter of the CIE;0.12
Total;Murcia, Regi¾n de;Diseases of the skin and subcutaneous tissue;Females;Standardised rate of PLYL;0.04
Total;Murcia, Regi¾n de;Diseases of the skin and subcutaneous tissue;Females;Average number of PLYL;12.50
Total;Murcia, Regi¾n de;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Number of PLYL;412.50
Total;Murcia, Regi¾n de;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Distribution by chapter of the CIE;0.64
Total;Murcia, Regi¾n de;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Standardised rate of PLYL;0.33
Total;Murcia, Regi¾n de;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Average number of PLYL;16.50
Total;Murcia, Regi¾n de;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Number of PLYL;205.00
Total;Murcia, Regi¾n de;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Distribution by chapter of the CIE;0.47
Total;Murcia, Regi¾n de;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Standardised rate of PLYL;0.33
Total;Murcia, Regi¾n de;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Average number of PLYL;20.50
Total;Murcia, Regi¾n de;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Number of PLYL;207.50
Total;Murcia, Regi¾n de;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Distribution by chapter of the CIE;1.02
Total;Murcia, Regi¾n de;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Standardised rate of PLYL;0.33
Total;Murcia, Regi¾n de;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Average number of PLYL;13.83
Total;Murcia, Regi¾n de;Diseases of the genitourinary system;Both sexes;Number of PLYL;767.00
Total;Murcia, Regi¾n de;Diseases of the genitourinary system;Both sexes;Distribution by chapter of the CIE;1.19
Total;Murcia, Regi¾n de;Diseases of the genitourinary system;Both sexes;Standardised rate of PLYL;0.63
Total;Murcia, Regi¾n de;Diseases of the genitourinary system;Both sexes;Average number of PLYL;7.75
Total;Murcia, Regi¾n de;Diseases of the genitourinary system;Males;Number of PLYL;497.00
Total;Murcia, Regi¾n de;Diseases of the genitourinary system;Males;Distribution by chapter of the CIE;1.13
Total;Murcia, Regi¾n de;Diseases of the genitourinary system;Males;Standardised rate of PLYL;0.78
Total;Murcia, Regi¾n de;Diseases of the genitourinary system;Males;Average number of PLYL;9.04
Total;Murcia, Regi¾n de;Diseases of the genitourinary system;Females;Number of PLYL;270.00
Total;Murcia, Regi¾n de;Diseases of the genitourinary system;Females;Distribution by chapter of the CIE;1.33
Total;Murcia, Regi¾n de;Diseases of the genitourinary system;Females;Standardised rate of PLYL;0.47
Total;Murcia, Regi¾n de;Diseases of the genitourinary system;Females;Average number of PLYL;6.14
Total;Murcia, Regi¾n de;Pregnancy, childbirth and the puerperium;Both sexes;Number of PLYL;..
Total;Murcia, Regi¾n de;Pregnancy, childbirth and the puerperium;Both sexes;Distribution by chapter of the CIE;..
Total;Murcia, Regi¾n de;Pregnancy, childbirth and the puerperium;Both sexes;Standardised rate of PLYL;..
Total;Murcia, Regi¾n de;Pregnancy, childbirth and the puerperium;Both sexes;Average number of PLYL;..
Total;Murcia, Regi¾n de;Pregnancy, childbirth and the puerperium;Males;Number of PLYL;..
Total;Murcia, Regi¾n de;Pregnancy, childbirth and the puerperium;Males;Distribution by chapter of the CIE;..
Total;Murcia, Regi¾n de;Pregnancy, childbirth and the puerperium;Males;Standardised rate of PLYL;..
Total;Murcia, Regi¾n de;Pregnancy, childbirth and the puerperium;Males;Average number of PLYL;..
Total;Murcia, Regi¾n de;Pregnancy, childbirth and the puerperium;Females;Number of PLYL;..
Total;Murcia, Regi¾n de;Pregnancy, childbirth and the puerperium;Females;Distribution by chapter of the CIE;..
Total;Murcia, Regi¾n de;Pregnancy, childbirth and the puerperium;Females;Standardised rate of PLYL;..
Total;Murcia, Regi¾n de;Pregnancy, childbirth and the puerperium;Females;Average number of PLYL;..
Total;Murcia, Regi¾n de;Affections originated in the perinatal period;Both sexes;Number of PLYL;112.50
Total;Murcia, Regi¾n de;Affections originated in the perinatal period;Both sexes;Distribution by chapter of the CIE;0.18
Total;Murcia, Regi¾n de;Affections originated in the perinatal period;Both sexes;Standardised rate of PLYL;0.08
Total;Murcia, Regi¾n de;Affections originated in the perinatal period;Both sexes;Average number of PLYL;37.50
Total;Murcia, Regi¾n de;Affections originated in the perinatal period;Males;Number of PLYL;22.50
Total;Murcia, Regi¾n de;Affections originated in the perinatal period;Males;Distribution by chapter of the CIE;0.05
Total;Murcia, Regi¾n de;Affections originated in the perinatal period;Males;Standardised rate of PLYL;0.03
Total;Murcia, Regi¾n de;Affections originated in the perinatal period;Males;Average number of PLYL;22.50
Total;Murcia, Regi¾n de;Affections originated in the perinatal period;Females;Number of PLYL;90.00
Total;Murcia, Regi¾n de;Affections originated in the perinatal period;Females;Distribution by chapter of the CIE;0.44
Total;Murcia, Regi¾n de;Affections originated in the perinatal period;Females;Standardised rate of PLYL;0.13
Total;Murcia, Regi¾n de;Affections originated in the perinatal period;Females;Average number of PLYL;45.00
Total;Murcia, Regi¾n de;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Number of PLYL;591.00
Total;Murcia, Regi¾n de;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Distribution by chapter of the CIE;0.92
Total;Murcia, Regi¾n de;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Standardised rate of PLYL;0.36
Total;Murcia, Regi¾n de;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Average number of PLYL;39.40
Total;Murcia, Regi¾n de;Congenital malformations, deformities and chromosomal abnormalities;Males;Number of PLYL;326.50
Total;Murcia, Regi¾n de;Congenital malformations, deformities and chromosomal abnormalities;Males;Distribution by chapter of the CIE;0.74
Total;Murcia, Regi¾n de;Congenital malformations, deformities and chromosomal abnormalities;Males;Standardised rate of PLYL;0.39
Total;Murcia, Regi¾n de;Congenital malformations, deformities and chromosomal abnormalities;Males;Average number of PLYL;46.64
Total;Murcia, Regi¾n de;Congenital malformations, deformities and chromosomal abnormalities;Females;Number of PLYL;264.50
Total;Murcia, Regi¾n de;Congenital malformations, deformities and chromosomal abnormalities;Females;Distribution by chapter of the CIE;1.31
Total;Murcia, Regi¾n de;Congenital malformations, deformities and chromosomal abnormalities;Females;Standardised rate of PLYL;0.34
Total;Murcia, Regi¾n de;Congenital malformations, deformities and chromosomal abnormalities;Females;Average number of PLYL;33.06
Total;Murcia, Regi¾n de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Number of PLYL;497.00
Total;Murcia, Regi¾n de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Distribution by chapter of the CIE;0.77
Total;Murcia, Regi¾n de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Standardised rate of PLYL;0.36
Total;Murcia, Regi¾n de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Average number of PLYL;21.61
Total;Murcia, Regi¾n de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Number of PLYL;439.50
Total;Murcia, Regi¾n de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Distribution by chapter of the CIE;1.00
Total;Murcia, Regi¾n de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Standardised rate of PLYL;0.62
Total;Murcia, Regi¾n de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Average number of PLYL;24.42
Total;Murcia, Regi¾n de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Number of PLYL;57.50
Total;Murcia, Regi¾n de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Distribution by chapter of the CIE;0.28
Total;Murcia, Regi¾n de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Standardised rate of PLYL;0.10
Total;Murcia, Regi¾n de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Average number of PLYL;11.50
Total;Murcia, Regi¾n de;External causes of mortality;Both sexes;Number of PLYL;8,999.00
Total;Murcia, Regi¾n de;External causes of mortality;Both sexes;Distribution by chapter of the CIE;14.01
Total;Murcia, Regi¾n de;External causes of mortality;Both sexes;Standardised rate of PLYL;6.41
Total;Murcia, Regi¾n de;External causes of mortality;Both sexes;Average number of PLYL;30.20
Total;Murcia, Regi¾n de;External causes of mortality;Males;Number of PLYL;7,441.50
Total;Murcia, Regi¾n de;External causes of mortality;Males;Distribution by chapter of the CIE;16.93
Total;Murcia, Regi¾n de;External causes of mortality;Males;Standardised rate of PLYL;10.34
Total;Murcia, Regi¾n de;External causes of mortality;Males;Average number of PLYL;31.67
Total;Murcia, Regi¾n de;External causes of mortality;Females;Number of PLYL;1,557.50
Total;Murcia, Regi¾n de;External causes of mortality;Females;Distribution by chapter of the CIE;7.69
Total;Murcia, Regi¾n de;External causes of mortality;Females;Standardised rate of PLYL;2.29
Total;Murcia, Regi¾n de;External causes of mortality;Females;Average number of PLYL;24.72
Total;Navarra, Comunidad Foral de;All causes;Both sexes;Number of PLYL;24,922.00
Total;Navarra, Comunidad Foral de;All causes;Both sexes;Distribution by chapter of the CIE;100.00
Total;Navarra, Comunidad Foral de;All causes;Both sexes;Standardised rate of PLYL;41.42
Total;Navarra, Comunidad Foral de;All causes;Both sexes;Average number of PLYL;13.56
Total;Navarra, Comunidad Foral de;All causes;Males;Number of PLYL;17,280.00
Total;Navarra, Comunidad Foral de;All causes;Males;Distribution by chapter of the CIE;100.00
Total;Navarra, Comunidad Foral de;All causes;Males;Standardised rate of PLYL;56.48
Total;Navarra, Comunidad Foral de;All causes;Males;Average number of PLYL;14.18
Total;Navarra, Comunidad Foral de;All causes;Females;Number of PLYL;7,642.00
Total;Navarra, Comunidad Foral de;All causes;Females;Distribution by chapter of the CIE;100.00
Total;Navarra, Comunidad Foral de;All causes;Females;Standardised rate of PLYL;25.70
Total;Navarra, Comunidad Foral de;All causes;Females;Average number of PLYL;12.35
Total;Navarra, Comunidad Foral de;Infectious and parasitic diseases (1);Both sexes;Number of PLYL;779.50
Total;Navarra, Comunidad Foral de;Infectious and parasitic diseases (1);Both sexes;Distribution by chapter of the CIE;3.13
Total;Navarra, Comunidad Foral de;Infectious and parasitic diseases (1);Both sexes;Standardised rate of PLYL;1.23
Total;Navarra, Comunidad Foral de;Infectious and parasitic diseases (1);Both sexes;Average number of PLYL;19.49
Total;Navarra, Comunidad Foral de;Infectious and parasitic diseases (1);Males;Number of PLYL;527.00
Total;Navarra, Comunidad Foral de;Infectious and parasitic diseases (1);Males;Distribution by chapter of the CIE;3.05
Total;Navarra, Comunidad Foral de;Infectious and parasitic diseases (1);Males;Standardised rate of PLYL;1.53
Total;Navarra, Comunidad Foral de;Infectious and parasitic diseases (1);Males;Average number of PLYL;19.52
Total;Navarra, Comunidad Foral de;Infectious and parasitic diseases (1);Females;Number of PLYL;252.50
Total;Navarra, Comunidad Foral de;Infectious and parasitic diseases (1);Females;Distribution by chapter of the CIE;3.30
Total;Navarra, Comunidad Foral de;Infectious and parasitic diseases (1);Females;Standardised rate of PLYL;0.90
Total;Navarra, Comunidad Foral de;Infectious and parasitic diseases (1);Females;Average number of PLYL;19.42
Total;Navarra, Comunidad Foral de;Tumours;Both sexes;Number of PLYL;11,020.00
Total;Navarra, Comunidad Foral de;Tumours;Both sexes;Distribution by chapter of the CIE;44.22
Total;Navarra, Comunidad Foral de;Tumours;Both sexes;Standardised rate of PLYL;17.86
Total;Navarra, Comunidad Foral de;Tumours;Both sexes;Average number of PLYL;13.06
Total;Navarra, Comunidad Foral de;Tumours;Males;Number of PLYL;6,865.00
Total;Navarra, Comunidad Foral de;Tumours;Males;Distribution by chapter of the CIE;39.73
Total;Navarra, Comunidad Foral de;Tumours;Males;Standardised rate of PLYL;21.97
Total;Navarra, Comunidad Foral de;Tumours;Males;Average number of PLYL;12.39
Total;Navarra, Comunidad Foral de;Tumours;Females;Number of PLYL;4,155.00
Total;Navarra, Comunidad Foral de;Tumours;Females;Distribution by chapter of the CIE;54.37
Total;Navarra, Comunidad Foral de;Tumours;Females;Standardised rate of PLYL;13.50
Total;Navarra, Comunidad Foral de;Tumours;Females;Average number of PLYL;14.33
Total;Navarra, Comunidad Foral de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Number of PLYL;5.00
Total;Navarra, Comunidad Foral de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Distribution by chapter of the CIE;0.02
Total;Navarra, Comunidad Foral de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Standardised rate of PLYL;0.01
Total;Navarra, Comunidad Foral de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Average number of PLYL;2.50
Total;Navarra, Comunidad Foral de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Number of PLYL;5.00
Total;Navarra, Comunidad Foral de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Distribution by chapter of the CIE;0.03
Total;Navarra, Comunidad Foral de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Standardised rate of PLYL;0.01
Total;Navarra, Comunidad Foral de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Average number of PLYL;2.50
Total;Navarra, Comunidad Foral de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Number of PLYL;..
Total;Navarra, Comunidad Foral de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Distribution by chapter of the CIE;..
Total;Navarra, Comunidad Foral de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Standardised rate of PLYL;..
Total;Navarra, Comunidad Foral de;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Average number of PLYL;..
Total;Navarra, Comunidad Foral de;Endocrine, nutritional and metabolic diseases;Both sexes;Number of PLYL;490.00
Total;Navarra, Comunidad Foral de;Endocrine, nutritional and metabolic diseases;Both sexes;Distribution by chapter of the CIE;1.97
Total;Navarra, Comunidad Foral de;Endocrine, nutritional and metabolic diseases;Both sexes;Standardised rate of PLYL;0.83
Total;Navarra, Comunidad Foral de;Endocrine, nutritional and metabolic diseases;Both sexes;Average number of PLYL;8.45
Total;Navarra, Comunidad Foral de;Endocrine, nutritional and metabolic diseases;Males;Number of PLYL;292.50
Total;Navarra, Comunidad Foral de;Endocrine, nutritional and metabolic diseases;Males;Distribution by chapter of the CIE;1.69
Total;Navarra, Comunidad Foral de;Endocrine, nutritional and metabolic diseases;Males;Standardised rate of PLYL;0.95
Total;Navarra, Comunidad Foral de;Endocrine, nutritional and metabolic diseases;Males;Average number of PLYL;8.86
Total;Navarra, Comunidad Foral de;Endocrine, nutritional and metabolic diseases;Females;Number of PLYL;197.50
Total;Navarra, Comunidad Foral de;Endocrine, nutritional and metabolic diseases;Females;Distribution by chapter of the CIE;2.58
Total;Navarra, Comunidad Foral de;Endocrine, nutritional and metabolic diseases;Females;Standardised rate of PLYL;0.69
Total;Navarra, Comunidad Foral de;Endocrine, nutritional and metabolic diseases;Females;Average number of PLYL;7.90
Total;Navarra, Comunidad Foral de;Mental and behavioural disorders;Both sexes;Number of PLYL;190.00
Total;Navarra, Comunidad Foral de;Mental and behavioural disorders;Both sexes;Distribution by chapter of the CIE;0.76
Total;Navarra, Comunidad Foral de;Mental and behavioural disorders;Both sexes;Standardised rate of PLYL;0.38
Total;Navarra, Comunidad Foral de;Mental and behavioural disorders;Both sexes;Average number of PLYL;7.92
Total;Navarra, Comunidad Foral de;Mental and behavioural disorders;Males;Number of PLYL;72.50
Total;Navarra, Comunidad Foral de;Mental and behavioural disorders;Males;Distribution by chapter of the CIE;0.42
Total;Navarra, Comunidad Foral de;Mental and behavioural disorders;Males;Standardised rate of PLYL;0.24
Total;Navarra, Comunidad Foral de;Mental and behavioural disorders;Males;Average number of PLYL;6.59
Total;Navarra, Comunidad Foral de;Mental and behavioural disorders;Females;Number of PLYL;117.50
Total;Navarra, Comunidad Foral de;Mental and behavioural disorders;Females;Distribution by chapter of the CIE;1.54
Total;Navarra, Comunidad Foral de;Mental and behavioural disorders;Females;Standardised rate of PLYL;0.50
Total;Navarra, Comunidad Foral de;Mental and behavioural disorders;Females;Average number of PLYL;9.04
Total;Navarra, Comunidad Foral de;Diseases of the nervous system and the sense organs;Both sexes;Number of PLYL;942.50
Total;Navarra, Comunidad Foral de;Diseases of the nervous system and the sense organs;Both sexes;Distribution by chapter of the CIE;3.78
Total;Navarra, Comunidad Foral de;Diseases of the nervous system and the sense organs;Both sexes;Standardised rate of PLYL;1.66
Total;Navarra, Comunidad Foral de;Diseases of the nervous system and the sense organs;Both sexes;Average number of PLYL;10.59
Total;Navarra, Comunidad Foral de;Diseases of the nervous system and the sense organs;Males;Number of PLYL;662.50
Total;Navarra, Comunidad Foral de;Diseases of the nervous system and the sense organs;Males;Distribution by chapter of the CIE;3.83
Total;Navarra, Comunidad Foral de;Diseases of the nervous system and the sense organs;Males;Standardised rate of PLYL;2.35
Total;Navarra, Comunidad Foral de;Diseases of the nervous system and the sense organs;Males;Average number of PLYL;13.52
Total;Navarra, Comunidad Foral de;Diseases of the nervous system and the sense organs;Females;Number of PLYL;280.00
Total;Navarra, Comunidad Foral de;Diseases of the nervous system and the sense organs;Females;Distribution by chapter of the CIE;3.66
Total;Navarra, Comunidad Foral de;Diseases of the nervous system and the sense organs;Females;Standardised rate of PLYL;0.96
Total;Navarra, Comunidad Foral de;Diseases of the nervous system and the sense organs;Females;Average number of PLYL;7.00
Total;Navarra, Comunidad Foral de;Diseases of the circulatory system;Both sexes;Number of PLYL;4,652.00
Total;Navarra, Comunidad Foral de;Diseases of the circulatory system;Both sexes;Distribution by chapter of the CIE;18.67
Total;Navarra, Comunidad Foral de;Diseases of the circulatory system;Both sexes;Standardised rate of PLYL;7.54
Total;Navarra, Comunidad Foral de;Diseases of the circulatory system;Both sexes;Average number of PLYL;11.96
Total;Navarra, Comunidad Foral de;Diseases of the circulatory system;Males;Number of PLYL;3,447.00
Total;Navarra, Comunidad Foral de;Diseases of the circulatory system;Males;Distribution by chapter of the CIE;19.95
Total;Navarra, Comunidad Foral de;Diseases of the circulatory system;Males;Standardised rate of PLYL;10.86
Total;Navarra, Comunidad Foral de;Diseases of the circulatory system;Males;Average number of PLYL;13.11
Total;Navarra, Comunidad Foral de;Diseases of the circulatory system;Females;Number of PLYL;1,205.00
Total;Navarra, Comunidad Foral de;Diseases of the circulatory system;Females;Distribution by chapter of the CIE;15.77
Total;Navarra, Comunidad Foral de;Diseases of the circulatory system;Females;Standardised rate of PLYL;4.06
Total;Navarra, Comunidad Foral de;Diseases of the circulatory system;Females;Average number of PLYL;9.56
Total;Navarra, Comunidad Foral de;Diseases of the respiratory system;Both sexes;Number of PLYL;1,152.50
Total;Navarra, Comunidad Foral de;Diseases of the respiratory system;Both sexes;Distribution by chapter of the CIE;4.62
Total;Navarra, Comunidad Foral de;Diseases of the respiratory system;Both sexes;Standardised rate of PLYL;1.93
Total;Navarra, Comunidad Foral de;Diseases of the respiratory system;Both sexes;Average number of PLYL;9.07
Total;Navarra, Comunidad Foral de;Diseases of the respiratory system;Males;Number of PLYL;792.50
Total;Navarra, Comunidad Foral de;Diseases of the respiratory system;Males;Distribution by chapter of the CIE;4.59
Total;Navarra, Comunidad Foral de;Diseases of the respiratory system;Males;Standardised rate of PLYL;2.61
Total;Navarra, Comunidad Foral de;Diseases of the respiratory system;Males;Average number of PLYL;9.11
Total;Navarra, Comunidad Foral de;Diseases of the respiratory system;Females;Number of PLYL;360.00
Total;Navarra, Comunidad Foral de;Diseases of the respiratory system;Females;Distribution by chapter of the CIE;4.71
Total;Navarra, Comunidad Foral de;Diseases of the respiratory system;Females;Standardised rate of PLYL;1.20
Total;Navarra, Comunidad Foral de;Diseases of the respiratory system;Females;Average number of PLYL;9.00
Total;Navarra, Comunidad Foral de;Diseases of the digestive system;Both sexes;Number of PLYL;1,030.00
Total;Navarra, Comunidad Foral de;Diseases of the digestive system;Both sexes;Distribution by chapter of the CIE;4.13
Total;Navarra, Comunidad Foral de;Diseases of the digestive system;Both sexes;Standardised rate of PLYL;1.67
Total;Navarra, Comunidad Foral de;Diseases of the digestive system;Both sexes;Average number of PLYL;11.70
Total;Navarra, Comunidad Foral de;Diseases of the digestive system;Males;Number of PLYL;767.50
Total;Navarra, Comunidad Foral de;Diseases of the digestive system;Males;Distribution by chapter of the CIE;4.44
Total;Navarra, Comunidad Foral de;Diseases of the digestive system;Males;Standardised rate of PLYL;2.36
Total;Navarra, Comunidad Foral de;Diseases of the digestive system;Males;Average number of PLYL;13.01
Total;Navarra, Comunidad Foral de;Diseases of the digestive system;Females;Number of PLYL;262.50
Total;Navarra, Comunidad Foral de;Diseases of the digestive system;Females;Distribution by chapter of the CIE;3.43
Total;Navarra, Comunidad Foral de;Diseases of the digestive system;Females;Standardised rate of PLYL;0.93
Total;Navarra, Comunidad Foral de;Diseases of the digestive system;Females;Average number of PLYL;9.05
Total;Navarra, Comunidad Foral de;Diseases of the skin and subcutaneous tissue;Both sexes;Number of PLYL;2.50
Total;Navarra, Comunidad Foral de;Diseases of the skin and subcutaneous tissue;Both sexes;Distribution by chapter of the CIE;0.01
Total;Navarra, Comunidad Foral de;Diseases of the skin and subcutaneous tissue;Both sexes;Standardised rate of PLYL;0.00
Total;Navarra, Comunidad Foral de;Diseases of the skin and subcutaneous tissue;Both sexes;Average number of PLYL;2.50
Total;Navarra, Comunidad Foral de;Diseases of the skin and subcutaneous tissue;Males;Number of PLYL;..
Total;Navarra, Comunidad Foral de;Diseases of the skin and subcutaneous tissue;Males;Distribution by chapter of the CIE;..
Total;Navarra, Comunidad Foral de;Diseases of the skin and subcutaneous tissue;Males;Standardised rate of PLYL;..
Total;Navarra, Comunidad Foral de;Diseases of the skin and subcutaneous tissue;Males;Average number of PLYL;..
Total;Navarra, Comunidad Foral de;Diseases of the skin and subcutaneous tissue;Females;Number of PLYL;2.50
Total;Navarra, Comunidad Foral de;Diseases of the skin and subcutaneous tissue;Females;Distribution by chapter of the CIE;0.03
Total;Navarra, Comunidad Foral de;Diseases of the skin and subcutaneous tissue;Females;Standardised rate of PLYL;0.01
Total;Navarra, Comunidad Foral de;Diseases of the skin and subcutaneous tissue;Females;Average number of PLYL;2.50
Total;Navarra, Comunidad Foral de;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Number of PLYL;97.50
Total;Navarra, Comunidad Foral de;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Distribution by chapter of the CIE;0.39
Total;Navarra, Comunidad Foral de;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Standardised rate of PLYL;0.16
Total;Navarra, Comunidad Foral de;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Average number of PLYL;7.50
Total;Navarra, Comunidad Foral de;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Number of PLYL;32.50
Total;Navarra, Comunidad Foral de;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Distribution by chapter of the CIE;0.19
Total;Navarra, Comunidad Foral de;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Standardised rate of PLYL;0.09
Total;Navarra, Comunidad Foral de;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Average number of PLYL;10.83
Total;Navarra, Comunidad Foral de;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Number of PLYL;65.00
Total;Navarra, Comunidad Foral de;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Distribution by chapter of the CIE;0.85
Total;Navarra, Comunidad Foral de;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Standardised rate of PLYL;0.23
Total;Navarra, Comunidad Foral de;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Average number of PLYL;6.50
Total;Navarra, Comunidad Foral de;Diseases of the genitourinary system;Both sexes;Number of PLYL;127.50
Total;Navarra, Comunidad Foral de;Diseases of the genitourinary system;Both sexes;Distribution by chapter of the CIE;0.51
Total;Navarra, Comunidad Foral de;Diseases of the genitourinary system;Both sexes;Standardised rate of PLYL;0.22
Total;Navarra, Comunidad Foral de;Diseases of the genitourinary system;Both sexes;Average number of PLYL;7.50
Total;Navarra, Comunidad Foral de;Diseases of the genitourinary system;Males;Number of PLYL;102.50
Total;Navarra, Comunidad Foral de;Diseases of the genitourinary system;Males;Distribution by chapter of the CIE;0.59
Total;Navarra, Comunidad Foral de;Diseases of the genitourinary system;Males;Standardised rate of PLYL;0.34
Total;Navarra, Comunidad Foral de;Diseases of the genitourinary system;Males;Average number of PLYL;9.32
Total;Navarra, Comunidad Foral de;Diseases of the genitourinary system;Females;Number of PLYL;25.00
Total;Navarra, Comunidad Foral de;Diseases of the genitourinary system;Females;Distribution by chapter of the CIE;0.33
Total;Navarra, Comunidad Foral de;Diseases of the genitourinary system;Females;Standardised rate of PLYL;0.09
Total;Navarra, Comunidad Foral de;Diseases of the genitourinary system;Females;Average number of PLYL;4.17
Total;Navarra, Comunidad Foral de;Pregnancy, childbirth and the puerperium;Both sexes;Number of PLYL;..
Total;Navarra, Comunidad Foral de;Pregnancy, childbirth and the puerperium;Both sexes;Distribution by chapter of the CIE;..
Total;Navarra, Comunidad Foral de;Pregnancy, childbirth and the puerperium;Both sexes;Standardised rate of PLYL;..
Total;Navarra, Comunidad Foral de;Pregnancy, childbirth and the puerperium;Both sexes;Average number of PLYL;..
Total;Navarra, Comunidad Foral de;Pregnancy, childbirth and the puerperium;Males;Number of PLYL;..
Total;Navarra, Comunidad Foral de;Pregnancy, childbirth and the puerperium;Males;Distribution by chapter of the CIE;..
Total;Navarra, Comunidad Foral de;Pregnancy, childbirth and the puerperium;Males;Standardised rate of PLYL;..
Total;Navarra, Comunidad Foral de;Pregnancy, childbirth and the puerperium;Males;Average number of PLYL;..
Total;Navarra, Comunidad Foral de;Pregnancy, childbirth and the puerperium;Females;Number of PLYL;..
Total;Navarra, Comunidad Foral de;Pregnancy, childbirth and the puerperium;Females;Distribution by chapter of the CIE;..
Total;Navarra, Comunidad Foral de;Pregnancy, childbirth and the puerperium;Females;Standardised rate of PLYL;..
Total;Navarra, Comunidad Foral de;Pregnancy, childbirth and the puerperium;Females;Average number of PLYL;..
Total;Navarra, Comunidad Foral de;Affections originated in the perinatal period;Both sexes;Number of PLYL;62.50
Total;Navarra, Comunidad Foral de;Affections originated in the perinatal period;Both sexes;Distribution by chapter of the CIE;0.25
Total;Navarra, Comunidad Foral de;Affections originated in the perinatal period;Both sexes;Standardised rate of PLYL;0.16
Total;Navarra, Comunidad Foral de;Affections originated in the perinatal period;Both sexes;Average number of PLYL;62.50
Total;Navarra, Comunidad Foral de;Affections originated in the perinatal period;Males;Number of PLYL;62.50
Total;Navarra, Comunidad Foral de;Affections originated in the perinatal period;Males;Distribution by chapter of the CIE;0.36
Total;Navarra, Comunidad Foral de;Affections originated in the perinatal period;Males;Standardised rate of PLYL;0.32
Total;Navarra, Comunidad Foral de;Affections originated in the perinatal period;Males;Average number of PLYL;62.50
Total;Navarra, Comunidad Foral de;Affections originated in the perinatal period;Females;Number of PLYL;..
Total;Navarra, Comunidad Foral de;Affections originated in the perinatal period;Females;Distribution by chapter of the CIE;..
Total;Navarra, Comunidad Foral de;Affections originated in the perinatal period;Females;Standardised rate of PLYL;..
Total;Navarra, Comunidad Foral de;Affections originated in the perinatal period;Females;Average number of PLYL;..
Total;Navarra, Comunidad Foral de;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Number of PLYL;112.00
Total;Navarra, Comunidad Foral de;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Distribution by chapter of the CIE;0.45
Total;Navarra, Comunidad Foral de;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Standardised rate of PLYL;0.17
Total;Navarra, Comunidad Foral de;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Average number of PLYL;37.33
Total;Navarra, Comunidad Foral de;Congenital malformations, deformities and chromosomal abnormalities;Males;Number of PLYL;84.50
Total;Navarra, Comunidad Foral de;Congenital malformations, deformities and chromosomal abnormalities;Males;Distribution by chapter of the CIE;0.49
Total;Navarra, Comunidad Foral de;Congenital malformations, deformities and chromosomal abnormalities;Males;Standardised rate of PLYL;0.25
Total;Navarra, Comunidad Foral de;Congenital malformations, deformities and chromosomal abnormalities;Males;Average number of PLYL;42.25
Total;Navarra, Comunidad Foral de;Congenital malformations, deformities and chromosomal abnormalities;Females;Number of PLYL;27.50
Total;Navarra, Comunidad Foral de;Congenital malformations, deformities and chromosomal abnormalities;Females;Distribution by chapter of the CIE;0.36
Total;Navarra, Comunidad Foral de;Congenital malformations, deformities and chromosomal abnormalities;Females;Standardised rate of PLYL;0.08
Total;Navarra, Comunidad Foral de;Congenital malformations, deformities and chromosomal abnormalities;Females;Average number of PLYL;27.50
Total;Navarra, Comunidad Foral de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Number of PLYL;92.50
Total;Navarra, Comunidad Foral de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Distribution by chapter of the CIE;0.37
Total;Navarra, Comunidad Foral de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Standardised rate of PLYL;0.15
Total;Navarra, Comunidad Foral de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Average number of PLYL;10.28
Total;Navarra, Comunidad Foral de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Number of PLYL;90.00
Total;Navarra, Comunidad Foral de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Distribution by chapter of the CIE;0.52
Total;Navarra, Comunidad Foral de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Standardised rate of PLYL;0.28
Total;Navarra, Comunidad Foral de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Average number of PLYL;11.25
Total;Navarra, Comunidad Foral de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Number of PLYL;2.50
Total;Navarra, Comunidad Foral de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Distribution by chapter of the CIE;0.03
Total;Navarra, Comunidad Foral de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Standardised rate of PLYL;0.01
Total;Navarra, Comunidad Foral de;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Average number of PLYL;2.50
Total;Navarra, Comunidad Foral de;External causes of mortality;Both sexes;Number of PLYL;4,166.00
Total;Navarra, Comunidad Foral de;External causes of mortality;Both sexes;Distribution by chapter of the CIE;16.72
Total;Navarra, Comunidad Foral de;External causes of mortality;Both sexes;Standardised rate of PLYL;7.47
Total;Navarra, Comunidad Foral de;External causes of mortality;Both sexes;Average number of PLYL;31.32
Total;Navarra, Comunidad Foral de;External causes of mortality;Males;Number of PLYL;3,476.50
Total;Navarra, Comunidad Foral de;External causes of mortality;Males;Distribution by chapter of the CIE;20.12
Total;Navarra, Comunidad Foral de;External causes of mortality;Males;Standardised rate of PLYL;12.30
Total;Navarra, Comunidad Foral de;External causes of mortality;Males;Average number of PLYL;31.89
Total;Navarra, Comunidad Foral de;External causes of mortality;Females;Number of PLYL;689.50
Total;Navarra, Comunidad Foral de;External causes of mortality;Females;Distribution by chapter of the CIE;9.02
Total;Navarra, Comunidad Foral de;External causes of mortality;Females;Standardised rate of PLYL;2.53
Total;Navarra, Comunidad Foral de;External causes of mortality;Females;Average number of PLYL;28.73
Total;PaÝs Vasco;All causes;Both sexes;Number of PLYL;113,808.00
Total;PaÝs Vasco;All causes;Both sexes;Distribution by chapter of the CIE;100.00
Total;PaÝs Vasco;All causes;Both sexes;Standardised rate of PLYL;50.00
Total;PaÝs Vasco;All causes;Both sexes;Average number of PLYL;13.82
Total;PaÝs Vasco;All causes;Males;Number of PLYL;76,809.00
Total;PaÝs Vasco;All causes;Males;Distribution by chapter of the CIE;100.00
Total;PaÝs Vasco;All causes;Males;Standardised rate of PLYL;67.68
Total;PaÝs Vasco;All causes;Males;Average number of PLYL;13.89
Total;PaÝs Vasco;All causes;Females;Number of PLYL;36,999.00
Total;PaÝs Vasco;All causes;Females;Distribution by chapter of the CIE;100.00
Total;PaÝs Vasco;All causes;Females;Standardised rate of PLYL;32.35
Total;PaÝs Vasco;All causes;Females;Average number of PLYL;13.67
Total;PaÝs Vasco;Infectious and parasitic diseases (1);Both sexes;Number of PLYL;2,497.50
Total;PaÝs Vasco;Infectious and parasitic diseases (1);Both sexes;Distribution by chapter of the CIE;2.19
Total;PaÝs Vasco;Infectious and parasitic diseases (1);Both sexes;Standardised rate of PLYL;1.06
Total;PaÝs Vasco;Infectious and parasitic diseases (1);Both sexes;Average number of PLYL;17.97
Total;PaÝs Vasco;Infectious and parasitic diseases (1);Males;Number of PLYL;1,895.00
Total;PaÝs Vasco;Infectious and parasitic diseases (1);Males;Distribution by chapter of the CIE;2.47
Total;PaÝs Vasco;Infectious and parasitic diseases (1);Males;Standardised rate of PLYL;1.62
Total;PaÝs Vasco;Infectious and parasitic diseases (1);Males;Average number of PLYL;20.16
Total;PaÝs Vasco;Infectious and parasitic diseases (1);Females;Number of PLYL;602.50
Total;PaÝs Vasco;Infectious and parasitic diseases (1);Females;Distribution by chapter of the CIE;1.63
Total;PaÝs Vasco;Infectious and parasitic diseases (1);Females;Standardised rate of PLYL;0.51
Total;PaÝs Vasco;Infectious and parasitic diseases (1);Females;Average number of PLYL;13.39
Total;PaÝs Vasco;Tumours;Both sexes;Number of PLYL;55,327.00
Total;PaÝs Vasco;Tumours;Both sexes;Distribution by chapter of the CIE;48.61
Total;PaÝs Vasco;Tumours;Both sexes;Standardised rate of PLYL;23.60
Total;PaÝs Vasco;Tumours;Both sexes;Average number of PLYL;14.28
Total;PaÝs Vasco;Tumours;Males;Number of PLYL;34,613.50
Total;PaÝs Vasco;Tumours;Males;Distribution by chapter of the CIE;45.06
Total;PaÝs Vasco;Tumours;Males;Standardised rate of PLYL;29.48
Total;PaÝs Vasco;Tumours;Males;Average number of PLYL;13.58
Total;PaÝs Vasco;Tumours;Females;Number of PLYL;20,713.50
Total;PaÝs Vasco;Tumours;Females;Distribution by chapter of the CIE;55.98
Total;PaÝs Vasco;Tumours;Females;Standardised rate of PLYL;17.69
Total;PaÝs Vasco;Tumours;Females;Average number of PLYL;15.62
Total;PaÝs Vasco;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Number of PLYL;442.00
Total;PaÝs Vasco;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Distribution by chapter of the CIE;0.39
Total;PaÝs Vasco;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Standardised rate of PLYL;0.22
Total;PaÝs Vasco;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Average number of PLYL;19.22
Total;PaÝs Vasco;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Number of PLYL;290.00
Total;PaÝs Vasco;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Distribution by chapter of the CIE;0.38
Total;PaÝs Vasco;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Standardised rate of PLYL;0.30
Total;PaÝs Vasco;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Average number of PLYL;20.71
Total;PaÝs Vasco;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Number of PLYL;152.00
Total;PaÝs Vasco;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Distribution by chapter of the CIE;0.41
Total;PaÝs Vasco;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Standardised rate of PLYL;0.14
Total;PaÝs Vasco;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Average number of PLYL;16.89
Total;PaÝs Vasco;Endocrine, nutritional and metabolic diseases;Both sexes;Number of PLYL;2,342.50
Total;PaÝs Vasco;Endocrine, nutritional and metabolic diseases;Both sexes;Distribution by chapter of the CIE;2.06
Total;PaÝs Vasco;Endocrine, nutritional and metabolic diseases;Both sexes;Standardised rate of PLYL;1.09
Total;PaÝs Vasco;Endocrine, nutritional and metabolic diseases;Both sexes;Average number of PLYL;10.41
Total;PaÝs Vasco;Endocrine, nutritional and metabolic diseases;Males;Number of PLYL;1,342.50
Total;PaÝs Vasco;Endocrine, nutritional and metabolic diseases;Males;Distribution by chapter of the CIE;1.75
Total;PaÝs Vasco;Endocrine, nutritional and metabolic diseases;Males;Standardised rate of PLYL;1.27
Total;PaÝs Vasco;Endocrine, nutritional and metabolic diseases;Males;Average number of PLYL;10.74
Total;PaÝs Vasco;Endocrine, nutritional and metabolic diseases;Females;Number of PLYL;1,000.00
Total;PaÝs Vasco;Endocrine, nutritional and metabolic diseases;Females;Distribution by chapter of the CIE;2.70
Total;PaÝs Vasco;Endocrine, nutritional and metabolic diseases;Females;Standardised rate of PLYL;0.91
Total;PaÝs Vasco;Endocrine, nutritional and metabolic diseases;Females;Average number of PLYL;10.00
Total;PaÝs Vasco;Mental and behavioural disorders;Both sexes;Number of PLYL;810.00
Total;PaÝs Vasco;Mental and behavioural disorders;Both sexes;Distribution by chapter of the CIE;0.71
Total;PaÝs Vasco;Mental and behavioural disorders;Both sexes;Standardised rate of PLYL;0.35
Total;PaÝs Vasco;Mental and behavioural disorders;Both sexes;Average number of PLYL;5.96
Total;PaÝs Vasco;Mental and behavioural disorders;Males;Number of PLYL;485.00
Total;PaÝs Vasco;Mental and behavioural disorders;Males;Distribution by chapter of the CIE;0.63
Total;PaÝs Vasco;Mental and behavioural disorders;Males;Standardised rate of PLYL;0.42
Total;PaÝs Vasco;Mental and behavioural disorders;Males;Average number of PLYL;6.74
Total;PaÝs Vasco;Mental and behavioural disorders;Females;Number of PLYL;325.00
Total;PaÝs Vasco;Mental and behavioural disorders;Females;Distribution by chapter of the CIE;0.88
Total;PaÝs Vasco;Mental and behavioural disorders;Females;Standardised rate of PLYL;0.28
Total;PaÝs Vasco;Mental and behavioural disorders;Females;Average number of PLYL;5.08
Total;PaÝs Vasco;Diseases of the nervous system and the sense organs;Both sexes;Number of PLYL;4,128.50
Total;PaÝs Vasco;Diseases of the nervous system and the sense organs;Both sexes;Distribution by chapter of the CIE;3.63
Total;PaÝs Vasco;Diseases of the nervous system and the sense organs;Both sexes;Standardised rate of PLYL;1.84
Total;PaÝs Vasco;Diseases of the nervous system and the sense organs;Both sexes;Average number of PLYL;11.60
Total;PaÝs Vasco;Diseases of the nervous system and the sense organs;Males;Number of PLYL;2,389.50
Total;PaÝs Vasco;Diseases of the nervous system and the sense organs;Males;Distribution by chapter of the CIE;3.11
Total;PaÝs Vasco;Diseases of the nervous system and the sense organs;Males;Standardised rate of PLYL;2.09
Total;PaÝs Vasco;Diseases of the nervous system and the sense organs;Males;Average number of PLYL;12.32
Total;PaÝs Vasco;Diseases of the nervous system and the sense organs;Females;Number of PLYL;1,739.00
Total;PaÝs Vasco;Diseases of the nervous system and the sense organs;Females;Distribution by chapter of the CIE;4.70
Total;PaÝs Vasco;Diseases of the nervous system and the sense organs;Females;Standardised rate of PLYL;1.59
Total;PaÝs Vasco;Diseases of the nervous system and the sense organs;Females;Average number of PLYL;10.73
Total;PaÝs Vasco;Diseases of the circulatory system;Both sexes;Number of PLYL;20,577.00
Total;PaÝs Vasco;Diseases of the circulatory system;Both sexes;Distribution by chapter of the CIE;18.08
Total;PaÝs Vasco;Diseases of the circulatory system;Both sexes;Standardised rate of PLYL;8.83
Total;PaÝs Vasco;Diseases of the circulatory system;Both sexes;Average number of PLYL;11.36
Total;PaÝs Vasco;Diseases of the circulatory system;Males;Number of PLYL;15,442.50
Total;PaÝs Vasco;Diseases of the circulatory system;Males;Distribution by chapter of the CIE;20.11
Total;PaÝs Vasco;Diseases of the circulatory system;Males;Standardised rate of PLYL;13.21
Total;PaÝs Vasco;Diseases of the circulatory system;Males;Average number of PLYL;12.06
Total;PaÝs Vasco;Diseases of the circulatory system;Females;Number of PLYL;5,134.50
Total;PaÝs Vasco;Diseases of the circulatory system;Females;Distribution by chapter of the CIE;13.88
Total;PaÝs Vasco;Diseases of the circulatory system;Females;Standardised rate of PLYL;4.44
Total;PaÝs Vasco;Diseases of the circulatory system;Females;Average number of PLYL;9.69
Total;PaÝs Vasco;Diseases of the respiratory system;Both sexes;Number of PLYL;4,610.00
Total;PaÝs Vasco;Diseases of the respiratory system;Both sexes;Distribution by chapter of the CIE;4.05
Total;PaÝs Vasco;Diseases of the respiratory system;Both sexes;Standardised rate of PLYL;1.96
Total;PaÝs Vasco;Diseases of the respiratory system;Both sexes;Average number of PLYL;9.26
Total;PaÝs Vasco;Diseases of the respiratory system;Males;Number of PLYL;3,040.00
Total;PaÝs Vasco;Diseases of the respiratory system;Males;Distribution by chapter of the CIE;3.96
Total;PaÝs Vasco;Diseases of the respiratory system;Males;Standardised rate of PLYL;2.56
Total;PaÝs Vasco;Diseases of the respiratory system;Males;Average number of PLYL;8.26
Total;PaÝs Vasco;Diseases of the respiratory system;Females;Number of PLYL;1,570.00
Total;PaÝs Vasco;Diseases of the respiratory system;Females;Distribution by chapter of the CIE;4.24
Total;PaÝs Vasco;Diseases of the respiratory system;Females;Standardised rate of PLYL;1.35
Total;PaÝs Vasco;Diseases of the respiratory system;Females;Average number of PLYL;12.08
Total;PaÝs Vasco;Diseases of the digestive system;Both sexes;Number of PLYL;6,449.50
Total;PaÝs Vasco;Diseases of the digestive system;Both sexes;Distribution by chapter of the CIE;5.67
Total;PaÝs Vasco;Diseases of the digestive system;Both sexes;Standardised rate of PLYL;2.65
Total;PaÝs Vasco;Diseases of the digestive system;Both sexes;Average number of PLYL;14.86
Total;PaÝs Vasco;Diseases of the digestive system;Males;Number of PLYL;4,710.00
Total;PaÝs Vasco;Diseases of the digestive system;Males;Distribution by chapter of the CIE;6.13
Total;PaÝs Vasco;Diseases of the digestive system;Males;Standardised rate of PLYL;3.87
Total;PaÝs Vasco;Diseases of the digestive system;Males;Average number of PLYL;15.10
Total;PaÝs Vasco;Diseases of the digestive system;Females;Number of PLYL;1,739.50
Total;PaÝs Vasco;Diseases of the digestive system;Females;Distribution by chapter of the CIE;4.70
Total;PaÝs Vasco;Diseases of the digestive system;Females;Standardised rate of PLYL;1.43
Total;PaÝs Vasco;Diseases of the digestive system;Females;Average number of PLYL;14.26
Total;PaÝs Vasco;Diseases of the skin and subcutaneous tissue;Both sexes;Number of PLYL;102.50
Total;PaÝs Vasco;Diseases of the skin and subcutaneous tissue;Both sexes;Distribution by chapter of the CIE;0.09
Total;PaÝs Vasco;Diseases of the skin and subcutaneous tissue;Both sexes;Standardised rate of PLYL;0.05
Total;PaÝs Vasco;Diseases of the skin and subcutaneous tissue;Both sexes;Average number of PLYL;11.39
Total;PaÝs Vasco;Diseases of the skin and subcutaneous tissue;Males;Number of PLYL;35.00
Total;PaÝs Vasco;Diseases of the skin and subcutaneous tissue;Males;Distribution by chapter of the CIE;0.05
Total;PaÝs Vasco;Diseases of the skin and subcutaneous tissue;Males;Standardised rate of PLYL;0.03
Total;PaÝs Vasco;Diseases of the skin and subcutaneous tissue;Males;Average number of PLYL;8.75
Total;PaÝs Vasco;Diseases of the skin and subcutaneous tissue;Females;Number of PLYL;67.50
Total;PaÝs Vasco;Diseases of the skin and subcutaneous tissue;Females;Distribution by chapter of the CIE;0.18
Total;PaÝs Vasco;Diseases of the skin and subcutaneous tissue;Females;Standardised rate of PLYL;0.07
Total;PaÝs Vasco;Diseases of the skin and subcutaneous tissue;Females;Average number of PLYL;13.50
Total;PaÝs Vasco;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Number of PLYL;492.50
Total;PaÝs Vasco;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Distribution by chapter of the CIE;0.43
Total;PaÝs Vasco;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Standardised rate of PLYL;0.23
Total;PaÝs Vasco;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Average number of PLYL;11.45
Total;PaÝs Vasco;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Number of PLYL;240.00
Total;PaÝs Vasco;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Distribution by chapter of the CIE;0.31
Total;PaÝs Vasco;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Standardised rate of PLYL;0.20
Total;PaÝs Vasco;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Average number of PLYL;12.00
Total;PaÝs Vasco;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Number of PLYL;252.50
Total;PaÝs Vasco;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Distribution by chapter of the CIE;0.68
Total;PaÝs Vasco;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Standardised rate of PLYL;0.26
Total;PaÝs Vasco;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Average number of PLYL;10.98
Total;PaÝs Vasco;Diseases of the genitourinary system;Both sexes;Number of PLYL;784.50
Total;PaÝs Vasco;Diseases of the genitourinary system;Both sexes;Distribution by chapter of the CIE;0.69
Total;PaÝs Vasco;Diseases of the genitourinary system;Both sexes;Standardised rate of PLYL;0.34
Total;PaÝs Vasco;Diseases of the genitourinary system;Both sexes;Average number of PLYL;8.53
Total;PaÝs Vasco;Diseases of the genitourinary system;Males;Number of PLYL;547.00
Total;PaÝs Vasco;Diseases of the genitourinary system;Males;Distribution by chapter of the CIE;0.71
Total;PaÝs Vasco;Diseases of the genitourinary system;Males;Standardised rate of PLYL;0.47
Total;PaÝs Vasco;Diseases of the genitourinary system;Males;Average number of PLYL;10.32
Total;PaÝs Vasco;Diseases of the genitourinary system;Females;Number of PLYL;237.50
Total;PaÝs Vasco;Diseases of the genitourinary system;Females;Distribution by chapter of the CIE;0.64
Total;PaÝs Vasco;Diseases of the genitourinary system;Females;Standardised rate of PLYL;0.21
Total;PaÝs Vasco;Diseases of the genitourinary system;Females;Average number of PLYL;6.09
Total;PaÝs Vasco;Pregnancy, childbirth and the puerperium;Both sexes;Number of PLYL;47.50
Total;PaÝs Vasco;Pregnancy, childbirth and the puerperium;Both sexes;Distribution by chapter of the CIE;0.04
Total;PaÝs Vasco;Pregnancy, childbirth and the puerperium;Both sexes;Standardised rate of PLYL;0.02
Total;PaÝs Vasco;Pregnancy, childbirth and the puerperium;Both sexes;Average number of PLYL;47.50
Total;PaÝs Vasco;Pregnancy, childbirth and the puerperium;Males;Number of PLYL;..
Total;PaÝs Vasco;Pregnancy, childbirth and the puerperium;Males;Distribution by chapter of the CIE;..
Total;PaÝs Vasco;Pregnancy, childbirth and the puerperium;Males;Standardised rate of PLYL;..
Total;PaÝs Vasco;Pregnancy, childbirth and the puerperium;Males;Average number of PLYL;..
Total;PaÝs Vasco;Pregnancy, childbirth and the puerperium;Females;Number of PLYL;47.50
Total;PaÝs Vasco;Pregnancy, childbirth and the puerperium;Females;Distribution by chapter of the CIE;0.13
Total;PaÝs Vasco;Pregnancy, childbirth and the puerperium;Females;Standardised rate of PLYL;0.05
Total;PaÝs Vasco;Pregnancy, childbirth and the puerperium;Females;Average number of PLYL;47.50
Total;PaÝs Vasco;Affections originated in the perinatal period;Both sexes;Number of PLYL;..
Total;PaÝs Vasco;Affections originated in the perinatal period;Both sexes;Distribution by chapter of the CIE;..
Total;PaÝs Vasco;Affections originated in the perinatal period;Both sexes;Standardised rate of PLYL;..
Total;PaÝs Vasco;Affections originated in the perinatal period;Both sexes;Average number of PLYL;..
Total;PaÝs Vasco;Affections originated in the perinatal period;Males;Number of PLYL;..
Total;PaÝs Vasco;Affections originated in the perinatal period;Males;Distribution by chapter of the CIE;..
Total;PaÝs Vasco;Affections originated in the perinatal period;Males;Standardised rate of PLYL;..
Total;PaÝs Vasco;Affections originated in the perinatal period;Males;Average number of PLYL;..
Total;PaÝs Vasco;Affections originated in the perinatal period;Females;Number of PLYL;..
Total;PaÝs Vasco;Affections originated in the perinatal period;Females;Distribution by chapter of the CIE;..
Total;PaÝs Vasco;Affections originated in the perinatal period;Females;Standardised rate of PLYL;..
Total;PaÝs Vasco;Affections originated in the perinatal period;Females;Average number of PLYL;..
Total;PaÝs Vasco;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Number of PLYL;856.50
Total;PaÝs Vasco;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Distribution by chapter of the CIE;0.75
Total;PaÝs Vasco;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Standardised rate of PLYL;0.44
Total;PaÝs Vasco;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Average number of PLYL;34.26
Total;PaÝs Vasco;Congenital malformations, deformities and chromosomal abnormalities;Males;Number of PLYL;400.00
Total;PaÝs Vasco;Congenital malformations, deformities and chromosomal abnormalities;Males;Distribution by chapter of the CIE;0.52
Total;PaÝs Vasco;Congenital malformations, deformities and chromosomal abnormalities;Males;Standardised rate of PLYL;0.46
Total;PaÝs Vasco;Congenital malformations, deformities and chromosomal abnormalities;Males;Average number of PLYL;33.33
Total;PaÝs Vasco;Congenital malformations, deformities and chromosomal abnormalities;Females;Number of PLYL;456.50
Total;PaÝs Vasco;Congenital malformations, deformities and chromosomal abnormalities;Females;Distribution by chapter of the CIE;1.23
Total;PaÝs Vasco;Congenital malformations, deformities and chromosomal abnormalities;Females;Standardised rate of PLYL;0.43
Total;PaÝs Vasco;Congenital malformations, deformities and chromosomal abnormalities;Females;Average number of PLYL;35.12
Total;PaÝs Vasco;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Number of PLYL;2,465.00
Total;PaÝs Vasco;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Distribution by chapter of the CIE;2.17
Total;PaÝs Vasco;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Standardised rate of PLYL;1.10
Total;PaÝs Vasco;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Average number of PLYL;17.12
Total;PaÝs Vasco;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Number of PLYL;2,000.00
Total;PaÝs Vasco;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Distribution by chapter of the CIE;2.60
Total;PaÝs Vasco;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Standardised rate of PLYL;1.82
Total;PaÝs Vasco;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Average number of PLYL;18.87
Total;PaÝs Vasco;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Number of PLYL;465.00
Total;PaÝs Vasco;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Distribution by chapter of the CIE;1.26
Total;PaÝs Vasco;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Standardised rate of PLYL;0.39
Total;PaÝs Vasco;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Average number of PLYL;12.24
Total;PaÝs Vasco;External causes of mortality;Both sexes;Number of PLYL;11,875.50
Total;PaÝs Vasco;External causes of mortality;Both sexes;Distribution by chapter of the CIE;10.43
Total;PaÝs Vasco;External causes of mortality;Both sexes;Standardised rate of PLYL;6.21
Total;PaÝs Vasco;External causes of mortality;Both sexes;Average number of PLYL;27.94
Total;PaÝs Vasco;External causes of mortality;Males;Number of PLYL;9,379.00
Total;PaÝs Vasco;External causes of mortality;Males;Distribution by chapter of the CIE;12.21
Total;PaÝs Vasco;External causes of mortality;Males;Standardised rate of PLYL;9.89
Total;PaÝs Vasco;External causes of mortality;Males;Average number of PLYL;28.77
Total;PaÝs Vasco;External causes of mortality;Females;Number of PLYL;2,496.50
Total;PaÝs Vasco;External causes of mortality;Females;Distribution by chapter of the CIE;6.75
Total;PaÝs Vasco;External causes of mortality;Females;Standardised rate of PLYL;2.59
Total;PaÝs Vasco;External causes of mortality;Females;Average number of PLYL;25.22
Total;Rioja, La;All causes;Both sexes;Number of PLYL;13,533.50
Total;Rioja, La;All causes;Both sexes;Distribution by chapter of the CIE;100.00
Total;Rioja, La;All causes;Both sexes;Standardised rate of PLYL;43.05
Total;Rioja, La;All causes;Both sexes;Average number of PLYL;12.74
Total;Rioja, La;All causes;Males;Number of PLYL;9,554.00
Total;Rioja, La;All causes;Males;Distribution by chapter of the CIE;100.00
Total;Rioja, La;All causes;Males;Standardised rate of PLYL;58.95
Total;Rioja, La;All causes;Males;Average number of PLYL;13.38
Total;Rioja, La;All causes;Females;Number of PLYL;3,979.50
Total;Rioja, La;All causes;Females;Distribution by chapter of the CIE;100.00
Total;Rioja, La;All causes;Females;Standardised rate of PLYL;26.12
Total;Rioja, La;All causes;Females;Average number of PLYL;11.44
Total;Rioja, La;Infectious and parasitic diseases (1);Both sexes;Number of PLYL;499.00
Total;Rioja, La;Infectious and parasitic diseases (1);Both sexes;Distribution by chapter of the CIE;3.69
Total;Rioja, La;Infectious and parasitic diseases (1);Both sexes;Standardised rate of PLYL;1.53
Total;Rioja, La;Infectious and parasitic diseases (1);Both sexes;Average number of PLYL;24.95
Total;Rioja, La;Infectious and parasitic diseases (1);Males;Number of PLYL;302.00
Total;Rioja, La;Infectious and parasitic diseases (1);Males;Distribution by chapter of the CIE;3.16
Total;Rioja, La;Infectious and parasitic diseases (1);Males;Standardised rate of PLYL;1.89
Total;Rioja, La;Infectious and parasitic diseases (1);Males;Average number of PLYL;27.45
Total;Rioja, La;Infectious and parasitic diseases (1);Females;Number of PLYL;197.00
Total;Rioja, La;Infectious and parasitic diseases (1);Females;Distribution by chapter of the CIE;4.95
Total;Rioja, La;Infectious and parasitic diseases (1);Females;Standardised rate of PLYL;1.16
Total;Rioja, La;Infectious and parasitic diseases (1);Females;Average number of PLYL;21.89
Total;Rioja, La;Tumours;Both sexes;Number of PLYL;5,825.00
Total;Rioja, La;Tumours;Both sexes;Distribution by chapter of the CIE;43.04
Total;Rioja, La;Tumours;Both sexes;Standardised rate of PLYL;18.45
Total;Rioja, La;Tumours;Both sexes;Average number of PLYL;12.34
Total;Rioja, La;Tumours;Males;Number of PLYL;3,867.50
Total;Rioja, La;Tumours;Males;Distribution by chapter of the CIE;40.48
Total;Rioja, La;Tumours;Males;Standardised rate of PLYL;23.93
Total;Rioja, La;Tumours;Males;Average number of PLYL;12.12
Total;Rioja, La;Tumours;Females;Number of PLYL;1,957.50
Total;Rioja, La;Tumours;Females;Distribution by chapter of the CIE;49.19
Total;Rioja, La;Tumours;Females;Standardised rate of PLYL;12.55
Total;Rioja, La;Tumours;Females;Average number of PLYL;12.79
Total;Rioja, La;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Number of PLYL;17.50
Total;Rioja, La;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Distribution by chapter of the CIE;0.13
Total;Rioja, La;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Standardised rate of PLYL;0.05
Total;Rioja, La;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Average number of PLYL;17.50
Total;Rioja, La;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Number of PLYL;..
Total;Rioja, La;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Distribution by chapter of the CIE;..
Total;Rioja, La;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Standardised rate of PLYL;..
Total;Rioja, La;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Average number of PLYL;..
Total;Rioja, La;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Number of PLYL;17.50
Total;Rioja, La;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Distribution by chapter of the CIE;0.44
Total;Rioja, La;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Standardised rate of PLYL;0.11
Total;Rioja, La;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Average number of PLYL;17.50
Total;Rioja, La;Endocrine, nutritional and metabolic diseases;Both sexes;Number of PLYL;277.50
Total;Rioja, La;Endocrine, nutritional and metabolic diseases;Both sexes;Distribution by chapter of the CIE;2.05
Total;Rioja, La;Endocrine, nutritional and metabolic diseases;Both sexes;Standardised rate of PLYL;0.87
Total;Rioja, La;Endocrine, nutritional and metabolic diseases;Both sexes;Average number of PLYL;13.21
Total;Rioja, La;Endocrine, nutritional and metabolic diseases;Males;Number of PLYL;205.00
Total;Rioja, La;Endocrine, nutritional and metabolic diseases;Males;Distribution by chapter of the CIE;2.15
Total;Rioja, La;Endocrine, nutritional and metabolic diseases;Males;Standardised rate of PLYL;1.25
Total;Rioja, La;Endocrine, nutritional and metabolic diseases;Males;Average number of PLYL;12.81
Total;Rioja, La;Endocrine, nutritional and metabolic diseases;Females;Number of PLYL;72.50
Total;Rioja, La;Endocrine, nutritional and metabolic diseases;Females;Distribution by chapter of the CIE;1.82
Total;Rioja, La;Endocrine, nutritional and metabolic diseases;Females;Standardised rate of PLYL;0.46
Total;Rioja, La;Endocrine, nutritional and metabolic diseases;Females;Average number of PLYL;14.50
Total;Rioja, La;Mental and behavioural disorders;Both sexes;Number of PLYL;105.00
Total;Rioja, La;Mental and behavioural disorders;Both sexes;Distribution by chapter of the CIE;0.78
Total;Rioja, La;Mental and behavioural disorders;Both sexes;Standardised rate of PLYL;0.33
Total;Rioja, La;Mental and behavioural disorders;Both sexes;Average number of PLYL;10.50
Total;Rioja, La;Mental and behavioural disorders;Males;Number of PLYL;97.50
Total;Rioja, La;Mental and behavioural disorders;Males;Distribution by chapter of the CIE;1.02
Total;Rioja, La;Mental and behavioural disorders;Males;Standardised rate of PLYL;0.59
Total;Rioja, La;Mental and behavioural disorders;Males;Average number of PLYL;13.93
Total;Rioja, La;Mental and behavioural disorders;Females;Number of PLYL;7.50
Total;Rioja, La;Mental and behavioural disorders;Females;Distribution by chapter of the CIE;0.19
Total;Rioja, La;Mental and behavioural disorders;Females;Standardised rate of PLYL;0.04
Total;Rioja, La;Mental and behavioural disorders;Females;Average number of PLYL;2.50
Total;Rioja, La;Diseases of the nervous system and the sense organs;Both sexes;Number of PLYL;665.00
Total;Rioja, La;Diseases of the nervous system and the sense organs;Both sexes;Distribution by chapter of the CIE;4.91
Total;Rioja, La;Diseases of the nervous system and the sense organs;Both sexes;Standardised rate of PLYL;2.25
Total;Rioja, La;Diseases of the nervous system and the sense organs;Both sexes;Average number of PLYL;11.08
Total;Rioja, La;Diseases of the nervous system and the sense organs;Males;Number of PLYL;340.00
Total;Rioja, La;Diseases of the nervous system and the sense organs;Males;Distribution by chapter of the CIE;3.56
Total;Rioja, La;Diseases of the nervous system and the sense organs;Males;Standardised rate of PLYL;2.45
Total;Rioja, La;Diseases of the nervous system and the sense organs;Males;Average number of PLYL;13.08
Total;Rioja, La;Diseases of the nervous system and the sense organs;Females;Number of PLYL;325.00
Total;Rioja, La;Diseases of the nervous system and the sense organs;Females;Distribution by chapter of the CIE;8.17
Total;Rioja, La;Diseases of the nervous system and the sense organs;Females;Standardised rate of PLYL;2.06
Total;Rioja, La;Diseases of the nervous system and the sense organs;Females;Average number of PLYL;9.56
Total;Rioja, La;Diseases of the circulatory system;Both sexes;Number of PLYL;2,777.50
Total;Rioja, La;Diseases of the circulatory system;Both sexes;Distribution by chapter of the CIE;20.52
Total;Rioja, La;Diseases of the circulatory system;Both sexes;Standardised rate of PLYL;8.72
Total;Rioja, La;Diseases of the circulatory system;Both sexes;Average number of PLYL;10.64
Total;Rioja, La;Diseases of the circulatory system;Males;Number of PLYL;2,265.00
Total;Rioja, La;Diseases of the circulatory system;Males;Distribution by chapter of the CIE;23.71
Total;Rioja, La;Diseases of the circulatory system;Males;Standardised rate of PLYL;13.70
Total;Rioja, La;Diseases of the circulatory system;Males;Average number of PLYL;12.58
Total;Rioja, La;Diseases of the circulatory system;Females;Number of PLYL;512.50
Total;Rioja, La;Diseases of the circulatory system;Females;Distribution by chapter of the CIE;12.88
Total;Rioja, La;Diseases of the circulatory system;Females;Standardised rate of PLYL;3.43
Total;Rioja, La;Diseases of the circulatory system;Females;Average number of PLYL;6.33
Total;Rioja, La;Diseases of the respiratory system;Both sexes;Number of PLYL;455.00
Total;Rioja, La;Diseases of the respiratory system;Both sexes;Distribution by chapter of the CIE;3.36
Total;Rioja, La;Diseases of the respiratory system;Both sexes;Standardised rate of PLYL;1.46
Total;Rioja, La;Diseases of the respiratory system;Both sexes;Average number of PLYL;7.11
Total;Rioja, La;Diseases of the respiratory system;Males;Number of PLYL;345.00
Total;Rioja, La;Diseases of the respiratory system;Males;Distribution by chapter of the CIE;3.61
Total;Rioja, La;Diseases of the respiratory system;Males;Standardised rate of PLYL;2.11
Total;Rioja, La;Diseases of the respiratory system;Males;Average number of PLYL;7.19
Total;Rioja, La;Diseases of the respiratory system;Females;Number of PLYL;110.00
Total;Rioja, La;Diseases of the respiratory system;Females;Distribution by chapter of the CIE;2.76
Total;Rioja, La;Diseases of the respiratory system;Females;Standardised rate of PLYL;0.75
Total;Rioja, La;Diseases of the respiratory system;Females;Average number of PLYL;6.88
Total;Rioja, La;Diseases of the digestive system;Both sexes;Number of PLYL;822.50
Total;Rioja, La;Diseases of the digestive system;Both sexes;Distribution by chapter of the CIE;6.08
Total;Rioja, La;Diseases of the digestive system;Both sexes;Standardised rate of PLYL;2.51
Total;Rioja, La;Diseases of the digestive system;Both sexes;Average number of PLYL;14.43
Total;Rioja, La;Diseases of the digestive system;Males;Number of PLYL;665.00
Total;Rioja, La;Diseases of the digestive system;Males;Distribution by chapter of the CIE;6.96
Total;Rioja, La;Diseases of the digestive system;Males;Standardised rate of PLYL;3.91
Total;Rioja, La;Diseases of the digestive system;Males;Average number of PLYL;15.83
Total;Rioja, La;Diseases of the digestive system;Females;Number of PLYL;157.50
Total;Rioja, La;Diseases of the digestive system;Females;Distribution by chapter of the CIE;3.96
Total;Rioja, La;Diseases of the digestive system;Females;Standardised rate of PLYL;1.04
Total;Rioja, La;Diseases of the digestive system;Females;Average number of PLYL;10.50
Total;Rioja, La;Diseases of the skin and subcutaneous tissue;Both sexes;Number of PLYL;17.50
Total;Rioja, La;Diseases of the skin and subcutaneous tissue;Both sexes;Distribution by chapter of the CIE;0.13
Total;Rioja, La;Diseases of the skin and subcutaneous tissue;Both sexes;Standardised rate of PLYL;0.05
Total;Rioja, La;Diseases of the skin and subcutaneous tissue;Both sexes;Average number of PLYL;17.50
Total;Rioja, La;Diseases of the skin and subcutaneous tissue;Males;Number of PLYL;..
Total;Rioja, La;Diseases of the skin and subcutaneous tissue;Males;Distribution by chapter of the CIE;..
Total;Rioja, La;Diseases of the skin and subcutaneous tissue;Males;Standardised rate of PLYL;..
Total;Rioja, La;Diseases of the skin and subcutaneous tissue;Males;Average number of PLYL;..
Total;Rioja, La;Diseases of the skin and subcutaneous tissue;Females;Number of PLYL;17.50
Total;Rioja, La;Diseases of the skin and subcutaneous tissue;Females;Distribution by chapter of the CIE;0.44
Total;Rioja, La;Diseases of the skin and subcutaneous tissue;Females;Standardised rate of PLYL;0.11
Total;Rioja, La;Diseases of the skin and subcutaneous tissue;Females;Average number of PLYL;17.50
Total;Rioja, La;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Number of PLYL;20.00
Total;Rioja, La;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Distribution by chapter of the CIE;0.15
Total;Rioja, La;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Standardised rate of PLYL;0.07
Total;Rioja, La;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Average number of PLYL;5.00
Total;Rioja, La;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Number of PLYL;2.50
Total;Rioja, La;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Distribution by chapter of the CIE;0.03
Total;Rioja, La;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Standardised rate of PLYL;0.01
Total;Rioja, La;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Average number of PLYL;2.50
Total;Rioja, La;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Number of PLYL;17.50
Total;Rioja, La;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Distribution by chapter of the CIE;0.44
Total;Rioja, La;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Standardised rate of PLYL;0.13
Total;Rioja, La;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Average number of PLYL;5.83
Total;Rioja, La;Diseases of the genitourinary system;Both sexes;Number of PLYL;117.50
Total;Rioja, La;Diseases of the genitourinary system;Both sexes;Distribution by chapter of the CIE;0.87
Total;Rioja, La;Diseases of the genitourinary system;Both sexes;Standardised rate of PLYL;0.40
Total;Rioja, La;Diseases of the genitourinary system;Both sexes;Average number of PLYL;7.83
Total;Rioja, La;Diseases of the genitourinary system;Males;Number of PLYL;97.50
Total;Rioja, La;Diseases of the genitourinary system;Males;Distribution by chapter of the CIE;1.02
Total;Rioja, La;Diseases of the genitourinary system;Males;Standardised rate of PLYL;0.63
Total;Rioja, La;Diseases of the genitourinary system;Males;Average number of PLYL;8.86
Total;Rioja, La;Diseases of the genitourinary system;Females;Number of PLYL;20.00
Total;Rioja, La;Diseases of the genitourinary system;Females;Distribution by chapter of the CIE;0.50
Total;Rioja, La;Diseases of the genitourinary system;Females;Standardised rate of PLYL;0.14
Total;Rioja, La;Diseases of the genitourinary system;Females;Average number of PLYL;5.00
Total;Rioja, La;Pregnancy, childbirth and the puerperium;Both sexes;Number of PLYL;47.50
Total;Rioja, La;Pregnancy, childbirth and the puerperium;Both sexes;Distribution by chapter of the CIE;0.35
Total;Rioja, La;Pregnancy, childbirth and the puerperium;Both sexes;Standardised rate of PLYL;0.15
Total;Rioja, La;Pregnancy, childbirth and the puerperium;Both sexes;Average number of PLYL;47.50
Total;Rioja, La;Pregnancy, childbirth and the puerperium;Males;Number of PLYL;..
Total;Rioja, La;Pregnancy, childbirth and the puerperium;Males;Distribution by chapter of the CIE;..
Total;Rioja, La;Pregnancy, childbirth and the puerperium;Males;Standardised rate of PLYL;..
Total;Rioja, La;Pregnancy, childbirth and the puerperium;Males;Average number of PLYL;..
Total;Rioja, La;Pregnancy, childbirth and the puerperium;Females;Number of PLYL;47.50
Total;Rioja, La;Pregnancy, childbirth and the puerperium;Females;Distribution by chapter of the CIE;1.19
Total;Rioja, La;Pregnancy, childbirth and the puerperium;Females;Standardised rate of PLYL;0.30
Total;Rioja, La;Pregnancy, childbirth and the puerperium;Females;Average number of PLYL;47.50
Total;Rioja, La;Affections originated in the perinatal period;Both sexes;Number of PLYL;..
Total;Rioja, La;Affections originated in the perinatal period;Both sexes;Distribution by chapter of the CIE;..
Total;Rioja, La;Affections originated in the perinatal period;Both sexes;Standardised rate of PLYL;..
Total;Rioja, La;Affections originated in the perinatal period;Both sexes;Average number of PLYL;..
Total;Rioja, La;Affections originated in the perinatal period;Males;Number of PLYL;..
Total;Rioja, La;Affections originated in the perinatal period;Males;Distribution by chapter of the CIE;..
Total;Rioja, La;Affections originated in the perinatal period;Males;Standardised rate of PLYL;..
Total;Rioja, La;Affections originated in the perinatal period;Males;Average number of PLYL;..
Total;Rioja, La;Affections originated in the perinatal period;Females;Number of PLYL;..
Total;Rioja, La;Affections originated in the perinatal period;Females;Distribution by chapter of the CIE;..
Total;Rioja, La;Affections originated in the perinatal period;Females;Standardised rate of PLYL;..
Total;Rioja, La;Affections originated in the perinatal period;Females;Average number of PLYL;..
Total;Rioja, La;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Number of PLYL;95.00
Total;Rioja, La;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Distribution by chapter of the CIE;0.70
Total;Rioja, La;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Standardised rate of PLYL;0.28
Total;Rioja, La;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Average number of PLYL;23.75
Total;Rioja, La;Congenital malformations, deformities and chromosomal abnormalities;Males;Number of PLYL;22.50
Total;Rioja, La;Congenital malformations, deformities and chromosomal abnormalities;Males;Distribution by chapter of the CIE;0.24
Total;Rioja, La;Congenital malformations, deformities and chromosomal abnormalities;Males;Standardised rate of PLYL;0.13
Total;Rioja, La;Congenital malformations, deformities and chromosomal abnormalities;Males;Average number of PLYL;22.50
Total;Rioja, La;Congenital malformations, deformities and chromosomal abnormalities;Females;Number of PLYL;72.50
Total;Rioja, La;Congenital malformations, deformities and chromosomal abnormalities;Females;Distribution by chapter of the CIE;1.82
Total;Rioja, La;Congenital malformations, deformities and chromosomal abnormalities;Females;Standardised rate of PLYL;0.43
Total;Rioja, La;Congenital malformations, deformities and chromosomal abnormalities;Females;Average number of PLYL;24.17
Total;Rioja, La;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Number of PLYL;102.50
Total;Rioja, La;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Distribution by chapter of the CIE;0.76
Total;Rioja, La;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Standardised rate of PLYL;0.31
Total;Rioja, La;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Average number of PLYL;14.64
Total;Rioja, La;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Number of PLYL;57.50
Total;Rioja, La;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Distribution by chapter of the CIE;0.60
Total;Rioja, La;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Standardised rate of PLYL;0.34
Total;Rioja, La;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Average number of PLYL;11.50
Total;Rioja, La;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Number of PLYL;45.00
Total;Rioja, La;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Distribution by chapter of the CIE;1.13
Total;Rioja, La;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Standardised rate of PLYL;0.27
Total;Rioja, La;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Average number of PLYL;22.50
Total;Rioja, La;External causes of mortality;Both sexes;Number of PLYL;1,689.50
Total;Rioja, La;External causes of mortality;Both sexes;Distribution by chapter of the CIE;12.48
Total;Rioja, La;External causes of mortality;Both sexes;Standardised rate of PLYL;5.63
Total;Rioja, La;External causes of mortality;Both sexes;Average number of PLYL;26.40
Total;Rioja, La;External causes of mortality;Males;Number of PLYL;1,287.00
Total;Rioja, La;External causes of mortality;Males;Distribution by chapter of the CIE;13.47
Total;Rioja, La;External causes of mortality;Males;Standardised rate of PLYL;7.99
Total;Rioja, La;External causes of mortality;Males;Average number of PLYL;27.38
Total;Rioja, La;External causes of mortality;Females;Number of PLYL;402.50
Total;Rioja, La;External causes of mortality;Females;Distribution by chapter of the CIE;10.11
Total;Rioja, La;External causes of mortality;Females;Standardised rate of PLYL;3.14
Total;Rioja, La;External causes of mortality;Females;Average number of PLYL;23.68
Total;Ceuta;All causes;Both sexes;Number of PLYL;5,007.00
Total;Ceuta;All causes;Both sexes;Distribution by chapter of the CIE;100.00
Total;Ceuta;All causes;Both sexes;Standardised rate of PLYL;74.34
Total;Ceuta;All causes;Both sexes;Average number of PLYL;15.70
Total;Ceuta;All causes;Males;Number of PLYL;3,470.00
Total;Ceuta;All causes;Males;Distribution by chapter of the CIE;100.00
Total;Ceuta;All causes;Males;Standardised rate of PLYL;99.78
Total;Ceuta;All causes;Males;Average number of PLYL;16.84
Total;Ceuta;All causes;Females;Number of PLYL;1,537.00
Total;Ceuta;All causes;Females;Distribution by chapter of the CIE;100.00
Total;Ceuta;All causes;Females;Standardised rate of PLYL;47.80
Total;Ceuta;All causes;Females;Average number of PLYL;13.60
Total;Ceuta;Infectious and parasitic diseases (1);Both sexes;Number of PLYL;412.50
Total;Ceuta;Infectious and parasitic diseases (1);Both sexes;Distribution by chapter of the CIE;8.24
Total;Ceuta;Infectious and parasitic diseases (1);Both sexes;Standardised rate of PLYL;5.84
Total;Ceuta;Infectious and parasitic diseases (1);Both sexes;Average number of PLYL;17.93
Total;Ceuta;Infectious and parasitic diseases (1);Males;Number of PLYL;322.50
Total;Ceuta;Infectious and parasitic diseases (1);Males;Distribution by chapter of the CIE;9.29
Total;Ceuta;Infectious and parasitic diseases (1);Males;Standardised rate of PLYL;8.80
Total;Ceuta;Infectious and parasitic diseases (1);Males;Average number of PLYL;21.50
Total;Ceuta;Infectious and parasitic diseases (1);Females;Number of PLYL;90.00
Total;Ceuta;Infectious and parasitic diseases (1);Females;Distribution by chapter of the CIE;5.86
Total;Ceuta;Infectious and parasitic diseases (1);Females;Standardised rate of PLYL;2.80
Total;Ceuta;Infectious and parasitic diseases (1);Females;Average number of PLYL;11.25
Total;Ceuta;Tumours;Both sexes;Number of PLYL;1,555.00
Total;Ceuta;Tumours;Both sexes;Distribution by chapter of the CIE;31.06
Total;Ceuta;Tumours;Both sexes;Standardised rate of PLYL;23.25
Total;Ceuta;Tumours;Both sexes;Average number of PLYL;15.87
Total;Ceuta;Tumours;Males;Number of PLYL;962.50
Total;Ceuta;Tumours;Males;Distribution by chapter of the CIE;27.74
Total;Ceuta;Tumours;Males;Standardised rate of PLYL;28.57
Total;Ceuta;Tumours;Males;Average number of PLYL;14.37
Total;Ceuta;Tumours;Females;Number of PLYL;592.50
Total;Ceuta;Tumours;Females;Distribution by chapter of the CIE;38.55
Total;Ceuta;Tumours;Females;Standardised rate of PLYL;17.54
Total;Ceuta;Tumours;Females;Average number of PLYL;19.11
Total;Ceuta;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Number of PLYL;37.50
Total;Ceuta;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Distribution by chapter of the CIE;0.75
Total;Ceuta;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Standardised rate of PLYL;0.48
Total;Ceuta;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Average number of PLYL;37.50
Total;Ceuta;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Number of PLYL;37.50
Total;Ceuta;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Distribution by chapter of the CIE;1.08
Total;Ceuta;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Standardised rate of PLYL;0.95
Total;Ceuta;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Average number of PLYL;37.50
Total;Ceuta;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Number of PLYL;..
Total;Ceuta;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Distribution by chapter of the CIE;..
Total;Ceuta;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Standardised rate of PLYL;..
Total;Ceuta;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Average number of PLYL;..
Total;Ceuta;Endocrine, nutritional and metabolic diseases;Both sexes;Number of PLYL;155.00
Total;Ceuta;Endocrine, nutritional and metabolic diseases;Both sexes;Distribution by chapter of the CIE;3.10
Total;Ceuta;Endocrine, nutritional and metabolic diseases;Both sexes;Standardised rate of PLYL;2.46
Total;Ceuta;Endocrine, nutritional and metabolic diseases;Both sexes;Average number of PLYL;11.07
Total;Ceuta;Endocrine, nutritional and metabolic diseases;Males;Number of PLYL;85.00
Total;Ceuta;Endocrine, nutritional and metabolic diseases;Males;Distribution by chapter of the CIE;2.45
Total;Ceuta;Endocrine, nutritional and metabolic diseases;Males;Standardised rate of PLYL;2.62
Total;Ceuta;Endocrine, nutritional and metabolic diseases;Males;Average number of PLYL;10.63
Total;Ceuta;Endocrine, nutritional and metabolic diseases;Females;Number of PLYL;70.00
Total;Ceuta;Endocrine, nutritional and metabolic diseases;Females;Distribution by chapter of the CIE;4.55
Total;Ceuta;Endocrine, nutritional and metabolic diseases;Females;Standardised rate of PLYL;2.30
Total;Ceuta;Endocrine, nutritional and metabolic diseases;Females;Average number of PLYL;11.67
Total;Ceuta;Mental and behavioural disorders;Both sexes;Number of PLYL;45.00
Total;Ceuta;Mental and behavioural disorders;Both sexes;Distribution by chapter of the CIE;0.90
Total;Ceuta;Mental and behavioural disorders;Both sexes;Standardised rate of PLYL;0.61
Total;Ceuta;Mental and behavioural disorders;Both sexes;Average number of PLYL;11.25
Total;Ceuta;Mental and behavioural disorders;Males;Number of PLYL;42.50
Total;Ceuta;Mental and behavioural disorders;Males;Distribution by chapter of the CIE;1.22
Total;Ceuta;Mental and behavioural disorders;Males;Standardised rate of PLYL;1.13
Total;Ceuta;Mental and behavioural disorders;Males;Average number of PLYL;14.17
Total;Ceuta;Mental and behavioural disorders;Females;Number of PLYL;2.50
Total;Ceuta;Mental and behavioural disorders;Females;Distribution by chapter of the CIE;0.16
Total;Ceuta;Mental and behavioural disorders;Females;Standardised rate of PLYL;0.09
Total;Ceuta;Mental and behavioural disorders;Females;Average number of PLYL;2.50
Total;Ceuta;Diseases of the nervous system and the sense organs;Both sexes;Number of PLYL;140.00
Total;Ceuta;Diseases of the nervous system and the sense organs;Both sexes;Distribution by chapter of the CIE;2.80
Total;Ceuta;Diseases of the nervous system and the sense organs;Both sexes;Standardised rate of PLYL;2.03
Total;Ceuta;Diseases of the nervous system and the sense organs;Both sexes;Average number of PLYL;23.33
Total;Ceuta;Diseases of the nervous system and the sense organs;Males;Number of PLYL;117.50
Total;Ceuta;Diseases of the nervous system and the sense organs;Males;Distribution by chapter of the CIE;3.39
Total;Ceuta;Diseases of the nervous system and the sense organs;Males;Standardised rate of PLYL;3.12
Total;Ceuta;Diseases of the nervous system and the sense organs;Males;Average number of PLYL;39.17
Total;Ceuta;Diseases of the nervous system and the sense organs;Females;Number of PLYL;22.50
Total;Ceuta;Diseases of the nervous system and the sense organs;Females;Distribution by chapter of the CIE;1.46
Total;Ceuta;Diseases of the nervous system and the sense organs;Females;Standardised rate of PLYL;0.89
Total;Ceuta;Diseases of the nervous system and the sense organs;Females;Average number of PLYL;7.50
Total;Ceuta;Diseases of the circulatory system;Both sexes;Number of PLYL;835.00
Total;Ceuta;Diseases of the circulatory system;Both sexes;Distribution by chapter of the CIE;16.68
Total;Ceuta;Diseases of the circulatory system;Both sexes;Standardised rate of PLYL;12.93
Total;Ceuta;Diseases of the circulatory system;Both sexes;Average number of PLYL;11.28
Total;Ceuta;Diseases of the circulatory system;Males;Number of PLYL;570.00
Total;Ceuta;Diseases of the circulatory system;Males;Distribution by chapter of the CIE;16.43
Total;Ceuta;Diseases of the circulatory system;Males;Standardised rate of PLYL;16.24
Total;Ceuta;Diseases of the circulatory system;Males;Average number of PLYL;15.00
Total;Ceuta;Diseases of the circulatory system;Females;Number of PLYL;265.00
Total;Ceuta;Diseases of the circulatory system;Females;Distribution by chapter of the CIE;17.24
Total;Ceuta;Diseases of the circulatory system;Females;Standardised rate of PLYL;9.51
Total;Ceuta;Diseases of the circulatory system;Females;Average number of PLYL;7.36
Total;Ceuta;Diseases of the respiratory system;Both sexes;Number of PLYL;492.50
Total;Ceuta;Diseases of the respiratory system;Both sexes;Distribution by chapter of the CIE;9.84
Total;Ceuta;Diseases of the respiratory system;Both sexes;Standardised rate of PLYL;7.72
Total;Ceuta;Diseases of the respiratory system;Both sexes;Average number of PLYL;13.31
Total;Ceuta;Diseases of the respiratory system;Males;Number of PLYL;465.00
Total;Ceuta;Diseases of the respiratory system;Males;Distribution by chapter of the CIE;13.40
Total;Ceuta;Diseases of the respiratory system;Males;Standardised rate of PLYL;14.08
Total;Ceuta;Diseases of the respiratory system;Males;Average number of PLYL;14.53
Total;Ceuta;Diseases of the respiratory system;Females;Number of PLYL;27.50
Total;Ceuta;Diseases of the respiratory system;Females;Distribution by chapter of the CIE;1.79
Total;Ceuta;Diseases of the respiratory system;Females;Standardised rate of PLYL;1.06
Total;Ceuta;Diseases of the respiratory system;Females;Average number of PLYL;5.50
Total;Ceuta;Diseases of the digestive system;Both sexes;Number of PLYL;287.50
Total;Ceuta;Diseases of the digestive system;Both sexes;Distribution by chapter of the CIE;5.74
Total;Ceuta;Diseases of the digestive system;Both sexes;Standardised rate of PLYL;4.21
Total;Ceuta;Diseases of the digestive system;Both sexes;Average number of PLYL;19.17
Total;Ceuta;Diseases of the digestive system;Males;Number of PLYL;172.50
Total;Ceuta;Diseases of the digestive system;Males;Distribution by chapter of the CIE;4.97
Total;Ceuta;Diseases of the digestive system;Males;Standardised rate of PLYL;4.88
Total;Ceuta;Diseases of the digestive system;Males;Average number of PLYL;15.68
Total;Ceuta;Diseases of the digestive system;Females;Number of PLYL;115.00
Total;Ceuta;Diseases of the digestive system;Females;Distribution by chapter of the CIE;7.48
Total;Ceuta;Diseases of the digestive system;Females;Standardised rate of PLYL;3.51
Total;Ceuta;Diseases of the digestive system;Females;Average number of PLYL;28.75
Total;Ceuta;Diseases of the skin and subcutaneous tissue;Both sexes;Number of PLYL;15.00
Total;Ceuta;Diseases of the skin and subcutaneous tissue;Both sexes;Distribution by chapter of the CIE;0.30
Total;Ceuta;Diseases of the skin and subcutaneous tissue;Both sexes;Standardised rate of PLYL;0.29
Total;Ceuta;Diseases of the skin and subcutaneous tissue;Both sexes;Average number of PLYL;7.50
Total;Ceuta;Diseases of the skin and subcutaneous tissue;Males;Number of PLYL;7.50
Total;Ceuta;Diseases of the skin and subcutaneous tissue;Males;Distribution by chapter of the CIE;0.22
Total;Ceuta;Diseases of the skin and subcutaneous tissue;Males;Standardised rate of PLYL;0.29
Total;Ceuta;Diseases of the skin and subcutaneous tissue;Males;Average number of PLYL;7.50
Total;Ceuta;Diseases of the skin and subcutaneous tissue;Females;Number of PLYL;7.50
Total;Ceuta;Diseases of the skin and subcutaneous tissue;Females;Distribution by chapter of the CIE;0.49
Total;Ceuta;Diseases of the skin and subcutaneous tissue;Females;Standardised rate of PLYL;0.29
Total;Ceuta;Diseases of the skin and subcutaneous tissue;Females;Average number of PLYL;7.50
Total;Ceuta;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Number of PLYL;50.00
Total;Ceuta;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Distribution by chapter of the CIE;1.00
Total;Ceuta;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Standardised rate of PLYL;0.72
Total;Ceuta;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Average number of PLYL;25.00
Total;Ceuta;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Number of PLYL;..
Total;Ceuta;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Distribution by chapter of the CIE;..
Total;Ceuta;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Standardised rate of PLYL;..
Total;Ceuta;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Average number of PLYL;..
Total;Ceuta;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Number of PLYL;50.00
Total;Ceuta;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Distribution by chapter of the CIE;3.25
Total;Ceuta;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Standardised rate of PLYL;1.49
Total;Ceuta;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Average number of PLYL;25.00
Total;Ceuta;Diseases of the genitourinary system;Both sexes;Number of PLYL;152.50
Total;Ceuta;Diseases of the genitourinary system;Both sexes;Distribution by chapter of the CIE;3.05
Total;Ceuta;Diseases of the genitourinary system;Both sexes;Standardised rate of PLYL;2.67
Total;Ceuta;Diseases of the genitourinary system;Both sexes;Average number of PLYL;11.73
Total;Ceuta;Diseases of the genitourinary system;Males;Number of PLYL;57.50
Total;Ceuta;Diseases of the genitourinary system;Males;Distribution by chapter of the CIE;1.66
Total;Ceuta;Diseases of the genitourinary system;Males;Standardised rate of PLYL;2.22
Total;Ceuta;Diseases of the genitourinary system;Males;Average number of PLYL;8.21
Total;Ceuta;Diseases of the genitourinary system;Females;Number of PLYL;95.00
Total;Ceuta;Diseases of the genitourinary system;Females;Distribution by chapter of the CIE;6.18
Total;Ceuta;Diseases of the genitourinary system;Females;Standardised rate of PLYL;3.17
Total;Ceuta;Diseases of the genitourinary system;Females;Average number of PLYL;15.83
Total;Ceuta;Pregnancy, childbirth and the puerperium;Both sexes;Number of PLYL;42.50
Total;Ceuta;Pregnancy, childbirth and the puerperium;Both sexes;Distribution by chapter of the CIE;0.85
Total;Ceuta;Pregnancy, childbirth and the puerperium;Both sexes;Standardised rate of PLYL;0.58
Total;Ceuta;Pregnancy, childbirth and the puerperium;Both sexes;Average number of PLYL;42.50
Total;Ceuta;Pregnancy, childbirth and the puerperium;Males;Number of PLYL;..
Total;Ceuta;Pregnancy, childbirth and the puerperium;Males;Distribution by chapter of the CIE;..
Total;Ceuta;Pregnancy, childbirth and the puerperium;Males;Standardised rate of PLYL;..
Total;Ceuta;Pregnancy, childbirth and the puerperium;Males;Average number of PLYL;..
Total;Ceuta;Pregnancy, childbirth and the puerperium;Females;Number of PLYL;42.50
Total;Ceuta;Pregnancy, childbirth and the puerperium;Females;Distribution by chapter of the CIE;2.77
Total;Ceuta;Pregnancy, childbirth and the puerperium;Females;Standardised rate of PLYL;1.19
Total;Ceuta;Pregnancy, childbirth and the puerperium;Females;Average number of PLYL;42.50
Total;Ceuta;Affections originated in the perinatal period;Both sexes;Number of PLYL;..
Total;Ceuta;Affections originated in the perinatal period;Both sexes;Distribution by chapter of the CIE;..
Total;Ceuta;Affections originated in the perinatal period;Both sexes;Standardised rate of PLYL;..
Total;Ceuta;Affections originated in the perinatal period;Both sexes;Average number of PLYL;..
Total;Ceuta;Affections originated in the perinatal period;Males;Number of PLYL;..
Total;Ceuta;Affections originated in the perinatal period;Males;Distribution by chapter of the CIE;..
Total;Ceuta;Affections originated in the perinatal period;Males;Standardised rate of PLYL;..
Total;Ceuta;Affections originated in the perinatal period;Males;Average number of PLYL;..
Total;Ceuta;Affections originated in the perinatal period;Females;Number of PLYL;..
Total;Ceuta;Affections originated in the perinatal period;Females;Distribution by chapter of the CIE;..
Total;Ceuta;Affections originated in the perinatal period;Females;Standardised rate of PLYL;..
Total;Ceuta;Affections originated in the perinatal period;Females;Average number of PLYL;..
Total;Ceuta;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Number of PLYL;..
Total;Ceuta;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Distribution by chapter of the CIE;..
Total;Ceuta;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Standardised rate of PLYL;..
Total;Ceuta;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Average number of PLYL;..
Total;Ceuta;Congenital malformations, deformities and chromosomal abnormalities;Males;Number of PLYL;..
Total;Ceuta;Congenital malformations, deformities and chromosomal abnormalities;Males;Distribution by chapter of the CIE;..
Total;Ceuta;Congenital malformations, deformities and chromosomal abnormalities;Males;Standardised rate of PLYL;..
Total;Ceuta;Congenital malformations, deformities and chromosomal abnormalities;Males;Average number of PLYL;..
Total;Ceuta;Congenital malformations, deformities and chromosomal abnormalities;Females;Number of PLYL;..
Total;Ceuta;Congenital malformations, deformities and chromosomal abnormalities;Females;Distribution by chapter of the CIE;..
Total;Ceuta;Congenital malformations, deformities and chromosomal abnormalities;Females;Standardised rate of PLYL;..
Total;Ceuta;Congenital malformations, deformities and chromosomal abnormalities;Females;Average number of PLYL;..
Total;Ceuta;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Number of PLYL;180.00
Total;Ceuta;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Distribution by chapter of the CIE;3.59
Total;Ceuta;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Standardised rate of PLYL;2.61
Total;Ceuta;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Average number of PLYL;15.00
Total;Ceuta;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Number of PLYL;100.00
Total;Ceuta;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Distribution by chapter of the CIE;2.88
Total;Ceuta;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Standardised rate of PLYL;2.58
Total;Ceuta;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Average number of PLYL;25.00
Total;Ceuta;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Number of PLYL;80.00
Total;Ceuta;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Distribution by chapter of the CIE;5.20
Total;Ceuta;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Standardised rate of PLYL;2.61
Total;Ceuta;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Average number of PLYL;10.00
Total;Ceuta;External causes of mortality;Both sexes;Number of PLYL;607.00
Total;Ceuta;External causes of mortality;Both sexes;Distribution by chapter of the CIE;12.12
Total;Ceuta;External causes of mortality;Both sexes;Standardised rate of PLYL;7.93
Total;Ceuta;External causes of mortality;Both sexes;Average number of PLYL;35.71
Total;Ceuta;External causes of mortality;Males;Number of PLYL;530.00
Total;Ceuta;External causes of mortality;Males;Distribution by chapter of the CIE;15.27
Total;Ceuta;External causes of mortality;Males;Standardised rate of PLYL;14.30
Total;Ceuta;External causes of mortality;Males;Average number of PLYL;33.13
Total;Ceuta;External causes of mortality;Females;Number of PLYL;77.00
Total;Ceuta;External causes of mortality;Females;Distribution by chapter of the CIE;5.01
Total;Ceuta;External causes of mortality;Females;Standardised rate of PLYL;1.36
Total;Ceuta;External causes of mortality;Females;Average number of PLYL;77.00
Total;Melilla;All causes;Both sexes;Number of PLYL;3,169.00
Total;Melilla;All causes;Both sexes;Distribution by chapter of the CIE;100.00
Total;Melilla;All causes;Both sexes;Standardised rate of PLYL;52.18
Total;Melilla;All causes;Both sexes;Average number of PLYL;14.81
Total;Melilla;All causes;Males;Number of PLYL;2,085.00
Total;Melilla;All causes;Males;Distribution by chapter of the CIE;100.00
Total;Melilla;All causes;Males;Standardised rate of PLYL;69.27
Total;Melilla;All causes;Males;Average number of PLYL;15.80
Total;Melilla;All causes;Females;Number of PLYL;1,084.00
Total;Melilla;All causes;Females;Distribution by chapter of the CIE;100.00
Total;Melilla;All causes;Females;Standardised rate of PLYL;34.79
Total;Melilla;All causes;Females;Average number of PLYL;13.22
Total;Melilla;Infectious and parasitic diseases (1);Both sexes;Number of PLYL;67.50
Total;Melilla;Infectious and parasitic diseases (1);Both sexes;Distribution by chapter of the CIE;2.13
Total;Melilla;Infectious and parasitic diseases (1);Both sexes;Standardised rate of PLYL;1.44
Total;Melilla;Infectious and parasitic diseases (1);Both sexes;Average number of PLYL;7.50
Total;Melilla;Infectious and parasitic diseases (1);Males;Number of PLYL;50.00
Total;Melilla;Infectious and parasitic diseases (1);Males;Distribution by chapter of the CIE;2.40
Total;Melilla;Infectious and parasitic diseases (1);Males;Standardised rate of PLYL;2.14
Total;Melilla;Infectious and parasitic diseases (1);Males;Average number of PLYL;8.33
Total;Melilla;Infectious and parasitic diseases (1);Females;Number of PLYL;17.50
Total;Melilla;Infectious and parasitic diseases (1);Females;Distribution by chapter of the CIE;1.61
Total;Melilla;Infectious and parasitic diseases (1);Females;Standardised rate of PLYL;0.75
Total;Melilla;Infectious and parasitic diseases (1);Females;Average number of PLYL;5.83
Total;Melilla;Tumours;Both sexes;Number of PLYL;1,154.50
Total;Melilla;Tumours;Both sexes;Distribution by chapter of the CIE;36.43
Total;Melilla;Tumours;Both sexes;Standardised rate of PLYL;18.06
Total;Melilla;Tumours;Both sexes;Average number of PLYL;16.98
Total;Melilla;Tumours;Males;Number of PLYL;682.50
Total;Melilla;Tumours;Males;Distribution by chapter of the CIE;32.73
Total;Melilla;Tumours;Males;Standardised rate of PLYL;22.02
Total;Melilla;Tumours;Males;Average number of PLYL;16.65
Total;Melilla;Tumours;Females;Number of PLYL;472.00
Total;Melilla;Tumours;Females;Distribution by chapter of the CIE;43.54
Total;Melilla;Tumours;Females;Standardised rate of PLYL;13.94
Total;Melilla;Tumours;Females;Average number of PLYL;17.48
Total;Melilla;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Number of PLYL;2.50
Total;Melilla;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Distribution by chapter of the CIE;0.08
Total;Melilla;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Standardised rate of PLYL;0.05
Total;Melilla;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Both sexes;Average number of PLYL;2.50
Total;Melilla;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Number of PLYL;..
Total;Melilla;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Distribution by chapter of the CIE;..
Total;Melilla;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Standardised rate of PLYL;..
Total;Melilla;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Males;Average number of PLYL;..
Total;Melilla;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Number of PLYL;2.50
Total;Melilla;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Distribution by chapter of the CIE;0.23
Total;Melilla;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Standardised rate of PLYL;0.10
Total;Melilla;Diseases of the blood and haematopoeitic organs, and certain disorders affecting the immune system;Females;Average number of PLYL;2.50
Total;Melilla;Endocrine, nutritional and metabolic diseases;Both sexes;Number of PLYL;227.50
Total;Melilla;Endocrine, nutritional and metabolic diseases;Both sexes;Distribution by chapter of the CIE;7.18
Total;Melilla;Endocrine, nutritional and metabolic diseases;Both sexes;Standardised rate of PLYL;4.05
Total;Melilla;Endocrine, nutritional and metabolic diseases;Both sexes;Average number of PLYL;13.38
Total;Melilla;Endocrine, nutritional and metabolic diseases;Males;Number of PLYL;167.50
Total;Melilla;Endocrine, nutritional and metabolic diseases;Males;Distribution by chapter of the CIE;8.03
Total;Melilla;Endocrine, nutritional and metabolic diseases;Males;Standardised rate of PLYL;5.51
Total;Melilla;Endocrine, nutritional and metabolic diseases;Males;Average number of PLYL;15.23
Total;Melilla;Endocrine, nutritional and metabolic diseases;Females;Number of PLYL;60.00
Total;Melilla;Endocrine, nutritional and metabolic diseases;Females;Distribution by chapter of the CIE;5.54
Total;Melilla;Endocrine, nutritional and metabolic diseases;Females;Standardised rate of PLYL;2.58
Total;Melilla;Endocrine, nutritional and metabolic diseases;Females;Average number of PLYL;10.00
Total;Melilla;Mental and behavioural disorders;Both sexes;Number of PLYL;15.00
Total;Melilla;Mental and behavioural disorders;Both sexes;Distribution by chapter of the CIE;0.47
Total;Melilla;Mental and behavioural disorders;Both sexes;Standardised rate of PLYL;0.33
Total;Melilla;Mental and behavioural disorders;Both sexes;Average number of PLYL;7.50
Total;Melilla;Mental and behavioural disorders;Males;Number of PLYL;7.50
Total;Melilla;Mental and behavioural disorders;Males;Distribution by chapter of the CIE;0.36
Total;Melilla;Mental and behavioural disorders;Males;Standardised rate of PLYL;0.34
Total;Melilla;Mental and behavioural disorders;Males;Average number of PLYL;7.50
Total;Melilla;Mental and behavioural disorders;Females;Number of PLYL;7.50
Total;Melilla;Mental and behavioural disorders;Females;Distribution by chapter of the CIE;0.69
Total;Melilla;Mental and behavioural disorders;Females;Standardised rate of PLYL;0.33
Total;Melilla;Mental and behavioural disorders;Females;Average number of PLYL;7.50
Total;Melilla;Diseases of the nervous system and the sense organs;Both sexes;Number of PLYL;15.00
Total;Melilla;Diseases of the nervous system and the sense organs;Both sexes;Distribution by chapter of the CIE;0.47
Total;Melilla;Diseases of the nervous system and the sense organs;Both sexes;Standardised rate of PLYL;0.32
Total;Melilla;Diseases of the nervous system and the sense organs;Both sexes;Average number of PLYL;3.75
Total;Melilla;Diseases of the nervous system and the sense organs;Males;Number of PLYL;5.00
Total;Melilla;Diseases of the nervous system and the sense organs;Males;Distribution by chapter of the CIE;0.24
Total;Melilla;Diseases of the nervous system and the sense organs;Males;Standardised rate of PLYL;0.22
Total;Melilla;Diseases of the nervous system and the sense organs;Males;Average number of PLYL;2.50
Total;Melilla;Diseases of the nervous system and the sense organs;Females;Number of PLYL;10.00
Total;Melilla;Diseases of the nervous system and the sense organs;Females;Distribution by chapter of the CIE;0.92
Total;Melilla;Diseases of the nervous system and the sense organs;Females;Standardised rate of PLYL;0.42
Total;Melilla;Diseases of the nervous system and the sense organs;Females;Average number of PLYL;5.00
Total;Melilla;Diseases of the circulatory system;Both sexes;Number of PLYL;737.50
Total;Melilla;Diseases of the circulatory system;Both sexes;Distribution by chapter of the CIE;23.27
Total;Melilla;Diseases of the circulatory system;Both sexes;Standardised rate of PLYL;12.43
Total;Melilla;Diseases of the circulatory system;Both sexes;Average number of PLYL;12.94
Total;Melilla;Diseases of the circulatory system;Males;Number of PLYL;450.00
Total;Melilla;Diseases of the circulatory system;Males;Distribution by chapter of the CIE;21.58
Total;Melilla;Diseases of the circulatory system;Males;Standardised rate of PLYL;14.71
Total;Melilla;Diseases of the circulatory system;Males;Average number of PLYL;15.00
Total;Melilla;Diseases of the circulatory system;Females;Number of PLYL;287.50
Total;Melilla;Diseases of the circulatory system;Females;Distribution by chapter of the CIE;26.52
Total;Melilla;Diseases of the circulatory system;Females;Standardised rate of PLYL;10.13
Total;Melilla;Diseases of the circulatory system;Females;Average number of PLYL;10.65
Total;Melilla;Diseases of the respiratory system;Both sexes;Number of PLYL;210.00
Total;Melilla;Diseases of the respiratory system;Both sexes;Distribution by chapter of the CIE;6.63
Total;Melilla;Diseases of the respiratory system;Both sexes;Standardised rate of PLYL;4.12
Total;Melilla;Diseases of the respiratory system;Both sexes;Average number of PLYL;10.50
Total;Melilla;Diseases of the respiratory system;Males;Number of PLYL;192.50
Total;Melilla;Diseases of the respiratory system;Males;Distribution by chapter of the CIE;9.23
Total;Melilla;Diseases of the respiratory system;Males;Standardised rate of PLYL;7.47
Total;Melilla;Diseases of the respiratory system;Males;Average number of PLYL;11.32
Total;Melilla;Diseases of the respiratory system;Females;Number of PLYL;17.50
Total;Melilla;Diseases of the respiratory system;Females;Distribution by chapter of the CIE;1.61
Total;Melilla;Diseases of the respiratory system;Females;Standardised rate of PLYL;0.77
Total;Melilla;Diseases of the respiratory system;Females;Average number of PLYL;5.83
Total;Melilla;Diseases of the digestive system;Both sexes;Number of PLYL;75.00
Total;Melilla;Diseases of the digestive system;Both sexes;Distribution by chapter of the CIE;2.37
Total;Melilla;Diseases of the digestive system;Both sexes;Standardised rate of PLYL;1.35
Total;Melilla;Diseases of the digestive system;Both sexes;Average number of PLYL;9.38
Total;Melilla;Diseases of the digestive system;Males;Number of PLYL;50.00
Total;Melilla;Diseases of the digestive system;Males;Distribution by chapter of the CIE;2.40
Total;Melilla;Diseases of the digestive system;Males;Standardised rate of PLYL;1.57
Total;Melilla;Diseases of the digestive system;Males;Average number of PLYL;12.50
Total;Melilla;Diseases of the digestive system;Females;Number of PLYL;25.00
Total;Melilla;Diseases of the digestive system;Females;Distribution by chapter of the CIE;2.31
Total;Melilla;Diseases of the digestive system;Females;Standardised rate of PLYL;1.10
Total;Melilla;Diseases of the digestive system;Females;Average number of PLYL;6.25
Total;Melilla;Diseases of the skin and subcutaneous tissue;Both sexes;Number of PLYL;..
Total;Melilla;Diseases of the skin and subcutaneous tissue;Both sexes;Distribution by chapter of the CIE;..
Total;Melilla;Diseases of the skin and subcutaneous tissue;Both sexes;Standardised rate of PLYL;..
Total;Melilla;Diseases of the skin and subcutaneous tissue;Both sexes;Average number of PLYL;..
Total;Melilla;Diseases of the skin and subcutaneous tissue;Males;Number of PLYL;..
Total;Melilla;Diseases of the skin and subcutaneous tissue;Males;Distribution by chapter of the CIE;..
Total;Melilla;Diseases of the skin and subcutaneous tissue;Males;Standardised rate of PLYL;..
Total;Melilla;Diseases of the skin and subcutaneous tissue;Males;Average number of PLYL;..
Total;Melilla;Diseases of the skin and subcutaneous tissue;Females;Number of PLYL;..
Total;Melilla;Diseases of the skin and subcutaneous tissue;Females;Distribution by chapter of the CIE;..
Total;Melilla;Diseases of the skin and subcutaneous tissue;Females;Standardised rate of PLYL;..
Total;Melilla;Diseases of the skin and subcutaneous tissue;Females;Average number of PLYL;..
Total;Melilla;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Number of PLYL;7.50
Total;Melilla;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Distribution by chapter of the CIE;0.24
Total;Melilla;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Standardised rate of PLYL;0.17
Total;Melilla;Diseases of the osteomuscular system and of the conjunctive tissue;Both sexes;Average number of PLYL;7.50
Total;Melilla;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Number of PLYL;7.50
Total;Melilla;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Distribution by chapter of the CIE;0.36
Total;Melilla;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Standardised rate of PLYL;0.34
Total;Melilla;Diseases of the osteomuscular system and of the conjunctive tissue;Males;Average number of PLYL;7.50
Total;Melilla;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Number of PLYL;..
Total;Melilla;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Distribution by chapter of the CIE;..
Total;Melilla;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Standardised rate of PLYL;..
Total;Melilla;Diseases of the osteomuscular system and of the conjunctive tissue;Females;Average number of PLYL;..
Total;Melilla;Diseases of the genitourinary system;Both sexes;Number of PLYL;30.00
Total;Melilla;Diseases of the genitourinary system;Both sexes;Distribution by chapter of the CIE;0.95
Total;Melilla;Diseases of the genitourinary system;Both sexes;Standardised rate of PLYL;0.61
Total;Melilla;Diseases of the genitourinary system;Both sexes;Average number of PLYL;7.50
Total;Melilla;Diseases of the genitourinary system;Males;Number of PLYL;27.50
Total;Melilla;Diseases of the genitourinary system;Males;Distribution by chapter of the CIE;1.32
Total;Melilla;Diseases of the genitourinary system;Males;Standardised rate of PLYL;1.12
Total;Melilla;Diseases of the genitourinary system;Males;Average number of PLYL;9.17
Total;Melilla;Diseases of the genitourinary system;Females;Number of PLYL;2.50
Total;Melilla;Diseases of the genitourinary system;Females;Distribution by chapter of the CIE;0.23
Total;Melilla;Diseases of the genitourinary system;Females;Standardised rate of PLYL;0.10
Total;Melilla;Diseases of the genitourinary system;Females;Average number of PLYL;2.50
Total;Melilla;Pregnancy, childbirth and the puerperium;Both sexes;Number of PLYL;..
Total;Melilla;Pregnancy, childbirth and the puerperium;Both sexes;Distribution by chapter of the CIE;..
Total;Melilla;Pregnancy, childbirth and the puerperium;Both sexes;Standardised rate of PLYL;..
Total;Melilla;Pregnancy, childbirth and the puerperium;Both sexes;Average number of PLYL;..
Total;Melilla;Pregnancy, childbirth and the puerperium;Males;Number of PLYL;..
Total;Melilla;Pregnancy, childbirth and the puerperium;Males;Distribution by chapter of the CIE;..
Total;Melilla;Pregnancy, childbirth and the puerperium;Males;Standardised rate of PLYL;..
Total;Melilla;Pregnancy, childbirth and the puerperium;Males;Average number of PLYL;..
Total;Melilla;Pregnancy, childbirth and the puerperium;Females;Number of PLYL;..
Total;Melilla;Pregnancy, childbirth and the puerperium;Females;Distribution by chapter of the CIE;..
Total;Melilla;Pregnancy, childbirth and the puerperium;Females;Standardised rate of PLYL;..
Total;Melilla;Pregnancy, childbirth and the puerperium;Females;Average number of PLYL;..
Total;Melilla;Affections originated in the perinatal period;Both sexes;Number of PLYL;..
Total;Melilla;Affections originated in the perinatal period;Both sexes;Distribution by chapter of the CIE;..
Total;Melilla;Affections originated in the perinatal period;Both sexes;Standardised rate of PLYL;..
Total;Melilla;Affections originated in the perinatal period;Both sexes;Average number of PLYL;..
Total;Melilla;Affections originated in the perinatal period;Males;Number of PLYL;..
Total;Melilla;Affections originated in the perinatal period;Males;Distribution by chapter of the CIE;..
Total;Melilla;Affections originated in the perinatal period;Males;Standardised rate of PLYL;..
Total;Melilla;Affections originated in the perinatal period;Males;Average number of PLYL;..
Total;Melilla;Affections originated in the perinatal period;Females;Number of PLYL;..
Total;Melilla;Affections originated in the perinatal period;Females;Distribution by chapter of the CIE;..
Total;Melilla;Affections originated in the perinatal period;Females;Standardised rate of PLYL;..
Total;Melilla;Affections originated in the perinatal period;Females;Average number of PLYL;..
Total;Melilla;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Number of PLYL;77.00
Total;Melilla;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Distribution by chapter of the CIE;2.43
Total;Melilla;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Standardised rate of PLYL;0.64
Total;Melilla;Congenital malformations, deformities and chromosomal abnormalities;Both sexes;Average number of PLYL;77.00
Total;Melilla;Congenital malformations, deformities and chromosomal abnormalities;Males;Number of PLYL;..
Total;Melilla;Congenital malformations, deformities and chromosomal abnormalities;Males;Distribution by chapter of the CIE;..
Total;Melilla;Congenital malformations, deformities and chromosomal abnormalities;Males;Standardised rate of PLYL;..
Total;Melilla;Congenital malformations, deformities and chromosomal abnormalities;Males;Average number of PLYL;..
Total;Melilla;Congenital malformations, deformities and chromosomal abnormalities;Females;Number of PLYL;77.00
Total;Melilla;Congenital malformations, deformities and chromosomal abnormalities;Females;Distribution by chapter of the CIE;7.10
Total;Melilla;Congenital malformations, deformities and chromosomal abnormalities;Females;Standardised rate of PLYL;1.27
Total;Melilla;Congenital malformations, deformities and chromosomal abnormalities;Females;Average number of PLYL;77.00
Total;Melilla;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Number of PLYL;322.50
Total;Melilla;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Distribution by chapter of the CIE;10.18
Total;Melilla;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Standardised rate of PLYL;4.82
Total;Melilla;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Both sexes;Average number of PLYL;21.50
Total;Melilla;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Number of PLYL;240.00
Total;Melilla;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Distribution by chapter of the CIE;11.51
Total;Melilla;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Standardised rate of PLYL;7.01
Total;Melilla;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Males;Average number of PLYL;24.00
Total;Melilla;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Number of PLYL;82.50
Total;Melilla;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Distribution by chapter of the CIE;7.61
Total;Melilla;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Standardised rate of PLYL;2.61
Total;Melilla;Symptoms, signs and abnormal clinical and laboratory findings, not classified elsewhere (2);Females;Average number of PLYL;16.50
Total;Melilla;External causes of mortality;Both sexes;Number of PLYL;227.50
Total;Melilla;External causes of mortality;Both sexes;Distribution by chapter of the CIE;7.18
Total;Melilla;External causes of mortality;Both sexes;Standardised rate of PLYL;3.79
Total;Melilla;External causes of mortality;Both sexes;Average number of PLYL;32.50
Total;Melilla;External causes of mortality;Males;Number of PLYL;205.00
Total;Melilla;External causes of mortality;Males;Distribution by chapter of the CIE;9.83
Total;Melilla;External causes of mortality;Males;Standardised rate of PLYL;6.82
Total;Melilla;External causes of mortality;Males;Average number of PLYL;34.17
Total;Melilla;External causes of mortality;Females;Number of PLYL;22.50
Total;Melilla;External causes of mortality;Females;Distribution by chapter of the CIE;2.08
Total;Melilla;External causes of mortality;Females;Standardised rate of PLYL;0.71
Total;Melilla;External causes of mortality;Females;Average number of PLYL;22.50